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Abstract
Quantitative bio-analytical techniques that enable parallel measurements of large
numbers of biomolecules generate vast amounts of information for studying and
characterising biological systems. These analytical methods are commonly referred
to as omics technologies, and can be applied for measurements of e.g. mRNA tran-
script, protein or metabolite abundances in a biological sample.
The work presented in this thesis focuses on the application of multivariate pre-
diction models for modelling and analysis of biological data generated by omics
technologies. Omics data commonly contain up to tens of thousands of variables,
which are often both noisy and multicollinear. Multivariate statistical methods have
previously been shown to be valuable for visualisation and predictive modelling of
biological and chemical data with similar properties to omics data. In this the-
sis currently available multivariate modelling methods are used in new applications,
and new methods are developed to address some of the specific challenges associated
with modelling of biological data.
Three closely related areas of multivariate modelling of biological data are de-
scribed and demonstrated in this thesis. First, a multivariate projection method is
used in a novel application for predictive modelling between omics data sets, demon-
strating how data from two analytical sources can be integrated and modelled to-
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gether by exploring covariation patterns between the data sets. This approach is
exemplified by modelling of data from two studies, the first containing proteomic
and metabolic profiling data and the second containing transcriptomic and metabolic
profiling data. Second, a method for piecewise multivariate modelling of short time-
series data is developed and demonstrated by modelling of simulated data as well
as metabolic profiling data from a toxicity study, providing a new method for char-
acterisation of multivariate bio-analytical time-series data. Third, a kernel-based
method is developed and applied for non-linear multivariate prediction modelling
of omics data, addressing the specific challenge of modelling non-linear variation in
biological data.
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Table 1: Abbreviations
ANN Artificial Neural Network
a.u. Arbitrary Unit
cDNA Complementary DNA
CPMG Carr-Purcell-Meiboom-Gill
DA Discriminant Analysis
DNA Deoxyribonucleic Acid
DIGE Difference Gel Electrophoresis
K-OPLS Kernel-based OPLS
KNN K Nearest Neighbour
LV Latent Variable
MLR Multiple Linear Regression
mRNA Messenger RNA
MS Mass Spectrometry
NMR Nuclear Magnetic Resonance Spectroscopy
ODE Ordinary Differential Equation
OLS Ordinary Least Squares
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OPLS-DA OPLS Discriminant Analysis
O2PLS Bi-directional OPLS
PC-3 Prostatic Carcinoma -3 (Cell line)
PCA Principal Component Analysis
PCR Principal Component Regression
PLS Partial Least Squares
PLS-DA PLS Discriminant Analysis
PSA Prostate-Specific Antigen
QTOF Quadrupole-Time of Flight
RMSECV Root-Mean-Square Error of Cross-Validation
RMSEP Root-Mean-Square Error of Prediction
RNA Ribonucleic acid
SDS Sodium dodecyl sulfate
SIMCA Soft Independent Modelling of Class Analogies
SVD Singular Value Decomposition
SVM Support Vector Machine
TOF Time of Flight
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Notations
Table 2 contains a list of general notations used in the thesis, in places where addi-
tional variables are introduced, they are defined in the text. Variables representing
vectors are represented as bold lower-case letters and matrices as bold upper-case
letters.
Table 2: General notations
A Number of model components (scalar)
B Regression Coefficients [K ×M ]
E Residual matrix of X [N ×K]
F Residual matrix of Y [N ×M ]
K Number of input variables (scalar)
M Number of response variables (scalar)
N Number of observations (scalar)
T Score matrix [N ×A]
P Loading matrix [K ×A]
W Weight matrix [K ×A]
X Matrix of descriptor variables, of dimension [N ×K]
Y Matrix of response variables, of dimension [N ×M ]
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CHAPTER 1
INTRODUCTION
Omics technologies, e.g. transcriptomics, proteomics and metabonomics, provide
means for massively parallel measurements on biological systems. As a result of
increasing throughput in the analysis of samples, and the ability to quantitatively
measure thousands of variables in parallel for each sample, the application of com-
putational and statistical methods are essential for the analysis of the resulting
experimental data. The purpose of data analysis and modelling is to transform raw
data into useful information, and to generate knowledge of some properties of the
biological system. The concurrent developments in experimental and computational
methods are together providing the technology for advancing biological and medical
sciences, resulting for example in new ways for diagnosing and treating disease, as
well as for increasing the fundamental understanding of biological systems.
Biological systems possess some properties that in certain aspects make them
substantially different to many other areas where computational and statistical
methods are applied for data analysis. The biological system operates on multi-
ple scales, both in terms of organisational levels as well as in terms of spatial and
temporal scales. In analogy with the organisation of the biological system itself,
modelling of biological data can be carried out on many levels, ranging from mod-
elling of individual biochemical reactions to full organism responses to perturbations,
depending on the purpose and objective of the study. Biological systems generally
19
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have a high level of noise, which is reflected in experimental data, in addition to
the analytical inaccuracies introduced by the measurement technologies. The high
noise levels found in biological data are a limiting factor in the modelling. While
omics data are in most cases not directly suitable for detailed modelling of individ-
ual biochemical reactions, such data are valuable for high level modelling aimed at
characterising the state of a biological system, or for modelling and prediction of
the responses after for example a perturbation. The multivariate modelling methods
described in this thesis are aimed at using omics data to establish high-level models
of the biological systems under various conditions.
1.1 Scope of the thesis
The work presented here covers the application of multivariate prediction models for
modelling of high-dimensional bio-analytical data. Recently developed multivariate
methods have been employed in new applications for modelling of bio-analytical data
and new methods have been developed to address some specific challenges related
to modelling of bio-analytical data. Three related areas of biological data analysis
and modelling were investigated.
In the first part of the thesis it is demonstrated how multivariate projection
methods can be used to establish joint models of two high-dimensional omics data
sets. This type of model explores covariation patterns between the two data sets
in order to establish a predictive model, which integrates both the data sets. This
modelling approach was demonstrated and evaluated by assessing prediction results
of data from two separate studies with omics data. Integration of data from different
sources is an important part of analysis and modelling of biological data, especially
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in context where several omics platforms are applied in parallel for characterisation
of the same biological system. Being able to model data from multiple sources in
the same model has the potential to improve predictive models and improve inter-
pretation. An application of specific interest is to establish how data from different
biological organisation levels are covarying with each other, and to determine the
amount of variation shared between them, and the amount of variation unique to
each one of them.
The second part of the thesis is focused on prediction modelling of high-dimensional
time-series data with few time-points, which are common data characteristics in
omics and systems biology studies. A method based on piecewise multivariate mod-
elling of short time-series data is proposed and demonstrated on simulated data
as well as metabolic profiling data from a toxicology study. The piecewise multi-
variate method provides a model with both descriptive and predictive properties
and is suitable for modelling of high-dimensional biological data with multicollinear
variables. Measuring biological systems over time can provide information about dy-
namic properties of the system as well as characterisation of different time-related
states of the system. Objectives of studies where time-related data is collected are for
example monitoring of disease progression over time or to study the effect of a pertur-
bation over time. Omics-based analytical technologies render time-series data with
many thousands of measured variables, while the sampling in the time-direction is
usually performed with a relatively low frequency in comparison to molecular events
that are taking place. This creates a series of snapshots of the state of the biological
system at the discrete time-points sampled, rather than continuous measurements in
the time-dimension. Models describing the time-related events also provide means
for prediction of the time-state based upon a snapshot measurement of the biolog-
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ical system. This type of prediction model can be used for prediction of stages of
disease, or potentially for modelling of the efficacy of a disease intervention. The
proposed method is able to model variation that is non-linearly related to time, it
possesses predictive capabilities and provides a model framework that can be easily
interpreted in terms of the original descriptor variables.
In the third part of the thesis, a novel kernel-based algorithm is introduced and
demonstrated, addressing the specific challenge of modelling non-linear variation
structures in biological data. Non-linear variation patterns are common in biologi-
cal data, and when prediction performance is the main objective, models handling
non-linear variation have the potential to improve prediction results significantly.
Linear multivariate models have a great strength in providing transparent models,
which facilitates interpretation. In most cases, they also provide good prediction
performance. However, in some cases it is essential to utilise non-linear models to
achieve optimal prediction performance. Kernel-based methods have previously been
successful for this purpose; common examples of kernel-based methods are Support
Vector Machines (SVM) and Kernel-Partial Least Squares regression (Kernel-PLS).
The new method described here, Kernel-based Orthogonal Projections to Latent
Structures (K-OPLS), is an extension of the linear Orthogonal Projections to Latent
Structures (OPLS) method that enables non-linear modelling, while maintaining the
benefits of the OPLS method. The kernel-based OPLS algorithm was developed to
allow non-linear regression and discriminant analysis for applications where the pre-
dictive performance takes priority over model interpretation compared to the linear
case. However, compared to other kernel-based methods, the K-OPLS has proper-
ties that provide improved interpretation. By separating the modelling of covarying
and orthogonal variation, these two types of systematic variation in the data can be
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interpreted separately, which potentially improves the interpretation and provides
additional information. In the case of discriminant analysis, the method also has
the potential to improve prediction further if the amount of within-class variation
differs between the classes. The K-OPLS method is demonstrated by modelling of
simulated data as well as metabolic profiling data.
Common to the three areas of multivariate data analysis that are presented here
are the focus on predictive models and transparent models, i.e. models that have
properties that also enable interpretation. The thesis is organised as outlined in Fig-
ure 1.1. Chapter 2 and 3 introduces related work and provide relevant background
information relating to the work presented in this thesis, Chapters 4 - 6 contain the
main results and findings and Chapter 7 contains general conclusions and outlines
future directions.
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Figure 1.1: Overview of the structure of the thesis and how the chapters are related
to each other.
CHAPTER 2
BACKGROUND
In this chapter, an introduction is first given to post-genomic (omics) biology and to
systems biology, followed by an introduction to some of the most common analytical
platforms used in experimental work in these fields. The latter part of this chapter
gives an overview of data analysis methods used for analyses of omics data, and the
ideas behind multivariate data analysis are outlined.
The omics technologies include analytical platforms for collecting data from a
number of the so-called ‘Omes’, for example the genome, transcriptome, proteome
and metabolome. Common properties of these analytical techniques are that they
are quantitative∗ rather than qualitative and that the measurements are made in
parallel so that a high number of bio-molecules are quantified at the same time,
rather than one by one, resulting in the generation of large amounts of quantitative
data. I refer to the term quantitative in the relative sense throughout this thesis, i.e.
relative in the between-sample sense, but not necessarily quantitative in the absolute
sense, as in quantification of actual concentrations of individual bio-molecules in a
sample.
The procedures used for collecting samples to be profiled by currently available
∗ It should be noted that some analytical technologies used in omics studies are not strictly quan-
titative by default. Some methods may only be semi-quantitative, or require estimation of e.g.
calibration curves to achieve quantitative results.
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omics-based methods are often invasive to the biological system, putting constraints
on how samples can be collected. Another limitation of the omics methods is that
the resulting data commonly have relatively low sensitivity and high noise levels.
Despite these shortcomings, the omics technologies provide immense benefits by
enabling acquisition of data from a high number of different bio-molecules in parallel.
A limitation of most of the commonly used analytical methods is the inability to
perform measurements on the single cell level, reducing the potential for acquiring
data to facilitate modelling of dynamic behaviour in the biological system on a
pathway level. A sample is instead most commonly made up of a high number of
cells, of potentially different types. The result is that the sample analysed may be
a mixture of multiple cell types or tissues, making it harder to model and interpret
the resulting data. However, recent advancements have been made towards single
cell measurements of proteins1, 2, mRNA transcripts3 and metabolites4.
Systems biology 5, 6, 7, 8, 9 is a field of biological sciences concerned with system
level studies of biological organisms. Systems biology differentiates in its approach
compared to other branches of biological science in that it aims to study and de-
scribe biological processes from a systems perspective rather than by a reductionist
approach, which has been, and to some extent still is, the convention in for example
molecular biology. The sequencing of the full genomes from a range of organisms,
including the human genome10, 11, have immensely increased the information avail-
able on the genetic level. The genome information provides the blueprint of the
biological system, but does not describe how all the parts of the system fit together,
how they function or what their properties are. The aim of systems biology is to
study and model biological organisms at the systems level, by integrating data from
multiple sources in order to understand the system as a whole. Due to the com-
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plexity and the amount of data generated from omics biology and systems biology
studies, an essential part of these areas of biology is the computational and statis-
tical modelling of the data. The only way to understand and visualise the results is
to employ various types of data analysis methods that can help in turning the raw
data into meaningful information about the biological system.
2.1 Introduction to bio-analytical technologies
The advancements of analytical technologies have been essential for the develop-
ment of systems biology and other areas of quantitative biology. The bio-molecules
measured by means of omics technologies have very different physical properties,
therefore a number of different technology platforms are needed to accomplish quan-
titative measurements of the different categories of molecules. Worth noting is that
different analytical platforms have different strengths and weaknesses in terms of
sensitivity, noise and information content. For example, the microarray platform
enables measurement of the complete set of known mRNA transcripts in a sample,
and is consequently information rich in the aspect of the number of biomolecules
that are measured. However, the ability to detect small changes in individual mRNA
transcript abundances is quite poor for microarray-based transcriptomic profiling
technologies and noise levels are relatively high. The situation is different for Nu-
clear Magnetic Resonance (NMR) spectroscopy for metabolic profiling, where the
sensitivity is low, but the ability to quantify small changes accurately and with a low
noise level is rather good. In this case, the information content is restricted to the
limited number of molecules that can be detected, but the quantitative information
is relatively high. An alternative to NMR spectroscopy for metabolic profiling is
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chromatography-coupled Mass Spectrometry. Mass Spectrometry provides a much
higher sensitivity compared to NMR, but has instead poorer quantitative perfor-
mance and a higher level of noise.
In the case of transcriptomics, most available analytical platforms are based on
microarray technology, making differences in performance minor. In comparison, in
the field of metabolic profiling there are several technology platforms available with
fundamentally different characteristics, making a correct choice of platform more
important and open for consideration depending on the application area of interest.
The three most prominent areas in omics biology, transcriptomics, proteomics
and metabolic profiling, are described in the following sections, while the experi-
mental details related to the data sets analysed in Chapters 4-6 are briefly described
in each one of those chapters.
2.1.1 Transcriptomics
The set of all mRNA transcripts is usually referred to as the transcriptome, and
the omics field concerned with measuring transcript levels is usually referred to as
transcriptomics. The abundance of individual mRNA transcripts is directly linked
to gene-activity. Microarray12 technology is the most commonly applied transcrip-
tomic technology. A number of different microarray platforms are available, based
on slightly different principles. In general, the principle behind microarrays is based
on hybridisation of labelled cDNA to the microarray, which is made up of a high
number of spots in a grid layout, Figure 2.1 shows an image of an cDNA microarray.
Each spot on the microarray matches one gene in the genome, and contain probes,
i.e. DNA strands attached to the surface of the microarray slide, which are com-
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plementary in sequence to the labelled cDNA originating from the mRNA for one
particular gene. The extracted mRNA, which is reverse transcribed into cDNA, is
labelled using a fluorescent marker, and thereafter, hybridised onto the microarray.
The amount of mRNA from a particular gene is reflected by the amount hybridised
to the spot that is complementary to that gene. A laser-based scanner is used to
read the fluorescence intensity of each spot on the array, providing a quantitative
measurement of the abundance of each mRNA transcript in the sample analysed.
In some microarray-based platforms, such as cDNA and various oligo-DNA based
ones, the ratio in signal intensity between a sample and a reference is measured
by labelling them with two different fluorescent dyes. Other microarray platforms,
such as Affymetrix13, hybridise only the sample itself and measure the signal inten-
sity corresponding to the mRNA expression level from each gene directly. Recently
transcriptomic measurements by sequencing have also been demonstrated, which is
a result of the emergence of more efficient DNA sequencers14, 15.
2.1.2 Proteomics
Proteomics16 is an omics field focused on parallel quantification of multiple protein
abundances in biological samples. The most commonly applied technology is based
on two-dimensional (2D)-gel electrophoresis17, 18 combined with mass spectrometry19.
In the case of 2D-gel based proteomics, mass spectrometry is commonly used to
identify the proteins, while the quantification of the proteins is based on the 2D-gel.
Depending on the technology platform used, different levels of information can be
acquired. Most commonly, information is collected about the protein identity, based
on its sequence, while post-translational modifications such as phosphorylation can-
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Figure 2.1: Example of a cDNA microarray image, each spot on the image represent
the expression level of one gene. (Image courtesy of Åsa Hedman, Imperial College
London.)
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not be detected. Since post-translational modification of proteins are closely linked
to protein activity, the characterisation and measurements by proteomic technolo-
gies are largely limited to measurement of protein abundance rather than protein
activity. Non gel-based technology platforms applied in the field of proteomics, such
as Isotope-Coded Affinity Tags (ICAT) and Immobilized Metal Ion Affinity Chro-
matography (IMAC) were reviewed by Roe and Griffin20 and a general review of
assay-based proteomics methods was produced by Panicker21. Data acquired by 2D
Differential Gel Electrophoresis (2D-DIGE) is analysed in Chapter 4, therefore this
particular methodology is described in further detail in the following section.
Fluorescence 2D Differential Gel Electrophoresis (2D-DIGE)
Fluorescence 2D Differential Gel Electrophoresis (2D-DIGE) is a technology applied
in proteomics for differentiating and quantifying proteins. The principle behind 2D-
DIGE is based on measuring the relative fluorescence signal intensity between two
(or more) protein samples labelled by different fluorescent tags and separated on the
same 2D-gel. The first step involves labelling of the two samples (reference and test
sample), before they are pooled and thereafter separated by 2D gel electrophoresis.
The first dimension is isoelectric focusing, which separates proteins based on their
isoelectric point (pI), and the second dimension is a SDS-polyacrylamide gel, which
separates proteins based on their molecular weight (MW). Subsequently, the two
different fluorescent dyes are measured by a scanner, and a relative abundance for
each spot on the gel is acquired after automated image processing. An example of
a 2D-DIGE gel can be seen in Figure 2.2. Subsequently, the protein spots may be
annotated by application of mass spectrometry and database search against known
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protein mass-spectra profiles.
Figure 2.2: A typical example of a proteomics 2D gel of a blood plasma sample22.
2.1.3 Metabonomics
Parallel measurements of small molecules, metabolites, in biological samples are
commonly referred to as metabolic profiling, the terms ‘metabonomics’23 and ‘metabo-
lomics’24 are also commonly used. Nicholson25 define metabonomics as ‘The quan-
titative measurement of the multiparametric time-related metabolic responses of a
complex (multicellular) system to a pathophysiological intervention or genetic mod-
ification.’, and metabolomics as ‘The comprehensive quantitative analysis of all the
metabolites of an organism or specified biological sample.’25, thus making a distinc-
tion between the two.
Chapter 2. Background 33
Metabolic profiling is an omics science aimed at quantifying metabolite abun-
dances for a large set of metabolites in a biological sample. Metabolites play an im-
portant role in the biological system as they often are the most ‘downstream’ effect
of ‘upstream’ events in the biological system, e.g. on the gene regulation or protein
level. Metabolic profiling also provides an opportunity to measure some aspects of
the biological system relatively non-invasively compared to e.g. transcriptomic and
proteomic methods. While for example gene expression studies (transcriptomics)
rely on having cell or tissue samples from which messenger RNA (mRNA) can be
extracted, metabolic profiling can be applied for analysis of a variety of bio-fluids
that can be extracted more easily. Common examples of such bio-fluids are urine
and blood plasma samples, which can both be collected with a minimally invasive
procedure. Bio-fluids from mammalian animals are also expected to contain infor-
mation that is a result of the biological system as a whole, and therefore valuable
for diagnostic purposes.
Metabolic profiling can be based upon a number of analytical platforms; exam-
ples include Near Infrared Spectroscopy (NIR), Mass Spectrometry (MS), Capillary
Electrophoresis Mass Spectrometry (CE-MS) and NMR. See Dunn and Ellis26 for a
review of commonly used analytical platforms and their applications in metabolic
profiling. NMR-based metabolic profiling has been applied to generate the data
that are modelled in the following chapters and is described briefly in the following
section.
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Nuclear Magnetic Resonance (NMR) spectroscopy
NMR spectroscopy utilises the quantum magnetical properties of the nuclei of atoms
for detection and measurement of molecules in fluid or solid samples. A NMR spec-
trum is acquired by exposing the sample to an external and static magnetic field,
forcing the magnetic momentum of the nuclei with a net spin to align with or against
the direction of the external field. The sample is thereafter pulsed with transient
radio frequency pulses, resulting in the perturbation of the alignment of the nuclei,
this perturbation is detected as a current induced in a coil surrounding the sample.
Four main properties of NMR spectra can be easily utilised to generate structural
and quantitative information on particular molecules, namely; chemical shift, peak
intensity, spin-spin coupling and the relaxation time constant. The chemical shift is
an effect of shielding due to the local electron density of a nucleus, and is indicated
in the spectrum by the position of a peak on the chemical shift scale along the ab-
scissa. The local variations in chemical environment are due to a varying amount
of shielding effect from surrounding electrons, effectively exposing the different nu-
cleus, to slightly different strength of the magnetic component of the external radio
frequency pulse. The peak intensity provides quantitative information on metabo-
lites present in the NMR spectra, the integral of a single peak or multiplet being
proportional to the concentration of nuclei of the molecule that give rise to the
peak. Peak multiplicity, e.g. doublet, triplet or quartet peak patterns, are the ef-
fect of spin-spin coupling between nuclei. Spin-spin coupling occurs as neighbouring
(non-equivalent) nuclei exert a small magnetic influence on each other, leading to a
splitting pattern of peaks in the spectrum. Relaxation is the process in which the
excited nuclei are returning to their equilibrium states. Relaxation that take place
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due to spin-lattice relaxation (interaction with the surrounding environment that
the nuclei are contained in) is called T 1 relaxation. Relaxation due to interaction
with neighbouring nuclei is called the T 2 relaxation process (spin-spin relaxation).
Proton NMR is a commonly applied analytical technology for metabolic profil-
ing. In the application of NMR to metabolic profiling, a complex mixture (e.g. a
bio-fluid) of molecules (metabolites) are analysed, resulting in a quantitative rep-
resentation of the detectable compounds in the sample in a spectral form. NMR
has the ability to measure a high number of molecules in a mixture, an additional
benefit with NMR is that is can be used without almost any pre-processing of the
sample. NMR spectroscopy is also quantitative (given that a quantitative NMR
pulse-sequence is applied). One of the drawbacks of NMR spectroscopy is relatively
low sensitivity, which can result in failure to detect very low abundance molecules.
Additional challenges when applying NMR spectroscopy for metabolic profiling are
overlapping peaks in the spectrum and peak position variability. Overlapping peaks
will in general result in lower quantitative relation between the signal intensity and
the abundance of the molecule generating the signal, due to a confounding between
signals of two or more peaks that are overlapping. Peak shift variability27 is the
effect of factors such as pH and ionic strength in the sample, which gives rise to a
variability in the peak position for some peaks. Peak shift variability can be a prob-
lem if the effect is large and no further pre-processing of the spectra is carried out
to reduce these effects prior to e.g. multivariate data analysis. The primary adverse
effect arising from misaligned peaks is that the variables are (locally) not represent-
ing exactly the same feature in the spectrum, since peaks are located at slightly
different positions. In most cases, only a few signals show this type of effect, making
the overall impact on the data analysis limited. Spectral alignment can be applied
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to reduce peak position variability between samples; alignment methods also have
the potential risk of introducing artefacts in the data as a side effect. Since spectral
alignment is currently not a standard pre-processing step for metabonomic data,
data have not been aligned prior to analysis in this thesis. A typical 1D 1H NMR
urine spectrum can be seen in Figure 2.3. Further information regarding the prin-
ciples behind NMR spectroscopy can be found in works by Hore28 and Claridge29.
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Figure 2.3: A Typical 600 Mhz 1D 1H NMR spectrum of urine.
2.2 Introduction to modelling and analysis of biological data
The complex behaviour of biological systems originates from the high number of
parts in the system and can only be understood by the combined knowledge about
the properties of the parts and how they interact, rather than from the functionality
of the individual parts30. Therefore, relevant data need to be collected, and also
integrated.
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Biological sciences are generating vast amounts of data, and in order to trans-
form the experimental data into useful information and knowledge, computational
modelling and analysis are essential. A model can be seen as an abstract repre-
sentation of prior knowledge and / or experimental data from a modelled system.
Prediction models are models which do not only fit model parameters in order to
describe the data, but also have the ability to predict some property of interest
from new data, given an existing model. Prediction models can be established on
a multitude of biological organisation levels, from very detailed models describing
reaction mechanisms for individual bio-molecules to modelling of system-wide re-
sponses to perturbation. Models of biological data from these different levels can
be seen as representations of the system at different levels of detail, also serving
different modelling purposes. Measurement of individual molecular mechanisms can
provide detailed understanding of a small part of the system, but such experimental
methods are rarely feasible to apply for system-wide measurements at this most
detailed level. An alternative approach is to study the whole or a large part of the
system on a less detailed level, with the benefit of a higher coverage in terms of the
number of variables (bio-molecules) that can be quantified. The first approach is a
bottom-up approach, starting from low level modelling of the system to gradually
move towards a full system model. The latter method can be seen as a top-down
approach, where the system wide behaviour is modelled as a representation of the
system on a higher level of abstraction, with less detailed information.
The choice of experimental approach and modelling methods are important and
directly related to the objective of the study and resources available. As data and
models are generated from the biological system, hypothesises about the system
can iteratively be refined and fed back into the design of subsequent experiments.
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This process is naturally iterative, starting out with an initial phenomenon to be
modelled, and as data are collected and modelled, new information is generated
which can be used in the design of the next iteration of the experimentation and
modelling cycle. In general, the usefulness of a model of any kind lies in its ability
to be able to predict some property based on patterns in the data, or even to
predict the outcome of a modification of the system. Prediction modelling thus
aims to establish models that can predict some aspects of how the biological system
behaves in response to e.g. a system perturbation. Examples of application areas of
prediction models include disease diagnostics31, 32, evaluation of drug efficacy33 and
in-vivo and in-vitro toxicity testing23, 34, 35.
The main objective of the modelling methods discussed throughout this thesis is
to provide means for understanding the data collected from the biological systems
studied, as well as establishing models able to predict some properties of the system
from the measured data. In general, computational modelling approaches address
the problem of representing relationships between measurable variables and some
properties (responses) of interest. An important criterion for evaluating if a model
is a good, or relevant, representation of data is to assess its predictive performance
when applied to new data. Model evaluation based on prediction performance is
central, particularly in cases where the model is not established from first principles,
but rather from empirical data, which is common in biology. When models are based
upon measured data, they are usually referred to as empirical models. A common
aim of this category of modelling methods involves modelling of consistent variation
patterns within the data. In the commonest case a set of descriptor variables,
represented in vector form (Figure 2.4), are measured for each subject included in
the study. The measurements from all observations in a particular study can then be
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represented in matrix form, see Figure 2.5. A common representation, also used here,
is to let each row in the matrix represent the measurements of a biological sample,
and to let each column represents a measured variable (e.g. a protein or metabolite
abundance). The level of detail that can be captured by any model is limited by
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Figure 2.4: The process of acquiring a vector representation of some compounds of
a biological sample.
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Figure 2.5: The descriptor matrix (X) is composed of data acquired from a set of
biological samples, each one represented as a row vector in X.
the accuracy with which the variables in the system can be measured. Modelling on
a more coarse grained level, thus excluding the finer details, may be the best way to
use the available information for modelling purposes. Equally important in making
the right choice of modelling method is to collect data by an experimental method
which generates data that is of sufficient detail and accuracy for the modelling
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approach chosen. In this thesis, mainly relatively high-level modelling approaches
are considered, aiming at describing the biological system on a high abstraction level,
in opposite to mechanistic modelling, which is aimed at modelling of for example
molecular events and interactions on a detailed level. The high level modelling is well
suited for many types of omics data. A common objective of these types of modelling
methods is to establish prediction models that are exploiting the covariation patterns
in data, relating to for example a perturbation of the biological system.
2.2.1 Data analysis of omics data
Computational biology includes the use of methods from scientific fields such as ap-
plied mathematics, statistics and computer science to address computational prob-
lems in biology. A plethora of methods used for modelling and analysis of many
different types of biological data are available. Common methods for analysis and
visualisation of omics data include clustering and dimensionality reduction meth-
ods. Clustering analysis provide means for finding observations or variables that
have similar properties in a data set, and can be useful for both visualisation and
interpretation of data. Clustering is an unsupervised approach to data analysis;
hence, it does not take into account any known properties of the data such as class
of observations. Instead clustering algorithms utilise similarity metrics to define
distances between observations and variables. Examples of such similarity measure-
ments may be parametric or non-parametric measurements of correlation. Common
clustering36 algorithms include Hierarchical Cluster Analysis (HCA) and K-Nearest
Neighbour (KNN). Clustering has been applied in many instances for the analysis
of biological data acquired via transcriptomics37, proteomics38 and metabonomics39
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studies. Widely used dimensionality reduction methods include PCA40 and Multi
Dimensional Scaling41 (MDS). The objective of such methods is to reduce the initial
high dimensional space defined by the measured variables and represent the data in
a space of low dimensionality for visualisation or further analysis.
Supervised data analysis methods utilise additional information about each ob-
servation in the data set, such as class membership, during the model estimation.
Therefore, supervised models have the ability to model information in the data that
is directly relevant for the objective of the analysis. Supervised methods include
different types of multivariate regression methods, such as Multiple Linear Regres-
sion, Ridge Regression42 (RR) and PLS43. Regression models provide a model where
some descriptor variables are used to predict one or more response variables by lin-
ear, or non-linear, combinations of the descriptor variables. For analysis of biological
pathways and their dynamic properties, Ordinary Differential Equations (ODE) or
stochastic models are commonly applied. Other examples of supervised data analysis
methods are Artificial Neural Networks44 (ANN), Decision Trees45, Self Organising
Maps46 (SOM) and Bayesian Networks47.
2.2.2 Multivariate analysis
Most real world problems are multivariate in nature, i.e. in order to fully describe an
observed phenomena multiple variables have to be considered together rather than
one variable at a time. Chemometrics48, 49, 50 is a branch of chemistry where compu-
tational and statistical methods are applied for modelling and analysis of chemical
data of various kinds, including bio-analytical data from metabolic profiling studies.
Among the most commonly applied data analysis method used in chemometrics for
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analyses of for example spectral data, are multivariate projection methods. Biolog-
ical data are inherently multivariate in character; one variable is rarely by itself the
sole effect of some change in the system. In most cases, the response instead occurs
as changes in multiple variables simultaneously. Therefore, the application of mul-
tivariate modelling methods is natural when dealing with multivariate data. Figure
2.6 illustrates how a multivariate approach can provide a successful model (discrim-
inant analysis), while analysis of one variable at a time fails in producing a good
decision boundary for discriminating between the two classes. Modelling biological
data using multivariate statistical methods thus provides a framework allowing the
biological data to be characterised, while a univariate approach in many cases will
not provide enough information to allow successful prediction of a response variable
of interest.
In principle, all types of models utilising multiple descriptor variables can be
considered as multivariate methods. However, the work presented in this thesis
is focused around multivariate statistical methods, in particular multivariate pro-
jection methods, and I will refer to the term multivariate in this particular sense
throughout the thesis.
Some commonly applied multivariate projection methods, e.g. PCA or PLS, can
be seen as so-called linear latent variable51 (LV) models. Latent variables, or hidden
variables, can be thought of as underlying variables that are not directly measur-
able, but which are related to the observed data. The number of latent variables are
commonly assumed to be of much lower dimensionality than the number of observed
descriptor variables. Alternatively, one can think of the latent variables as a repre-
sentation of the biological system on a higher abstraction level. In this perspective,
the latent variables can be seen as a representation of some relevant characteristics
Chapter 2. Background 43
−4 −3 −2 −1 0 1 2 3
0
1
2
3
4
5
6
7
8
9
X1
X 2
Figure 2.6: Illustration of a simulated data set with two-variables and two classes.
The example illustrates how a multivariate approach can be applied to define a
linear decision boundary (illustrated by dashed line), which is able to perfectly
discriminate between the red and the blue class. While considering one variable at
a time, a perfect discrimination cannot be achieved, which can be seen in the two
density plots describing the (smoothed) distribution of each variable in this data for
each class (below and to the left of the main panel).
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of the data that is modelled. Worth noting is that latent variable based models
rarely resemble the true mechanistic structure of the system modelled, particularly
in biology, but may nonetheless provide a useful model for understanding certain
properties of the system. In many studies where omics techniques are applied, the
objective is mainly to study the effects of specific perturbations. In such applica-
tions, where the objective is high level modelling, and the interest is focused around
describing and predicting the overall system state, multivariate latent variable mod-
els have very attractive properties in that they can handle multicollinear variables
as well as data where the number of observations are lower than the number of vari-
ables (the curse of dimensionality). In addition, the computational cost of model
estimation is relatively low, even for high-dimensional data sets, which can be of
great importance, especially in the modelling of large data sets.
CHAPTER 3
METHODS
This chapter describes a number of methods related to data analysis and prediction
modelling, which are applied or referred to in the following chapters. The details of
experimental procedures used for data acquisition are beyond the scope of the thesis
since experimental data serve the purpose of illustrating the application of the mod-
elling methods rather than being in the centre of the work presented. Experimental
details are instead briefly described in each chapter together with relevant refer-
ences to provide the necessary background to each data set modelled. This chapter
starts with outlining data pre-processing methods and continues by describing some
commonly used multivariate data analysis methods.
3.1 Data pre-processing
Pre-processing of data is an essential step in the analysis of experimental biological
data. Pre-processing of raw data includes extraction of meaningful features, normal-
isation of data so that experimental data are comparable between observations as
well as centring and scaling of data prior to modelling. Feature extraction is out of
the remit of this thesis, but an example of an area in which it is frequently applied
is for analysis of the raw images from microarray experiments. In this case, a spot
detecting algorithm is used for automatically locating the positions of all spots on
45
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the microarray in order to allow measurement of the intensities of the pixels of each
spot in the image and turn them into numerical values. Normalisation, centring and
scaling are important pre-processing steps applied to most omics data prior to mod-
elling, and some of these pre-processing methods will be described in the following
sections.
3.1.1 Normalisation
Normalisation is a procedure which has the objective of reducing inter-sample vari-
ability due to systematic effects introduced by the experimental procedures or the
data acquisition methods. Metabolic profiling of urine samples provides an example
of where normalisation is essential. In this case systematic variability in metabolite
concentrations are expected due to differences in excretion rate between different
subjects in the study. Normalisation procedures can be applied to reduce the ef-
fect of these differences. Different normalisation methods are based upon different
underlying assumptions of the properties of the data and the characteristics of the
variability that is to be normalised. Frequently applied normalisation methods in-
clude total sum normalisation (Equation 3.1) and global median normalisation52
(Equation 3.2). In the case of spectral data, normalisation to the total signal sum is
frequently used as a close approximation for total area normalisation when working
with digital spectra. For example, for metabolic profiling of urine samples nor-
malisation to the total sum of the spectrum is based on the assumption that the
total excretion of metabolites per time unit is expected to be constant between the
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subjects.
xn =
x∑k
j=1 |x|
(3.1)
The global median normalisation (Equation 3.2∗) method has been used to some
extent for microarray data53 and also recently for metabonomics data52. The global
median normalisation (also referred to as probabilistic quotient normalisation52)
is based on an assumption that the most common (median) concentration ratio
between the sample and a reference, among all measured variables (e.g. metabolites),
is due to some systematic effect rather than to the perturbation studied (e.g. toxicity
assessment, disease or treatment).
xn =
x
median(x • 1
xref
)
(3.2)
Other common normalisation methods are normalisation to a reference feature in the
data, often called a ‘house-keeping’ compound in a biological context. The reference
feature is implicitly expected to be present on a constant level over time in the
biological system, thus suitable to normalise to. The reliability of reference features
can however be questionable, since it is in most cases hard (or impossible) to establish
if any such compounds exist and to which extent they are actually present at a
constant level. One can also consider to perform a weighted normalisation, where
some of the features in the data are influencing the normalisation more than others,
or where only a sub-set of features are used in the estimation of the normalisation
factor, and other features are given a weight of zero.
∗ The symbol • represent element-wise vector multiplication
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A number of difficulties are associated with the application of normalisation pro-
cedures. Two statistical properties associated with difficulties in the normalisation
are: spurious correlations and closure. Spurious correlations54 are essentially cor-
relations between two variables introduced as the result of division of both of the
variables by a common third independent variable (i.e. a normalisation factor).
Thus, normalisation to a reference feature in the spectra may give rise to distor-
tion of the true covariance patterns between variables in the data by introducing
spurious correlations. Closure refers to dependency between variables introduced
through the normalisation process. This is due to the closure of each feature vector
by using a common normalisation factor, such as assuming a constant total area or
total sum for all observations in the data set 55, 56. The variable dependency that
is introduced can easily be realised by investigating Equation 3.3, which shows that
when the vector is closed, one element in the feature vector can be expressed as a
function of the remaining set of variables in the vector describing the observation55.
xi = 1−
∑
j 6=i
xj (3.3)
The effect of closure can be seen e.g. when a large signal is introduced in a spectrum,
due to administration of a drug, or other compound. In this case, the presence of
a non-endogenous compound in the biological sample when applying, for example,
total area normalisation, may cause the rest of the spectra to be reduced in intensity
merely due to the closure effect (an introduced artefact). Under such circumstances,
it may be essential to eliminate some parts of the spectra prior to estimating the nor-
malisation factor, or to apply a more suitable normalisation method. Normalisation
is in many cases an essential pre-processing step, but it is important to make sure
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that spurious patterns are not introduced into the data through the normalisation
process.
Throughout this thesis, NMR based data has been normalised to a constant sum,
since this is the de-facto standard normalisation method used for metabonomic data,
a thorough evaluation of different normalisation methods was not carried out since
this was not central to the main work presented.
3.1.2 Centring and scaling
Centring of the data is usually performed on a variable by variable basis of a data
matrix X. Mean centring (Equation 3.4), in the commonest type of centring, which
is achieved by subtraction of each column mean from all the rows (observations) in
each column (variable). Other measurements of the centre (location) can also be
used, an obvious example being the median. Centring is typically applied prior to
application of most multivariate data analysis methods such as PCA or regression
based methods such as PLS, since the main interest is in assessing and modelling
the variation in the data rather than the absolute values (location) of the variables.
xmc = x− x¯ (3.4)
Scaling in the variable direction is typically applied prior to estimation of regression
or discriminant analysis models. Scaling is applied if the variance of the variables
are not directly linked to information of interest. E.g. if no scaling is applied the
implicit assumption is that variables with high variance (i.e. usually high abundance
metabolites or proteins, which usually also have a relatively high variance) should
have higher impact on the model than relatively low variance variables should have.
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In the case of supervised modelling, scaling can in many cases improve the predictive
power of the model, by e.g. giving all variables the same influence on the model by
applying unit variance scaling. Unit variance scaling is performed by dividing the
variable by its standard deviation (Equation 3.5). Variables may also be scaled by
other methods, such as Pareto scaling which scales by a factor of the square-root of
the standard deviation. The choice of scaling method (if any) can be made either
based on prior knowledge regarding the properties of the data, or based upon for
example cross-validation of the model used to analyse the data. In the latter case,
the scaling method would be treated as any other parameter to be optimised.
xuv = x/σx (3.5)
Related to scaling of data are various transformation functions that can be applied
to the data. For example, in some instances it may be suitable to log-transform data
so that the distribution of each variable will be more similar to normal distribution.
Another type of transformation functions are the so-called variance stabilising trans-
formations, recently the generalised logarithm transformation has been proposed for
transformation of microarray data as well as metabonomic data57, 58, 59, 60 to reduce
the effect of technical variability. Essentially a separate data-set of technical repli-
cates are acquired, and the scaling parameters are acquired from this data set with
the objective of reducing the influence of technical variability in the full data-set
prior to further analysis.
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3.2 Multivariate analysis
In the following sections a set of frequently used multivariate projection methods
are described to provide a background for the methods being applied and devel-
oped in the later chapters. The set of methods presented here are all commonly
used in the field of chemometrics, and have also been used for analysis of biological
data. The methods described in the following sections have proven to be valuable
tools for data analysis in a high number of different application areas. Despite their
usefulness, these multivariate methods have limitations and drawbacks under some
conditions. The most obvious limitation is the assumption that the variability of
the data can be described by a low number of linear components, which can be a
limitation if data show significant non-linear behaviour. Another important limita-
tions of the multivariate methods described here, is that they are all based on linear
least squares estimations of the model components, making the models non-robust
to strong outliers in the data. Hence, it is important to remove outliers prior to fit-
ting the final models. Ultimately the choice of data analysis method has to be based
upon an evaluation of the objective of the analysis and the properties of the data
that is modelled. In the area of supervised regression and discriminant modelling,
the OPLS method has emerged as a method that provides clearer and easier inter-
pretation of the model compared to e.g. PLS, which is one of the most commonly
employed regression methods used in chemometric applications. The work described
in Chapter 4 - 6 is based on, or related to, the original OPLS method, which has been
applied in novel ways and also extended to handle additional modelling challenges
found in biological applications.
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3.2.1 Principal Component Analysis (PCA)
PCA is an unsupervised multivariate projection method commonly used for dimen-
sionality reduction (data compression) and visualisation. The data matrix X is
decomposed into a set of linear components that are orthogonal to each other (prin-
cipal components), the components describe the projections from the original space
which maximises the variance described by the PCA model. The vectors describ-
ing how the original variables relate to each principal component are called loading
vectors, and the vectors representing the observations in the space spanned by the
principal component are called score vectors. PCA can also be seen as a matrix
decomposition method that transforms the original data to a new coordinate space
of linear orthogonal components. The PCA model of a matrix X usually has much
lower dimensionality than the original data, while still being able to describe the
majority of the variance in X. This is a direct effect of multicollinearities present
between the variables in the X matrix. Hence, PCA can be seen as a dimensionality
reduction method. A PCA model can be calculated by either the NIPALS PCA al-
gorithm (Algorithm 1) or through Singular Value Decomposition (SVD). PCA and
SVD have been applied in the analysis of biological data, such as transcriptomics 61,
metabonomics62 and proteomics63. Usually PCA is described in the nomenclature of
scores (T) and loadings (P) as seen in Equation 3.6, where E is the residual matrix.
X = TPT + E (3.6)
PCA is an eigenvalue decomposition of the covariance matrix of X, where the
PCA loadings are corresponding to the eigenvectors of the covariance matrix of X
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Algorithm 1 NIPALS PCA
1: for i = 1 to A do
2: ti ← X[:, 1]
3: τ ← 10×  (Initialise τ so that τ > )
4: while τ >  do
5: pi ← XT ti/(tTi ti)
6: pi ← pi/‖pi‖
7: ti,old ← ti
8: ti ← Xpi
9: τ ← (ti − ti,old)T (ti − ti,old)
10: end while
11: X← X− tipTi
12: end for
sorted in a descending order of their eigenvalues, so that the greatest variation in X
is described by the first component, and the second component describe the second
largest direction of variation, while also being orthogonal to the first component.
The PCA scores correspond to the projection of the X matrix onto the loading
vector (Figure 3.1), and can be interpreted as a new (latent) variable describing the
main variation in the data.
3.2.2 Ordinary Least Squares (OLS)
Ordinary Least Squares, also known as Multiple Linear Regression (MLR), is a mul-
tivariate regression method for modelling the relationship between a set of descriptor
variables (X) and a set of response variables (Y). OLS requires the descriptor vari-
ables to be linearly independent and the number of observations to be greater than
the number of descriptor variables, so that an inverse of XTX exist. OLS has the
objective function of fitting the linear regression model so that the residuals F are
minimised. The OLS model is described in Equation 3.7 and 3.8, where X is the
descriptor matrix, Y is the response matrix, F is the Y residual matrix and Bols is
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Figure 3.1: Illustration of how data points (black) in a two-dimensional space are
projected down orthogonally onto the first principal component. The red points
indicate the projection on the component; the position of the projected points on
the principal component is equivalent to the score of the observation for component
one.
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the matrix of regression coefficients.
Y = XBols + F (3.7)
Bols = (X
TX)−1XTY (3.8)
3.2.3 Principal Component Regression (PCR)
Principal Component Regression is a regression method based on the PCA scores of a
data matrix X. In order to apply the OLS regression method, the XTX matrix needs
to be of full rank in order for its inverse to exist. In many cases this is not possible, for
instance when the number of variables exceeds the number of observations, or when
the variables in X are multicollinear, both common properties of high-dimensional
biological data. In this case, PCA can first be applied on the X matrix to form
a new and low dimensional orthogonal basis of X, described by the PCA scores.
Subsequently, the scores can be used as regressors in an OLS model. This approach
is commonly referred to as PCR. In Equations 3.9 - 3.10, X is the descriptor matrix,
Y is the response matrix, F is the Y residual matrix, T is the PCA score matrix
and Bpcr are the PCR regression coefficients.
Y = TBpcr + F (3.9)
Bpcr = (T
TT)−1TTY (3.10)
The OLS regression method can thus be used in cases when XTX is singular or
close to singular, by applying PCA first. However, the PCA components do not
necessarily produce a good relation to the response matrix Y, unless the main
directions of variance in X happen to covary with Y. This may render the PCR
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model hard to interpret, and the predictions of Y may be sub-optimal.
3.2.4 Partial Least Squares regression (PLS)
PLS is a multivariate regression method for predictive regression modelling. PLS
is particularly useful in cases when the descriptor matrix has more variables than
observations, and in cases where the descriptor variables are multicollinear. PLS is
a multivariate linear latent variable model that models the relationship between a
descriptor matrix X and a response matrix Y by maximising the covariation between
the latent variables in the model and the response variables in Y.
The PLS model is usually estimated through the iterative NIPALS43 algorithm
(Algorithm 2). An alternative PLS algorithm is the SIMPLS64 algorithm which
computes the solution faster and yields similar, but not identical, results to the
NIPALS algorithm. In Equation 3.11 - 3.12, X is the descriptor matrix, Y is the
response matrix, E is the X residual matrix, F is the Y residual matrix, T is the
PLS score matrix, P is the PLS loading matrix and Bpls is the PLS regression
coefficients. The PLS model is interpreted in terms of the PLS scores, representing
the observations, and the corresponding weights or loadings, which describe the
relation to the original variables in the descriptor matrix.
X = TPT + E (3.11)
Y = XBpls + F (3.12)
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Algorithm 2 NIPALS PLS (single response variable (y) case)
1: for i = 1 to A do
2: wi ← XTy/(yTy)
3: wi ← wi/‖wi‖
4: ti ← Xwi
5: ci ← yT ti/(tTi ti)
6: pi ← XT ti/(tTi ti)
7: X← X− tipTi
8: y← y − ticTi
9: end for
10: bpls ←W(PTW)−1cT
PLS-Discriminant Analysis (PLS-DA)
PLS can also be used for discriminant analysis, in this case the response matrix Y
is a dummy matrix of ones and zeros describing the class label of each observation
in the data.
3.2.5 Orthogonal Signal Correction (OSC)
Regression methods such as PLS (Section 3.2.4) and Principal Component Regres-
sion (PCR) (Section 3.2.3) commonly incorporate substantial systematic variation
from the descriptor matrix (X) despite it being orthogonal to the response matrix
(Y). In cases when systematic Y-orthogonal variation is present in the X matrix,
this will have adverse effects on the interpretation of the model since it is hard to
separate the covarying variation from the systematic Y-orthogonal variation. Ex-
amples of systematic Y-orthogonal variation (structured noise) include instrumental
drift over time, batch differences and unanticipated sub-classes in data. Orthogonal
Signal Correction (OSC)65 is a pre-processing method with the objective of remov-
ing systematic Y-orthogonal variation from the X-matrix prior to estimation of the
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final model. The OSC methods estimates a set of Y-orthogonal components, which
are composed of one or more OSC score vectors (to) and corresponding OSC load-
ing vectors (po), see Equation 3.13. The residual matrix, E, is subsequently used
for further modelling. Since the original OSC method was published by Wold et
al.65, a number of different OSC filter have been developed66, 67, 68. Because OSC
filtering is separated from the subsequent modelling of the data, the application of
OSC pre-processing may increase the risk of over-fitting the data, therefore caution
needs to be taken when applying the filter.
X = ToP
T
o + E (3.13)
3.2.6 Orthogonal Projections to Latent Structures (OPLS)
The OSC method for pre-processing presented in Section 3.2.5 removes Y-orthogonal
variation from the X matrix leading to improvement of models under some condi-
tions. However, the OSC method has some drawbacks. The most significant one
being the separation of pre-processing and subsequent modelling, making it harder
to cross-validate the final model including the OSC filtering step, which increases
the risk of model over-fitting. OPLS69 is a multivariate regression method, simi-
lar to PLS, which has an integrated Orthogonal Signal Correction filter65 specially
designed for PLS. The OPLS method is designed to separate the variance of the
descriptor data matrix X into three parts: variation that is covarying with the re-
sponse matrix Y; systematic variation in X that is captured in the predictive score
matrix Tp while orthogonal to Y and the residual variance E, which is not modelled.
Compared to PLS, the OPLS model captures approximately the same amount of
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variation in the descriptor matrix, while separating the covarying variation from the
Y-orthogonal variation, thus making the model more coherent and clearer to inter-
pret. The simplicity of interpretation is due to the separate modelling of covarying
components and Y-orthogonal components in the OPLS model, resulting in fewer
model parameters (e.g. predictive components) and clearer interpretation.
The OPLS algorithm (Algorithm 3) decomposes X into a set of predictive weight
vectors, Wp, representing components of X-Y covarying variance, and a set of
predictive score vectors, Tp, representing the orthogonal projection of X onto Wp
(Equation 3.14). If Y-orthogonal variance is present in X, an optimally predictive
PLS model requires additional components beyond the true rank of the X-Y cross-
covariance matrix, i.e. a PLS models with a single response variable y, may require
more than one PLS component. In the case of the OPLS model this is equivalent
to a model with one predictive component, and a set of additional Y-orthogonal
components, see equation 3.14, where To is the Y-orthogonal score matrix and PTo
is the Y-orthogonal loading matrix. This results in the separated modelling of the X-
Y covarying variation, described by the predictive components, and the modelling of
the Y-orthogonal variation, described by the Y-orthogonal components. Equations
3.14-3.16 describe the model of X and the prediction of Y. In many applications of
OPLS modelling, it is of interest to analyse the Y-orthogonal variance further, either
separately or together with the X residuals E, to understand the variance patterns
present in the data that are not covarying with Y. This may provide information
of systematic noise in the data, e.g. instrumentation drift or systematic biological
variation not related to Y. In Equations 3.14-3.16, XE is the X matrix with the
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modelled Y-orthogonal variation removed and Bopls are the OPLS coefficients.
X = TpW
T
p + ToP
T
o + E (3.14)
XE = X−ToPTo (3.15)
Y = XEBopls + F (3.16)
Algorithm 3 OPLS (single response variable (y) case)
1: wp ← XTy/(yTy)
2: wp ← wp/‖wp‖
3: for i = 1 to Ao do
4: tp ← Xwp
5: cp ← yT tp/(tTp tp)
6: up ← ycp/(cpT cp)
7: pp ← XT tp/(tTp tp)
8: wio ← pp −
(
wTp pp
)
wp
9: wio ← wio/‖wio‖
10: tio ← Xwio
11: pio ← XT tio/(tioT tio)
12: X← X− tiopioT
13: end for
14: tp ← Xwp
15: cp ← yT tp/(tTp tp)
16: bopls ← wpcTp
OPLS-Discriminant Analysis (OPLS-DA)
By using a dummy-matrix as the Y-matrix the OPLS algorithm can be applied
for Discriminant Analysis (DA) in analogy with the previously described PLS-DA
method (Section 3.2.4). In this case, the OPLS model is established to maximise
covariation in the descriptor matrix with the classes in the data. The OPLS-DA
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model can also be used to improve classification over PLS-DA in some cases. Bylesjö
et al.70 described how OPLS-DA also can combine the benefits of a PLS-DA classifier
with the Soft Independent Modelling of Class Analogies71 (SIMCA) approach∗ .
This was achieved by modelling the level of within-class variance described by the
Y-orthogonal components, which can improve upon classification in situations where
difference in within class-variation exists between the classes.
3.2.7 O2PLS
The O2PLS72, 73 method, a generalisation of OPLS, allows modelling and prediction
in both directions between two data matrices X and Y. In the O2PLS algorithm
(Algorithm 4) the shared covariation patterns between the X and Y matrices are
modelled by a set of predictive components as in the OPLS algorithm, but in addition
to the set of Y-orthogonal components present in the OPLS model for the X matrix,
a set of X-orthogonal components are also estimated for the Y matrix. This results
in an OPLS model that is bi-directional, i.e. the model is predictive in the X to Y
direction, but also in the reverse direction. By separating the modelling of the X -
Y covarying (predictive) variation and the structured noise (Y-orthogonal) present
in each data matrix, prediction in both directions is possible despite the possibility
of each data matrix containing collinear variables as well as structured noise. The
separation of covarying and orthogonal variation facilitate a better interpretation
and also enable interpretation of the variation that is not related between the two
matrices. The O2PLS model for X and Y is described in Equations 3.17 and 3.18,
∗ SIMCA is a multivariate classification method based on disjoint PCA models, which are fitted
for each class in the data. Classification is based on model residuals for each sub-model. SIMCA
allow samples to be assigned to one class, multiple classes or no class.
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where Tp are the predictive scores for X, Wp are the predictive weights for X, To are
the Y-orthogonal scores, PTyo are the Y-orthogonal loadings,YE is the Ymatrix with
the modelled X-orthogonal variation removed (see Equation 3.19) and BoplsY are the
O2PLS coefficients for the Y matrix. In Equation 3.18 Up are the predictive scores
for Y, Cp are the predictive weights for Y, Uo are the X-orthogonal scores, PTxo
are the X-orthogonal loadings, XE is the X matrix with the modelled Y-orthogonal
variation removed (see Equation 3.20) and BoplsX are the O2PLS coefficients for the
X matrix.
X = TpW
T
p + ToP
T
yo + E = YEBoplsY + E (3.17)
Y = UpC
T
p + UoP
T
xo + F = XEBoplsX + F (3.18)
YE = X−UoPTxo (3.19)
XE = X−ToPTyo (3.20)
3.2.8 Hierarchical multivariate methods
Another area of modelling is so-called hierarchical multivariate models. In this
framework, models are estimated on two levels, the first level being based on each
data-block of descriptor data, and the second level (or super-level), being based on
model parameters from the first level of modelling. The procedure is approximately
the same as taking the score components from a set of first level models, potentially
scaling them based on e.g. the amount of variance they describe, and in a second
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Algorithm 4 O2PLS
1: (Cp,Σp,Wp)← SVD(YTX) (Extract A linear components by SVD)
2: for i = 1 to Aoy do
3: Tp ← XWp
4: EXY ← X−TpWTp
5: (wio, σ
i
o,d
i
o)← SVD(ETXY Tp) (Extract the first component by SVD)
6: tio ← Xwio
7: pioy ← XT tio/(tioT tio)
8: X← X− tiopioyT
9: end for
10: Tp ← XWp
11: for j = 1 to Aox do
12: Up ← YCp
13: FXY ← Y −UpCTp
14: (cjo, σ
j
o,d
j
o)← SVD(FTXY Up) (Extract the first component by SVD)
15: ujo ← Ycjo
16: pjox ← YTujo/(ujoTujo)
17: Y ← Y − ujopjoxT
18: end for
19: Up ← YCp
20: BU ← (UTp Up)−1UTp Tp
21: BT ← (TTp Tp)−1TTp Up
22: BoplsX ←WpBTCTp
23: BoplsY ← CpBUWTp
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step use them together (concatenated) as a descriptor data matrix in the second
level model. Both hierarchical PCA (HPCA) and PLS (HPLS) 74 models have been
developed. An excellent review of the field of multivariate hierarchical models, also
including a description and detailed comparison between different algorithms was
written by Westerhuis75.
Multivariate hierarchical models can help to reduce the computational complex-
ity if numerous high dimensional data sets are available, e.g. from multiple omics
methods. There are however, a trade-off between the benefits of reduced computa-
tional complexity and the risk of loosing crucial features in the data by assuming
that all variability of relevance is captured by the first level PCA or PLS model. If
the aim is to find cross-covariance patterns between two data matrices, O2PLS may
instead be more suitable than hierarchical models, since the objective of O2PLS is
exactly to model cross-covariance patterns, while this is not the case for the hierar-
chical models. In addition, hierarchical models make the model interpretation more
complex. This is because the variables in the second level (super-level) model do
not directly relate back to measured descriptor variables, but instead to the score
components of the first level models. Resulting in that the interpretation has to
be done through two levels of model components with scores and loadings. Despite
these shortcomings, hierarchical PCA and PLS may provide benefits in some in-
stance when the aim is to combine large amounts of data into a single model, while
reducing the computational complexity to some extent.
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3.2.9 Kernel-based methods
Kernel-based pattern recognition methods emerged during the 1990s, providing
means for non-linear modelling with the same computational efficiency as for linear
models. Non-linear patterns in data emerge in many different areas, including bi-
ology, making kernel-based methods attractive in a number of applications. Kernel
methods essentially transform the descriptor matrix from the input space X into a
higher-dimensional feature space F by a mapping function φ(·). The implicit expec-
tation is that the applied map φ(·) will lead to improved linear correlations between
φ(X) and Y in the generated feature space F . For highly complex transformation
functions, the explicit calculation of φ(X), which may be of high dimensionality, is
likely to be a limiting factor both in terms of computational complexity and memory
requirements. In some instances, the feature space F can even be infinitely large for
a particular φ(·). To accomplish the transformation in a computationally feasible
way, the explicit transformation can be circumvented by utilising what is commonly
referred to as the ‘kernel trick’76. In order to accomplish this, the dot products∗
are defined as κ(x,y) = 〈φ(x), φ(y)〉, also known as the kernel function. Now only
the kernel matrix K with entries Ki,j = κ(xi,xj) (where xi and xj corresponds
to the ith and jth row vector respectively in the descriptor matrix X) require ex-
plicit calculation. With proper use of the kernel function, one can avoid explicitly
mapping X to higher-dimensional spaces as well as computing dot products in the
feature space. The vector kernel function κ(·) is itself bound by several constraints
according to Mercer’s theorem77, stating that any continuous, symmetric and posi-
∗ The dot product, also referred to as the scalar product, is a function of two real-valued vectors
returning a real-valued scalar (e.g. xTx). The inner product 〈·, ·〉 is a generalisation of the dot
(scalar) product in a vector space.
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tive semi-definite kernel function can be expressed as a dot product in a (potentially
high-dimensional) inner product space (the feature space). However the detailed
properties of kernel functions are beyond the scope of this thesis, Shawe-Taylor and
Christiani78 provide relevant background in this area. The choice of kernel function
is evidently important, as it determines the transformation type and characteristics
of the feature space F . Frequently employed kernel functions involve polynomial
kernels and radial basis kernels78, but there are numerous other kernel functions
available, including kernel functions applicable for analysis of text and graph ob-
jects.
One particularly useful property of kernel-based models is that they can be seen
in a modularised fashion on a conceptual level so that the mapping of the input
data matrix X into some feature space F can be treated separately from the choice
of modelling method applied in the feature space. One of the most well known
methods utilising the ‘kernel trick’ is the SVM79. However, the ‘kernel trick’ can
also be used for a range of other linear methods, including kernel-PLS80 and kernel-
PCA, as long as they can be stated in so-called dual form, i.e. all instances of the
descriptor matrix X are expressed as a dot product XXT . This enables the data
to be represented in the feature space F , by a potentially non-linear transformation
function. Effectively ‘the kernel trick’ facilitates the estimation of a linear model
in F , corresponding to fitting a non-linear function in the original descriptor space.
Figure 3.2 illustrates on a conceptual level how the non-linear mapping function φ(·)
enables a linear function to discriminate between two classes in the feature space F ,
which cannot be achieved in the input space.
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Figure 3.2: Illustration of a classification problem where a linear discriminant func-
tion is not able to separate the two classes (indicated by x and o) in the two dimen-
sional space (upper left panel). After mapping of the descriptor data to the feature
space, by a non-linear mapping function φ(·), it is possible to find a linear discrimi-
nant function able to separate the two classes. The linear discriminant function in
feature space is equivalent to a non-linear decision boundary in the original input
space (lower panel).
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3.2.10 Cross-Validation
Cross-validation is commonly applied in the process of estimating the model com-
plexity of empirical models, e.g. the number of model components included in
multivariate models such as PCA and PLS models81. Regression or classification
models are also commonly validated by estimation of the model prediction error.
When working with such prediction models, the model is ideally validated using an
independent validation (test) data set, which was not used in the model estima-
tion phase. However, in many practical applications an external validation set is
not available, particularly in many biological application areas where the number of
samples may be restricted due to cost or e.g. ethical considerations in relation to
animal experiments. In such circumstances cross-validation may be used to estimate
the (cross-validation) prediction error of a prediction model.
During cross-validation the data is iteratively split into a unique training set
(i.e. sampling without replacement), which is used for model estimation, and a
validation set, which is used to test the prediction performance of the model. A
commonly applied cross-validation method is the n-fold cross-validation procedure
where 1/n−th of the samples are used as validation set and the rest of the obser-
vations are used to train the model. In this case the cross-validation is repeated
n times so that each observation is included in the validation-set once, and only
once. Other cross-validation methods such as Monte-Carlo cross-validation82 are
also available. In Monte-Carlo cross-validation the observations are randomly split
into a training and validation-set over a high number of cross-validation rounds in
order to get a better estimate of the cross-validation prediction error. In Monte-
Carlo cross-validation each sample may be used in the validation-set several times
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over the cross-validation rounds.
Cross-validation thus provide a way of estimating model complexity, or alterna-
tively provide means for evaluating the predictive performance of a model in cases
where no external validation-set is available. The predictive power of a model is
best evaluated using a completely external validation-set of samples, since a cross-
validation estimate of the prediction error is likely to be positively biased. If model
parameters need to be evaluated in addition to the prediction performance, it may
be desirable to use a nested cross-validation procedure in order to minimise the
prediction error bias, see for instance Varma83.
3.2.11 Model statistics
In Equations 3.21 - 3.26 some model statistics are defined, which are used in the
following chapters. The subscripts X and Y indicate if the statistic refers to the
descriptor data matrix X or the response data matrix Y. R2 describes the amount of
variance modelled, and can be considered to be a statistic describing the ‘goodness
of fit’ of the model. Q2 describes the amount of variance predicted by the model and
is inverse proportional to the generalisation error of the model, it can be seen as a
statistic describing the ‘goodness of prediction’. RMSEP is the Root-Mean-Square
Error of Prediction, describing the error of prediction. RMSECV is the Root-Mean-
Square Error of Prediction in cross-validation, which describe the error of prediction
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based on cross-validation.
R2X = 1−
∑
E2/
∑
X2 (3.21)
Q2X = 1−
∑
(Xˆcv −X)2/
∑
X2 (3.22)
R2Y = 1−
∑
F2/
∑
Y2 (3.23)
Q2Y = 1−
∑
(Yˆcv −Y)2/
∑
Y2 (3.24)
RMSEPY =
√∑
(Y − Yˆtest)2/N (3.25)
RMSECVYcv =
√∑
(Y − Yˆcv)2/N (3.26)
CHAPTER 4
INTEGRATED MODELLING OF OMICS
DATA
This chapter describes the application of multivariate modelling using the O2PLS
method for joint modelling and prediction between two omics data sets. The O2PLS
model explores cross-covariance patterns between the two data sets in order to es-
tablish a prediction model between them. In this chapter, the application of multiple
omics platforms for characterisation of biological samples is first motivated, followed
by an introduction to the modelling approach; finally, results from two real data
sets are presented. The main body of work presented in this chapter was previously
published in Rantalainen et al. 200622, which addressed the integrated modelling
of proteomic and metabonomic datasets. Here an additional example of application
is demonstrated, for modelling of a data set with transcriptomic and metabonomic
data.
4.1 Introduction
Omics technologies (see Section 2.1) enable quantitative measurement of various
types of biological molecules (e.g. mRNA transcripts, proteins and metabolites) in
a parallel fashion. Data from any one of these technologies can contain tens of thou-
sands of variables, but each one of the analytical platforms only provides a limited
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source of information about the biological system. Thus, application of multiple
omics platforms for characterisation of biological samples can be applied to acquire
data from multiple biological organisation levels, providing a more extensive source
of information about the current state of the biological system studied. There have
previously been several studies published where multiple omics platforms have been
used for studying various types of biological systems, including yeast 84, plants85, 86
and mammals87, 88. In some of these studies, it has been shown that the correlations
between measured proteins, transcripts and metabolites related to the same gene, or
pathway, are in many cases low. One contributing factor to this observation is that
the temporal displacement between events at the various systems levels is not easily
accommodated when acquiring data, since sampling cannot be done continuously
over time. Despite a low level of correlation between the measured molecules at
different biological organisation levels, it is well known that many of these entities
are directly dependent on each other. Here we investigate if a multivariate latent
variable approach is able to model the most prominent cross-covariation patterns
present in the data.
The O2PLS model (see Section 3.2.7) was applied for multivariate regression
modelling of consistent covariation patterns between two omics data sets. Estab-
lishing a common model of data from multiple bio-molecular organisation levels
has the potential to improve the understanding of the biological system studied, by
defining how variables and observations are related to each other or to a system
perturbation. Defining such relationships between the different biological levels has
the potential to increase our ability to understand and e.g. find sets of biomarkers
that are both specific and reliable in applications such as disease diagnostics. For
example, by integrating information from proteomics and metabonomics, the bio-
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logical endpoint (metabolites), could help to validate and confirm hypotheses built
on proteomic information. The O2PLS method is here applied for modelling of two
data sets. In the first application, data from a study of a human tumour xenograft
mouse model of prostate cancer was modelled. In this data set parallel 2D-DIGE
proteomic and 1H NMR metabolic profiling data were collected on blood plasma
from mice implanted with a prostate cancer (PC-3) xenograft and from matched
control animals. To further demonstrate the O2PLS method, a second data set
containing metabolic profiling data and gene expression data from a study of mul-
tiple topographical samples representing human gastrointestinal tract biopsies were
analysed.
4.2 Data sets
4.2.1 A human tumour xenograft mouse model of prostate cancer (the
PC-3 data set)
This data set is from an application area that might be expected to benefit sub-
stantially from integration of omics data, drawn from the area of cancer biology
where drug discovery programs frequently use human tumour xenografts as an in
vivo model of the disease. Such preclinical models utilise human cancer cells or tis-
sues, which are transplanted into immuno-compromised rodents. One widely used
preclinical model system for prostate cancer is the PC-3 tumour xenograft in the
athymic nude mouse. Prostate cancer is a malignant neoplasm that arises in the male
prostate gland. The disease is diagnosed in 30,000 men annually across the UK and
is responsible for 10,100 of the deaths attributable to cancer89, and thus represents
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an important area for the discovery of new medicines and treatment regimens.
Within the oncology therapeutic area there are several established biochemical
biomarkers/clinical-assays, which have demonstrated some clinical utility including
the serine protease prostate specific antigen (PSA)90, and carcinoembryonic antigen
(CEA)91, 92. Whilst the PSA test remains the ‘gold’ standard diagnostic for prostate
cancer, it has been shown to be unreliable in many cases with both a high rate of
both false negative and false positive discovery rates, which results in a high fre-
quency of unnecessary and invasive biopsies being carried out. Thus, despite recent
advances and the promises of emerging technologies there is still a need in oncology
to identify and validate more biochemical or molecular biomarkers that are cost ef-
fective, easy to implement with applicability to different cancer types and different
disease settings. Here, using a prostate tumour xenograft model, both proteomic
and metabonomic data were obtained. In addition to examining the individual lev-
els of bio-molecular information, a global strategy was applied to integrate the data
to identify candidate molecular biomarkers for preclinical cancer studies.
Animal model and data collection
Pre-processing of 1H NMR data
The sample collection and preparation was carried out at AstraZeneca (Alderley
Park, UK) by AstraZeneca personnel. Male Swiss athymic nude (nu/nu genotype)
mice were bred at AstraZeneca, Aldereley Park, UK. Experiments were conducted
on mice greater than 18 g in weight at the ages of 8-12 weeks (in accordance with the
U.K. Home Office Animal Act 1986). Animals were randomised into two groups of
five, where one group received a PC-3 tumour transplant and the control group did
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not. Animals were terminally bled on day 30. Blood was collected in heparinised
tubes and centrifuged at 3000 rpm for 15 min at room temperature to obtain plasma,
which was removed and frozen at -20◦C. Further details can be found in Rantalainen
et al.22. 1H NMR data were acquired on a Bruker DRX600 spectrometer using a
CPMG pulse sequence, and details can be found in Rantalainen et al.22. Proteomics
data were acquired at AstraZeneca using the 2D-DIGE method, see Section 2.1.2
for a general description. Mass spectrometry was used for protein identifications,
the details of these procedures have been described previously22. 1H NMR data
were calibrated from the glucose anomeric doublet at δ 5.23. The spectra were
interpolated on a common chemical shift scale using cubic spline interpolation, due
to the potential difference in shift scale due to digitization. The water peak area (δ
4.5 - 6) was excluded from each spectrum. Due to slight difference in plasma volume,
each spectrum was normalised to the total sum of 100 units. All pre-processing of
data and multivariate modelling was carried out in MATLAB (Version 7.01, The
Mathworks inc, Natick, MA), using in-house routines.
Pre-processing of 2D gel data
For each spot on each 2D gel, spot volume was used to calculate log2 ratios between
the reference sample (Cy3) and the internal standard control pool (Cy5). The
reference sample was either control or PC-3 mouse plasma. A total of 392 spots
were detected, which were present on all gels; these spots were selected and used
for further multivariate data analysis. DIGE data were mean centred and scaled to
unit variance prior to multivariate modelling.
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4.2.2 Topographical biopsies from the human gastrointestinal tract
(the GIT data set)
The second data set used to illustrate the application of O2PLS modelling of omics
data, contains gene expression data and metabonomic data from a human gas-
trointenstinal study. The objective here is to explore if there may be structured
covariation patterns between these two data sources. Many human diseases are re-
lated to different types of gut disorders. Therefore, understanding variation in gut
biochemistry and gene expression have the potential to advance our knowledge of
the gastrointestinal biochemistry leading to improved understanding and ability to
recognise disease states. The aim of the work carried out here is however mainly fo-
cused on evaluating if the O2PLS method is useful for prediction modelling between
the two omics data sets. This data set originates from a study of metabolic profiling
and gene expression of topographical variations between samples from human gas-
trointestinal tract biopsies. Biopsy samples from the antrum, duodenum, jejunum,
ileum, and transverse colon were collected by endoscopy or colonoscopy under seda-
tion. Data were collected using high-resolution magic-angle spinning (HRMAS) 1H
NMR and Affymetrix13 microarray technology. Twenty healthy men (n = 10) and
women (n = 10) aged between 20 and 30 years participated in the study. Details of
the study and the experimental methods can be found in Wang et al.93.
Pre-processing of 1H NMR data
1H NMR data were calibrated on the glucose anomeric doublet at δ 5.23. The spectra
were interpolated on a common chemical shift scale using cubic spline interpolation.
The water peak area (δ 4.5 - 6) was excluded from each spectrum and each spectrum
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was normalised to the sum of 100 units.
Pre-processing of microarray data
Data were normalised using the MAS 5.0 normalisation method94 and log trans-
formed prior to analysis.
4.3 Methods
Chemometric methods have previously been applied for analysis of a variety of high
dimensional data sets and are one of the most common ways of analysing high
resolution NMR data sets within metabonomics95, 96, 97. OPLS69 (Section 3.2.6),
is a supervised multivariate projection method similar to PLS98(Section 3.2.4) but
with an integrated OSC filter65(Section 3.2.5) modified for PLS.
In the following sections, the X matrix is the descriptor data matrix, e.g. NMR
data. The Y-matrix represents a matrix of response variables, or in the case of
OPLS Discriminant Analysis (OPLS-DA) the Y matrix is made of dummy vari-
ables, consisting of ones and zeros that indicate the class for each observation. In
the O2PLS modelling approach, both X and Y matrices are made up of measured
omics data, which may have collinear and noisy variables. The score matrices and
the corresponding weight matrices provide means for model interpretation in terms
of the modelled variance, both for the predictive components, describing relating
variance between X and Y, and the orthogonal components, describing system-
atic but orthogonal variation between X and Y. Thus it is possible to analyse e.g.
NMR data matrix (X) and proteomic data matrix (Y) in a joint model. The O2PLS
method is described in Section 3.2.7. The influence of the original variables on the
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OPLS/O2PLS model can be interpreted by inspection of the predictive OPLS coef-
ficients or the OPLS weights, which are related to how each variable influences the
model for prediction of the response variables (Y). For interpretation and visualisa-
tion of the OPLS coefficients, the method developed by Cloarec et al.99 was applied.
Five-fold cross-validation was applied for validation of all multivariate models.
4.3.1 Multivariate modelling of PC-3 data set
The NMR data analysis was performed in four steps, as outlined in Figure 4.1,
with the two objectives of analysing the class differences between the two groups
of animals as well as analysing the relationship between the NMR variables and
the DIGE variables. The PC-3 data set was mainly designed for investigation of
potential differences between control and tumour-bearing animals, therefore OPLS
discriminant analysis model was initially carried out, using mean centred and unit
variance scaled data, to investigate differences between control and PC-3 tumour-
implanted animals. With the aim of exploring the potential for predictive modelling
of individual variables between the NMR and the DIGE data, joint modelling was
carried out between the data sets in the following steps. The predictive OPLS
coefficients from the initial OPLS-DA model were used to interpret the NMR and
DIGE data and define the most prominent differences between control and PC-
3 observations, here annotated metabolites with an OPLS coefficient larger than
0.7 were selected for further analysis. Subsequently, the set of metabolic variables
that were most prominently contributing to the discrimination between the two
classes were then used as regressands in an OPLS model (mean centred and unit
variance scaled data), where the relationship between selected metabolic variables
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and the DIGE data matrix were investigated (Figure 4.1). As examples, two of
the metabolites with the highest OPLS weights (which were also of interest to the
collaborating biologists) were chosen to illustrate this analysis approach.
DIGE data
(X)
Class
(Y)
Regression modelling of relevant X variables
based on OPLS-DA model
Class
(Y)
NMR data
(X)
Regression modelling of relevant X variables
based on OPLS-DA model
OPLS-DAOPLS-DA
NMR data
(y)
DIGE data
(X)
OPLS
DIGE data
(y)
NMR data
(X)
OPLS
Figure 4.1: Schematics of the modelling steps taken in the investigation of the dif-
ferences between control and cancer-implanted animals. NMR and DIGE data were
first independently analysed and subsequently individual variables were modelled
between the two biological levels.
The 1H NMR and DIGE data were then modelled together using the O2PLS
method (Figure 4.2). The O2PLS algorithm enables construction of a linear latent
variable model which is predictive in both directions between X and Y matrices
(represented by metabonomic and proteomic data respectively). The O2PLS model
also provides an estimate of how much of the variance present in each omics data
matrix is shared between the NMR and DIGE data, and how much variance is
unique to each data matrix (Figure 4.2).
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Figure 4.2: Schematic of O2PLS model of PC-3 data and overview of the structure
of the resulting O2PLS model for the joint modelling of NMR and DIGE data.
4.3.2 Multivariate modelling of GIT data set
The GIT data set was first modelled with a O2PLS model using all variables. In
addition a variable selection procedure was applied to both the transcriptomic and
metabonomic data, and a subsequent O2PLS model was established from the se-
lected variables in each data set (Figure 4.3). Variable selection was based upon
whether a variable could be predicted by the complementary omics data set, using a
single response variable at a time. In other words, one prediction model was estab-
lished for each response variable (e.g. each variable in the microarray data set) using
the NMR data set as the descriptor matrix. The prediction performance (Q2) was
then used for variable selection. Variables were kept in the data-set for further mod-
elling if they were considered significant based upon a permutation test on the Q2
value for each variable (10,000 permutations, variables were considered significant if
they had a p-value < 0.05, using a one-sided test). This modelling was performed in
opposite ‘direction’ as well, using the microarray data set as the descriptor matrix,
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and the NMR data set as the response variables. Subsequently, based upon variable
selection in both of these two data sets, an O2PLS model was estimated (Figure
4.3). The objective of the variable selection procedure was to reduce the number of
non-informative variables in both of the data matrices so that the amount of noise in
the O2PLS model would be reduced, with the objective of establishing a predictive
O2PLS model that may reveal multivariate patterns of interest.
Microarray data
(X)
NMR data
(Y
i
)
Variable selection in NMR data
Microarray data
(Y
i
)
NMR data
(X)
Variable selection in microarray data
Microarray data
(X)
NMR data
(Y)
OPLSOPLS
O2PLS
Figure 4.3: Schematic of the modelling steps taken for variable selection and sub-
sequent O2PLS modelling of the microarray and NMR data in the GIT data set.
4.4 Results
4.4.1 PC-3 data set
OPLS-DA modelling of the 1H NMR data was used to investigate the differences in
metabolic concentrations between samples obtained from PC-3 xenograft implanted
mice and the matched controls, using a model with one predictive component and
one class-orthogonal component. Complete discrimination between control mice and
xenograft mice was not observed in the OPLS-DA score plot (scores were calculated
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from cross-validation to ensure that over fitting was avoided), see Figure 4.4. How-
ever, there was an underlying difference between the two sample groups, which was
further analysed. The corresponding predictive OPLS coefficients for the OPLS
model provide an interpretation of the difference between the classes in terms of the
chemical shifts that are most influential on the model (Figure 4.4). The 1H NMR
shifts that had the largest influence on the OPLS-DA model (based upon visual
inspection), i.e. those that changed the most between the two classes contained
resonances from the amino acids valine, isoleucine, glutamine, leucine, lysine, ty-
rosine, and phenylalanine together with glucose, 3-D-hydroxybutyrate and acetate
(Appendix A, Table 7.1).
OPLS-DA (one predictive component and one orthogonal component) was used
to analyse changes in protein levels between the control and PC-3 animals based
on the DIGE data. A pattern of class discrimination was observable in an OPLS-
DA model, described by the score plot of the DIGE model, indicating a consistent
difference between the two classes (Figure 4.5), although as with the NMR data,
complete discrimination between the control and disease class was not achieved.
The predictive OPLS-DA coefficients for the DIGE model show several variables of
importance for the discriminant model (Figure 4.5). A list of the most important
proteins/DIGE spots for discrimination between PC-3 and control animals is found
in Appendix A, Table 7.2.
O2PLS modelling
O2PLS modelling was used to integrate and model common covariance patterns
in the 1H NMR and the DIGE data matrices. This approach enables modelling
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Figure 4.4: Cross-validated OPLS-DA scores calculated from the NMR data showing
differentiation between the control and PC-3 xenograft group with the corresponding
OPLS-DA coefficients. Upward oriented signals represent plasma metabolites that
are present in greater concentrations in the PC-3 group and downward facing signals
represent metabolites found in higher concentrations in control plasma. In the OPLS
coefficient plot, the magnitude of the OPLS coefficients are shown from a model with
mean-centred data, while the colouring is proportional to the absolute value of the
OPLS coefficients from a model with mean-centred and unit-variance scaled data99.
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Figure 4.5: Cross-validated OPLS-DA scores calculated from the DIGE data show-
ing differentiation between the control and PC-3 Xenograft group with the corre-
sponding OPLS-DA coefficients. In the OPLS coefficient plot, the magnitude of
the OPLS coefficients are shown from a model with mean-centred data, while the
colouring is proportional to the absolute value of the OPLS coefficients from a model
with mean-centred and unit-variance scaled data99.
Chapter 4. Integrated modelling of omics data 85
and prediction between the data sets based on of how the data matrices share
variance patterns between them, and also enables quantification of the extent to
which they can be predicted from one to the other. An O2PLS model with three
predictive components, five orthogonal components for the NMR data matrix and
three orthogonal components for the DIGE data matrix was calculated. The amount
of variance in the DIGE data that was covarying with the NMR data, expressed as
R2X, was found to be 59.7%, while the amount of variance in the NMR data that
was covarying with the DIGE data (R2Y) was 51.0%. Although the summarising
measurement of predictive ability of the model over all variables (Q2), i.e. ability
to predict DIGE levels from the NMR data and vice versa, was low (9%), we were
able to define subsets of variables where the Q2 level was high (>50%). In other
words, a subset of the variables (metabolites and proteins) in each data matrix is
possible to model and predict using the other, indicated by a high Q2, while ignoring
a majority of variables which do not vary in patterns that allow prediction between
the two data sets. The goodness of prediction (Q2) for each individual variable in
the NMR data is plotted in Figure 4.6A and the equivalent plot of Q2 levels for the
DIGE data is found in Figure 4.6B.
OPLS modelling of individual protein variables
In order to further investigate and confirm the relationships observed between NMR
regions and protein spots, OPLS was used. OPLS models were constructed between
2D-DIGE data spots and individual 1H NMR data peaks that showed the highest
discriminatory power between control and PC-3 animals. This approach provides
a mean of adding further confidence in analysing correlations between NMR and
Chapter 4. Integrated modelling of omics data 86
123456789
0
0.01
0.02
0.03
0.04
0.05
0.06
NM
R 
Si
gn
al 
In
te
ns
ity
≤ 0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
≥ 0.5 
0 50 100 150 200 250 300 350 400
−1
−0.5
0
0.5
1
1.5
2
DIGE Spot Labels
DI
GE
 ra
tio
 (l
og
2)
≤ 0
0.05
0.1
0.15
0.2
0.25
0.3
0.35
0.4
0.45
≥ 0.5
A
Bδ H1
Q2
Q2
Figure 4.6: O2PLS model of NMR and DIGE data (mean centred). A) Q2 values are
indicated by the colour of the NMR spectrum, high Q2 values indicate regions that
are well predicted when using the proteomic (DIGE) data to predict the metabolite
levels (NMR). B) The bar plot describes the DIGE data (average ratio between
PC-3 and control animals) while the colour represents the Q2 value for each DIGE
variable; high Q2 values indicate variables that are well predicted when using the
metabonomic (NMR) data to predict the protein levels (DIGE).
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DIGE variables since we are able to apply cross-validation for the OPLS models. The
separate OPLS models were built by regressing all NMR variables against a single
DIGE variable, as well as by regressing all variables in the DIGE data against one
particular NMR shift. For example, 3-D-hydroxybutyrate was found in significantly
higher concentrations in the plasma of PC-3 mice. Interpretation of the predictive
OPLS coefficients for a model where DIGE data were regressed against the 3-D-
hydroxybutyrate NMR signal (Figure 4.7) allowed the identification of several DIGE
spots with both high positive and negative predictive regression coefficients against
this metabolite. Likewise the OPLS model generated for the tyrosine resonance at δ
6.9 (down regulated in PC-3 animals), showed associations between this metabolite
and several protein spots, Figure 4.8). In both these examples (Figure 4.7 and Figure
4.8) a NMR peak from each metabolite with the least overlap with other peaks was
used in the model, however one could also consider to combine all peaks from each
metabolite, which may improve the signal to noise ration in some circumstances.
The predictive OPLS coefficients provide a means of interpretation of which, and
how, variables in one data matrix, e.g. NMR, relate to the variables in the other
data matrix, e.g. DIGE. In addition to a transparent model, which enables inter-
pretation of the patterns of change, model statistics such as R2 (goodness of fit) and
Q2 (goodness of prediction) yield information about how well the data are modelled
as well as quantitative information relating to the proportion of variance that is pre-
dicted. DIGE spots with a high influence on the regression model for prediction of
the intensity of the δ 2.38 NMR resonance, corresponding to 3-D-hydroxybutyrate,
are listed in Table 7.3 in Appendix A. DIGE spots with high influence on the regres-
sion model for prediction of the intensity of the δ 6.9 NMR resonance, corresponding
to tyrosine, are listed in Table 7.4 in Appendix A. To investigate if there was any
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Figure 4.7: NMR spectral region for the 3-D-hydroxybutyrate resonance at δ 1.20
and δ 2.38 (red NMR spectra represent controls) and predictive DIGE regression
coefficients for the OPLS models, where DIGE data are regressed against the δ 2.38
NMR peak from 3-D-hydroxybutyrate. Upright oriented signals represent proteins
that have a positive covariation with the 3-D-hydroxybutyrate NMR signal. Down-
ward oriented signals represent proteins that have a negative covariation with the
3-D-hydroxybutyrate NMR signal. In the OPLS coefficient plot, the magnitude of
the OPLS coefficients are shown from a model with mean-centred data, while the
colouring is proportional to the absolute value of the OPLS coefficients from a model
with mean-centred and unit-variance scaled data99, indicating those DIGE variables
that are important for predicting the 3-D-hydroxybutyrate abundance.
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Figure 4.8: NMR spectral region for the tyrosine resonances at δ 6.9 and 7.2 (red
NMR spectra represent controls) and the corresponding predictive DIGE OPLS
coefficients for the OPLS models where DIGE data is regressed against the δ 6.90
NMR peak from tyrosine. In the OPLS coefficient plot, the magnitude of the OPLS
coefficients are shown from a model with mean-centred data, while the colouring
is proportional to the absolute value of the OPLS coefficients from a model with
mean-centred and unit-variance scaled data99.
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discriminatory information present in the DIGE-orthogonal (ToPTo ) and residual
(E) part of the NMR data, as defined by the O2PLS model, we used this part of the
variance (ToPTo + E) for discriminant analysis. The OPLS-DA model revealed that
most of the discriminatory variance between classes was found in the predictive com-
ponents. Thus, in this case, the NMR variance described by the DIGE-orthogonal
components and in the residual matrix, describes metabolite variation not related
to class discrimination nor to the DIGE data. The DIGE orthogonal variation in
the NMR data, i.e. that part of the NMR data which was not correlated with the
DIGE data, was added together with the NMR residuals and further analysed by
PCA to elucidate which of the variable regions where high variance between the
samples existed, were not discriminative nor predictable by the DIGE data matrix.
The PCA loading, describing the regions of this variance in the NMR spectra, is
plotted in Figure 4.9, showing that lactate, lipoproteins, TMAO and glucose have a
high PCA loading, describing the main sources of variance not related to the DIGE
data matrix.
4.4.2 GIT data set
Since the GIT data set does not have any obvious classes, unlike the PC-3 data, the
analysis is focused on prediction modelling between the NMR and the microarray
data.
O2PLS modelling
Microarray and NMR data were modelled together using a O2PLS model using all
variables in the two data sets. Both data matrices were mean-centred and Pareto-
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Figure 4.9: A) PCA loadings of the residual matrix added together with the DIGE
orthogonal variation (ToPTo + E) from the O2PLS model between NMR and DIGE
data matrices. High loadings represent NMR regions where variance patterns are
present that are not present in the DIGE data, indicating NMR variables that have
a unique variation pattern, are very variable or are very noisy. B) PCA loadings of
the residual matrix added together with the NMR orthogonal variation (UoCTo +F)
from the O2PLS model between NMR and DIGE data matrices. High PCA loadings
represent DIGE regions where variance patterns are present that are not present in
the NMR data.
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scaled prior to analysis. The O2PLS model was estimated using six predictive
components and zero microarray orthogonal components and three NMR orthogonal
components, based on cross-validation. The overall Q2Y and Q2X values were negative.
To evaluate the results further, the distribution of the Q2 values for each variable in
the microarray and the NMR data was assessed. The distribution of the Q2 values
for the microarray data can be seen in Figure 4.10 (red line), and the equivalent
distribution of the Q2 values for the NMR data can be seen in Figure 4.11 (red line).
This initial model, based on all variables in both data sets, does not indicate reliable
prediction results, and for this reason further interpretation of the model was not
carried out.
O2PLS modelling on a sub-set of variables
In order to evaluate if it is possible to isolate sub-sets of variables in the NMR and
microarray data matrices that may lead to a predictive O2PLS model, a number of
OPLS regression models were estimated, each one using all variables in one of the
data sets (microarray or NMR) to predict one variable at a time in the other data
set (microarray or NMR), see Figure 4.3. To establish a significance level for the
Q2 values, a permutation test was applied, with a total of 10,000 permutations. In
each permuted model a variable was chosen by random from the response matrix
as the response variable. The Q2 values from the initial models were tested against
the null-distribution, as estimated by the permutation test. Variables having a
Q2 value with a p-value < 0.05 were selected in both the NMR and microarray
data matrices. 1249 NMR variables and 1498 microarray variables were selected
using this selection procedure. No correction for multiple testing was applied to the
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p-values in the permutation test, since the main concern was to find a subset of
variables which were related between the NMR and the microarray data. Variable
selection will result in underestimation of the true variability in model parameters
and predictions, since variables with low cross-covariance between X and Y matrices
are likely to be excluded in the variable selection process. To estimate the true
prediction performance of the model after variable selection, it would be essential to
have access to an external test-set to validate the final model, which unfortunately
was not possible in this study.
An O2PLS model was estimated using the selected variables with three predic-
tive components, zero NMR-orthogonal component and one microarray-orthogonal
component. The distribution of the Q2 values for all the microarray variables in this
model can be seen as the blue line in Figure 4.10 whereas the distribution of the
Q2 values for the model with all variables included are depicted by a red line. The
equivalent plot for the NMR data is shown in Figure 4.11. The distributions of the
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Figure 4.10: Distribution of the Q2 values from the O2PLS model including all
variables (red), and an O2PLS model including selected variables (blue), for the
microarray data in the GIT data set.
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Figure 4.11: Distribution of the Q2 values from the O2PLS model including all
variables (red), and an O2PLS model including selected variables (blue), for the
NMR data in the GIT data set.
Q2 values indicate that a fair number of variables are possible to predict. The over-
all Q2 values were also positive for this model (Microarray data: Q2 = 0.17, R2 =
0.55, NMR data: Q2 = 0.13, R2 = 0.64). For interpretation of potential covariation
patterns the score plots from the model can be investigated. Figure 4.12 shows the
predictive scores for the microarray data. It is clear that the first predictive score
vector t1p mainly describes the trend related to the position of the tissue samples
(Antrum to transverse colon). Figure 4.13 displays the predictive scores and the
microarray-orthogonal score for the NMR data, and the same pattern as for the
microarray data was seen here, the variation described in the first predictive score
component primarily appears to relate to the positional trend in the tissue samples,
which is indicated by the marker size in the scatter plot. This suggests that the
first predictive component (latent variable) found in the data relate to the biological
property that the study design was set out to investigate, which is the relationship
between the position of the sampled tissues and the relation to the metabolic and
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gene expression profiles. Interpretation of the score plots was achieved by inspec-
tion of the corresponding weights from the model. An example of a weight plot,
the weights for the first predictive weight component for the NMR data is shown in
Figure 4.14.
4.5 Discussion
Discovering and defining the relationships between quantified bio-molecules from
different biological organisation levels in a biological system is a challenging task,
which has a great potential for improving the way we understand biological infor-
mation and generate biological knowledge. Here a multivariate regression method,
O2PLS, was applied for joint modelling of different omics data sets generated from
the same biological samples. The O2PLS method provides a bi-directional multivari-
ate regression method with an integrated orthogonal signal correction filter, which
handles data sets with more variables than number of observations and provides a
model that is transparent and which thus allows interpretation. The method is suit-
able for modelling and prediction of data sets where the primary interest is focused
on modelling of covariation patterns that are shared between the data sets that are
modelled, as well as detecting and analysing the non-covarying variation in each
data set. The model is based on the assumption of linear latent variables which are
a function of all variables in the data set, which may lead to a model less sensitive to
patterns of variation that are present in very few variables. Since the score compo-
nents are made up of weighted sums of the original variables, highly noisy data with
very few informative variables compared to the number of non-informative variables
may result in a noisy model with poor predictions. In addition to the benefits of a
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Figure 4.12: O2PLS scores relating to the microarray data. Predictive components
1-3 are plotted against each other. Symbol size indicates the type of GIT samples.
The largest symbol size belongs to antrum samples; duodenum, jejunum, ileum and
transverse colon samples are shown in decreasing marker size order. The colour
indicates each individual person participating in the study.
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Figure 4.13: O2PLS scores relating to the NMR data. Predictive components 1-
3 and microarray-orthogonal component 1 are plotted against each other. Marker
size indicates the type of GIT samples. The largest symbol size belongs to antrum
samples; duodenum, jejunum, ileum and transverse colon samples are shown in de-
creasing marker size order. The colour indicate each individual person participating
in the study.
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Figure 4.14: O2PLS predictive weight for the NMR data for the first component.
The upper panel show the mean NMR profile, while the lower panel show the pre-
dictive weights for those variables included in the model after variable selection.
Inset A in the upper panel show a magnification of the region δ 6-9.5, inset B show
a magnification of the region δ 6-7.1.
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transparent model providing opportunity to interpret the influence of the original
descriptor variables on the model, the O2PLS method is relatively fast from a com-
putational perspective. Speed of computation is a factor that can not be neglected
for this type of modelling, especially when dealing with a potentially large number
of data sets, with many variables, and possibly also many observations.
The PC-3 data set which was modelled using the O2PLS method provided
promising results, while it contains very few observations (N=10). Small numbers of
observations is common in many omics data sets, particularly those including pro-
teomics data. In addition to studying the effects of PC-3 tumour implantation on
the plasma metabonomic and proteomic profiles, integrative modelling of proteomic
and metabonomic data was demonstrated for the first time using the multivariate
O2PLS modelling framework.
The O2PLS method requires that the data have been collected in parallel on
samples from the same animals and that the data matrices are as complete as possi-
ble. Using the OPLS modelling framework it was possible to establish co-expression
patterns between metabolite and protein changes in combination in response to dis-
ease. The O2PLS model allowed the separation and quantification of shared and
unique variance between metabolic and proteomic data. In addition, the data could
also be separated or modelled in distinct parts relating to metabolites and proteins
that covary in response to a biological challenge and parts not covarying (residual
and class-orthogonal) i.e. those not affected by the tumour implantation. Where
biological sense can be made out of covarying proteins and metabolites, the change
in protein expression can to some extent validate the change in metabolite levels and
vice versa100. Additionally the appearance of abnormal behaviour in one of the data
matrices, for example an animal with abnormal levels of a particular metabolite can
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be confirmed as being biologically idiosyncratic where the protein expression profile
is also abnormal. However, not all changes in the levels or activities of proteins will
result in a change in metabolite levels in the same tissue at the same time, or even
at all, and the parts of the NMR matrix that do not covary with the proteomic
matrix will include this information.
The second example demonstrating the application of the O2PLS method for
integrated modelling of omics data was the GIT data set, consisting of transcriptomic
and metabonomic data. This data set contains biopsy samples from five different
parts of the gastrointestinal tract, thus the data could be considered to consist of five
distinct classes of samples. In the analysis carried out here, none of the information
related to topology of the biopsies are actually used in the modelling, instead the
focus is put on modelling potential covariation patterns between the NMR and the
microarray data sets without including this prior knowledge. The initial model
including all variables had poor prediction results as seen from the Q2 values. This
may be due to only limited number of variables with covarying information relative
to the number of variables not related between the two data sets. Alternatively, the
poor prediction results could be due to a high number of noisy variables relative
to variables covarying between the two data sets. To investigate this further, a
variable selection procedure was applied prior to the O2PLS modelling. A set of
OPLS models were established and cross-validated, for each response variable, i.e.
for each variable in both data sets, since it was of interest to evaluate the prediction
performance in both directions between the microarray and NMR data sets. The
Q2 values for each variable was estimated using cross-validation, and a permutation
test was applied to elucidate which variables were significantly predicted. In the
subsequent O2PLS model that was established, using only the set of variables that
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were selected, prediction results improved, indicating that a large number of the
initial variables had noisy variation or variation with low, or no, covariation with
the complementary omics data set. However, we can observe that some of the
weights of the included variables (Figure 4.14) may be contributions from baseline
variables where it is hard to distinguish real signals from noise. In the magnified
region of the spectrum (Figure 4.14,inset A and B) it can be seen that there are a
mixture of very low-intensity signals together with what is likely to be noise in the
region 6-9 ppm, where there are also corresponding predictive weights that may be
related to noisy regions in the spectrum. This highlights the importance of model
validation and having access to an external test-set not used in the model estimation
to evaluate the prediction performance (and validity) of the model, unfortunately
no such data-set was available in this study.
The biological interpretation of the GIT data set is out of the scope of this
chapter, which set out to demonstrate how the O2PLS modelling approach could
be used for integrated modelling of multiple data sets, but is interesting for future
studies.
The results from the PC-3 and the GIT data sets indicate that O2PLS models
may be used to model covariation patterns in large omics data sets. Cross-validation
was applied for validation of all multivariate models reported here, which allow
estimation of the predictive ability (Q2) for the models, and thereby ensure that
models are not over-fitted, in addition to providing information about of which
variables were well predicted by the model.
It is expected that the variance described by the orthogonal components has the
potential to provide more information for larger data set, where it is expected that
systematic, but not treatment and/or class related, variation is present to larger
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extent. For example, for a large data set with many observations, one would be
expected to observe metabolites which are varying between animals but independent
of class. Variables showing this type of variation, which is not to be considered as
random biological noise but rather variation linked to some unobserved factors,
might also have systematic covariation in between them, and between biological
organisation levels, which could be further exploited.
Appropriate multivariate data analysis methods, which have the ability to han-
dle high dimensional, collinear and noisy data, used together with data generated
by omics based methods, such as metabonomics, proteomics or transcriptomics,
have the potential to provide improved methods for disease diagnosis in the future.
Here a framework for modelling complex data, derived from multiple analytical plat-
forms was presented and it was also shown that the integration of such data, e.g.
metabolite and protein expression changes, can enable the derivation of statisti-
cal relationships between certain metabolites and proteins from which hypotheses
regarding biological relationships may be formed and subsequently tested.
CHAPTER 5
PIECEWISE MULTIVARIATE
TIME-SERIES MODELLING
In this chapter a new approach for modelling of time-series data with few time-
points and with high-dimensional data is described. This type of data is common in
studies using omics technologies, and here a method is proposed that both facilitates
interpretation of the data as well as enables prediction of the time-point based on
the descriptor data. The chapter starts with putting the problem and the proposed
method into context and continues with a description of the method. Finally, the
method is demonstrated using both a simulated data set and a real world example
from a NMR-based metabonomic toxicity study.
5.1 Introduction
Modelling the time-related behaviour of biological systems is essential for under-
standing their dynamic responses to perturbations. In metabolic profiling studies,
the sampling rate is often restricted due to experimental and biological constraints,
and the time-series are commonly relatively limited (< 20 time-points). In this
chapter, a supervised multivariate modelling method is described, which has the
objective of modelling time-related variation in data originating from short and
sparsely sampled time-series studies.
103
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In many studies applying omics methodologies the biological system is followed
over time, generating a multivariate metabolic time course. For example, staging
of a disease process may be more important than merely detecting the presence or
absence of the disease. The ability to accurately define and predict disease stage
also has obvious application in assessment of response to therapeutic intervention.
Ideally such time-series data should be well-sampled in the time domain and have
an adequate statistical experimental design, which is an essential component for
the outcome of the study and quality of data101. However, for practical reasons,
collection of an optimal dataset is not always possible. In the case of multivariate
time-series data with low sample rate, many classical statistical methods are not
appropriate for analysis and characterisation of the time-related variance due to the
low number of time-points and the inability of many methods to handle multivariate
and multicollinear data. PCA40 (Section 3.2.1) has previously been applied for the
analysis of time-series data in metabonomics102, 103, 96, 62, 104, allowing visualisation
of the main time-related patterns of variation. PCA has the objective of describing
the main variance in the data in a low-dimensional subspace spanned by a few linear
components. Since PCA does not explicitly model time-related variation, it does not
necessarily provide an optimal representation of time-related data. In addition, the
PCA model usually has more than one component, making subtle changes described
over multiple components hard to interpret. PLS regression43 (Section 3.2.4) with
the time as the regressand has also been used for analysis of time-series metabo-
nomic data102, 96, 104, 105, but the assumption of a linear relation between descriptor
variables and time is valid only under some specific circumstances, and not in the
general case. Smilde et al.106 described a generalisation of the ANOVA approach
to the multivariate case for data generated from an experimental design, labelled
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as ANOVA-Simultaneous Component Analysis (ASCA), with application to time-
series data. However, in ASCA the time-related effects are assumed to be linear
in relation to time, which is rarely a valid assumption, and neither does the ASCA
method provide a predictive model. For short and univariate time-series, piecewise
linear modelling methods can be used to describe progression over a time-series,
which is similar in some aspects to the method proposed here for the multivariate
case. Other statistical methods applied for the analysis and modelling of time-series
data in omics biology include Clustering107, Dynamic Bayesian Networks108 and
Batch Statistical Process Control96, 109, 110. Applications of time-series analysis have
been described by Trygg et al.101 in a review of chemometric techniques applied in
metabonomics, and some of the current issues with regard to analysis of time-series
gene expression data were reviewed by Bar-Joseph111.
Here a new method for piecewise multivariate modelling of spectroscopically gen-
erated metabolic time-series data is proposed, which can be used for characterisation
and modelling of short (less than 20 time-points) and sparsely sampled (sampling
frequency is low relative the time-scale of the events studied) time-series data of
high dimensionality. The method is well suited for analysis of spectral data where
variables are intrinsically multicollinear, from e.g metabolic profiling studies, but is
also generally applicable to other types of omics data. The suggested method also
provides descriptive information, enables visualisation and establishes a predictive
model based on time-related variance, putting the focus on effects seen between local
time-points. The proposed method is based on multivariate piecewise models, where
each sub-model describes changes occurring between neighbouring time-points in a
series of time frames over the time course, and the piecewise model is an OPLS69
model. Overall, the set of sub-models describe the time-related changes over the
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full time course, also encompassing the modelling of non-linear changes in relation
to time. Visualisation of the piecewise multivariate model can be accomplished by
investigation of sub-models separately, cumulatively over all time frames and as a
time-trajectory. One can interpret the local changes as the rate of metabolic change
in the time course. This aspect of explicitly investigating the multivariate charac-
teristics of change, together with the magnitude of change over time in a biological
system, has not been explored previously to the knowledge of the author. In ad-
dition, it is shown how this approach can be used for prediction of one or more
time-points along a time-series, based upon measured metabolic profiles. Prediction
of time-points by the model could be used for monitoring disease progression over
time, as well as for evaluation of the efficacy of an intervention, e.g. by assessing
change in predicted disease stage after an intervention.
The results in this chapter are presented in two separate parts; the first describing
the method that has been developed and the second demonstrating the application
of the method for modelling of simulated and metabonomic data.
5.2 Results – method development
With the objective of describing the time-related variance in the data, a set of multi-
variate piecewise models are estimated, describing the transitions between metabolic
states in neighbouring time-points, using the OPLS method. Each model establishes
a function for the transition between two time-points, such a model will be referred
to as sub-model in the following sections. The distinction is made between the piece-
wise approach, consisting of a set of OPLS sub-models, and the OPLS regression
approach where the descriptor matrix is regressed against time, using all time-points
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in a common model, and thus assuming a linear relationship between the data and
time. Let the matrix X[N×K] (for N observations and K descriptor variables) rep-
resent the matrix of descriptor variables, where each observation, e.g. a metabolic
profile, is a row-vector of X. The data vector for time-point i for individual n is
denoted by xn,i. Y is the response matrix [N × M ] (for N observations and M
response variables). T represents the total number of time-points, resulting in T-1
sub-models.
The OPLS method allow the estimation of an optimal model (in the predictive
sense) with a single predictive component for the single y-variable case, contrary to
the PLS model which may have several components if structured Y-orthogonal noise
is present in data. This property of the OPLS algorithm (Section 3.2.6, Algorithm
3), guaranteeing a single predictive component for the single y-variable case, is
utilised in the method proposed here. It confers an advantage compared to other
similar multivariate projection methods, in terms of clearer interpretation of the
model and enabling a straightforward extension to the piecewise model described
here. The simplicity of interpretation is due to the separate modelling of correlated
components and Y-orthogonal components in the OPLS model.
5.2.1 Estimation of piecewise sub-models
Estimation of a multivariate sub-model between time-point i and i+1 can be treated
as a discriminant analysis problem between two time-points, describing the time (Y)
as a function of the input matrix (X). Let the Xi[Ni×K] matrix consist of training
data from time t = i and t = i + 1 with Ni observations, and let the Yi[Ni × 1]
matrix be a dummy matrix of zeros and ones, indicating which observation belongs
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to time-point t = i and t = i + 1 respectively. The OPLS algorithm is described in
closer detail in Section 3.2.6. Essentially it decomposes Xi into a predictive weight
vector, wp,i[K×1], describing the direction in the K-dimensional space between the
two time-points (i and i+ 1), and a predictive score vector, tp,i[Ni×1], representing
the orthogonal projection of X onto wp,i (Equation 5.1). If Y-orthogonal variance
is present in the data, the optimal predictive PLS model would include more than
one PLS component, which in the OPLS model is equivalent to the estimation
of additional Y-orthogonal components in addition to the predictive component
in the model (Equation 5.1). This results in the guarantee of a single predictive
component wp,i, describing the discriminative (locally time-related) direction in Xi,
and Ao Y-orthogonal components with loading matrix Po,i[K×Ao] and score matrix
To,i[Ni×Ao], describing the systematic Y-orthogonal variation present in the data,
if any.
Xi = tp,iw
T
p,i + To,iP
T
o,i + Ei (5.1)
The Y-orthogonal variance may be analysed further, either separately or together
with the X residuals (Ei) to understand the variance patterns present in the data
that are not time-related. This variance may provide information of systematic in-
strumentation errors or of biological variation not directly related to time, which
may still be of interest. In Equation 5.1, wp,i may be interpreted as the direction
of change in the ‘metabolic space’ in the local time frame, describing the transition
between two neighbouring time-points, i and i+ 1. wp,i may also be interpreted as
an approximation to the derivative of the time dependent function of the metabolic
state. wp,i only describes a direction but does not contain any information quanti-
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fying the magnitude of the change in each time frame. An intuitive measurement of
the magnitude of change would be the Euclidean norm of the predictive score vector
‖tp,i‖. However, this may be affected by even moderate outliers and is therefore not
an optimal choice. Instead the median distance in the score space is here used as
the metric for the magnitude of change (Equation 5.2).
di = |median(tp,i)−median(tp,i+1)| (5.2)
wdist,i = wp,idi (5.3)
wdist,i is then defined as wp,i weighted by a scalar (di) defining the magnitude of the
change in the local time frame i (Equation 5.3), thus incorporating the information
about the direction as well as magnitude of change. wdist will be referred to as
the magnitude weights and may be used as a way of describing and visualising the
profile of time-related change in any given sub-model. wdist is also comparable in
magnitude between the different sub models, contrary to wp, which is scaled to unit
norm.
5.2.2 Interpretation of time-related changes in model
By applying elementary vector algebra the cumulative wdist, wdist.cum can be defined,
which represents the total time related changes as described by the sub models
between t = 1 and t = T (Equation 5.4). This provides useful information for
interpretation and visualisation of the time related changes described by the sub-
models over the whole time-series.
wdist.cum,i = wdist,1 + wdist,2 . . .+ wdist,i (5.4)
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wdist.cum provides information on the overall change from a given reference point
(e.g. t = 1). This enables us to not only track the changes in the local time frames,
but also to depict the accumulated change over the time course. This descriptor may
prove to be useful for investigations of systems where there is a change occurring
from a homeostatic state or when studying the recovery over time after a pertur-
bation to establish whether the system either returns to the biological state prior
to the perturbation, or alternatively, to a new state. A return back to the original
biological state would result in a wdist.cumvector close to a vector of zeros. For vi-
sualisation purposes, and to summarise the changes described by wdist.cum vectors,
PCA may be applied on the Wdist.cum matrix to visualise the major patterns in a
low dimensional subspace, describing the main changes in the time-series. The low
dimensional representation of the time-points provides an overview of the relation-
ship and similarity between the temporal states, or stages, rather than modelling
the most variance in the original data, hence providing a less noisy visualisation of
the time-related variation in the data compared to a conventional PCA trajectory.
5.2.3 Prediction of time-points
Time predictions, i.e. predictions of the ‘time-point’ within the modelled time-
domain for new observations, can be done using the estimated model and new data
points represented by e.g. NMR profiles. The prediction algorithm has two steps.
First the sub-model that best fits the new observation is established and within this
sub-model a more detailed time prediction is then made. The decision of which
sub-models fit best to the test-set observation is determined by two probability
distributions. The first is p(tp,test|mi), the distribution for a test-set observation
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(represented by the predicted score, tp,test) to fit to the sub-model (with set of
parameters mi, based on the score (tp)), where the distribution is based upon the
Hotellings T2 statistic estimated from the training data. The second is based upon
analysis of the model residual vector (e). Using the distribution of the residuals
from the training set, the Q-statistic112 can be calculated. Alternatively DmodX113
statistic can be used, which shows similar characteristics. The Q-statistic (Equation
5.5), is based upon the sums of squares of the residuals, which is used to estimate the
parameter of the distribution p(e|mi) for the test-set observation. Q-statistics for
residual analysis have been described by Jackson114, 112. Equations 5.5 -5.10 describe
how the parameter c, which follows an approximate N(0, 1) distribution, can be
calculated114, 112, leading us to the distribution of p(e|mi) ≈ p(Q|mi) (Equation
5.11). In Equation 5.5 etest represent the residual vector for a test-set observation.
In Equation 5.6, ΣEi is the covariance matrix of Ei, which is the residual matrix for
the training data for sub-model i. In Equation 5.11 c’ represent an instance of c as
calculated in Equation 5.10 for a specific test-set observation.
Qtest = e
T
testetest (5.5)
Θi,1 = tr (ΣEi) (5.6)
Θi,2 = tr
(
ΣE2i
)
(5.7)
Θi,3 = tr
(
ΣE3i
)
(5.8)
hi,0 = 1− 2Θi,1Θi,3
3Θ2i,2
(5.9)
c = Θi,1
(
Qtest
Θi,1
)hi,0
− Θi,2hi,0 (hi,0 − 1)
Θ2i,1
− 1√
2Θi,2h2i,0
(5.10)
p(Qtest ≤ q) = p(c ≤ c′), c ∼ N(0, 1) (5.11)
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However, to improve the prediction performance of the model it is of interest
to consider p(Q|mi) together with p(tp|mi) when performing predictions. With this
objective, a heuristic is proposed for combining p(Q|mi) and p(tp|mi) (Equation
5.12). Where p(mi|tp, Q) is to be considered a statistical index, or scoring function,
rather than a probability since p(Q|mi) and p(tp|mi) cannot be guaranteed to be
independent as a full probability model for the data has never been explicitly defined.
Nevertheless, this scoring function is Bayesian inspired. p(mi|tp, Q) is calculated as
described in Equation 5.12 and Equation 5.13, where T − 1 is the number of sub-
models.
p(mi|tp, Q) = z−1p(mi)p(tp|mi)p(Q|mi) (5.12)
z =
∑T−1
i=1 p(mi)p(tp|mi)p(Q|mi) (5.13)
Equation 5.12 provides selection criterion for selecting the sub-model with the best
fit, which is used for the prediction (Equation 5.15). The prior probability of each
sub-model, p(mi) (Equation 5.12), can be used too if there are known prior probabil-
ities for each sub-model, or otherwise assigned uniformly for all sub-models. Time
(Yˆ) is predicted as described in Equations 5.14 and 5.15, where Xpred.new is the
prediction set X matrix after Y-orthogonal variation has been removed, Xpred is
the prediction set matrix, Tpred.o is the Y-orthogonal scores matrix calculated from
Xpred, Ptraining.o represents the matrix of Y-orthogonal loadings derived from the
training X matrix, yoffset,i is equal to time-point i (in sub-model i, which include
time-point i and i + 1), Bi is the matrix of OPLS predictive coefficients for the
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selected sub-model i.
Xpred.new = Xpred −Tpred.oPTtraining.o (5.14)
Yˆ = yoffset,i + Xpred.newBi (5.15)
5.3 Data sets
5.3.1 The simulated data set
To illustrate some of the properties of the piecewise multivariate modelling approach,
a tractable example based on simulated data, which has both linear and non-linear
time-related variation present, was used. A spectral-like data set with 200 spec-
tral variables, 11 time-points, and 100 replicates for each time-point was simulated
using a bilinear model. The data contains two time dependent components, one
non-linearly (u1) and one linearly (u2) related to time, in addition to a constant
component (u3) which contains only random variation (Figure 5.1A), described in
Equations 5.16-5.22. Each one of these three components is related to a specific spec-
tral profile (p1, p2, p3) (Figure 5.1B). Random variation (ε ∼ N(0, 0.1)) was added
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to the time dependent latent variables for each time-point and each observation.
j = 1, 2 . . . 100 (Number of replicates) (5.16)
ε ∼ N(0, 0.1) (5.17)
t = [0, 0.1, 0.2 . . . 1.0] (5.18)
u1,i,j = sin(piti) + εi (5.19)
u2,i,j = ti + εi (5.20)
u3,i,j = 0.5 + εi (5.21)
xi,j = u1,i,jp
T
1 + u2,i,jp
T
2 + u3,i,jp
T
3 (5.22)
Figure 5.1: A) The variation over time for the two time dependent latent variables
(u1,u2) in the simulated data set, and for one variable independent of time (u3). B)
Loading profiles for the latent variables in the simulated data set.
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5.3.2 The Mercury II Chloride data set
The second data set analysed is from a renal toxicity study where Mercury II Chlo-
ride was used to induce renal proximal tubular damage115 in the rat. The study
is a 1H NMR based metabonomic study of rat urine with data from seven sample
collection periods (pre-dose, 0h, 8h, 24h, 48h, 72h, 96h) and included ten animals
in total. Prior to analysis the data were preprocessed using standard methods.
First the spectra were interpolated to a common chemical shift scale using cubic
spline interpolation, due to the potential difference in shift scale due to digitization.
The region corresponding to water and urea resonances (δ4.5 − 6) was excluded
from each spectrum and data were subsequently integrated over adjacent δ0.04 ppm
width bins. Each spectrum was normalised to the total sum of 100 units to reduce
the overall dilution effect due to inter-animal variability in urine excretion rates. A
typical integrated NMR spectrum after preprocessing is shown in Figure 5.2. After
48 hours post treatment, five animals were sacrificed for histopathology analysis,
leaving N=5 animals in the study from 72-96h.
5.4 Results – data analysis
5.4.1 The simulated data set
Principal Component Analysis
Results from PCA analysis (data were mean-centred prior to analysis) of the simu-
lated data are shown in Figure 5.3A-C visualised as a PCA trajectory plot, where the
centroids in the score space are calculated for each time-point and then connected
to form the trajectory (Figure 5.3A). The loading plots for components one and two
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Figure 5.2: A Typical integrated 1H NMR urine spectrum from the HgCl2 data set.
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(Figure 5.3B and 5.3C) show that the two sources of variation in the simulated data
are slightly confounded between the two PCA components.
Figure 5.3: Simulated data set visualised as a PCA-trajectory. A) PCA scores
trajectory plot of component 1 and 2. B) PCA loading component 1. C) PCA
loading component 2.
OPLS regression
The same data set was investigated using the OPLS regression approach and the
simulated spectral data were regressed against time, using one predictive component.
Figure 5.4A shows OPLS predictive weights, indicating the predictive (Y-related)
variation that is described by the OPLS model. As expected, only the leftmost
peak (representing the linear component) in the spectral profile is given any weight
in the model, while the time related, but non-linear component, is not present at
all (compare with Figure 5.1). Predictions of a test-set (an independently drawn
sample from the same distribution and with the same number of observations as the
simulated training data set) using the OPLS model is shown in Figure 5.4B and has
a Root-Mean-Square Error of Prediction (RMSEP) of 9.7%.
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Figure 5.4: OPLS regression modelling of the simulated data set (linear regression
against time). A) OPLS predictive weights (Wp), indicating the parts of the input
data that are modelled. B) Time predictions results for the test-set plotted against
the true time represented as a boxplot.
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Piecewise multivariate modelling
In the piecewise model, the cumulative magnitude weights Wdist.cum illustrate the
cumulative change in the system over the time-series (Figure 5.5A). Figure 5.5B
illustrates the relative magnitude of change (di) in each sub-model, allowing the
magnitude of change in each sub-model to be established. It can be seen that di
approximately traces the gradient of the non-linear time-related component (Fig-
ure 5.1A) as expected. For the time-point predictions, the probability of sub-model
membership was calculated for each of the test-set observations. The probabilities
for all time-points and all sub-models for one time-series are shown as an exam-
ple in Figure 5.5C. The time predictions (RMSEP=6.5%) based on the best fitting
sub-model are displayed in Figure 5.5D in the form of a boxplot, indicating suc-
cessful predictions. The RMSEP is similar to the OPLS regression model, which is
expected in this case since there is one latent variable in the simulated data that is
linearly related to time. Crucially, the linear OPLS regression only models the lin-
early related time variation in the spectral profile, while the piecewise model shows
both the linear and non-linear time-related variation in the data. This provides a
model demonstrating a more complete representation of the time-related variation,
and enables a more comprehensive interpretation of the time-related variation.
5.4.2 The Mercury II Chloride data set
Principal component analysis
To test the method on real data, data from a renal toxicity study where Mercury II
Chloride (HgCl2) was used to induce a proximal tubular damage115 in the rat were
analysed. Results from PCA analysis of the HgCl2 data are shown in Figure 5.6A-
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Figure 5.5: Modelling and prediction of the simulated data set. A) Cumulative
magnitude weights (Wdist.cum) for each sub-model. B) Distance between time-points
in each sub-model (di) C) Probabilities for one observation over all time-points to
belong to each sub-model (in prediction). (D) Predicted time for each observation
in the test-set plotted against the true time represented as a boxplot.
Chapter 5. Piecewise multivariate time-series modelling 121
C visualised as a PCA trajectory plot, where the centroids in the score space are
calculated for each time-point and then connected in chronological order to form
the trajectory (Figure 5.6A). Figure 5.6B and Figure 5.6C show the loading for each
one of the two PCA components shown here. In many instances, the pattern of
change between time-points is a combination of variation in more than one PCA
component, making it hard to interpret the locally unique pattern of change over
different regions of the time-series, especially when these changes are subtle, as
between the time-points 48-96h.
Figure 5.6: Mercury II Chloride toxicity data visualised by PCA. A) PCA score
trajectory plot in component one and two (numerical values indicate time (h) post
dose). B) PCA loading component 1. C) PCA loading component 2.
OPLS regression
The HgCl2 data set was analysed by linear OPLS regression against time using
one predictive component and one time-orthogonal component (based on cross-
validation). Interpretation of the predictive component from the OPLS regres-
sion model against the time provides information about variance linearly related to
time, Figure 5.7A. The predictive performance of the model was evaluated by cross-
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validation, where all time-points from one animal at a time were left out from the
model estimation and used as a test-set, to evaluate time-predictions, Figure 5.7B.
The Root-Mean-Square Error of Cross-Validation (RMSECV) was 22.9%.
Figure 5.7: Mercury II Chloride toxicity data modelled by OPLS regression against
time. A) OPLS predictive weights (Wp) B) Time after administered of HgCl2 plotted
against the time predicted by the OPLS model. Results are shown from cross-
validation where all time-points from one animal at the time was left out from the
modelling to provide the test-set. Each colour indicates the predicted time-points
for one animal.
Piecewise multivariate modelling
The Piecewise multivariate modelling method was applied for modelling of the Mer-
cury II Chloride data. Figure 5.8 shows the magnitude weights (Wdist) (Figure 5.8A)
and the cumulative magnitude weights (Wdist.cum) (Figure 5.8B), describing the
metabolic changes over the time-series. The magnitude weights (Wdist) carry infor-
mation about profile (direction) and magnitude of the changes in each local time
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frame. The cumulative magnitude weights (Wdist.cum) represent the accumulated
metabolic state. Inspection of the magnitude of change in each piecewise model
provides further information about the degree of change at different parts of the
time-course (Figure 5.8C). In this case the largest magnitude of change is occurring
in time frame three (8-24h). The predicted time based on cross-validation, as de-
scribed in the previous section, plotted against the true time-point for each animal
in the study (Figure 5.9A; RMSECV=23.2%), shows a different pattern of predic-
tion results compared to the OPLS time regression model (Figure 5.7B). For the
time-points up to 48h the predictions are relatively good, but as the observation de-
crease from N=10 to N=5 after 48h, the model becomes less reliable as evidenced by
the poorer predictions. One may hypothesise that the different results seen between
the OPLS time regression model and the piecewise multivariate model suggest that
the OPLS time regression model may perform better when very few observations
are available and there are linear time-related variation in the data present. In such
cases, the OPLS time regression model can make use of all information from all time-
points when establishing the model, which is also used for predicting time-points
with few observations available, which may result in a more stable model, unless data
have a non-linear relationship to time. However, important information can still be
extracted, for example animal 18 is clearly a non-responder, which was confirmed
by histopathology data, which showed no renal damage, and clinical chemistry data,
which demonstrated osmolality and glucose levels in the same range as control an-
imals, indicating a negligible effect of the toxin on this animal. Figure 5.9B shows
the probabilities for all time-points of animal 16 for fitting each sub-model, as an
example of how sub-models are chosen. To provide an overview of the time-related
changes, PCA was used to visualise Wdist.cum as a trajectory (Figure 5.9C). The
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Figure 5.8: Mercury II Chloride toxicity data set modelled by piecewise multivariate
modelling. A) Magnitude weights (Wdist) for each sub-model, describing the differ-
ential time related changes in the NMR spectra. B) Cumulative magnitude weights
(Wdist.cum), showing the accumulated changes over the time course. C) Magnitude
of change (di) for each sub-model over the time-course.
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Figure 5.9: HgCl2 toxicity data modelled by piecewise multivariate modelling. A)
Predicted time by the piecewise multivariate model plotted against the true time
after administration of HgCl2. Results are shown from cross-validation where all
time-points from one animal were left out from the modelling to provide the test-
set. Animal 18 (marked by arrow) is a non-responder, which is also indicated by the
prediction results. B) Probability of sub-model membership for each sample for one
animal. C) Visualisation of Wdist.cum as a trajectory in a low-dimensional space,
estimated by PCA.
main information provided by this plot is for assessment of whether the perturbed
system has returned to its starting point, and to provide a visualisation of the over-
all time-events. In Figure 5.9C one can see a trend towards the metabolite profile
returning to a state close to that prior to the administration of HgCl2. However,
over the study duration the recovery was not complete, which may either be due to
presence of irreversible injury inflicted by the toxin or that the time span over which
the study was carried out was too short to allow observation of a full recovery.
5.5 Discussion
A framework for analysis of short time-series multivariate data, typical of post-
genomic (omic) biology has been presented. The method, which is based upon
piecewise multivariate modelling, was demonstrated by analysis of metabolic pro-
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filing data. However, this approach is applicable to other types of omics data as
well. The proposed method facilitates a transparent model allowing straightforward
interpretation of time-related variation in the data over the time course and en-
able prediction of the time-point for new samples. The method has applications
in areas such as monitoring and prediction of disease progression or the effects of
a perturbation over time. An example of such an application could be for moni-
toring of organ transplant patients, where intervention is guided by the metabolic
status of the patient, which can alter according to whether the graft is undergoing
rejection or alternatively if the patient is experiencing toxicity from the immunosup-
pressants administrated116. The piecewise approach makes no assumption of linear
relationship between the data and time and is therefore ideal for the analysis of
non-linear time-related events in a biological system, as exemplified in the analysis
of the simulated and the exemplar HgCl2 nephrotoxin data sets. In comparison to
PCA analysis of the data, the proposed method provides a more detailed picture
of the time-related events including small and local changes. In addition, the pro-
posed method can be utilised for prediction of different stages of time-dependent
biological events, such as disease or a toxic perturbation studied over time with e.g.
initial response phase followed by a recovery from the lesion. In comparison to linear
multivariate regression methods (e.g PLS and OPLS), using the time as a response
variable, the piecewise multivariate approach also models non-linear time-related
variation, producing a model framework describing additional time-related varia-
tion. This could improve the prediction if non-linear variation is dominant, in this
way providing a complement to both PCA and to OPLS regression against time.
PCA provides an overview of the main variation in the data, while OPLS regression
against time models monotonically increasing or decreasing signals over the time
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course. The piecewise OPLS approach provides detailed information of time-related
effects seen locally over the time-course as well as non-linear time-related variation.
The proposed method does not exploit autocorrelation structures in the time-
series and does not provide a tool for forecasting, as do methods like Auto-Regressive
Moving Average (ARMA)117. One reason why ARMA cannot be applied successfully
to the type of data described here is the restricted number of time-points available.
Non-linear modelling approaches, e.g. Artificial Neural Networks or kernel-based
regression methods, differ in the sense that the model is likely to provide good pre-
dictions, while it is hard or impossible to interpret the models in relation to the
descriptor variables. In many biological applications of predictive modelling, it is
essential to have access to transparent models that allow interpretation, rendering
the proposed method beneficial compared to less transparent alternatives. A pos-
sible limitation of the proposed method is handling of time-series samples that are
severely unsynchronised, e.g. high variability in response time between animals after
a perturbation.
A new perspective on the time dynamic data was achieved by placing the focus
on the analysis and comparison of data based on the changes over the time-series, i.e.
the derivative of the time-dependent function. This approach provides new insights
into the dynamics of the biological system, which may otherwise have been over-
looked. The method could also provide the basis for fast and large-scale comparison
of biological responses studied over time due to different types of perturbations. This
can be accomplished by means of comparison of the piecewise weights between sub-
models, which can be seen as a multivariate representation of the time-dependent
events taking place in the biological system. The common case of data sampled
in a synchronised fashion has mainly been discussed in this paper. The method
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could easily be modified to handle cases where individuals in the training set are
not sampled at the same time-points, but where the sampling time is known. In this
case the sub-model will be a regression model instead of a discriminant model. In
such cases, the boundaries of the local time frames will be chosen so that they are
sufficiently local and overlapping in the time domain. If changes between subsequent
time-points are very small and noisy, while the number of time-points is not limit-
ing, the same approach can be applied by treating some neighbouring time-points
together in a common time-frame when estimating sub-models.
Given short time-series data of high dimensionality, the proposed multivariate
piecewise approach provides more detailed information compared to other commonly
applied multivariate methods for analysis of post-genomic data. The temporal res-
olution for interpretation of the model is enhanced in the sense that it is easier to
conclude which changes occur over time and when they occur, improving the inter-
pretation of the data and providing a tool for the understanding of the biological
system. The method also allows time predictions, which is an important feature in
many biological and clinical applications, where time may be associated with for
example disease stage, and interventions are evaluated in relation to the disease
stage.
CHAPTER 6
NON-LINEAR KERNEL-BASED
PREDICTION MODELLING
In this chapter a novel method for non-linear multivariate prediction modelling is
presented. The OPLS method has been reformulated as a kernel-based method,
utilising the so-called ‘kernel trick’. First the proposed method is put into context
by outlining the principles behind kernel-based methods, before describing the algo-
rithm in detail. The Kernel-OPLS (K-OPLS) method is thereafter demonstrated on
both simulated and real data, with focus on demonstrating both the ability of the
K-OPLS method to model non-linear data as well as providing a model that enables
interpretation. The development of the K-OPLS method was done in collaboration
with Max Bylesjö† and the method has been published in Rantalainen et al. 2007118.
6.1 Introduction
OPLS regression72, 73, 69 (Section 3.2.6) exploits the notion of latent variables51 to
characterise the relationship between the descriptor matrix X[N × K] (where N
equals to the number of observations and K equals to the number of descriptor
variables) and the response matrix Y[N ×M ] (where M equals to the number of
† Research Group for Chemometrics, Department of Chemistry, Umeå University, Umeå, SE-901
87, Sweden
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response variables). The OPLS method generally enhance the interpretation com-
pared to PLS, since the predictive score and loading vectors are free from systematic
variation unrelated to the variation in Y.
In the case of chemical and biological systems, situations where the relation-
ship between X and Y display non-linear characteristics are frequent. If prediction
of Y is the primary objective, these characteristics must be acknowledged during
model construction. A common strategy has been to explicitly extend X accord-
ing to a lower-order polynomial function, incorporating e.g. quadratic terms119, 120.
However, such explicit transformation of the data can be computational costly, par-
ticularly if the input data X is of high dimension, which is the case in many biological
applications.
Consider the transformation of the original data from the input space X ∈ RK
into a higher-dimensional feature spaces F ⊆ RK∗ by a mapping function φ(·),
defined as xi ∈ RK 7→ φ(xi) ∈ F ⊆ RK∗ ∀i = 1 . . . N (where xi represents row
vector i in X). The implicit expectation is that the applied mapping function φ(·)
will lead to an improved linear correlation between φ(X) and Y in the feature space
F . As previously described in Section 3.2.9 the explicit calculation of φ(X), which
may be of high dimensionality, is likely to be a limiting factor both in terms of
computational complexity and of memory requirements. By utilising the so-called
‘kernel trick’76 one can avoid explicitly mapping X to higher-dimensional spaces,
as well as computing dot products in the feature space, which is computationally
beneficial. Let us define dot products as κ(x,y) = 〈φ(x), φ(y)〉, known as the kernel
function. Now only the kernel matrix K with entries Ki,j = κ(xi,xj) (where xi
and xj corresponds to the ith and jth row vector respectively in the descriptor
matrix X) require explicit calculation. Note the distinction between κ(·), which is
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a function; K, which is a scalar; and K, which is a [N ×N ] matrix. The choice of
kernel function is evidently important as it determines the transformation type and
characteristics of the feature space F . Frequently employed kernel functions involve
polynomial kernels or radial basis kernels78, which will be defined at a later stage.
Kernel-based methods for pattern analysis can be described in a modular fashion
at the conceptual level (Figure 6.1), where the distinction can be made between the
mapping of the input data matrix X ∈ RK into some feature space F ⊆ RK∗ and
the subsequent pattern analysis stage (in this case by K-OPLS). Through modu-
larisation, flexibility can be achieved in terms of choice of kernel function as well
as modelling algorithm to adapt to the specific objectives of the modelling and
properties of the data.
X κ(x
i
,x
j
) K K-OPLS
K-OPLS
model
Input data Kernel Matrix Model Algorithm ModelKernel Function 
Figure 6.1: Overview of the separate parts of the K-OPLS modelling framework,
illustrating the modularised nature of kernel-based methods.
Kernel-based versions of the traditional NIPALS PLS algorithm, KPLS, have
been described in the literature121, 122. The general idea has been to reformulate
the algorithm to involve calculations of XTX[K ×K] or XXT [N × N ] as replace-
ments of X as this may enable a more compact representation of X, depending on
the relation between N and K. Although the dominating motivation underlying
the development of KPLS was computational speed and reduced memory require-
ments, the progress indirectly enabled extensions to handle non-linear correlations
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between descriptor and response variables. An early example of such an extension
in a chemometric context is the radial basis function PLS (RBF-PLS), which was
introduced by Walczak and Massart123. The authors employed an activation matrix
A [N ×N ] to solve arbitrary non-linear problems with a reformulation of the PLS
algorithm. This activation matrix is equivalent to the kernel Gram matrix K em-
ployed here, calculated using a specific kernel function (the radial basis function).
The generalisation of KPLS and the relation to other kernel-based methods has been
formalised in recent work by Rosipal and Trejo80.
Here a reformulation of the original OPLS algorithm is outlined to support util-
isation of the kernel trick and consequently handle non-linear modelling of the rela-
tionship between descriptor and response variables. Specifically, instances of φ(X)
are rearranged in terms of the kernel Gram matrix K, with entries Ki,j = κ(xi,xj),
in order to fully support higher-order transformations. The reformulation has con-
siderable effects on the remaining steps in the OPLS algorithm, which are described
in detail. The main focus in the remainder of the text will be on formulating and
describing the K-OPLS algorithm. To demonstrate the unique properties of the
K-OPLS algorithm, two simulated data sets are employed; one illustrating a regres-
sion scenario and one a discriminant analysis case. In addition, results are shown
from modelling of one NMR spectroscopy based metabonomic data set to demon-
strate properties and behaviour of the K-OPLS method in a real application. It
is illustrated how the unique properties of the original OPLS method, for instance
interpretation of the predictive and Y-orthogonal score vectors, are maintained in
K-OPLS models, while also improving the predictive performance when non-linear
relationships exist between descriptor and response variables. Benchmarking of pre-
dictive performance against other alternative methods will not be considered here,
Chapter 6. Non-linear kernel-based prediction modelling 133
as this subject is peripheral to the aim of the work and largely handled elsewhere124.
The results in this chapter are presented in two separate parts; the first describing
the method that has been developed and the second demonstrating the application
of the method for modelling of simulated and metabonomic data.
6.2 Results – method development
6.2.1 Notation
In addition to the notation used throughout this thesis, this chapter has a more
complex notation that facilitates the description of the K-OPLS algorithm being
presented, Table 6.1 provides a complete list of symbols used in this chapter.
6.2.2 Centring of kernel matrices
The kernel matrices were centred prior to model estimation. Equation 6.1 describes
how the training kernel matrix is centred. Equation 6.2 describes the centring of
the prediction set kernel matrix.
Ktr,tr = (Itr − 1
Ntr
1tr1
T
tr)Ktr,tr(Itr −
1
Ntr
1tr1
T
tr) (6.1)
Kte,tr = (Kte,tr − (1/Ntr)1te1trTKtr,tr)(Itr − (1/Ntr)1tr1trT ) (6.2)
6.2.3 K-OPLS model estimation
The details of the OPLS algorithm, which is suitable for the linear case, can be
found in69, 72, 73 and in Section 3.2.6. The OPLS algorithm essentially consists of two
main parts: the estimation of the predictive weight matrix (Wp) and the iterative
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Table 6.1: Notations (K-OPLS)
Notation
Ntr = Number of observations in training data (scalar)
Nte = Number of observations in test data (scalar)
M = Number of response variables (scalar)
K = Number of input variables (scalar)
Itr = Identity matrix of dimension [Ntr ×Ntr]
Ite = Identity matrix of dimension [Nte ×Nte]
1tr = Column vector of ones of length Ntr
1te = Column vector of ones of length Nte
A = Number of predictive components (scalar)
Ao = Number of Y-orthogonal components (scalar)
Kj,itr,tr =Kernel descriptor matrix (training-training) of deflation order i and j
respectively of dimension [Ntr ×Ntr]
Kj,ite,tr =Kernel descriptor matrix (test -training) of deflation order i and j
respectively of dimension [Nte ×Ntr]
Ytr = Matrix of response variables, of dimension [Ntr ×M ]
Xtr = Matrix of descriptor variables, of dimension [Ntr ×K]
Yte = Matrix of response variables, of dimension [Nte ×M ]
Xte = Matrix of descriptor variables, of dimension [Nte ×K]
Tiptr =Predictive X training score matrix from deflation step i of dimension
[Ntr × A]
Tipte =Predictive X test score matrix from deflation step i of dimension [Nte×
A]
tiotr =Y-orthogonal X training score vector i of dimension [Ntr × 1]
tiote =Y-orthogonal X test score vector i of dimension [Nte × 1]
Up = Y score matrix of dimension [Ntr × A]
Cp = Y loading matrix of dimension [M × A]
cio = Y-orthogonal loading vector i of dimension [A× 1]
Σp =[A × A] matrix with the diagonal containing the eigenvalues when esti-
mating predictive components
σio =Scalar containing the eigenvalue from estimation of Y-orthogonal compo-
nent i
Bt = Matrix with the Up −Tp regression coefficients of dimension [A× A]
Wp = X predictive OPLS weights matrix of dimension[K × A]
Wo = Y-orthogonal OPLS weights matrix of dimension[K × Ao]
E = X residual matrix of dimension[Ntr ×K]
R = Real numbers
EVD(A, a)=Eigenvalue decomposition of the symmetric matrix A, extracting
a eigenvectors corresponding to the a largest eigenvalues
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estimation of a set of Y-orthogonal weight vectors, forming the Y-orthogonal weight
matrix Wo. Subsequent to the estimation step of each Y-orthogonal component,
the X matrix is deflated by the Y-orthogonal variation, followed by a subsequent
updating of the predictive score matrix Tp and estimation of further Y-orthogonal
components if required. The K-OPLS algorithm follows the principles of the linear
OPLS algorithm, but expressed in dual form. This implies that all expressions have
been rewritten so that the input matrix X is expressed as the inner products between
pairs of the observations, XXT (for the case where N << K). The matrix XXT is
subsequently replaced by the kernel matrix K in the K-OPLS algorithm. Specific
care has to be taken in how K is deflated for the Y-orthogonal components. In
simple terms, in the algorithm for model estimation, K consists of two instances
of the (transformed) data matrix. One of these instances represents the predictive
weights (Wp) and should thus be retained throughout the calculations, whereas the
other should be deflated according to the Y-orthogonal variation. Let Kj,i denote
different deflated generations i and j of K, where K1,1 is the original kernel Gram
matrix. The first instance of K: K1,i is used when implicitly using the predictive
weights in calculation of the predictive scores. The second instance of K: Ki,i, is
used for the estimation of Y-orthogonal components. Algorithm 5 outlines how
the K-OPLS model is estimated from the training set. Algorithm 6 shows pseudo
code describing the K-OPLS algorithm and how each step relates to the OPLS
algorithm. For the special case where the kernel function is linear, results are
theoretically identical for the predictive and Y-orthogonal score matrices compared
to the linear OPLS algorithm. In this context, it is worth mentioning that one of the
main consequences of the kernel implementation of OPLS is that none of the OPLS
model loadings relating directly to the descriptor variable space of X (e.g. Wp,Wo,
Chapter 6. Non-linear kernel-based prediction modelling 136
Algorithm 5 Estimation of K-OPLS model
1: (Cp,Σp)← EVD(YTK1,1tr,trY, A)
2: Up ← YCp
3: for i = 1 to Ao do
4: Tiptr ← K1,itr,tr
T
UpΣ
−1/2
p
5: (cio, σ
i
o)← EVD(Tiptr
T
(Ki,itr,tr −TiptrTiptr
T
)Tiptr , 1)
6: tiotr ← (Ki,itr,tr −TiptrTiptr
T
)Tiptrc
i
oσ
−1/2
o
7: ‖ tiotr ‖←
√
tiotr
T tiotr
8: tiotr ← tiotr/ ‖ tiotr ‖
9: K1,i+1tr,tr ← K1,itr,tr(Itr − tiotrtiotr
T
)
10: Ki+1,i+1tr,tr ← (Itr − tiotrtiotr
T
)Ki,itr,tr(Itr − tiotrtiotr
T
)
11: end for
12: TAo+1ptr ← K1,Ao+1tr,tr UpΣ−1/2p
13: Bt ← (TAo+1ptr
T
TAo+1ptr )
−1TAo+1ptr
T
Up
etc.) can be calculated explicitly. Instead, such parts of the model are rewritten in
the algorithm to encompass the kernel implementation. This is obvious since the
kernel trick is utilised, and thus only the inner product space is utilised in the model
estimation. As a consequence, the explicit mapping of X to the feature space F is
avoided. The choice of kernel function is important and depends on properties of
the data as well as on the assumptions and purpose that underlie the modelling.
A few commonly used kernels functions include the Gaussian radial basis function
(Equation 6.3), the polynomial kernel (Equation 6.4) and the linear kernel function
(Equation 6.5). For additional examples of kernels and their properties see78, 125, 126.
κ(x,y) = exp(
−‖x− y‖2
2σ2
) (6.3)
κ(x,y) = (〈x,y〉+ 1)p, p ∈ R (6.4)
κ(x,y) = 〈x,y〉 (6.5)
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Algorithm 6 Estimation of K-OPLS model - pseudo code and relation to the OPLS
algorithm
1: Calculate A predictive components by eigenvalue decomposition of YTKY {Cor-
responding to singular value decomposition of YTX in OPLS algorithm}
2: Calculate Y-scores {Same in OPLS algorithm}
3: for each Y-orthogonal component - if any {Same in OPLS algorithm} do
4: Calculate predictive score {Corresponding to Tp ← XWp in OPLS algorithm}
5: Calculate a Y-orthogonal component {Corresponding to singular value de-
composition of ETTp in OPLS algorithm}
6: Calculate a Y-orthogonal score vector {Corresponding to to = Xwo in OPLS
algorithm}
7: Calculate the norm of the Y-orthogonal score vector {Not applicable in OPLS
algorithm}
8: Normalise the Y-orthogonal score vector {Not applicable in OPLS algorithm}
9: Deflate the Wp−related kernel matrix in one direction for the Y-orthogonal
variation {Not applicable in OPLS algorithm}
10: Deflate the kernel matrix in both directions for the Y-orthogonal variation
{Corresponding to deflation of X for the Y-orthogonal variation in OPLS
algorithm}
11: end for
12: Calculate the updated predictive score matrix using the deflated kernel matrix
{Corresponding to Tp ← XWp using the X matrix which is deflated by the
sequential removal of Y-orthogonal variation in the OPLS algorithm}
13: Calculate the Up −Tp coefficients {Same in OPLS algorithm}
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6.2.4 Prediction by the K-OPLS model
Predictions using the K-OPLS model are accomplished as described in Algorithm
7, where the calculation of predicted scores and response variables are outlined.
Pseudo-code for the prediction algorithm can be found in Algorithm 8, where each
step is related to the OPLS algorithm.
Algorithm 7 Prediction by the K-OPLS model
1: for i = 1 to Ao do
2: Tipte ← Ki,1te,trUpΣ−1/2p
3: tiote ← (Ki,ite,tr −TipteTiptr
T
)Tiptrc
i
oσ
i
o
−1/2
4: tiote ← tiote/‖ tiotr ‖
5: Ki+1,1te,tr ← Ki,1te,tr − tiotetiotr
T
(K1,itr,tr)
T
6: Ki+1,i+1te,tr ← Ki,ite,tr −Ki,ite,trtiotrtiotr
T − tiotetiotr
T
Ki,itr,tr + t
i
otet
i
otr
T
Ki,itr,trt
i
otrt
i
otr
T
7: end for
8: TAo+1pte ← KAo+1,1te,tr UpΣ−1/2p
9: Yˆ ← TAo+1pte BtCTp
Algorithm 8 Prediction by K-OPLS model - pseudocode and relation to the OPLS
algorithm
1: for each Y-orthogonal component - if any {Same in OPLS algorithm} do
2: Calculate predictive score Tp {Corresponding to Tp ← XWp in OPLS algo-
rithm}
3: Calculate a Y-orthogonal score vector {Corresponding to to = Xwo in OPLS
algorithm}
4: Normalise the Y-orthogonal score vector {Not applicable in OPLS algorithm}
5: Deflate the kernel matrix K in one direction for the Y-orthogonal variation
{Not applicable in OPLS algorithm}
6: Deflate the kernel matrix K in both directions for the Y-orthogonal variation
{Corresponding to deflation of X for the Y-orthogonal variation in OPLS
algorithm}
7: end for
8: Calculate the updated predictive score matrix using the deflated K {Corre-
sponding Tp ← XWp in OPLS algorithm, where X is deflated by the sequential
removal of Y-orthogonal variation}
9: Calculate the estimated Yˆ {Same in OPLS algorithm}
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6.2.5 Implementation
I have implemented the K-OPLS algorithm for MATLAB and R in collaboration
with Max Bylesjö. The code is available at http://www.sourceforge.net/projects/kopls/.
The package, which is licensed under the GNU GPL license, includes essential func-
tionality and documentation for model evaluation (using cross-validation), training
and prediction of unknown samples. Also incorporated is a set of diagnostic tools
and plot functions to simplify the visualisation of data, e.g. for detecting trends or
for identification of outlying samples.
6.3 Data sets
6.3.1 The regression data set
The Swiss roll is a classical ‘toy’ example in non-linear regression modelling where
one wants to predict a response, starting from the centre of the roll and expanding
gradually outwards. This is depicted in Figure 6.2A-B for a simulated instance with
1000 observations where the response values range from 0 to 100%. The calibration
task is to use X [1000×2] (Figure 6.2A) to explain and predict Y [1000×1] (Figure
6.2B).
6.3.2 The classification data set
Classification of circular data structures, shown in Figure 6.3, is frequently used to
produce classification problems that require non-linear modelling techniques (see for
instance 124). In this case, we have added some complexity to the original problem
by assuming that the simulated variables shown in Figure 6.3 are score vectors
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Figure 6.2: In A) a simulated instance of the Swiss roll regression problem is de-
picted. In B) the response, starting at the centre of the roll and gradually expanding
outwards, is shown on the third axis.
T[500 × 2] (including Gaussian noise) and that the loadings are arbitrary spectral
profiles PT [2×1000] (not shown). The modelled data matrix is X = TPT [500×1000]
in the original space. The response vector y is set to +1 for all instances of class
1 (outer-most circle) and −1 for all instances of class 2 (inner-most circle). For
the purpose of generalisation, the response vector will be treated as a single-column
matrix Y[500× 1] in the following text.
6.3.3 The ANIT data set
This data set consist of 1H NMR data from a hepato-toxicty study using α-naphthyl-
isothiocyanate (ANIT), which induces cholestatic hepatitis in rat. The study is a
1H NMR based metabonomic study of rat urine with data from seven time points
(pre-dose, 0h, 8h, 24h, 48h, 72h, 96h), with ten animals in total. Prior to analysis,
the data were preprocessed using standard methods. First the spectra were inter-
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Figure 6.3: A simulated instance of data for the classification problem.
polated to a common chemical shift scale using cubic spline interpolation, due to
the potential difference in shift scale due to digitization. The region corresponding
to water and urea resonances (δ 4.5-6) was excluded from each spectrum and data
were subsequently integrated over adjacent 0.04 ppm width bins. Each spectrum
was normalised to the total sum of 100 units to reduce the overall dilution effect
due to inter animal variability in urine excretion rates. After 48 hours five animals
were sacrificed, rendering N=5 animals to be left in the study after 48h.
6.4 Results – data analysis
The properties and strengths of the K-OPLS method are illustrated by means of two
classical non-linear problems (simulated data) and one real-world calibration prob-
lems. The first simulated data set is a non-linear regression task whereas the second
is a classification problem where linear solutions are clearly insufficient. In addition
an example from a metabonomic toxicity study, where the K-OPLS ability to also
allow detection of unexpected variation patterns in data is demonstrated. Apart
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from the obvious task of generating predictive models, focus was placed on display-
ing the unique features in traditional linear OPLS, for instance that interpretation
of Y-orthogonal scores are still feasible in the K-OPLS model.
6.4.1 The regression problem
A K-OPLS model, with K calculated by the Gaussian kernel function, was fitted
using one predictive component and five Y-orthogonal components. The model
and kernel parameters were set mainly for illustrative clarity, and not necessarily to
minimise the generalisation error. The predictions for the training data as well as
an independent test set drawn from the same distribution as the training data are
shown in Figure 6.4A. The root mean squared error for the test set (RMSEP) was
1.34%, indicating that the predictions have excellent accuracy.
One can additionally utilise model residuals to categorise the reliability of the
predictions. In the K-OPLS model, the residual matrix E is available in the form of
the deflated kernel matrix K (equivalent to φ(E)φ(E)T [N×N ]), i.e. expressed in the
dual form compared to traditional PLS or OPLS models. Tr
(
φ(E)φ(E)T
)
describes
the squared estimates of the residual for each observation, which can be seen as a
distance to the model. Many distance-based alternatives for residual analysis exist
in the literature (see for instance127 and references therein), although the majority
are based on underlying assumptions of some known distribution. Here, I utilise
a simple non-parametric estimate from the empirical cumulative density function
of the squared residuals of the training data, scaled to a cumulative probability
density function. Based on this estimate, one can assign a probability of belonging
to the model for any observation given the squared residuals from the model. This
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is shown in Figure 6.4B, where the model has been probed at various positions for
subsequent assessment of model residuals and probability of belonging to the model.
This simple strategy clearly shows how residual information can also be useful for
assessing reliability of predictions for the kernel-based OPLS method.
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Figure 6.4: In A) a K-OPLS model has been constructed and used to predict the
response. In B) the probability of belonging to the K-OPLS model is shown for a
set of observations within and outside the roll.
6.4.2 The classification problem
A K-OPLS model, with K calculated by the Gaussian kernel function, was fitted
using one predictive component and one Y-orthogonal component. Model and kernel
parameters were set mainly for illustrative clarity, not necessarily to minimise the
generalisation error. A heatmap of the absolute predicted response values |Yˆ| is
shown for an external test set in Figure 6.5, where the dark region between the
classes constitutes a decision boundary for the model. Perfect discrimination is
achieved for both the training data as well as the test data.
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Figure 6.5: |Yˆ| is shown for a predicted external test set, where the dark region
between the classes constitutes a decision boundary for the model.
In Figure 6.6A, Y-orthogonal variation has been added, causing the circular
structure to become distorted, primarily for class 1. Using the same model settings
as in the previous example, 96.5% and 100.0% of the observations of an external test
set are correctly classified for class 1 and class 2, respectively. The Y-orthogonal
variation from the model is shown in Figure 6.6B, where one can see how the high
within-class variance of class 1 is clearly captured by the magnitude in the first
Y-orthogonal score vector t1o. This implies that Y-orthogonal variation can still
be interpreted to detect systematic trends and outlying samples. This ability to
separate predictive from Y-orthogonal variation is a unique property of the OPLS
and K-OPLS methods and can be highly beneficial for interpretational purposes.
This subject will be further elaborated in the discussion (section 6.5).
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Figure 6.6: In A) the simulated data in Figure 6.3 has been extended with Y-
orthogonal variation, causing primarily class 1 to become distorted. In B) The
first predictive and Y-orthogonal score components are shown, depicting how the
Y-orthogonal variation is captured by the K-OPLS model.
6.4.3 The ANIT data set
The objective of the modelling was to establish a regression model for prediction
of the time (h) after dosing. A K-OPLS model was fitted using a Gaussian kernel
with σ = 5, 1 predictive and 3 Y-orthogonal components, using the time as the
response variable. Seven-fold cross-validation was used to evaluate the predictive
power of the model. The model statistics R2X = 0.586, R2Y = 1.000 and Q2Y = 0.450,
indicate a moderate predictive power. Figure 6.7 shows the second Y-orthogonal
scores (t2o) plotted against the predictive scores (t1p). In Figure 6.7 it can be observed
that one animal is deviating from the rest, seen in time points 48h, 72h and 96h
for animal 4808 (orange colour), which is showing a high Y-orthogonal score on
the second Y-orthogonal score component (t2o) in comparison with the rest of the
samples, highlighting the unique property of K-OPLS to separately model predictive
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and Y-orthogonal variation.
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Figure 6.7: The second Y-orthogonal component t2o is plotted against the first K-
OPLS predictive component t1p. Each circle represents one animal at one time point,
the size of the circle is proportional to the time point of the corresponding sample,
the colour is based on the animal identifier and the numbering of each circle indicates
the sampling time-point (h) post dose (-16h indicates pre-dose samples).
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6.5 Discussion
There are numerous examples of biological and chemical systems where linear regres-
sion methods are insufficient to characterise and subsequently predict the estimated
behaviour128, 129, 130. The traditional way to handle non-linear problems in chemo-
metrics has been to extend the X matrix explicitly by some function φ(X), for
instance to incorporate quadratic terms119, 120 or lower-order polynomial terms in
X. However, if more complex transformations are required, the dimensionality of
φ(X) may be a limiting factor. This is the case both computationally and in terms
of memory requirements, particularly if the number of input variables K is high.
It has been shown how this can be circumvented by utilising the kernel trick to
avoid explicit mapping of X to higher-dimensional spaces, which is computationally
advantageous. The presented method, kernel-based orthogonal projections to latent
structures (K-OPLS), can separate predictive from Y-orthogonal variation in the
feature space F without explicitly calculating φ(X) ∈ F . Thus, while maintaining
the OPLS model framework, it is possible to solve problems of arbitrary complex-
ity by employing a suitable kernel function. The utility of the method has been
demonstrated using two toy examples where linear methods are clearly insufficient,
the examples show how the K-OPLS method handles the predictions by means of
the matrix kernel function κ(·). Should the data be (largely) linear, the special case
φ(X) = X can be exploited to produce theoretically identical result compared to
traditional OPLS using less memory in the model estimation. K-OPLS was also
demonstrated on data from a 1H NMR spectroscopy based metabolic study, where
the benefits of K-OPLS was highlighted by an example where interpretation of the
Y-orthogonal variation allowed the detection of an outlying animal.
Chapter 6. Non-linear kernel-based prediction modelling 148
In this chapter the K-OPLS algorithm was described and demonstrated. The
illustrated examples aim to provide a motivation for the potential usage of non-
linear transformations, but not to provide a comprehensive benchmarking platform
to claim the superior predictive capabilities of the K-OPLS method. In fact, for the
case where M = 1 the predictions are equivalent to KPLS80 and very similar for the
case where M > 1. Comparison of KPLS to for instance support vector machines
(SVMs)131 are already available elsewhere124 describing how the differences in terms
of classification rates are negligible in the general case considering that the same
kernel function is employed. Consequently, these results also apply to K-OPLS
where a corresponding number of latent variables have been utilised.
Similar strategies to the one presented here exist in the literature, where a re-
cent paper by Kim et al.132 is of particular interest. The authors combine orthogonal
signal correction, performed in the linear domain, with KPLS, performed in some
high-dimensional space (OSC-KPLS). This has the unfortunate effect that the score
vectors derived from the first (OSC) step has no clear relation to the score vectors
derived from the second (KPLS) step. In the presented approach, derived score vec-
tors, both predictive and Y-orthogonal, are mutually orthogonal, which is consistent
with the traditional OPLS interpretation. The OSC-KPLS approach may, as in one
out of three illustrated examples132, be beneficial in terms of predictions but there
are no underlying theoretical foundations to claim that this is generally the case.
A drawback using any method where the kernel trick is employed lies in the
subsequent model interpretation. For non-linear use of K-OPLS, predictive and Y-
orthogonal score matrices Tp and To are still valuable for detecting general trends,
clusters or outlying observations. This is shown in Figure 6.6B, where class-specific
systematic variation is captured in the Y-orthogonal score vector t1o and in Figure 6.7
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where some unanticipated pattern in the second Y-orthogonal component could be
observed for three of the time-points from one animal in the study. Such effects are
neither easily detected nor explicitly modelled by other commonly used kernel-based
method, e.g. KPLS or SVMs. Furthermore, the difference in magnitude in t1o could
be utilised for classification purposes, which has recently been demonstrated for
OPLS discriminant analysis70. Depending on the choice of kernel function, however,
the corresponding predictive loading vectors Pp = φ(X)
TTp may be undefined, or
at best difficult to interpret. Consider the case where the data is transformed using
the Gaussian kernel function. The dimensionality of Pp will be considerably higher
than K and thus complicated, if not impossible, to relate to the original variables.
Evidently, one can calculate Pp = XTTp although the effects are not clear-cut as
Tp has been derived from the feature space F , not from the original space. When it
comes to variable ranking and selection in neighbouring fields of machine learning,
a general approach has been to sequentially remove subsets of variables from the
(original) data in X and then estimate the impact based on the predictive ability of
the reduced model.
The choice of kernel function and its parameters are central to the successful
modelling of data when using any kernel based method. An interesting property
of the K-OPLS method is the opportunity to explore the relation between kernel
function optimisation and the characteristics of the Y-orthogonal variation that is
modelled. In cases where a sub-optimal kernel function is applied, more variation
may end up as structured Y-orthogonal variation, this is an interesting area for
future work. In the case where an optimal kernel function is used, in the sense
that it is directly incorporating all structured variation, no Y-orthogonal variation
should be present in the model. However, this case may never arise since the same
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kernel function is applied over all variables in the data, and a kernel function that
is optimal in all aspects is likely not to exist.
The K-OPLS method could also be applied as an OSC filter (see Section 3.2.5).
In this case the Y-orthogonal variation is extracted from the kernel matrix (K), and
the filtered K could subsequently be used with any other kernel based algorithm of
choice. This type of application would be in analogy with the benefits of using
OSC methods in the input space. Consequently, applying an Y-orthogonal filtering
method in the feature space would be expected to have similar benefits.
The K-OPLS method that has been outlined in this chapter has the potential to
improve predictive performance noticeably compared to a linear method when non-
linear relations exist between descriptor and response variables. In cases where these
associations are linear, K-OPLS generates equivalent results as the traditional OPLS
method. The complexity issues involved in data transformation are circumvented
by utilising the kernel trick to avoid explicit mapping of X into higher-dimensional
spaces. The presented K-OPLS strategy maintains the OPLS framework, thus sep-
arating the modelling of predictive and systematic Y-orthogonal variation between
the X and Y matrices and providing the potential benefit of enabling separate
interpretation of these two parts of the K-OPLS model.
CHAPTER 7
CONCLUSIONS AND FUTURE
DIRECTIONS
In this thesis, I have demonstrated novel applications of multivariate projection
methods for analysis and modelling of high-dimensional bio-analytical data. In
addition, I have developed two novel multivariate methods to address specific mod-
elling objectives related to analysis of biological data, with particular applicability
to omics data. A common theme of the work presented is the focus on prediction
ability as well as transparency of the models.
7.0.1 Integrated modelling of omics data
In Chapter 4 the problem of integrated modelling of omics data was addressed.
I applied the multivariate O2PLS model, which explores cross-covariance patterns
in between two data matrices in order to establish a predictive model. The O2PLS
method separately models predictive variation (covarying between the X and Y ma-
trices) from Y-orthogonal variation in the data, which improves the interpretation
of the model by allowing visualisation and interpretation of these two aspects of the
model separately. O2PLS is suitable for modelling of biological systems on a high
level of abstraction, and it provides information about potential latent variables in
the data. This renders the O2PLS model to be particularly suitable for modelling
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of omics studies where high dimensional data are collected from a low number of
states of the biological system.
7.0.2 Piecewise multivariate time-series modelling
Modelling of short time-series data of high-dimensionality is a common challenge
in metabonomic, and other omics, studies. However, suitable predictive modelling
methods have not been available for such data. In order to address this, I have devel-
oped a novel method for this purpose, based on a piecewise multivariate modelling
approach. The method was described in detail in Chapter 5, and demonstrated
by analysis of both simulated and real metabonomic data. The proposed method
enables time predictions as well as providing a transparent model. Compared to
regression models where data are regressed against time, the proposed piecewise
model provides a more general model, with the ability to also model non-linear
time-related variation in the data. Therefore, this model has the potential to en-
hance the prediction performance while also providing better interpretation of the
data. The method provides a straightforward way of visualisation and interpreta-
tion of local changes over time, as well as providing information about where the
maximum rate of change is occurring in the time-series. Areas of application for this
modelling approach include modelling of disease progression, time-related effects of
an intervention, or any other perturbation which can be studied over time.
7.0.3 Transparent non-linear kernel-based prediction modelling
Non-linear prediction modelling of biological data can improve prediction results
significantly in cases where strong non-linearities are present in the data. Kernel-
Chapter 7. Conclusions and future directions 153
based methods provide an efficient method for non-linear modelling. However, many
kernel-based methods have the character of being ‘black box’ models, which do not
allow any simple model interpretation. In order to address the problem of non-linear
modelling while improving the model transparency, a novel kernel-based method was
developed. Chapter 6 described the proposed kernel-OPLS method for non-linear
multivariate prediction modelling. Using the so-called ‘kernel trick’, a kernelised
version of the OPLS was developed. The K-OPLS method has similar prediction
performance to other kernel-based methods, whilst providing a more transparent
model by separating the modelling of covarying and orthogonal variation in the
feature space, in analogy with the conventional OPLS method. Thus, K-OPLS
provides the means for detection and interpretation of Y-orthogonal variation in the
feature space, enhancing the opportunity to interpret expected and unanticipated
variation patterns in the data. In cases when non-linear variation is dominating in
the data, kernel-OPLS also provides significantly improved prediction performance
compared to linear OPLS.
7.0.4 General conclusions
In this thesis, I have focused on two particular model properties that are impor-
tant for modelling of biological data: predictive capability and model transparency.
Prediction modelling can be utilised in numerous applications, and the predictive
capability of the models should also serve as a criteria for model evaluation. Exam-
ples of applications where prediction models are employed are medical diagnostics,
toxicity assessment and many other areas of basic biological or medical research.
A transparent model is the opposite of a ‘black box’ model, in that it provides a
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means for interpretation and understanding of the data, and model transparency is
in many cases an essential property when modelling biological data, as well as many
other types of data. Two distinct model properties enable interpretation in the
models described in this thesis: the latent variables, providing information regard-
ing the observations; and the model weights, describing how the descriptor variables
contribute to the latent variables.
The multivariate models that have been applied and developed in this thesis
are supervised models, but they are also data-driven in the sense that prior knowl-
edge about the structure of the biological system is not needed when estimating
the models. In contrast to data-driven models, mechanistic models based on first
principles have the advantage of enabling simulations of biological systems, and the
potential ability to predict novel system behaviour as a result of a previously unseen
perturbation, which is a highly desirable model property. However, the detailed
structure of biological systems and their parameters are to a large extent unknown
at the current point in time. Therefore, it is very difficult to establish accurate
mechanistic models of any biological system of substantial size, i.e. beyond the size
and complexity of a single well-characterised pathway. In this respect, I consider the
mechanistic and data-driven modelling approaches to be complementary in nature.
Data-driven models provide means for modelling and analysis of data, despite the
fact that the underlying biological system is not well characterised, while mechanis-
tic modelling can be informative for modelling of small parts of a biological system,
if the necessary information is available, by providing insights into the underlying
system characteristics on a detailed level. The data-driven approach thus enables
utilisation of high-dimensional data from e.g. omics studies in order to establish
prediction models and to enable interpretation of the data, leading to improved
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understanding of the biological system. The data-driven models also facilitate gen-
eration of essential information used for hypothesis generation, providing a way of
rationally designing new experiments, in order to maximise the acquired information
from these new experiments.
To conclude, omics technologies enable unprecedented ability to perform mea-
surements on biological systems. I have developed and applied methods for multi-
variate prediction modelling of bio-analytical data in order to address three mod-
elling areas: data integration and analysis of structured covariation patterns, mul-
tivariate time-series analysis and non-linear multivariate modelling. In addition,
applications of all of these models have been demonstrated for modelling of high-
dimensional bio-analytical data. The methods developed and demonstrated here
have the potential to advance prediction modelling and enable improved data in-
terpretation in medical and biological applications, ultimately advancing healthcare
and basic biological understanding. The methods described and developed in this
thesis could potentially also be applied with benefit in numerous other application
areas beyond the analysis of bio-analytical data, but such applications remains to
be demonstrated in the future. This thesis aims to contribute to the continuous
development of multivariate data analysis methods, in providing predictive and in-
terpretable models for analysis of current and future bio-analytical data.
7.1 Scope for further development
7.1.1 Local multivariate models for prediction modelling of omics data
In Chapter 4, I demonstrated how common covariation patterns between two data
matrices are modelled using the O2PLS model. The prediction results from this
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model were promising, but due to the assumption of latent variables as functions
of all descriptor variables, the O2PLS model is likely to be sub-optimal in the pre-
dictive sense. This is due to an expected high number of non-informative variables
contributing to each latent variable, while these variables would be expected to
contribute mainly noise to the model. Latent variable models assume that a low
dimensional space is sufficient to model a system. This assumption is often valid
for the modelling of data generated from for example factorial experimental designs
in biology, but in many other cases, this model assumption may not be optimal. A
low dimensional representation may also be considered too different from the highly
modular structure of the biological system, which may lead to a poor model. One
modelling approach that could improve prediction performance in such cases is to
establish a set of local models, as an alternative to a single global model. Simi-
lar ideas have been proposed previously, but in the context of establishing a single
model from a of sub-sets of variables in the descriptor data matrix X by selecting
consecutive blocks of variables in e.g. spectral data 133, 134, and also combined with
variable selection schemes135 to reduce the number of variables in the model.
As an alternative to the previous work, I propose to establish multiple models
where variables are included in a particular same sub-model based on shared infor-
mation content, which may be more suitable for modelling of multiple omics data
sets. In addition variables from both the descriptor data matrix X and the response
data matrix Y would both be considered together for inclusion in a sub-model. A
local model is considered local with respect to the variables dimension, and the set
of local models would together incorporate all the variables in the original data. The
set of variables included in each local model would be based upon variables that are
sharing some common information, so that the local model maximise prediction abil-
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ity while minimising the number of variables contributing noise, or non-informative
variation, to the model. By establishing local models based on sub-sets of variables,
one may expect benefits both in terms of interpretation as well as prediction perfor-
mance. This approach is also data-driven, but resemble the modularised structure of
a biological system to a larger extent than for example multivariate latent variable
models where all variables are contributing to each latent variable. By reducing
the level of noise that is introduced by a high number of non-informative variables,
prediction performance may be improved, and in some aspects, the model interpre-
tation may be improved, as the modelling framework would have a more similar
structure to the system being modelled.
7.1.2 K-OPLS as an OSC filter for kernel matrices
The K-OPLS method possesses properties that makes it interesting to apply as an
OSC filter for the kernel matrix. It is clear from the applications of OSC filter in
the area of linear models that analogous applications and benefits can be expected
when applied in the feature space by filtering of the kernel matrix. In addition,
it would be of interest to explore the characteristics of Y-orthogonal variation in
relation to the choice of kernel function and kernel parameters, as one can suspect
a relationship between the kernel function and optimisation of its parameters and
the Y-orthogonal variation in the K-OPLS model.
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7.1.3 Analysis of multicollinearities in the parameter space of mecha-
nistic models
In this thesis, multivariate methods have been described for analysis and modelling
of experimental data. Another area where multivariate methods could be applied is
to establish so-called ‘metamodels’ of mechanistic models. Objectives of such mod-
elling would be to analyse covariation patterns between model parameters, as well
as to use the multivariate models to represent the mechanistic model parameters in
a low-dimensional space in order to further understand the model. This also enables
the opportunity to perform sensitivity analysis based on the low dimensional repre-
sentation of the system studied. This approach could help to guide the experimental
design so that the most informative parts of the system are perturbed, and the most
relevant model parameters are being estimated through careful measurements, with
the aim of improving the model as efficiently as possible.
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Table 7.1: Metabolites that differentiate control group from the PC-3 Xenograft
group (based upon visual inspection of the most prominent OPLS-DA coefficients).
Identification of metabolites was achieved using OPLS-DA and metabolites are dis-
played with their assignment and corresponding NMR chemical shifts along with
control and PC-3 mean (a.u.) and predictive OPLS-DA regression coefficient.
Chemical shift (ppm)pred. regr. coeff mean(ctrl) mean(pc3) Assignment change in PC3
0.97, 1.02 -0.73 1.00E-02 6.58E-03 Valine 
1.0 -0.64 4.25E-03 3.16E-03 Isoleucine 
1.2, 2.3, 2.38 0.82 2.15E-03 2.84E-03 3-hyroxybutyrate 
1.91 0.69 7.02E-03 9.75E-03 Acetate 
2.44 0.74 3.21E-03 4.24E-03 Glutamine / Glutamate change in ratio
0.95, 1.71 -0.73 2.98E-03 2.30E-03 Leucine 
1.69, 1.91, 3.01 -0.75 3.83E-03 3.17E-03 Lysine 
3.1, 3.19, 4.42 0.76 8.86E-03 1.12E-02 Amino acid resonances mixed with Glucose
6.9, 7.2 -0.81 1.72E-03 1.00E-03 Tyrosine 
7.37 -0.82 4.35E-04 2.86E-04 Phenylalanine 
7.53, 7.27, 7.74 -0.71 4.45E-04 2.55E-04 Tryptophan 
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Table 7.2: List of protein spots with the largest predictive regression coefficients
as calculated from OPLS-DA analysis of the PC-3 DIGE data (coefficients larger
than 0.77 are shown, corresponding to p<0.01, based upon a test for significance of
the Pearson correlation coefficient between descriptor and response variables), NA
indicates unknown protein identity).
Spot pred. regr. coeff. log2(pc3/control) intensity Assignment
815 0.94 0.83 2.61 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t-815
558 0.92 0.37 0.60 No_ID-558
1154 0.90 1.25 5.85 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t_/_Fibrinogen_A_alpha_polypeptide_Q99K47_Tre
mbl-1154
612 -0.90 -0.43 0.97 Not_Visible-612
1164 0.90 1.91 3.85 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t_/_Fibrinogen_A_alpha_polypeptide_Q99K47_Tre
mbl-1164
1229 0.90 0.87 0.63 Alpha-enolase_ENOA_MOUSE_Swissnew_/_Beta-2-
Glycoprotein_1_precursor_APOH_MOUSE_Swisspr
ot
325 -0.88 -0.25 3.75 Complement_factor_H_precursor_CFAH_MOUSE_
Swissprot-325
994 0.87 0.96 1.97 Not_Visible-994
669 0.86 0.45 4.23 Gelsolin_precursor_GELS_MOUSE_Swissprot-669
657 -0.84 -0.87 0.60 Not_Visible-657
1404 -0.84 -0.85 2.80 Major_urinary_protein_1_precursor_MUP1_MOUS
E_Swissnew
599 0.84 1.16 0.33 Plasminogen_precursor_PLMN_MOUSE_Swissprot
_/_Fibrinogen_gamma_polypeptide_Q8VC87_Trem
327 -0.83 -0.35 2.19 Complement_factor_H_precursor_CFAH_MOUSE_
Swissprot-327
1269 0.83 0.41 1.79 Many_hits-1269
792 -0.83 -0.17 2.43 Not_Visible-792
664 0.82 0.41 15.27 Gelsolin_precursor_GELS_MOUSE_Swissprot-664
1132 0.82 0.16 13.54 #N/A
813 0.82 0.36 2.60 Not_Visible-813
1325 0.82 0.40 0.95 Complement_C4_precursor_CO4_MOUSE_Swisspr
ot
318 -0.81 -0.20 0.36 #N/A
606 -0.80 -0.36 0.80 Not_Visible-606
1267 0.80 0.50 1.31 Not_Visible-1267
1369 0.80 0.48 2.83 No_ID-1369
1131 0.80 0.17 80.47 #N/A
661 0.80 0.34 14.53 Gelsolin_precursor_GELS_MOUSE_Swissprot-661
1162 0.79 0.73 2.51 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t-1162
659 0.78 0.43 0.44 Not_Visible-659
617 0.77 1.20 0.75 Fibrinogen_gamma_polypeptide_Q8VC87_Trembl
1271 0.77 0.29 9.47 #N/A
Appendix 182
Table 7.3: List of protein spots in the PC-3 data set that correlated with 3-D-
hydroxybutyrate as determined by OPLS modelling between DIGE data and the
signal of 3-D-hydroxybutyrate at 2.38 in the NMR spectra. (coefficients >0.77 are
shown, corresponding to p<0.01, based upon a test for significance of the Pear-
son correlation coefficient between descriptor and response variables), NA indicates
unknown protein identity).
Spot pred. regr. coeff. log2(pc3/control) Intensity Assignment
815 0.95 0.83 2.61 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t-815
813 0.92 0.36 2.60 Not_Visible-813
561 -0.92 -0.54 1.50 Not_Visible-561
567 -0.89 -0.64 1.27 EGF_receptor_precursor_EGFR_MOUSE_Swisspro
t_/ _Alpha-1-antitrypsin_1-
1_precursor_A1T1_MOUSE_Swissprot
1377 0.85 0.76 2.95 L-immunoglobulin, 
_many_accessions_and_homologues
325 -0.85 -0.25 3.75 Complement_factor_H_precursor_CFAH_MOUSE_
Swissprot-325
557 -0.84 -0.34 2.04 Not_Visible-557
1154 0.82 1.25 5.85 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t_/_Fibrinogen_A_alpha_polypeptide_Q99K47_Tre
mbl-1154
558 0.81 0.37 0.60 No_ID-558
1162 0.81 0.73 2.51 Serotransferrin_precursor_TRFE_MOUSE_Swisspro
t-1162
607 -0.80 -0.29 0.85 #N/A
1369 0.80 0.48 2.83 No_ID-1369
659 0.79 0.43 0.44 Not_Visible-659
1381 0.79 0.44 8.93 #N/A
835 0.77 0.18 1.10 #N/A
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Table 7.4: OPLS derived list of protein spots correlated to tyrosine at 6.9 (coefficients
>0.77 are shown, corresponding to p<0.01, based upon a test for significance of
the Pearson correlation coefficient between descriptor and response variables), NA
indicates unknown protein identity)
Spot pred. regr. coeff. log2(pc3/control) Intensity Assignment
1394 0.93977 -0.32755 1.1196 Not_Visible-1394
606 0.92448 -0.35625 0.80146 Not_Visible-606
1164 -0.87737 1.9111 3.8519 Serotransferrin_precursor_TRFE_MOUSE_
Swissprot_/_Fibrinogen_A_alpha_polypepti
de_Q99K47_Trembl-1164
687 -0.87657 0.26526 1.2965 #N/A
1268 -0.87614 0.46461 1.1793 Many_hits-1268
661 -0.85964 0.33827 14.529 Gelsolin_precursor_GELS_MOUSE_Swiss
prot-661
669 -0.85953 0.44619 4.2317 Gelsolin_precursor_GELS_MOUSE_Swiss
prot-669
445 -0.85685 0.15232 25.334 #N/A
664 -0.85622 0.40892 15.266 Gelsolin_precursor_GELS_MOUSE_Swiss
prot-664
657 0.85239 -0.86555 0.59985 Not_Visible-657
558 -0.84613 0.37117 0.6003 #N/A
1245 -0.84159 0.59568 0.98304 Alpha-1-antitrypsin_1-
1_precursor_A1T1_MOUSE_Swissprotsee_
comment
998 -0.83225 0.14949 26.11 #N/A
653 0.83141 -0.26414 1.7734 #N/A
1154 -0.82511 1.2507 5.849 Serotransferrin_precursor_TRFE_MOUSE_
Swissprot_/_Fibrinogen_A_alpha_polypepti
de_Q99K47_Trembl-1154
1241 -0.8113 0.34979 0.80196 #N/A
1337 0.81062 -0.20541 2.8918 #N/A
607 0.79681 -0.2904 0.85119 #N/A
77 -0.78963 0.19651 18.724 #N/A
1246 -0.78801 0.39359 1.4509 #N/A
1377 -0.78739 0.75947 2.9547 L-
immunoglobulin,_many_accessions_and_ho
mologues
994 -0.78101 0.96443 1.971 Not_Visible-994
667 0.77968 -0.90524 0.67597 #N/A
1122 0.77607 -0.31947 13.061 #N/A
1276 -0.77393 0.45069 2.3157 #N/A
1267 -0.77068 0.50226 1.3077 Not_Visible-1267
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The orthogonal projections to latent structures (OPLS) method has been successfully applied in
various chemical and biological systems for modeling and interpretation of linear relationships
between a descriptor matrix and response matrix. A kernel-based reformulation of the original
OPLS algorithm is presented where the kernel Gram matrix is utilized as a replacement for the
descriptormatrix. This enablesusageof the ‘kernel trick’ to efﬁciently transform thedata into ahigher-
dimensional feature spacewherepredictive and response-orthogonal components are calculated. This
strategy has the capacity to improve predictive performance considerably in situations where strong
non-linear relationships exist between descriptor and response variables while retaining the OPLS
model framework. We put particular focus on describing properties of the rearranged algorithm
in relation to the original OPLS algorithm. Four separate problems, two simulated and two real
spectroscopic data sets, are employed to illustrate how the algorithm enables separate modeling of
predictive and response-orthogonal variation in the feature space. This separation can be highly
beneﬁcial for model interpretation purposes while providing a ﬂexible framework for supervised
regression. Copyright© 2007 John Wiley & Sons, Ltd.
KEYWORDS: K-OPLS; kernel methods; non-linear; OSC; OPLS; SVM; Kernel PLS
1. INTRODUCTION
Partial least squares (PLS) regression [1,2] is currently the
standard method in supervised linear modeling in the ﬁeld
of chemometrics. PLS regression exploits the notion of latent
variables [3] to characterize the relationship between the
descriptor matrix X[N × K] (where N equals the number
of observations and K equals to the number of descriptor
variables) and the response matrix Y[N × M] (where M
equals to the number of response variables). The success of
PLS regression stems mainly from the innate capability of the
method to handle high-dimensional, noisy data exhibiting
strong collinearity structures with (possibly) missing data.
Orthogonal projections to latent structures (OPLS) [4–6] has
later been introduced as an alternative to PLS regression
where systematic Y-orthogonal variation is separated from
predictive structures by integrating an orthogonal signal
correction (OSC) [7] ﬁlter. In terms of predictions, the PLS and
OPLS methods are equivalent (considering the case where
M = 1) but the interpretation is generally enhanced in OPLS
∗Correspondence to: J. Trygg, Research Group for Chemometrics,
Department of Chemistry, Umea˚ University, Umea˚, SE-901 87, Sweden.
E-mail: johan.trygg@chem.umu.se
†These authors contributed equally to this work.
as the predictive score and loading vectors are free from
systematic variation unrelated to the variation in Y. The
details of the OPLS algorithm and its relation to PLS has been
described previously [4–6].
In the case of chemical and biological systems, situations
where the relationship between X and Y display non-linear
characteristics are frequent. If prediction ofY is the primary
objective, these characteristicsmust be acknowledged during
model construction.A common strategyhas been to explicitly
extend X according to a lower-order polynomial function,
incorporating e.g. quadratic terms [8,9]. In general terms,
the original data is transformed from the input space X ∈
RK into a higher-dimensional feature space F ⊆ RK∗ by a
mapping functionφ(·), deﬁned asxi ∈ RK → φ(xi) ∈ F ⊆ RK∗
∀i = 1 . . . N (where xi represents row vector i in X). The
implicit expectation is that the applied map φ(·) will lead
to improved linear correlations between φ(X) and Y in the
generated feature space F.
For highly complex transformation functions, the explicit
calculation of φ(X), which may be of high dimensionality, is
likely to be a limiting factor both in terms of computational
complexity and memory requirements. In fact, the feature
space F can even be inﬁnitely large for particular φ(·). This
can be circumvented by utilizing what is commonly referred
Copyright© 2007 John Wiley & Sons, Ltd.
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Figure 1. Overview of the separate parts of the K-OPLS modeling framework,
illustrating the modularized nature of kernel-based methods.
to as the ‘kernel trick’ [10]. Let us deﬁne dot products as
κ(x,y) = 〈φ(x), φ(y)〉, known as the kernel function. Now
only the kernel matrixK with entriesKi,j = κ(xi,xj) (where
xi corresponds to the ith and jth rowvector respectively in the
descriptor matrixX) require explicit calculation. With proper
use of the kernel function, one can avoid explicitly mapping
X to higher-dimensional spaces as well as computing dot
products in the feature space, which is computationally
beneﬁcial. Note the distinction between κ(·), which is a
function; K, which is a scalar; and K, which is a [N ×
N] matrix. The vector kernel function κ(·) is itself bound
by several constraints according to Mercer’s theorem [11],
although implications of the theorem will not be discussed
here. The choice of kernel function is evidently important as
it determines the transformation type and characteristics of
the feature space F. Frequently employed kernel functions
involve polynomial kernels or radial basis kernels [12], which
will be deﬁned at a later stage.
Kernel-basedmethods forpattern analysis canbedescribed
in a modularized fashion on a conceptual level (Figure 1),
where the distinction can be made between the mapping of
the inputdatamatrixX ∈ RK into some feature spaceF ⊆ RK∗
and the subsequent pattern analysis stage (in this case by K-
OPLS). Through modularization, ﬂexibility can be achieved
in terms of choice of kernel function as well as modeling
algorithm to adapt to the speciﬁc objectives of the modeling
and properties of the data.
Kernel-based versions of the traditional NIPALS PLS
algorithm,KPLS, have beendescribed in the literature [13,14].
The general idea has been to reformulate the algorithm
to involve calculations of XTX[K × K] or XXT [N × N] as
replacements of X as this may enable a more compact
representation of X, depending on the relation between
N and K. Although the primary objective underlying the
development of KPLSwas computational speed andmemory
requirements, the progress indirectly enabled extensions
to handle non-linear correlations between descriptor and
response variables. An early example of such an extension in
a chemometric context is the radial basis function PLS (RBF-
PLS),whichwas introducedbyWalczakandMassart [15]. The
authors employed an activation matrix A [N × N] to solve
arbitrary non-linear problemswith a reformulation of the PLS
algorithm. This activation matrix is equivalent to the kernel
Gram matrix K employed here calculated using a speciﬁc
kernel function (the radial basis function). The generalization
of KPLS and the relation to other kernel-based methods has
been formalized in recent works by Rosipal and Trejo [16].
In the present work, we outline a reformulation of the
original OPLS algorithm to support utilization of the kernel
trick and consequently handle non-linear modeling of the
relationship between descriptor and response variables.
Speciﬁcally, instances of φ(X) are rearranged in terms of
the kernel Gram matrix K, with entries Ki,j = κ(xi,xj), in
order to fully support higher-order transformations. The
reformulationwill have considerable effects on the remaining
steps in the OPLS algorithm, which are described in detail.
The main focus in the remainder of the text will be
on formulating and describing the K-OPLS algorithm. To
demonstrate the unique properties of the K-OPLS algorithm,
two simulated data sets are employed; one illustrating a
regression scenario and one the discriminant analysis case. In
addition,weshowresults frommodelingof twospectroscopic
data sets to demonstrate properties and behavior of the
K-OPLS method in real applications. Furthermore, the
spectroscopic data sets will be utilized to explicitly relate
the K-OPLS method to the KPLS method and highlight
differences. We illustrate how the unique properties of the
original OPLS method, for instance interpretation of the
predictive andY-orthogonal score vectors, are maintained in
K-OPLS models while improving the predictive performance
when non-linear relationships exist between descriptor and
response variables. Benchmarking of predictive performance
against other alternative methods will not be considered here
as this subject is peripheral to the aim of the work and largely
handled elsewhere [17].
2. METHOD
2.1. Notation
Matrices are represented in bold uppercase letters, vectors
in bold lowercase letters, vectors are column vectors unless
otherwise stated, and scalars are denoted by italic characters.
Table I contains a list of symbols used in this paper.
2.2. Centering of kernel matrices
The kernel matrices were centered prior to model estimation.
Equation (1) describes how the training kernel matrix
is centered. Equation (2) describes the centering of the
prediction set kernel matrix.
Ktr,tr =
(
Itr − 1
Ntr
1tr1
T
tr
)
Ktr,tr
(
Itr − 1
Ntr
1tr1
T
tr
)
(1)
Kte,tr =
(
Kte,tr − (1/Ntr)1te1trTKtr,tr
) (
Itr − (1/Ntr)1tr1trT
)
(2)
2.3. K-OPLS model estimation
The details of the OPLS algorithm, which is suitable
for the linear case, can be found in References [4–6].
The OPLS algorithm essentially consists of two main parts:
the estimation of the predictive weight matrix (Wp) and the
iterative estimation of a set of Y-orthogonal weight vectors,
forming theY-orthogonal weight matrixWo. Subsequent to
the estimation step of each Y-orthogonal component, the X
matrix is deﬂated by theY-orthogonal variation, followed by
Copyright© 2007 John Wiley & Sons, Ltd. J. Chemometrics 2007; 21: 376–385
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Table I. List of symbols.
Symbol Deﬁnition
Ntr Number of observations in training data (scalar)
Nte Number of observations in test data (scalar)
M Number of response variables (scalar)
K Number of input variables (scalar)
Itr Identity matrix of dimension [Ntr × Ntr]
Ite Identity matrix of dimension [Nte × Nte]
1tr Column vector of ones of length Ntr
1te Column vector of ones of length Nte
A Number of predictive components (scalar)
Ao Number ofY-orthogonal components (scalar)
K
j,i
tr,tr Kernel descriptor matrix (training–training) of deﬂation order i and j respectively of dimension [Ntr × Ntr]
K
j,i
te,tr Kernel descriptor matrix (test–training) of deﬂation order i and j respectively of dimension [Nte × Ntr]
Ytr Matrix of response variables of dimension [Ntr × M]
Xtr Matrix of descriptor variables of dimension [Ntr × K]
Yte Matrix of response variables of dimension [Nte × M]
Xte Matrix of descriptor variables of dimension [Nte × K]
Tiptr PredictiveX training score matrix from deﬂation step i of dimension [Ntr × A]
Tipte PredictiveX test score matrix from deﬂation step i of dimension [Nte × A]
tiotr Y-orthogonalX training score vector i of dimension [Ntr × 1]
tiote Y-orthogonalX test score vector i of dimension [Nte × 1]
Up Y score matrix of dimension [Ntr × A]
Cp Y loading matrix of dimension [M × A]
cio Y-orthogonal loading vector i of dimension [A × 1]
p [A × A] matrix with the diagonal containing the eigenvalues when estimating predictive components
σio Scalar containing the eigenvalue from estimation ofY-orthogonal component i
Bt Matrix with theUp −Tp regression coefﬁcients of dimension [A × A]
Wp X predictive OPLS weights matrix of dimension [K × A]
Wo Y-orthogonal OPLS weights matrix of dimension [K × Ao]
E X residual matrix of dimension [Ntr × K]
R Set of real numbers
EVD(A, a) Eigenvalue decomposition of the symmetric matrixA, extracting a eigenvectors corresponding to the a largest eigenvalues
a subsequent updating of the predictive score matrixTp and
estimation of furtherY-orthogonal components if required.
The K-OPLS algorithm follows the principles of the linear
OPLS algorithm while it is written in dual form. This implies
that all expressions have been rewritten so that the input
matrix X is expressed as the outer product XXT in all
instances (for the casewhereN 	 K). The outer productXXT
is subsequently replaced by the kernel matrix K in the K-
OPLS algorithm.
Speciﬁc care has to be taken in how K is deﬂated for the
Y-orthogonal components. In simple terms, in the algorithm
for model estimation, K consists of two instances of the
(transformed) data matrix. One of these instances represents
the predictive weights (Wp) and should thus be retained
throughout the calculations, whereas the other should be
deﬂated accordingly by the Y-orthogonal variation. Let Kj,i
denote different deﬂated generations i and j of K, where
K1,1 is the original kernel Gram matrix. The ﬁrst instance
of K: K1,i is used when implicitly using the predictive
weights in the calculation of the predictive scores. The second
instance ofK:Ki,i, is used for the estimation ofY-orthogonal
components. Algorithm 1 outlines how the K-OPLS model is
estimated from the training set. Algorithm 2 shows a pseudo-
code describing the K-OPLS algorithm and how each step
relates to the OPLS algorithm.
For the special case where the kernel function is linear,
results are theoretically identical for the predictive and
Y-orthogonal score matrices compared to the linear OPLS
algorithm. In this context, it is worth mentioning that one
of the main consequences of the kernel implementation of
OPLS is that none of the OPLS model loadings relating
directly to the descriptor variable space of X (e.g.Wp,Wo,
etc.) can be calculated explicitly. Instead, such parts of the
model are rewritten in the algorithm to encompass the kernel
implementation. This is obvious since the kernel trick is
utilized, thus only the inner product space is utilized in the
model estimation. As a consequence, the explicit mapping of
X to the feature space F is avoided.
The choice of kernel function is important and depends
on properties of the data as well as on the assumptions and
Algorithm 1. Estimation of K-OPLS model
1. (Cp,p) ← EVD
(
YTK1,1tr,trY, A
)
2. Up ← YCp
3. for i = 1 to Ao do
4. Tiptr ←K
1,i
tr,tr
T
Up
−1/2
p
5.
(
cio, σ
i
o
) ← EVD (Tiptr T
(
Ki,itr,tr −TiptrTiptr
T
)
Tiptr , 1
)
6. tiotr ←
(
Ki,itr,tr −TiptrTiptr
T
)
Tiptrc
i
oσ
−1/2
o
7. ‖tiotr‖ ←
√
tiotr
Ttiotr
8. tiotr ← tiotr/‖tiotr‖
9. K1,i+1tr,tr ←K1,itr,tr
(
Itr − tiotrtiotr
T
)
10. Ki+1,i+1tr,tr ←
(
Itr − tiotrtiotr
T
)
Ki,itr,tr
(
Itr − tiotrtiotr
T
)
11. end for
12. TAo+1ptr ←K1,Ao+1tr,tr Up−1/2p
13. Bt ←
(
TAo+1ptr
T
TAo+1ptr
)−1
TAo+1ptr
T
Up
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Algorithm 2. Estimation of K-OPLS model—pseudo code and relation to the OPLS algorithm
1. Calculate A predictive components by eigenvalue decomposition ofYTKY {Corresponding to singular value decomposition ofYTX
in OPLS algorithm}
2. CalculateY-scores {Same in OPLS algorithm}
3. for eachY-orthogonal component—if any {Same in OPLS algorithm} do
4. Calculate predictive score {Corresponding toTp ← XWp in OPLS algorithm}
5. Calculate aY-orthogonal component {Corresponding to singular value decomposition of ETTp in OPLS algorithm}
6. Calculate aY-orthogonal score vector {Corresponding to to = Xwo in OPLS algorithm}
7. Calculate the norm of theY-orthogonal score vector {Not applicable in OPLS algorithm}
8. Normalize theY-orthogonal score vector {Not applicable in OPLS algorithm}
9. Deﬂate theWp−related kernel matrix in one direction for theY-orthogonal variation {Not applicable in OPLS algorithm}
10. Deﬂate the kernel matrix in both directions for theY-orthogonal variation {Corresponding to deﬂation ofX for theY-orthogonal
variation in OPLS algorithm}
11. end for
12. Calculate the updated predictive score matrix using the deﬂated kernel matrix {Corresponding to Tp ← XWp using the X matrix
which is deﬂated by the sequential removal ofY-orthogonal variation in the OPLS algorithm}
13. Calculate theUp −Tp coefﬁcients {Same in OPLS algorithm}
Algorithm 3. Prediction by the K-OPLS model
1. for i = 1 to Ao do
2. Tipte ←Ki,1te,trUp
−1/2
p
3. tiote ←
(
Ki,ite,tr −TipteTiptr
T
)
Tiptrc
i
oσ
i
o
−1/2
4. tiote ← tiote /‖tiotr‖
5. Ki+1,1te,tr ←Ki,1te,tr − tiotetiotr
T
(
K1,itr,tr
)T
6. Ki+1,i+1te,tr ←Ki,ite,tr −Ki,ite,trtiotrtiotr
T − tiotetiotr
T
Ki,itr,tr
+ tiotetiotr
T
Ki,itr,trt
i
otr
tiotr
T
7. end for
8. TAo+1pte ←KAo+1,1te,tr Up−1/2p
9. Yˆ← TAo+1pte BtCTp
purpose that is underlying the modeling. A few commonly
used kernels functions are the Gaussian radial basis function
(Equation (3)), the polynomial kernel (Equation (4)) and the
linear kernel function (Equation (5)). For additional examples
of kernels and their properties see References [12,18,19].
κ(x,y) = exp
(−‖x− y‖2
2σ2
)
(3)
κ(x,y) = (〈x,y〉 + 1)p, p ∈ R (4)
κ(x,y) = 〈x,y〉 (5)
2.4. Prediction by the K-OPLS model
Predictions using the K-OPLS model are accomplished as
described in Algorithm 3, where the calculation of predicted
scores and response variables are outlined. Pseudo-code for
the prediction algorithm can be found in Algorithm 4 where
each step is related to the OPLS algorithm.
3. RESULTS
We illustrate the properties and strengths of the K-OPLS
method by means of two classical non-linear problems
(simulated data) and two real-world calibration problems.
The ﬁrst simulated data set is a non-linear regression
task whereas the second is a classiﬁcation problem where
linear solutions are clearly insufﬁcient. The two calibration
data sets are based on measurements by near-infrared
(NIR) spectroscopy, where the ﬁrst study is concerned with
characterization of powder particle sizes and the second
study is concerned with quantiﬁcation of ﬁve different types
of carrageenans. Apart from the obvious task of generating
predictivemodels,weput focus ondisplaying that theunique
features in traditional linear OPLS, for instance interpretation
ofY-orthogonal scores are still feasible in the K-OPLS model.
More speciﬁcally, we demonstrate how separate modeling of
predictive and Y-orthogonal variation in K-OPLS provide
more informative models compared to the KPLS model in
the presence of systematicY-orthogonal variation.
Algorithm 4. Prediction by K-OPLS model—pseudocode and relation to the OPLS algorithm
1. for eachY-orthogonal component - if any {Same in OPLS algorithm} do
2. Calculate predictive scoreTp {Corresponding toTp ← XWp in OPLS algorithm}
3. Calculate a Y-orthogonal score vector {Corresponding to to = Xwo in OPLS algorithm}
4. Normalize theY-orthogonal score vector {Not applicable in OPLS algorithm}
5. Deﬂate the kernel matrixK in one direction for theY-orthogonal variation {Not applicable in OPLS algorithm}
6. Deﬂate the kernel matrixK in both directions for theY-orthogonal variation {Corresponding to deﬂation ofX for theY-orthogonal
variation in OPLS algorithm}
7. end for
8. Calculate the updatedpredictive scorematrix using the deﬂatedK {CorrespondingTp ← XWp inOPLS algorithm,whereX is deﬂated
by the sequential removal ofY-orthogonal variation}
9. Calculate the estimated Yˆ {Same in OPLS algorithm}
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Figure 2. In (A), a simulated instance of the Swiss roll regression problem is depicted. In (B),
the response, starting at the center of the roll and gradually expanding outwards, is shown on the
third axis. In (C), a K-OPLS model has been constructed and used to predict the response. In (D),
the probability of belonging to the K-OPLS model is shown for a set of observations within and
outside the roll. This ﬁgure is available in color online at www.interscience.wiley.com/journal/cem.
3.1. The regression problem
The Swiss roll is a classical toy example in non-linear regres-
sionmodelingwhere onewants to predict a response, starting
from the center of the roll and expanding gradually outwards.
This is depicted inFigure 2(A–B) for a simulated instancewith
1000 observations where the response values range from 0 to
100%. The calibration task is to useX [1000 × 2] (Figure 2(A))
to explain and predict Y [1000 × 1] (Figure 2(B)). A K-OPLS
model, with K calculated by the Gaussian kernel function,
was ﬁtted using one predictive component and ﬁve Y-
orthogonal components. Model and kernel parameters were
set mainly for illustrative clarity, not necessarily to minimize
the generalization error. The predictions for the training data
as well as an independent test set drawn from the same
distribution as the training data are shown in Figure 2(C). The
root mean squared error for the test set (RMSEP) was 1.34%,
indicating that the predictions have excellent accuracy.
One can additionally utilize model residuals to categorize
the reliability of the predictions. In the K-OPLS model, the
residualmatrixE is available in the formof thedeﬂatedkernel
matrix K (equivalent to φ(E)φ(E)T[N × N]), i.e. expressed
in the dual form compared to traditional PLS or OPLS
models. The diagonal of φ(E)φ(E)T describes the squared
estimates of the residual for each observation, which can
be seen as a distance to the model. Many distance-based
alternatives for residual analysis exist in the literature (see
for instance Reference [20] and references therein), although
the majority are based on underlying assumptions of some
knowndistribution.Here,we utilize a simple non-parametric
estimate from the empirical cumulative density function
of the squared residuals of the training data, scaled to
a cumulative probability density function. Based on this
estimate, one can assign a probability of belonging to the
model for any observation given the squared residuals from
the model. This is shown in Figure 2(D), where the model has
been probed at various positions for subsequent assessment
of model residuals and probability of belonging to the model.
This simple strategy clearly shows how residual information
can be useful for assessing reliability of predictions also for
the kernel-based OPLS method.
3.2. The classiﬁcation problem
Classiﬁcation of circular data structures, shown in Fig-
ure 3(A), is frequentlyused todescribe classiﬁcationproblems
that require non-linear modeling (see for instance Reference
[17]). In this case, we have added some complexity to the
original problem by assuming that the simulated variables
shown in Figure 3(A) are score vectors T[500 × 2] and that
the loadings are arbitrary spectral proﬁles PT[2 × 1000] (not
shown). The modeled data matrix isX = TPT[500 × 1000] in
the original space. The response vector y is set to +1 for all
instances of class 1 (outer-most circle) and −1 for all instances
of class 2 (inner-most circle). For generalization purposes,
the response vector will be treated as a single-column matrix
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Figure 3. In (A), a simulated instance of the classiﬁcation problem is shown. In (B), |Yˆ| is shown
for a predicted external test set, where the dark region between the classes constitutes a decision
boundary for the model. In (C), the simulated data in (A) has been extended with Y-orthogonal
variation, causing primarily class 1 to become distorted. In (D), the ﬁrst predictive andY-orthogonal
score components are shown, depicting how theY-orthogonal variation is captured by the K-OPLS
model.
Y[500 × 1] in the following text. A K-OPLS model, with K
calculated by the Gaussian kernel function, was ﬁtted using
onepredictive component andoneY-orthogonal component.
Model and kernel parameters were set mainly for illustrative
clarity, not necessarily to minimize the generalization error.
A heatmap of the absolute predicted response values |Yˆ| is
shown for an external test set in Figure 3(B), where the dark
region between the classes constitutes a decision boundary
for the model. Perfect discrimination is achieved for both the
training data as well as the test data.
In Figure 3(C), Y-orthogonal variation has been added,
causing the circular structure to become distorted primarily
for class 1. Using the same model settings as in the previous
example, 96.5 and 100.0% of the observations of an external
test set are correctly classiﬁed for class 1 and class 2,
respectively. The Y-orthogonal variation from the model is
shown in Figure 3(D), where one can see how the high
within-class variance of class 1 is clearly captured by the
magnitude in the ﬁrst Y-orthogonal score vector t1o. This
implies that Y-orthogonal variation can still be interpreted
to detect systematic trends and outlying samples. This
ability to separate predictive from Y-orthogonal variation
is a unique property of the OPLS and K-OPLS methods
and can be highly beneﬁcial for interpretational purposes.
This subject will be further elaborated in the discussion
(Section 4).
3.3. Powder particle size data set
The presented data set originates from a previous study
[21,22] characterizing two powders of different particle
sizes; ﬁne powder with particle size less than 200m and
coarse powder with particle size greater than 300m. The
two powders have been mixed in various fractions of coarse
powder: {0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100%} and
measured in 100 replicates (denoted as one batch) using NIR
spectroscopy as described by Berntsson et al. [21]. Batches
with a fraction of coarse powder of {0, 20, 40, 60, 80, 100%}
were utilized for model training whereas the remaining
batches were used as an independent test set. In this case,
the descriptor matrix X[600 × 280] contains the NIR data
and the response matrix Y[600 × 1] contains the fraction
of coarse powder. Both data sets were column-wise mean-
centered prior to modeling (see Equation (1) for a deﬁnition
of mean-centering of the kernel matrix). The aim is to ﬁnd a
predictive model that predicts the fraction of coarse powder
in the mixture based on the NIR spectral proﬁle.
A K-OPLS model, with K calculated by the Gaussian
kernel function, was ﬁtted with one predictive component
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Figure 4. In (A), the K-OPLS predictive component tp is plotted against the ﬁrst Y-orthogonal
component. In (B), the KPLS ﬁrst LV t1 is plotted against the second LV t2. This ﬁgure is available
in color online at www.interscience.wiley.com/journal/cem.
and nine Y-orthogonal components as recommended by
seven-fold cross-validation. The explained variation of X
(R2X) is 0.992, the explained variation of Y (R
2
Y ) is 1.000 and
the predicted variation ofY (Q2Y ) is 0.989 (as estimated from
the cross-validation) suggesting a highly predictive and
general model. The root mean squared error of prediction
(RMSEP) for the independent test set was 4.0%. Although the
model contains several latent variables (LVs), we will only
explicitly interpret the ﬁrst two. In Figure 4(A), the predictive
score component t1p is plotted against the ﬁrst Y-orthogonal
component based on the training data. From Figure 4(A) we
can clearly conclude that the characterization of the samples
is good based on the minimal overlap between the different
powder batches in the predictive direction t1p in conjunction
with the high value of Q2Y . There is an evident bimodality in
the 60% batch, seen in the ﬁrst Y-orthogonal component t1o,
which after closer inspection is shown to describe a spectral
offset change. This offset is likely to emanate from variations
in instrumental conditions during data collection as it is
independent ofY. Further inspection shows that thevariation
in t1o is highly linked to this spectral offset, represented as
a baseline for each proﬁle (Pearson correlation between the
row-wise average of X and t1o is 0.778). The K-OPLS model
clearly separates the modeling of variance correlated with
the response variableY which is seen in t1p, representing the
fractionof coarsepowder, fromvariation that isY-orthogonal
in t1o; in this case due to a spectral offset change.
In parallel, a KPLS model, with K calculated by the
Gaussian kernel function, was ﬁtted with 10 LVs [22]. In
Figure 4(B), the ﬁrst LV t1 is plotted against the second LV t2
based on the training data. From Figure 4(B) we see that the
regression direction follows a skewed trajectory involving
both t1 and t2 (and possibly also higher components). The
bimodality of the 60% batch is evident also from the KPLS
scores, but it is not possible to conclude whether this effect
is related to Y or not. Furthermore, the 100% batch deviates
from the remaining batches, suggesting that it is a model
outlier. Using only the information in the KPLS scores, it
is not possible to know if this is due to the fact that these
particular samples are badly characterized by the model or
that the deviating behavior is due to other systematic sources
in the data. Relating this to the K-OPLS model, we can clearly
see that the 100% batch has a slightly elevated source of
systematic variation, but that this is unrelated to Y and in
the same magnitude as other batches (e.g. the 0% batch).
3.4. Carrageenan types data set
The presented data set concerns a quantiﬁcation of ﬁve
different types of carrageenans (polysaccharides extracted
from seaweed). Carrageenans are used mainly as gelling
and thickening agents and are thus of commercial interest
in e.g. food and pharmaceutical industries. The aim of the
study is to characterize ﬁve different types of carrageenans by
means of multivariate modeling coupled with spectroscopic
methods. Although the original study [23] involved several
spectroscopic techniques,wewill only utilize theNIRdata for
demonstration purposes. The descriptor matrixX[128 × 699]
contains theNIRdata (1100–2500 nm)and the responsematrix
Y[128 × 5] contains the concentrations of the different types
of carrageenans according to a mixture design. TheXmatrix
was pre-processed using the standard normal variate (SNV)
transformation [24]. Both data sets were columnwise mean-
centeredprior tomodeling (see Equation (1) for a deﬁnition of
mean-centering of the kernel matrix). See also Reference [23]
for a more comprehensive description of the utilized
data set.
A K-OPLS model was ﬁtted using the polynomial kernel
function with p = 6, four predictive components and four
Y-orthogonal components as recommended by seven-fold
cross-validation. Themodel statisticsR2X = 0.997,R2Y = 1.000,
and Q2Y = 0.984 suggest a highly predictive and general
model. Inspection of the predictive and Y-orthogonal score
components reveal a distinct subcluster in the ﬁrst and
second Y-orthogonal score components (Figure 5(A)). After
closer inspection, this cluster is attributed to differences
between sampling days. Further inspection of the raw data
reveals a difference in the water region (approximately
1970 nm) due to varying moisture contents. In parallel, a
KPLS model was ﬁtted using the polynomial kernel function
with p = 6 and eight LVs. The best matching correspondence
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Figure 5. In (A), the K-OPLS ﬁrstY-orthogonal component t1o is plotted against the secondY-orthogonal
component t2o. The dashed ellipse indicates samples measured on day 3. In (B), the fourth KPLS LV t4 is
plotted against the ﬁfth LV t5, describing the best matching correspondence to the K-OPLS components
in (A). The dashed ellipse indicates samples measured on day 3. This ﬁgure is available in color online at
www.interscience.wiley.com/journal/cem.
to the sub-cluster detected by K-OPLS in Figure 5(A) is
shown by the latent variables t4 and t5 in Figure 5(B). In
the KPLS model, the trend is clearly not as evident as in the
K-OPLS model and is likely to be overlooked if one is not
searching speciﬁcally for sampling day effects.
4. DISCUSSION
There are numerous examples of biological and chemical
systems where linear regression methods are insufﬁcient to
characterize and subsequently predict the estimated behavior
[25–27]. The traditional way to handle non-linear problems
in chemometrics has been to extend the X matrix explicitly
by some function φ(X), for instance to incorporate quadratic
terms [8,9] or lower-order polynomial terms. Ifmore complex
transformations are required, however, the dimensionality
of φ(X) may be a limiting factor. This is the case both
computationally and in terms of memory requirements,
particularly if the number of input variables K is high.
We show how this can be circumvented by utilizing the
kernel trick to avoid explicit mapping of X to higher-
dimensional spaces, which is computationally advantageous.
The presented method, kernel-based orthogonal projections
to latent structures (K-OPLS), can separate predictive from
Y-orthogonal variation in the feature space F without
explicitly calculating φ(X) ∈ F. Thus, while maintaining the
OPLS model framework, it is possible to solve problems of
arbitrary complexity by employing a suitable kernel function.
We demonstrated the utility of the method using two toy
examples where linear methods are clearly insufﬁcient and
show how the K-OPLS method handles the predictions
by means of the matrix kernel function κ(·). Should the
data be (largely) linear, the special case φ(X) = X can be
exploited to produce theoretically identical results compared
to traditional OPLS using less memory in the model
estimation. K-OPLSwas also demonstrated on two realworld
NIR spectroscopy data sets, where we showed the beneﬁts of
K-OPLScompared toKPLS, speciﬁcally for interpretationand
detection of systematicY-orthogonal variation.
In the presented work, we have described the required
steps in the algorithm with a corresponding rationale. The
illustrated examples aim to provide a motivation behind
the potential usage of non-linear transformations, not to
provide a comprehensive benchmarking platform to claim
the superior predictive capabilities of the K-OPLS method. In
fact, for the case where M = 1 the predictions are equivalent
to KPLS [16] and very similar for the case where M > 1.
ComparisonofKPLS to, for instance, supportvectormachines
(SVMs) [28] are already available elsewhere [17] describing
how the differences in terms of classiﬁcation rates are
negligible in the general case considering that the samekernel
function is employed. Consequently, these results also apply
to K-OPLS where a corresponding number of latent variables
have been utilized.
Similar strategies to the one presented here exist in the lit-
erature, where a recent paper by Kim et al. [29] is of particular
interest. The authors combine orthogonal signal correction,
performed in the linear domain, with KPLS, performed
in some high-dimensional space (OSC-KPLS). This has the
unfortunate effect that the score vectors derived from the ﬁrst
(OSC) step has no clear relation to the score vectors derived
from the second (KPLS) step. In the presented approach,
derived score vectors, both predictive andY-orthogonal, are
mutually orthogonal, which is consistent with the traditional
OPLS interpretation. The OSC-KPLS approach may, as in
one out of three illustrated examples [29], be beneﬁcial in
terms of predictions but there are no underlying theoretical
foundations to claim that this is generally the case.
A drawback using any method where the kernel trick is
employed lies in the subsequent model interpretation. For
non-linear use of K-OPLS, predictive andY-orthogonal score
matrices Tp and To are still valuable for detecting general
trends, clusters or outlying observations. This is shown in Fig-
ure 3(D), where class-speciﬁc systematic variation is captured
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in theY-orthogonal score vector t1o, in Figure 4(A) where an
unanticipated change in the spectral baseline can be seen in t1o
and in Figure 5(A), where the ﬁrstY-orthogonal score vector
shows a distinct effect related to deviating sample moisture
content between sampling days. Such effects are neither
easily detected nor explicitly modeled by other commonly
used kernel-based method, e.g. KPLS or SVMs. Furthermore,
the difference in magnitude in t1o could be utilized for
classiﬁcation purposes, which has recently been demon-
strated for OPLS discriminant analysis [30]. Depending on
the choice of kernel function, however, the corresponding
predictive loading vectors Pp = φ(X)TTp may be undeﬁned
or at best difﬁcult to interpret. Consider the case where the
data are transformed using the Gaussian kernel function.
The dimensionality of Pp will be considerably higher than
K and thus complicated, if not impossible, to relate to the
original variables. Evidently, one can calculate Pp = XTTp
although the effects are not clear-cut as Tp has been derived
from the feature space F, not from the original space. When
it comes to variable ranking and selection in neighboring
ﬁelds of machine learning, a general approach has been to
sequentially remove subsets of variables from the (original)
data inXand thenestimate the impact basedon thepredictive
ability of the reduced model. See for instance Reference [31],
Section 4, for an overview or Reference [32] for an example
in gene expression. This is essentially a cross-validation in
the variable direction, which makes the approach potentially
helpful also in this case. However, variable ranking and
selection remains the interesting scope of a future study.
5. CONCLUSIONS
A reformulation of the OPLS algorithm has been outlined
to facilitate mapping of data into higher-dimensional spaces
in which predictive and Y-orthogonal components are
calculated. This gives the K-OPLS method the potential to
improve predictive performance noticeablywhere non-linear
associations exist between descriptor and response variables.
In the cases where these associations are linear, K-OPLS gen-
erates equivalent results as the traditional OPLS method. The
complexity issues involved indata transformationare circum-
vented by utilizing the kernel trick to avoid explicit mapping
ofX into higher-dimensional spaces. The presented K-OPLS
strategy maintains the OPLS framework, thus separating the
modeling of predictive andY-orthogonal variation between
theX andY matrices. By means of two simulated examples
and two spectroscopic data sets, it is demonstrated how this
methodology enhances interpretation of model and data in
the presence of systematicY-orthogonal variation compared
to conventional kernel-based pattern recognition methods.
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Samples
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Although NMR spectroscopic techniques coupled with
multivariate statistics can yield much useful information
for classifying biological samples based on metabolic
profiles, biomarker identification remains a time-consum-
ing and complex procedure involving separation methods,
two-dimensional NMR, and other spectroscopic tools. We
present a new approach to aid complex biomixture
analysis that combines diffusion ordered (DO) NMR
spectroscopy with statistical total correlation spectroscopy
(STOCSY) and demonstrate its application in the charac-
terization of urinary biomarkers and enhanced informa-
tion recovery from plasma NMR spectra. This method
relies on calculation and display of the covariance of signal
intensities from the various nuclei on the same molecule
across a series of spectra collected under different pulsed
field gradient conditions that differentially attenuate the
signal intensities according to translational molecular
diffusion rates. We term this statistical diffusion-ordered
spectroscopy (S-DOSY). We also have developed a new
visualization tool in which the apparent diffusion coef-
ficients from DO spectra are projected onto a 1D NMR
spectrum (diffusion-ordered projection spectroscopy,
DOPY). Both methods either alone or in combination have
the potential for general applications to any complex
mixture analysis where the sample contains compounds
with a range of diffusion coefficients.
There is great interest in the development of metabolic
biomarker identification tools for disease diagnosis and the
characterization of pathophysiological states.1 Biofluid NMR
spectroscopy, especially combined with pattern recognition tech-
niques, has proved powerful in biomarker discovery.1,2 Improve-
ments in sensitivity, resolution, and throughput times of NMR
spectroscopy3 and LC-MS4,5 have increased significantly the
number of metabolites that can be measured simultaneously and
extended the range of biological problems that can be addressed.
The identification and characterization of biomarkers in human
urine and plasma provides a major analytical challenge, as
endogenous, xenobiotic, nutritional and gut microflora metabolites
are often present in the same samples and information recovery
from heavily overlapped spectra is necessary.6,7 Recently, we
developed for metabonomic studies the concept of statistical total
correlation spectroscopy (STOCSY) as a method for facilitating
identification of latent biomarkers, complementing traditional 2D
NMR methods.8 STOCSY exploits the fixed proportionality be-
tween intensities of individual resonances from the same molecule
across a number of samples containing variable amounts of that
compound in NMR spectra. It has been successfully applied to
identify novel biomarkers, e.g., those associated with kidney
toxicity in the rat,9 to improve chromatographic resolution in on-
flow Cryo-LC-NMR experiments10 and for observing statistical
correlations between families of drug metabolites in molecular
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epidemiology studies.11 Similar methodology has been applied to
1D selective TOCSY NMR data to assign peaks in crowded
spectral regions.12 Other related statistical methods for linking
spectroscopic platforms, e.g., NMR and MS,13 or linking different
’omics platforms, e.g., proteomics and metabonomics,14 have also
proved successful, and the general application of chemometric
techniques with back-projected visualization of such correlations
is an important addition to systems biology biomarker identifica-
tion.
1H NMR spectra from biofluids are complex, comprising many
overlapping signals of varying multiplicities. These can be made
simpler using spectral editing techniques that exploit, for example,
spin relaxation (such as T1 and T2 filters)15 and diffusion proper-
ties.16 Diffusion depends on molecular size and can be measured
by NMR spectroscopy using a pulsed-field gradient spin echo
(PFG-SE) pulse sequence.17 NMR-based diffusion measurements
have wide biological applicability,18-22 and refinements of NMR
methods for diffusion measurements are developing accordingly.23-27
One approach plots the diffusion coefficient (D) corresponding
to each resonance, with a contour level related to its standard
deviation, in a pseudo-two-dimensional manner against the chemi-
cal shifts and is known as diffusion-ordered spectroscopy (DOSY).27
We show here, for the first time, application of the correlation
approach to diffusion-ordered spectra, statistical (S)-DOSY, to the
interpretation of problems in bioanalysis and also introduce a new
visualization enhancement tool to aid the interpretation of DOSY
spectra that we term diffusion-ordered projection spectroscopy
(DOPY).
METHODS
Materials. Chemicals were purchased from Sigma (St. Louis,
MO). D2O (99.9%) was from Goss Scientific Instruments Ltd.
(Essex, UK).
Sample Preparation. Standard compounds were prepared to
2.5% (w/v) in D2O into 5-mm NMR tubes (Goss).
Urine samples (24-h aggregate) were collected as part of the
INTERSALT Study.28,29 Urine (2 mL) was acidified to pH 2 with
1 M HCl and extracted on to a C18 bonded cartridge (Isolute,
200 mg, International Sorbent Technology Ltd., Hengoed, UK).
The cartridges had previously been activated by washing with
methanol (4 mL) and 2% methanol/H2O (6 mL, pH 2). Fractions
were eluted with 2, 5, 10, 30, 50, 70, and 90% methanol/H2O.
Samples were lyophilized and reconstituted in 550 íL of D2O for
NMR analysis.
Blood was withdrawn from the cubital fossa from healthy
participants, into heparinized tubes, and immediately stored on
ice, prior to being centrifuged at 3000g for 5 min. The plasma
was then carefully removed, and the cells and buffy coat were
discarded. Prior to NMR analysis, plasma samples were diluted 1
in 4 in physiological saline in 30:70 D2O/H2O.
NMR Analyses. 1H NMR. Spectra were acquired on Bruker
AVANCE spectrometers (Bruker Biospin, Karlsruhe, Germany)
operating at 400.13, 600.29, or 800.32 MHz, equipped with a
CryoProbe (600 and 800 MHz) and capable of delivering z-
gradients up to 53 G cm-1. Method development was performed
at 400 MHz and then extended to 600 and 800 MHz for real sample
observation and measurement. Diffusion measurements were
made using a bipolar pulse-pair longitudinal eddy current delay
(BPP-LED) pulse sequence23,30 with spoil gradients immediately
following the 90° pulses after the bipolar gradient pulse pairs.
Continuous wave irradiation was applied during the relaxation
delay at the frequency of the water (or HOD) resonance. Eddy
current recovery time (Te) was 5 ms, and the time interval between
the bipolar gradients (ô) was 0.5 ms. Prior to Fourier transforma-
tion, the time domain data were multiplied by an exponential
function corresponding to a line broadening factor of 1 Hz in the
frequency dimension and were zero-filled by a factor of 1.
Attenuation of the intensity, I, of an isolated NMR resonance
is a function of the applied magnetic field gradient strength, g.
For sine-shaped gradients this attenuation is described by
where I(0) is the signal intensity at 0% gradient strength, ç is the
magnetogyric ratio, ä is the gradient pulse time, ¢ is the time
from the beginning of the first gradient pulse pair to the beginning
of the second, and ô is the delay for gradient recovery. To calculate
D, eq 1 was rearranged by taking the natural logarithm of both
sides after dividing by I(0) to give
where
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The parameter m is simply the gradient of the line of best fit of a
plot of I(g)/I(0) versus g2, and D was then found by rearrangement
of eq 3.
For simple mixtures, D can be calculated with 19 values of g
(5-95% of maximum gradient strength).
Statistical Diffusion-Ordered Spectroscopy (S-DOSY). In this
novel variation on the STOCSY theme, we considered the series
of diffusion-ordered 1D 1H NMR spectra as a n  v data matrix
X, where n is the number of spectra and v is the number of
variables (ppm values). A vector of correlations was calculated
between each selected data point, corresponding to the apex of
the resonance of interest and the remaining spectral variables.
For visualization, this vector was back-scaled by its standard
deviation in order to preserve the original structure of the spectral
data or projected onto the 1D 1H NMR spectra.
Diffusion-Ordered Projection (DOPY) Spectroscopy. A stepwise
process for constructing DOPY plots using Matlab (Mathworks,
Natick, MA) or any similar program is as follows:
1. Plot the aligned NMR data matrix, X, described above,
normalize such that all spectra have the same average value for
noise.
2. Select a column vector vpeak in X known to correspond to a
resonance in the spectra that attenuates with increasing gradient
strength.
3. Compute the correlation matrix, Cpeak, between X and vpeak
using the equation8
and remove all columns in X in which the square of the correlation
coefficient is below a given threshold. This speeds up the
calculation by removing the parts of the data corresponding to
noise. For simple mixtures (2-5 compounds), a cutoff of 0.98 (i.e.,
Cpeak value) is sufficient. For biofluids, the threshold should be
lowered to 0.90.
4. Divide the remaining values of X by the corresponding
values of the respective variable at 0% gradient strength.
5. Compute the natural logarithm of X and solve for D using
eq 2. This generates a list of Ds (vector d) for each ppm value
corresponding to a spectral peak. Other ppm values that were
removed in step 3 can now be included and set to 0.
6. Use a suitable RGB color display function to plot the median
diffusion-edited spectrum colored with values taken from d.
RESULTS
Development of Methods Using Model Solutions. The new
analysis techniques were initially developed using a mixture of
sucrose and glucose in D2O, on which diffusion-related data have
been published.31 1H NMR spectra were acquired using a BPP-
LED pulse sequence with linearly increasing gradient strength.
D was calculated as described in the Methods and is plotted as a
function of chemical shift in Figure 1a. The annotations S and G
denote resonances from sucrose and glucose, respectively.
Chemical shifts for other isolated sucrose and glucose resonances
in this plot can be deduced as clusters with similar apparent D
(as indicated by the rectangles); several chemical shift values are
observable (ä3.5-ä4.0) for which the calculated D represents an
intermediate value for the two molecules because of signal overlap.
While many techniques exist to facilitate the interpretation of such
plots, our new visualization tool, DOPY, allows the diffusion
coefficient data to be projected as a color directly onto the original
1D 1H NMR spectrum of the mixture (Figure 1b). This type of
plot enhances spectroscopic interpretability as it retains the
multiplet structure (aiding structural assignment), and maintains
relative peak intensities (which are proportional to concentrations
of the corresponding metabolites in the mixture). D values for
sucrose, glucose, and trimethylsilyl [2,2,3,3-2H4]propionate (TSP)
were calculated (Table 1) and are in close agreement with
literature values.31
In DO NMR analyses, resonances are attenuated to different
degrees but peaks from a given molecule always have fixed
proportional intensities. In S-DOSY, we analyzed statistical cor-
relations between resonances in this series of spectra collected
under variable PFG conditions. In previous STOCSY applications,
we have used correlation methods to analyze multiple complex
mixtures but using the same experiment, while here only one
complex sample is analyzed at a time with multiple experiments.
This is formalistically analogous to previous applications of
correlation spectroscopy on single compounds to avoid using a
second-dimensional Fourier transform.32,33 The glucose resonance
at ä5.23 was selected as the variable from which to “drive” the
S-DOSY analysis. Figure 1c plots the covariance in a manner
similar to that for STOCSY, colored according to correlation with
the glucose resonance at ä5.23. This resulted in high correlations
with other glucose resonances and TSP (because of its similar
diffusion coefficient, not shown). Figure 1d shows the result from
S-DOSY analysis driven from the sucrose resonance at ä5.41;
correlations with other sucrose resonances were high (labeled
S).
We extended the S-DOSY approach to cover a mixture of
commonly observed urinary metabolites (citrate, taurine, alanine,
and trimethylamine (TMA) plus the reference compound TSP)
and to investigate effects of normalization on the spectral projec-
tions. In the DOSY plot (Figure 2a), the well-resolved resonances
from TSP and citrate can be identified readily. However, the
apparent D for other resonances are less resolved, and further
complicated by 13C satellite peaks. Figure 2b shows the corre-
sponding DOPY plot, which allows discrimination of spectral
resonances and clearly displays the apparent D. Note the similar
color of the alanine quartet at ä3.79 and doublet at ä1.48.
Moreover, the 13C satellites are now colored the same as 1H
resonance from the corresponding 12C molecule, enhancing
visibility and facilitating their assignment.
Assessment of Precision and Reproducibility. Several
S-DOSY models were constructed from the latter data set, driven
from the alanine doublet at ä1.48. Figure 3a shows the result of
the S-DOSY analysis after the spectra were normalized to total
(31) Antalek, B. Concepts Magn. Reson. 2002, 14, 225-258.
(32) Bruschweiler, R. J. Chem. Phys. 2004, 121, 409-414.
(33) Bruschweiler, R.; Zhang, F. J. Chem. Phys. 2004, 120, 5253-5260.
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intensity. The quartet at ä3.79 correlated with ä1.48 with a
coefficient of 1 and was less correlated with all other resonances.
In Figure 3b, the spectra were normalized so that the area under
the TSP resonance was equal for all spectra. High correlations
were seen to all other resonances except citrate, which was
anticorrelated. In Figure 3c, spectra were normalized to a constant
noise value (in absolute terms), and ä1.48 showed high correlation
with all resonances.
In many of the S-DOSY models, covariance could be either
positive or negative (e.g., Figure 3a). This can be explained by
plotting the resonance intensities as a function of the applied
gradient strength (g). Figure 3d shows that after normalizing to
total intensity the TMA resonance predominantly decreased in
intensity with increasing g, while alanine increased. Hence, when
S-DOSY was “driven” from the alanine ä1.48 signal, TMA was
anticorrelated and vice versa. Conversely, citrate remained posi-
tively correlated with alanine because its resonances increased
in intensity with increasing g. On the other hand, when the spectra
were normalized to noise (Figure 3c), all resonances decreased
with increasing g; hence, all had positive coefficients of variation.
Note that, in Figure 3b, the intensity of the TSP resonance was
invariant across the data set and as such had a covariance equal
to 0.
Application of S-DOSY and DOPY to the Interpretation
of an Unassigned Metabolite Spectral Peak. The initial motiva-
tion for this work was to facilitate assignment (chemical identifica-
tion) of metabolite resonances in biofluids. In human studies,
contributions to the metabolic profile can arise from many
endogenous and exogenous sources including drugs and dietary
and gut microbial metabolites.1 This poses severe spectral as-
signment problems in human samples taken from diverse popula-
tions and ethnic groups. The INTERSALT Study was a standard-
ized, worldwide epidemiologic study of large sample size (>10 000
people) primarily to investigate 24-h urinary sodium excretion and
blood pressure.29,34 Among the range of measurements made on
urinary samples was 1H NMR analysis for metabolic profiling.
Although pattern recognition techniques and STOCSY represent
(34) Stamler, J. Am. J. Clin. Nutr. 1997, 65, 626S-642.
Figure 1. 600-MHz 1H NMR DOSY, DOPY, and S-DOSY analysis of sucrose-glucose mixture 22 °C. The annotations S and G denote the
regions of the spectrum corresponding to anomeric proton resonances from sucrose and a-glucose, respectively. Total experiment time was 28
min (a), Pseudo 2D plot with D on the vertical axis and the ppm value on the horizontal axis. (b) 1D spectrum colored according to D. (c)
S-DOSY plot driven from the glucose doublet at ä5.23 (indicated by the arrow). (d) S-DOSY plot driven from the sucrose doublet at ä5.42 ppm.
Data in (c) and (d) were normalized to total intensity.
Table 1. Diffusion Coefficients ( 10-10 m2 s-1) for
Sucrose-Glucose Mixture in D2O at 22 °C
calculated value published value
sucrose 3.20 ( 0.13 3.20a
glucose 4.15 ( 0.12 4.20a
TSP 4.01 ( 0.19 n/a
a Taken from ref 31.
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viable alternatives to time-consuming 2D experiments,35-37 these
approaches are limited to metabolite resonances with moderately
conserved chemical shifts across a sample set. As an example,
inspection of the 1H NMR spectra from urine samples from a
group of Yanomamo Indians revealed an unknown singlet at ä1.14.
Proton singlets by definition have no scalar couplings; hence
identification by standard homonuclear correlation techniques is
impossible. To exemplify our new approach, diffusion-ordered
spectra were acquired for a typical urine sample containing the
unknown, incrementing the gradient strength from 0.7 to 31 G cm-1,
and a DOPY analysis was performed (Figure 4a). Several
resonances in the region between ä3.5 and ä4.0 were observed
to have similar D to the singlet at ä1.14.
Many resonances were statistically correlated with this peak
and a S-DOSY model was constructed, driven from the maximum
value computer point of this resonance (Figure 4b). Visualization
of the most highly correlated resonances was enhanced by color-
coding the correlation coefficients >0.9 (intramolecular correla-
tion), which identified only the resonances at ä3.6 and ä3.65
(Figure 4c). These resonances are consistent with the spectral
(35) Sweatman, B. C.; Farrant, R. D.; Holmes, E.; Ghauri, F. Y.; Nicholson, J. K.;
Lindon, J. C. J. Pharm. Biomed. Anal. 1993, 11, 651-664.
(36) Tolman, J. R.; Prestegard, J. H. Concepts Magn. Reson. 1995, 7, 247-262.
(37) Berners-Price, S. J.; Ronconi, L.; Sadler, P. J. Prog. Nucl. Magn. Reson.
Spectrosc. 2006, 49, 65-98.
Figure 2. 600-MHz 1H NMR DOSY and DOPY plots generated from a model mixture of alanine, trimethylamine, citrate, and taurine. (a)
DOSY plot with D on the vertical axis and the ppm value on the horizontal axis. (b) DOPY analysis of the same data set. Color bar shows
observed diffusion coefficient scale D. Total time for acquisition was 28 min.
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pattern of 2-methylerythritol (2ME)38 (Figure 4c shows the
structure). 2-Methyl erythritol-4-phosphate (MEP) is a well-known
intermediate in isoprenoid biosynthesis39 and has been reported
to occur in higher plants.40 MEP is also present in all intraeryth-
rocytic stages of the malaria-causing Plasmodium falciparum life
cycle.41 The presence of 2ME in the urine of Yanomamo is most
likely a result of dietary consumption of plant material containing
2ME or MEP. This assignment was later confirmed by 2D
heteronuclear NMR analyses on urine extracts requiring long
spectral acquisition times (data not shown). Thus, the combined
use of S-DOSY and DOPY methods allowed structural character-
ization of a metabolite from a highly complex mixture of small
molecules with similar diffusion coefficients and extensive chemi-
cal shift overlap.
DOPY and S-DOSY Analysis of Whole Human Plasma.
The versatility of the application of DOPY and S-DOSY methods
was also investigated in another key biofluid, human blood
plasma,42 which has a wide range of molecular sizes (hence Ds).
The 1D 1H NMR spectrum of plasma contains lipoprotein signals,
which are difficult to resolve even at high fields, and which are
superimposed with signals from low molecular weight metabolites.
Distributions of D across the lipoprotein profiles in blood plasma
were investigated using 800-MHz 1H NMR spectroscopy, with the
diffusion time, D, set to 250 ms. In Figure 5a, D is plotted on the
same graph as the 1D spectrum (lower trace), with apparent D
ranging between 8.25  10-11 and 4  10-11 m2 s-1 within the
chemical shift range ä0.84-ä1.29, consistent with previous as-
signments for these regions for very low density lipoprotein
(VLDL) and low density lipoprotein (LDL)43 and previously
published values.44 The corresponding DOPY plot is shown in
Figure 5b, clearly displaying differences in D within the lipoprotein
profiles that correspond to VLDL and LDL. S-DOSY analysis
driven from the VLDL resonance at ä0.87 revealed high correla-
tions with other VLDL peaks (Figure 5c). Results were similar
when ¢ was set to 75 ms and ä set to 16 ms (data not shown).
Diffusion edited analyses have been applied to blood plasma
previously,22 calculating an average diffusion coefficient for lipo-
proteins of 1  10-10 m2 s-1 at 37 °C. When corrected for
temperature and viscosity (using the Stokes-Einstein relation31),
this corresponds to 0.72  10-10 m2 s-1 at 22 °C, which is close
to our calculated average value of (0.65 ( 0.173)  10-10 m2 s-1
for the region of the spectrum between ä0.81 and ä0.93.
(38) Anthonsen, T. S.; Hagen, T. S.; Sallam, M. A. E. Phytochemistry 1980, 19,
2375-2377.
(39) Rodriguez-Concepcion, M.; Boronat, A. Plant Physiol. 2002, 130, 1079-
1089.
(40) Dittrich, P.; Angyal, S. J. Phytochemistry 1988, 27, 935.
(41) Cassera, M. B.; Gozzo, F. C.; D’Alexandri, F. L.; Merino, E. F.; del Portillo,
H. A.; Peres, V. J.; Almeida, I. C.; Eberlin, M. N.; Wunderlich, G.; Wiesner,
J.; Jomaa, H.; Kimura, E. A.; Katzin, A. M. J. Biol. Chem. 2004, 279, 51749-
51759.
(42) Brindle, J. T.; Antti, H.; Holmes, E.; Tranter, G.; Nicholson, J. K.; Bethell,
H. W.; Clarke, S.; Schofield, P. M.; McKilligin, E.; Mosedale, D. E.; Grainger,
D. J. Nat. Med. 2002, 8, 1439-1444.
(43) Nicholson, J. K.; Foxall, P. J.; Spraul, M.; Farrant, R. D.; Lindon, J. C. Anal.
Chem. 1995, 67, 793-811.
(44) Liu, M.; Tang, H.; Nicholson, J. K.; Lindon, J. C. Magn. Reson. Chem. 2002,
40, 83-88.
Figure 3. S-DOSY plots color-coded according to correlation with alanine doublet at ä1.48 using different types of normalization. (a) Normalized
to total intensity; (b) normalized to the area of the TSP resonance and (c) to noise. (d) Maximum resonance intensity for each molecule for the
spectra normalized to total intensity plotted as a function of gradient strength. Each line is identified with its associated metabolite.
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DISCUSSION
The DOPY method introduced in this paper provides a novel
way of coding the 1D NMR spectra according to D rather than
the more commonly used pseudo 2D plot of ä versus D.
Comparison of Figures 1a with 1b and 2a with 2b makes the
benefits of DOPY plots immediately apparent; adjacent resonances
from molecules with similar diffusion coefficients, such as taurine
and TMA, are difficult to distinguish in Figure 2a, but are clearly
distinct in the DOPY plot, Figure 2b. DOPY retains the multiplet
structure and relative resonance intensities associated with 1D
spectra, enhancing visualization, minimizing misinterpretation, and
includes 13C satellite signals. In the case of peak overlap, the
apparent D represents some type of average from the contributing
molecules. If necessary, potential ambiguity can be overcome
using more sophisticated data fitting techniques45 or by hyphenat-
Figure 4. 600-MHz 1H NMR analysis of solid-phase extraction
chromatography (SPEC) fraction of urine from the Yanomamo Indian.
(a) DOPY plot. (b) S-DOSY color-coded according to correlation with
the singlet at ä1.14. (c) 1D 1H NMR spectrum from the same sample,
colored red at ppm values with correlation with resonance at ä1.14
above 0.9; all other ä values are plotted in blue (The structure of
2-methyl erythritol is shown).
Figure 5. 800-MHz 1H NMR analysis of human plasma. (a) DOSY
plot of lipoprotein profiles from human plasma (dotted), superimposed
on the 1D spectrum (solid line). The annotations LDL and VLDL
indicate the assigned chemical shifts43 for low density and very low-
density lipoproteins, respectively. (b) DOPY plot of the same data.
Annotations are as in (a). (c) S-DOSY analysis of human plasma,
driven from the VLDL resonance at ä0.87, with only correlations over
90% (in red) projected onto the 1D spectrum. Uncorrelated parts of
the spectrum are in blue.
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ing diffusion pulse sequences with other spectral editing methods,
such as T1 filters.15,46
It is important to note that when constructing S-DOSY plots
from this type of data the normalization used is critical to the
outcome, as it is for modeling NMR data from a set of samples.
Usually urinary data are normalized to total intensity to take into
account differences in dilution due to the amount of water a subject
excretes. We observed that, for diffusion-ordered data, in the
absence of normalization (equivalent to normalizing to noise),
differential variations in variable intensities were too subtle to
detect correlations between resonances within a molecule (Figure
3c). When normalized to total intensity, correlations of close to
1.0 were observed at the apex of peaks from the same molecule,
such as the maximums of the alanine resonances that “light up”
in Figure 5c. The sign of the covariance in these plots will depend
on the relative changes in intensities across the dataset for each
peak, as shown in Figure 5d. It is interesting to note that, when
normalized to TSP, the covariance for TSP is 0 and is therefore
not present in Figure 3b, because it does not vary across the data
set. Thus, caution must be taken to ensure that, when normalizing,
the peak of interest is not set such that it has no variation across
the data set.
The results presented in Figure 5 show that DOPY can also
be used to help measure subclasses of lipoproteins in plasma, an
important analytical challenge.47-49 While in most DOSY analyses
attempts are made to resolve completely the D dimension,
information on lipoprotein distribution is contained in the diffusion
profile, seen in Figure 5a, and greatly simplified by the DOPY
plot in Figure 5b. Indeed, the advantage of projecting onto the
1D spectrum is underscored by the observation that this DOPY
plot shows both concentration and diffusion coefficient, the latter
related to the subclass of lipoprotein. This can be particularly
helpful in investigation of diseases with lipid profiles affected, such
as cardiovascular diseases, insulin resistance, and diabetes.50
Whereas LC-NMR methods51 have also been successfully applied
to lipoprotein separation with direct NMR detection,52 this ap-
proach is too slow for practical clinical implementation. The total
time taken to acquire the diffusion data on plasma was 28 min
with a spectrometer equipped with a CryoProbe, indicating that
this approach has potential for medium- to high-throughput
screening.
In conclusion, we have developed and successfully applied two
new visualization tools for use with diffusion-ordered methods of
analysis, further extending the wide range of applications of the
STOCSY approach.8 We have exemplified the S-DOSY and DOPY
approaches for metabolite structure elucidation, for deconvolving
overlapped signals from small and large molecules in plasma, and
for highlighting lipoprotein diffusional differences. These ap-
proaches can be, in principle, applied to any type of study involving
diffusion measurement or editing via NMR methods and may have
widespread application in metabonomic studies, tissue metabolite
profiling, food science, and other complex analysis problems
where mixtures of compounds of varying molecular size are
present.
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Individual and topographical variation in the metabolic profiles of multiple human gastrointestinal tract
(GIT) biopsies have been characterized using high-resolution magic-angle spinning (HRMAS) 1H NMR
spectroscopy and pattern recognition. Samples from antrum, duodenum, jejunum, ileum, and transverse
colon were obtained from 8 male and 8 female participants. Each gut region generated a highly
characteristic metabolic profile consistent with the varying structural and functional properties of the
tissue at different longitudinal levels of the gut. The antral (stomach) mucosa contained higher levels
of choline, glycogen, phosphorylethanolamine, and taurine than other gut regions. The spatially close
regions of the duodenum and jejunum were equivalent in terms of their gross biochemical composition
with high levels of choline, glutathione, glycerophosphocholine (GPC), and lipids relative to other gut
regions. The ileal mucosa showed poor discrimination from the duodenum and jejunum tissues and
generated strong amino acids signatures but had relative low GPC signals. The colon (large intestine)
was high in acetate, glutamate, inositols, and lactate and low in creatine, GPC, and taurine compared
to the small intestine. These longitudinal metabolic variations in the human GIT could be attributed to
functional variations in energy metabolism, osmoregulation, gut microbial activity, and oxidative
protection. This work indicates that 1H HRMAS NMR studies may be of value in analyzing local metabolic
variation due to pathological processes in gut biopsies.
Keywords: metabonomics ¥ antrum ¥ duodenum ¥ jejunum ¥ ileum ¥ intestine ¥ human ¥ pattern recognition ¥
biopsy ¥ magic-angle spinning NMR spectroscopy
Introduction
The gastrointestinal tract (GIT) is a primary interface be-
tween an animal and its environment, and apart from its
obvious critical role in digestive and nutrient absorption, it is
the site of interaction and entry of many pathogens and toxins.
The GIT is highly functionally specialized and longitudinally
stratified, with epithelial cell types, secretions, and generalized
anatomical wall structure varying accordingly.1 Many human
diseases are related to dysfunction of the gut itself or are
associated with a variety of gut disorders. Moreover, the
complex associations between nutrition and gut activity impact
strongly upon the development of potentially morbid condi-
tions such as obesity.2 Hence, understanding variation in gut
biochemistry in man may be of crucial importance with respect
to the understanding of the molecular etiology underpinning
many human diseases.3-6 Furthermore, the gut houses a
complex and flexible consortium of microbes (the microbiome)
present at extraordinarily high population densities conferring
a myriad of advanced digestive, metabolic, and immunological
properties on the host.7,8 These microbes exert a profound effect
on the development, structure, and digestive and absorptive
capabilities of the intestinal epithelium.9-11 The microbiota also
influence the activity of the enteric nervous system, aid the
extraction and processing of nutrients from otherwise indigest-
ible food,12 and may have long-range endocrine-regulatory
functions via their co-metabolic effects on bile acid composi-
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† Imperial College London.
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tion.13 Understanding the relationships between the molecular
features and the biological function of structurally and func-
tionally distinct regions of the GIT in a holistic manner is
important in knowing the state of health and in understanding
metabolic deviations associated with disease, diet, and envi-
ronment.
High-resolution magic-angle spinning (HRMAS) 1H NMR
spectroscopy of intact tissue samples is a powerful tool for the
non-destructive measurement of metabolic fingerprints in
small samples of biological tissues.14 We have previously shown
that this approach can be a valuable addition to high-resolution
NMR spectroscopic studies on biofluids for understanding
disease profiles, which are caused by experimental pathogens
or by other means, especially when combined with pattern
recognition methods.15-18 In addition, HRMAS NMR spectros-
copy has been applied to the characterization of intact rat
liver,19-21 heart,22 kidney,23,24 testis,25 human breast,26 and
prostate27 in healthy and diseased animals and humans.
HRMAS NMR spectroscopy has also been employed to study
the biochemistry of healthy human gastric mucosa, where more
than 40 metabolites have been identified.28 A recent study using
this technique to characterize the metabolic composition of
rat jejunum and ileum showed that the jejunum was rich in
lipids and triglycerides which is consistent with its role in fat
storage, whereas the ileum was more abundant in amino
acids.29 In addition, metabolic profiles of intestinal regions have
been found to vary with age; for example, the relative levels of
lipids, lactate, taurine, and creatinine were found to increase
with age, while the relative levels of amino acids and glycero-
phosphocholine (GPC) were decreased in older animals.29 Here,
we extend these studies to characterize systematically the
biochemical composition of a comprehensive range of intact
human intestinal biopsies from healthy men and women. We
apply 1H HRMAS NMR spectroscopy in combination with
orthogonal projection to latent structure-discriminant analysis
(O-PLS-DA) to metabolically profile samples from antrum,
duodenum, jejunum, ileum, and transverse colon with the aim
of providing baseline data that will be of value when assessing
disturbed metabolic profiles in biopsies from diseased patients.
Experimental Methods
Sample Collection. The study protocol was approved by the
Ethical Committee of the Etat de Vaud, Lausanne, Switzerland.
Twenty healthy men (n ) 10) and women (n ) 10) aged
between 20 and 30 years were enrolled in the study, and written
consent was obtained from each participant. The recruitment
was conducted according to the Helsinki declaration. A health
check on the participants was carried out prior to sampling to
ensure that they were free from certain diseases including
neoplastic, cardiovascular, hepatic, renal, or inflammatory
bowel diseases. In addition, blood tests were carried out
including assessment of Helicobacter pylori absence and normal
coagulation markers (thromboplastin time, TP > 70%, platelets
> 150 000/mm3, partial thromboplastin time, pTT, normal), and
it was established that participants were not hemophilic. The
participants had not been taking any drugs or anti-coagulative
treatment during the 4 weeks before sampling. All participants
were required to fast for 12 h and took a routinely used bowel
preparation on the evening before the procedure, which
consisted of 4 L of Fordtran solution and 3 L of Cololyt. Biopsy
samples from the antrum, duodenum, jejunum, ileum, and
transverse colon of these participants were collected at the
Gastroenterology Department of the Hospital University Centre
in Canton de Vaud, Lausanne, Switzerland by endoscopy or
colonoscopy under sedation (Dormicum 2.5-5 mg IV and/or
Pethidine 25-50 mg IV). Since the size of a biopsy is small
(10-15 mg), it can be assumed that mainly the mucosa was
sampled. Biopsies from 16 participants (8 males and 8 females)
were snap-frozen immediately after collection and stored at
-80 °C for NMR analysis, and the biopsies from the remaining
volunteers were frozen in RNA later solution for gene expres-
sion analysis which will be reported separately.
1H HRMAS NMR Spectroscopy. Samples of human biopsies
(10-15 mg) were packed individually into 4 mm diameter
zirconia rotors and closed with a spherical insert and Kel-F cap.
A drop of D2O was added into the rotor to provide a field lock
for the NMR spectrometer. All NMR experiments were carried
out on a Bruker DRX-600 spectrometer (Bruker Biospin, Rhei-
nstetten, Germany), operating at a 1H frequency of 600.11 MHz
and equipped with a triple-resonance, high-resolution, magic-
angle spinning (MAS) probe with a magic-angle gradient.
Samples were spun at 5 kHz at the magic angle (54.7°) and
maintained at 283 K in order to minimize degradation of
tissues.30 A total of 15 min was allowed for the temperature to
reach equilibration for each sample before a spectrum was
acquired. The 90° pulse length (9.0 ís) was adjusted individu-
ally for each sample. A total of 128 transients were collected
into 16 k data points for each spectrum with a spectral width
of 20 ppm and a recycle delay (RD) of 2.0 s.
Three 1H NMR spectra were acquired for each sample: (1)
A standard one-dimensional NMR spectrum which is a general
representation of the total biochemical composition, was
acquired using the first increment of the noesy pulse sequence
to achieve water presaturation [90-t1-90-tm-90-acq].31 (2) A Carr-
Purcell-Meiboom-Gill (CPMG) spin-echo pulse experiment
used to attenuate interfering signals from macromolecules with
short spin-spin relaxation times was acquired using the CPMG
pulse sequence [90-(T-180-T)n-acq].32 (3) A diffusion-edited
NMR spectrum which selectively measures large macromol-
ecules was acquired using the bipolar-pair longitudinal-eddy-
current (BPP-LED) pulse sequence [RD-90°-G1-ô-180°-G2-ô-90°-
¢-90°-G3-ô-180°-G4-ô-90°-Te-90°-acq].33 For the standard one-
dimensional experiment, the inter-pulse delay t1 was 3 ís, the
mixing time tm was 100 ms, and irradiation of the water
resonance was used during tm and RD. For the CPMG experi-
ment, water peak presaturation and a spin-spin relaxation
delay, 2nô, of 200 ms was used for all samples. A sine-shaped
gradient strength G 15.8 G/cm and duration of 2.5 ms was used
for diffusion-edited spectra, followed by a delay (ô) of 400 ís
to allow for the decay of eddy currents. A diffusion time (¢) of
100 ms and a delay Te of 5 ms were used together with water
peak irradiation during RD. For assignment purposes, two-
dimensional (2D) 1H-1H COrrelation SpectroscopY (COSY)34and
TOtal Correlation SpectroscopY (TOCSY)35 NMR spectra were
also acquired for selected intestinal samples as detailed previ-
ously.29
Data Analysis. Free induction decays were multiplied by an
exponential function equivalent to a 0.3 Hz line-broadening
factor prior to Fourier transformation and were corrected for
phase and baseline distortions using XWINNMR 3.5 (Bruker).
The spectra were referenced to the chemical shift of the peak
of the anomeric proton of R-glucose at ä 5.223. The spectra
over the range ä 0.5-10.0 were digitized using a Matlab script
developed in-house at Imperial College London (Dr. O. Cloarec).
The region ä 4.66-5.20 was removed to avoid the effects of
imperfect water suppression. The region ä 3.62-3.75 was also
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removed due to the presence of peaks from an exogenous
compound used in the bowel preparation. Normalization to
the sum of the spectrum was carried out on the data prior to
pattern recognition analyzes. Discriminant analysis using the
O-PLS36 algorithm was carried out on the NMR spectra; data
were mean-centered and scaled to unit variance prior to
analysis. O-PLS is an extension of the Partial Least-Square
regression method37 featuring an integrated Orthogonal Signal
Correction filter.38 For visualization purposes, the O-PLS coef-
ficients indicating those variables contributing to the discrimi-
nation in the model were back-transformed as described by
Cloarec et al.39 All data analysis was carried out using MATLAB
7.0 with scripts developed in-house at Imperial College London.
The validation of the model was conducted using 7-fold cross
validation, that is, iterative construction of models by repeat-
edly leaving out one-seventh of the samples, and predicting
them back into the model. The classification accuracy of the
O-PLS-DA model was established from the prediction-set
samples in the 7-fold cross-validation, using a decision-rule
based on the largest predicted Y value. Classification perfor-
mance was evaluated, by sensitivity and specificity levels.
Sensitivity is defined as the true positive ratio (i.e., number of
true positives/(number of true positives + number of false
negatives)), and specificity is defined as the true negative ratio
(i.e., number of true negatives/(number of true negatives +
number of false positives)). An additional confusion matrix was
established to allow for the assessment of how misclassified
samples were classified by the O-PLS-DA model. In addition,
the statistical total correlation spectroscopy (STOCSY)40 method
was also applied in order to correlate NMR resonances of
selected NMR signals as an aid to metabolite assignment.
Results
1H HRMAS NMR Spectra of Human Gastrointestinal Mu-
cosa. Typical 1H CPMG HRMAS NMR spectra of intact human
biopsies of the antrum, duodenum, jejunum, ileum, and
transverse colon obtained from a female participant are shown
in Figure 1. In total, 35 common metabolites were identified
including a range of amino acids, carboxylic acids, pyrimidines,
and membrane component metabolites, as well as creatine,
glucose, inositols, lipids, and triglycerides. The NMR resonance
assignments were taken from literature and confirmed using
two-dimensional NMR spectra.28,29 The assignment of betaine
was confirmed using STOCSY analysis which showed high
correlation between the singlet at ä 3.26 and the singlet at ä
3.91. The global biochemical composition of various human
GIT samples was similar irrespective of the position along the
intestine, but variation in the relative signal intensities could
be associated with specific topographical locations. For ex-
ample, ileal mucosa appeared to be rich in amino acids,
whereas a relative lower level of taurine was present in mucosa
of the transverse colon. To systematically investigate the relative
intensities of specific metabolites associated with each part of
the intestinal mucosa, O-PLS-DA36,39 was applied to these NMR
spectral data acquired for each region. Multivariate modeling
Figure 1. 600 MHz 1H HRMAS CPMG NMR spectra of human biopsies obtained from antrum (A), duodenum (B), jejunum (C), ileum
(D), and transverse colon (E). The region between ä 5.0-8.0 was magnified 8 times, and the region ä 0.7-3.1 was magnified 4 times
compared with the region ä 3.0-4.3 for the purpose of clarity. Keys: 1, alanine; 2, aspartic acid; 3, asparagine; 4, acetate; 5, arginine;
6, N-acetyl glycoproteins; 7, betaine; 8, choline; 9, creatine; 10, cytosine; 11, ethanolamine; 12, glutamate; 13, glutamine; 14, glutathione;
15, GPC; 16, R-glucose; 17, glycine; 18, glycogen; 19, isoleucine; 20, isocytosine; 21, leucine; 22, lactate; 23, lysine; 24, lipid; 25, myo-
inositol; 26, methionine; 27, proline; 28, propylene glycol; 29, phenylalanine; 30, phosphorylcholine; 31, phosphorylethanolamine; 32,
scyllo-inositol; 33, taurine; 34, tyrosine; 35, valine.
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of both the standard one-dimensional NMR spectral data and
the CPMG spectral data sets showed good discrimination of
mucosa types, but the diffusion-edited spectral data set did not
show such regional dependent variation. This indicates that
the lipoprotein/lipid profile was relatively consistent across the
sample types with the major variation being in the low
molecular weight metabolites. Therefore, only results from the
CPMG spectra data set are presented here to avoid unnecessary
duplication.
O-PLS-DA of NMR Spectra of Human Gastrointestinal
Mucosa. No gender variation was observed in the current study
for any part of the gastrointestinal mucosa using O-PLS-DA
modeling of unit variance scaled CPMG spectral data. Each
tissue region was compared with every other region in a series
of pairwise comparisons. The results suggested that the varia-
tions in biological composition between duodenum and je-
junum were negligible. Therefore, NMR data of mucosa samples
from duodenum and jejunum were combined and considered
as one group in subsequent analyses. An O-PLS-DA model was
constructed using NMR data as an X matrix and class informa-
tion as the Y variables,39 that is, antrum (class 1), ileum (class
2), duodenum and jejunum (class 3), and transverse colon
(class 4). Two Y orthogonal components and three predictive
O-PLS components were calculated for the model. The total
explained variation for the X matrix was 0.3 (R2X), and the
corresponding cross-validation parameter (Q2Y) indicating the
predictability of the model was 0.39. The cross-validated scores
plot showed good separation of the antrum samples in the first
component with differentiation of the colon and combined
duodenum and jejunum in the second component. Samples
from ileum overlapped partially with the samples from both
colon and the duodenum/jejunum (Figure 2). Table 1 illustrates
the sensitivity and specificity levels for each class in this O-PLS-
DA model, confirming the observation in the scores plot
indicating that the antrum was the best metabolically charac-
terized region, showing both high sensitivity (78%) and speci-
ficity (100%) levels. However, while the ileum showed low
sensitivity (40%), the confusion matrix (Table 1) indicates that
this is due to the ileum being poorly distinguished from
duodenum/jejunum (50% ileal samples were misclassified as
duodenum/jejunum). Some overlap of structure/function may
be expected between adjacent small intestinal segments.
O-PLS-DA coefficient plots illustrating the various metabo-
lites associated with a specific intestinal mucosa as compared
to mucosa obtained from all other regions of the intestine are
shown in Figure 3. The coefficient plot displays the differences
in metabolic profiles related to class or sample type. Here, the
direction of the resonances relates to the relative intensity of
metabolites in a class of interest with respect to the remaining
classes as calculated from the covariance matrix. Thus positive
peaks in Figure 3A, for example, indicate a relatively higher
intensity of metabolites associated with antrum in comparison
Figure 2. O-PLS-DA cross-validated scores plot showing differentiation of the metabolic profiles of localized gastrointestinal
compartments. Red, antrum; blue, combined duodenum and jejunum; brown, ileum; green, colon.
Table 1. Confusion Matrix Calculated from O-PLS-DA Model
Indicating the Classification Results for Each Classa
predicted class
true class antrum ileum duodenum/jejunum colon
Antrum 0.78 0 0.22 0
Ileum 0 0.40 0.50 0.10
Duodenum/Jejunum 0 0.10 0.90 0
Colon 0 0.10 0.10 0.80
a Values indicate the ratio between predicted samples and the total
number of samples in each intestinal segment class (row).
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to all other regions. The colors shown on the plot are associated
with the significance of metabolites in characterizing the NMR
data for the class of interest and are calculated using the
correlation matrix with the scale shown on the right-hand side
of each plot. The coefficients indicating the significance of the
metabolites correlated with mucosa obtained from different
compartments of human GIT are summarized in Table 2. Here,
the coefficient is considered to be significant when higher than
0.35, which corresponds to the critical value of a correlation
coefficient of 5% (p ) 0.05) for a given data point. These data
show that the antrum contained relative higher levels of
choline, glycogen, phosphorylethanolamine, taurine, and acetyl
glycoproteins than the other regions considered. These varia-
tions were associated with relatively lower levels of amino acids,
lipids, glucose, and lactate in the antrum. The duodenum and
jejunum were similar in terms of their biochemical composition
and were rich in choline, glutathione, GPC, lipids, and glyco-
proteins but contained relatively lower levels of acetate, betaine,
glycogen, inositols, and phosphorylethanolamine in compari-
son with other intestinal regions. In contrast to the other
regions, especially the antrum, the ileum was rich in amino
acids, but low in GPC. The metabolites exerting the greatest
influence on the separation of transverse colonic mucosa from
the other intestinal regions were acetate, glutamate, inositols,
lactate, which were all present in relatively high levels, and
creatine, GPC, and taurine, which were present in relatively
lower amount (Table 2).
Discussion
Each topographically distinct portion of the intestine was
characterized by its metabolic profile with closer metabolic
similarities generally observed between adjacent sections, such
as high similarity between ileum and the jejunum and duode-
num (Table 1) and clear boundaries observed between small
intestine and colon (Figure 2). This observation is consistent
Figure 3. O-PLS-DA coefficient plots corresponding to the characterization of antrum (A), duodenum/jejunum (B), ileum (C). and
transverse colon (D). The colors shown on the plot are associated with the significance of metabolites in characterizing the NMR data
for the class of interest with the scale shown on the right-hand side of each coefficient plot.
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the results obtained from gene expression profiles of the GIT
of adult mouse.41
Relatively higher levels of phospholipids intermediates in-
cluding choline, phosphorylethanolamine (PE), and GPC were
mainly associated with upper parts of the human GIT. Choline
is an important compound for mammals, as it is a precursor
for biosynthesis of phospholipids that are essential constituents
of all membranes. Previous investigations have reported a
relatively high level of GPC in the duodenum and jejunum,29
which is consistent with the data presented here and may be
explained by the functional role of these regions in the
intestinal absorption of dietary phospholipids. It has been
suggested that dietary phospholipids are hydrolyzed in the
intestinal lumen by pancreatic phospholipase-A to monoacyl-
glycerol, which on entering the epithelial cells is hydrolyzed
again by esterase and release fatty acids while the rest is further
hydrolyzed to GPC.42
Variation in the relative level of amino acids was a dominant
aspect of differentiation between human GIT regions. For
example, relatively higher levels of asparatate, glutamate,
glycine, leucine, isoleucine, and valine were found in the ileum
compared to other parts of intestine. This observation in man
is consistent with a previous investigation of rat intestine
composition.29 Amino acids are required by cells of the small
intestinal mucosa for protein and for energy generation.43,44 For
example, glutamine is an important fuel for the mucosal cells
of the small intestine and has a key role in maintaining the
function and integrity of the intestine.43 Other amino acids,
particularly glutamate and aspartate, are also catabolized as
fuel.45
The colon was characterized by a relatively high level of
lactate. It has been shown that the enzyme activities involved
in glycolysis along the small intestine of the rat, including
hexokinase and 6-phosphofructokinase, are decreased by 50%,
whereas glucose 6-phosphatase is decreased by an order of
magnitude from duodenum to caecum.46 The fact that the
activity of hexokinase is considerably greater than that of
glucose 6-phosphatase in the lower part of the intestine may
result in some of the glucose being metabolized to lactate,46
which is consistent with elevated lactate levels observed in
human mucosal of the colon. The possibility of lactate pro-
duced from anaerobic glycolysis during NMR acquisition can
be ruled out, since previous investigation has shown no change
in terms of the biochemical composition being observed for
liver standing on ice for 5 h.30
Acetate was also found in high level in colon biopsies when
compared to other parts of the intestine. Acetate is produced
from fibers fermentation by the gut microbiota.47 The microbial
population density increases distally along the GIT, and it is
highest in the colon,48,49 which is consistent with the observa-
tion of higher level of acetate in mucosa of the human colon.
Intestinal epithelial cells are subjected to hypertonic condi-
tions when digested foods enter the GIT. Therefore, osmotic
regulation is important in the GIT for balancing the osmotic
equilibrium between the cell and its surrounding medium. Such
regulation is achieved through maintaining a high intracellular
content of osmolytes such as betaine, myo-inositol, scyllo-
inositol, and taurine.50 It is interesting to note that, although
the above-mentioned organic osmolytes were present in all
intestinal regions, variations in terms of their relative intensities
were associated with specific parts of the human GIT. For
example, the relative level of betaine was found to be the
highest in the ileal mucosa, whereas that of taurine was the
highest in the antrum. The transverse colon was rich in myo-
inositol and scyllo-inositol. Accumulation of betaine has been
found in the intestine of hamsters,51 rabbits,52 and broiler
chicks.53,54 Myo-inositol and its various biochemical derivatives
are broadly distributed in mammalian organs and cells, such
as in the brain, testis, secretory tissues, and kidney. Recently,
the cDNA encoding for myo-inositiol 1-phosphate synthase, an
important enzyme for controlling the concentration of myo-
inositiol, has been cloned from human colon.55 Taurine is
another commonly found osmolyte in animal organs such as
the kidney. Specific roles for taurine in maintaining cell volume
under short-term hypo-osmotic stress, and inositol for long-
term hypo-osmotic/hyper-osmotic stress, have been reported.56
The different functions of these two organic osmolytes could
be related to the localization of the organic osmolytes at specific
intestinal mucosa, that is, association of taurine with antrum
and inositols with colon, and hence to the physiological state.
The human GIT is also subjected to oxidative stress, espe-
cially from free radicals generated from lipid metabolism.
Distribution of glutathione, one of the most important anti-
carcinogens and antioxidants in mammalian cells,57 was found
throughout the human intestine with its level being relatively
high in the mucosa of duodenum and jejunum. This observa-
tion is consistent with previous studies in both humans58,59 and
rats.57 Additional glutathione could also arise from the release
of bile from the bile duct which is connected to the duodenum
and jejunum.57 We have also observed a relative decreased level
of glutathione in the ileum and colon. This could be associated
with increased microbial population density in these regions
compared to more proximal intestinal segments, since it has
been suggested that microbiota toxins production may be
related to glutathione levels.60
The human GIT is prone to mechanical and chemical stress.
In the current investigation, higher levels of acetyl glycoproteins
were found in the antrum and duodenum when compared to
Table 2. The Coefficients of Metabolites in the CPMG Spectra
Contributing to the Separation of a Specific Human
Gastrointestinal Region from All the Others (R2Y ) 0.84, R2X )
0.30, Q2Y ) 0.39)a
metabolites (ä ppm) antrum
duodenum
jejunum ileum colon
alanine (1.46) -0.49
acetate (1.91) -0.35 +0.35
aspartic acid (2.78) -0.57 +0.50
betaine (3.26) -0.40 +0.59
choline (3.19) +0.69 +0.40 -0.35 -0.36
creatine (3.03) -0.55 +0.32
ethanolamine (3.13) -0.46 +0.46
glutamate (2.34) -0.61 +0.52 +0.48
glycine (3.55) -0.44 +0.51
glycogen (5.41) +0.77 -0.40
glutathione (2.55) +0.37
glucose (4.63) -0.40
GPC (3.23) +0.38 -0.45 -0.38
leucine/isoleucine (1.00) +0.44
lipids (5.32) -0.36 +0.36
lactate (1.33) -0.55 +0.40
myo-inositol (4.04) -0.53 +0.75
N-acetyl glycoproteins (2.07) +0.39 +0.40 +0.35
phosphorylethanolamine (3.98) +0.69 -0.38
scyllo-inositol (3.34) -0.37 +0.61
taurine (3.25) +0.69 -0.40
valine (1.04) +0.48
a The + and - symbols indicate the presence of higher (+) or lower (-)
levels of metabolite with respect to the levels found in other intestinal tissues.
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the other parts of the GIT. The results obtained here are also
consistent with the recent discovery of a high level of synap-
tophysin, a glycoprotein found in the antrum of the human
GIT.61 Glycoproteins are high molecular weight polymers and
important constituents of mucins.44,62 The functions of mucins
are tissue lubrication and modulation of water and electrolyte
absorption, and most importantly, they provide protection of
the epithelium from mechanical and chemical stress.63 The
observation of high levels of glycoproteins in antrum and
duodenum could be anticipated, since the mucosal lining of
the antrum and duodenum is exposed to high levels of
hydrochloric acid and pepsin, essential for protein digestion.
This therefore requires mucin-secreting cells to produce a
healthy layer of mucins for protective purposes.
It is also anticipated that the bowel preparation used prior
to sample collection, a necessary procedure to obtain intestinal
tissues, could induce certain stress and alter physiological
conditions. However, since the regeneration of intestinal
epithelium is exceptionally rapid64 and the stress induced would
be equivalent for all the samples, variation in the physiological
functions discussed above result largely from the topographical
differences of the tissue rather than the bowel preparation. In
addition, lipids distribution appeared to be uniform along
human intestinal mucosa, which is in contrast to investigations
carried out on rats, where enrichment of lipids was observed
in jejunum.29 The major difference between the current and
previous investigations was sampling position. Here, human
intestinal samples were biopsies, mainly comprising the mu-
cosa part of the intestine, whereas previous work on rats was
performed on a cross-sectional biopsy including mucosa,
muscle, and peritoneum which could partly contribute to the
discrepancy observed.
In conclusion, the biochemical characterization of mucosa
along the human GIT including the antrum, duodenum,
jejunum, ileum, and transverse colon was achieved from
O-PLS-DA data analysis of both the standard 1D and CPMG
1H HRMAS NMR spectra. The biological composition of the
mucosa of human GIT is highly consistent; nevertheless, the
variation in patterns of metabolites longitudinally is consistent
with local gut function and hence will be of value in assessing
disrupted gut mucosal function in pathological tissue samples
obtained at biopsies.
Abbreviations: CPMG, Carr-Purcell-Meiboom-Gill; GPC, glyc-
erophosphocholine; HRMAS, high-resolution magic-angle spin-
ning; NMR, nuclear magnetic resonance; PE, phosphoryleth-
anolamine; O-PLS-DA, orthogonal projection to latent structure-
discriminant analysis; COSY, 1H-1H correlation spectroscopy;
TOCSY, 1H-1H total correlation spectroscopy. STOCSY, statisti-
cal total correlation spectroscopy; GIT, gastrointestinal tract;
PCA, principal component analysis.
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OPLS discriminant analysis: combining the strengths
of PLS-DA and SIMCA classificationy
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The characteristics of the OPLS method have been investigated for the purpose of discriminant
analysis (OPLS-DA). We demonstrate how class-orthogonal variation can be exploited to augment
classification performance in cases where the individual classes exhibit divergence in within-class
variation, in analogy with soft independent modelling of class analogy (SIMCA) classification. The
prediction results will be largely equivalent to traditional supervised classification using PLS-DA if
no such variation is present in the classes. A discriminatory strategy is thus outlined, combining the
strengths of PLS-DA and SIMCA classification within the framework of the OPLS-DA method.
Furthermore, resampling methods have been employed to generate distributions of predicted
classification results and subsequently assess classification belief. This enables utilisation of the
class-orthogonal variation in a proper statistical context. The proposed decision rule is compared
to common decision rules and is shown to produce comparable or less class-biased classification
results. Copyright # 2007 John Wiley & Sons, Ltd.
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1. INTRODUCTION
In many areas of life sciences today, classification problems
constitute the most prevalent forms of intricacies, both in
terms of discrimination between groups and interpretation
of group differences in meaningful ways. Currently, a
multitude of linear and non-linear multivariate classification
approaches exist, such as support vector machines (SVMs)
[1], Quadratic Discriminant Analysis (QDA) (see, for
instance Reference [2]) and Partial Least Squares (PLS) [3]
regression. Non-linear methods may occasionally outper-
form linear methods in terms of classification rates [4,5] but
typically lack the powerful interpretational capabilities that
have become the distinctive characteristics of linear methods
such as PLS. The choice of method adopted might thus be
related to whether discriminatory power is of greater
importance than the ability to interpret the underlying
chemical or biological changes related to class differences.
Soft independent modelling of class analogy (SIMCA) [6]
is an established method for multivariate classification.
Disjoint Principal Component Analysis (PCA) [7] models are
fitted for each class, and model residuals are utilised to
classify unknown observations to no class, one class or
several classes [8]. The method effectively handles a
multitude of classes demonstrating high within-class varia-
bility and has been utilised in numerous fields, such as
metabonomics [9] and transcriptomics [10]. However, each
disjoint PCAmodel is generated based on the direction in the
data demonstrating the highest variation, which might be
distinctly different from the direction separating the classes.
Consequently, maximum class-separation is not explicitly
the objective function of the method. Furthermore, due to the
usage of several local PCA models, information regarding
between-class differences is not easily accessible, which
hampers the quality of interpretation (transparency) of the
classification model.
PLS [3] regression is a multivariate method for assessing a
relationship between a descriptor matrix X and a response
matrix Y. PLS regression has foremost been used in the field
of multivariate calibration [11] where the response matrix is
quantitative, but might additionally be employed for
qualitative data structures typical in discrimination analysis
in the form of PLS-DA. PLS-DA typically outperforms
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SIMCA in classification rates, provided that within-class
variability is low, as class-separation is maximised. The
methodology has successfully been used in a large number of
areas, including metabonomic [12] and transcriptomic [13]
studies. However, as PLS-DA explains differences between
overall class properties, the interpretation becomes pro-
gressively more complicated as the number of classes
increase.
Orthogonal signal correction (OSC) [14] is a methodology
initially developed for spectral data pre-processing by Wold
et al. By employing information in the response matrix Y
(containing, for instance, toxicity measurements), strong
systematic variation in the descriptor matrix X (containing,
for instance, spectral data) that is orthogonal (non-correlated)
to Y can be identified. This variation, henceforth, denoted as
Y-orthogonal variation, can subsequently be studied and,
depending on the problem at hand, be discarded or retained.
Despite the fairly unambiguous concept of OSC, a multitude
of implementations occur in the literature [14–16].
OPLS [15] is an extension to the supervised PLS regression
method featuring an integrated OSC-filter. In simple terms,
OPLS uses information in the Y matrix to decompose the X
matrix into blocks of structured variation correlated to and
orthogonal to Y, respectively. The block containing the
correlated variation, also referred to as the predictive
variation, can also be derived from the normalised PLS
regression vectors followed by a procedure called ‘target
rotation’ developed by Kvalheim and Karstang [17]. OPLS
can, analogously to PLS-DA, be used for discrimination
(OPLS-DA) which has been demonstrated in a recent
metabonomic study by Cloarec et al. [18]. The integrated
OSC-filter introduces a noteworthy advance compared to
PLS regression, mainly related to the transparency of the
generated models.
The main benefit in interpretation using OPLS-DA
compared to PLS-DA thus lies in the ability of OPLS-DA
to separate predictive from non-predictive (orthogonal)
variation. This advantage can be demonstrated using a
simple two-class scenario based on spectral data as shown in
Figure 1. For PLS-DA, two components t1 and t2 are required
to find a perfectly discriminating plane between the two
classes as shown in Figure 1A. The corresponding loading
vectors p1 and p2 will contain a mixture of both the
discriminatory properties as well as the non-discriminatory
properties that are mainly confounded with the direction of
t2. In the same example, OPLS-DA effectively separates the
discriminatory direction in tp,1 from the Y-orthogonal
direction to,1 making the corresponding predictive loading
vector pp,1 straightforward to interpret (Figure 1B). The parts
of the spectra responsible for the remaining variation can be
identified from theY-orthogonal po,1 loading vector, which is
mainly related to high within-class variance of one of the
classes.
Another interesting aspect from the displayed example is
the difference in magnitude in the Y-orthogonal direction
(Figure 1B). The Y-orthogonal component is, on its own,
practically sufficient to separate the two classes. In a case
where the classes are overlapping in the predictive direction,
Y-orthogonal variation might thus be employed to increase
classification rates. This may, in a sense, contradict the view
of the Y-orthogonal variation as it is orthogonal to the classes
in the model. However, the Y-orthogonal components can, in
Figure 1. Demonstration of the main differences between PLS-DA and OPLS-DA. The example consists of a
two-class case based on simulated spectral data. Observations in class 1 are denoted by circles whereas
observations in class 2 are denoted by x-marks. Approximate confidence limits are shown using dotted ellipses
(global), dashed ellipses (class 1) and dot-dashed ellipses (class 2). (A) For PLS-DA, the discriminatory direction
between the classes is a combination of both t1 and t2. Class 2 has a high within-class variance, which is mixed with
the discriminatory direction making the corresponding loadings, p1 and p2, difficult to interpret. In (B), OPLS-DA
separates the discriminatory direction in tp,1 from the Y-orthogonal direction to,1 making the corresponding loading
pp,1 straightforward to interpret. It is also seen in the Y-orthogonal po,1 loading vector that a single peak is the cause
of the high within-class variance of class 2. This difference between OPLS-DA and PLS-DA is accentuated when
employing more than two model components.
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terms of magnitude, be considered to represent parts of the
within-class variance, which occasionally may be useful for
discrimination. This approach shares conceptual similarities
with SIMCA classification, which employs observation
residuals to assign class memberships based on local models.
We thus aim to delineate a classification solution combining
the strengths of PLS-DA (maximum class-separation) with
the strengths of SIMCA classification (handling within-class
variation) while maintaining the interpretational advantages
[19] of the OPLS-DA method.
A general aspect of classification models lies in the general
belief of the classification result; which is a characteristic that
has largely been neglected in the past for PLS-DA and
SIMCA classification. In PLS-DA (and consequently also
OPLS-DA), all observations are assigned a class-specific
numerical value yhat based on the final model. The yhat value
should be as close to 1 as possible to belong to a certain class
or close to 0 otherwise. For the two-class case, a straightfor-
ward 0.5 threshold has frequently been employed (see, for
instance Reference [20]) to determine class belonging.
However, if the classes are inhomogeneous or greatly
differing in size, this might not be an optimal way of
assigning class membership. Simply defining an interval
of yhat that is ‘acceptable’ in some sense, solely based on the
final model, is inherently hazardous due to the risk of
overfitting.
One possible remedy regarding these issues is the usage of
QDA on the predictive PLS scores as demonstrated by
Nguyen and Rocke [21]. A related approach would be to
utilise a resampling-based methodology to generate distri-
butions of yhat and subsequently assign probabilities of class
membership based on conventional probability theory.
Similar functionality for PLS-DA is already available in
the PLS toolbox (http://software.eigenvector.com/faq/?38).
Here, we utilise this resampling strategy, which is insensitive
to the number of classes or a priori probabilities resulting
from skewed class sizes. Furthermore, the methodology can
easily be extended to include additional classification
information from the Y-orthogonal components, which is
explicitly demonstrated.
A flowchart of the outlined probabilistic classification
strategy is depicted in Figure 2. To conclude, the presented
study illustrates further aspects of the added benefits of
OPLS-DA compared to PLS-DA by employing the
Y-orthogonal variation for interpretational and discrimina-
tory purposes. Analogies to SIMCA classification will be
employed to illustrate how the Y-orthogonal variation can be
used to generate PLS-DA/SIMCA hybrid discriminatory
models. Furthermore, resampling methods and a set of
straightforward decision rules will be utilised to assess
classification belief based on traditional probability theory.
2. NOTATION
The following notation has been used throughout. Vectors
are denoted by bold, lower-case letters and are assumed to be
column vectors unless indicated by a transposition, for
Figure 2. Flowchart of the outlined classification strategy. The classification process uses a
multi-class training data, which is resampled n times to generate distributions of the predictions for
all classes. Subsequently, anOPLS-DAmodel is fitted on all observations for interpretations, future
predictions of external data sets and to estimate the modifier of the Y-orthogonal components.
External data sets are predicted from the full OPLS-DA model and classified based on the
resampled distributions and Y-orthogonal modifiers.
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example, pT.Matrices are denoted by bold upper-case letters,
for instance X and matrix inverses are denoted by X1.
3. METHODS
3.1. OPLS-DA
OPLS-DA uses information in the categorical response
matrix Y to decompose the Xmatrix into three distinct parts
as described in Equation (1), where Tp denotes the predictive
score matrix for X, Pp denotes the predictive loading matrix
for X, To denotes the corresponding Y-orthogonal score
matrix, Po denotes the loading matrix of Y-orthogonal
components and E denotes the residual matrix of X. Further
details of the OPLS algorithm are described by Trygg [15,22].
X ¼ TpPTp þ ToPTo þ E (1)
Classification by the estimated OPLS-DA model is
accomplished in two steps. First, the Y-orthogonal variation
is removed from the data matrix X as shown in Equation (2),
where To is the Y-orthogonal score matrix for X and Po is the
Y-orthogonal loading matrix.
Xp ¼ X ToPTo (2)
Second, Yhat is estimated using the updated Xp and the
predictive components from the OPLS-DA model, which are
estimated from the training data set.
3.2. SIMCA
In SIMCA classification, the residuals of several disjoint PCA
models are utilised to assign an observation to one or several
of the available classes. During the training of each
class-specific PCA model, a distribution of the residuals
for each class is generated. Given this class-specific residual
distribution, any given observation can subsequently be
assigned a probability of equal variance compared to the
model residuals according to a F-test. The probability
assignment is then ultimately used to accept or reject the
observation to or from each class, which is essentially a tool
for detecting model outliers. This is captured in the distance
to model (DModX) [6] criterion for an observation i as
defined in Equation (3), where E is the residual matrix, N is
the number of samples, K is the number of variables, A is the
number of model components and A0 is 1 if the data have
been mean-centred or 0 otherwise.
DModXðiÞ ¼
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPK
k¼1
ðEi;kÞ2
KA
s
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃPN
j¼1
PK
k¼1
Ej;k
ðNAA0ÞðKAÞ
vuut
(3)
SIMCA may be extended to also take into account the
distributions of the PCA score matrix T in addition to
the residual distribution. In a similar way as described for
DModX, the Hotelling’s T2 statistic (see below) can be
applied to estimate a probability for each observation to
belong to each disjoint PCA model based on the score
distribution of the training data. We will refer to the SIMCA
implementation that uses both residual statistics as well as
score based statistics as the ‘DmodXþ’ method and the
corresponding decision rule as the DRdmodxþ rule.
3.3. Hotelling’s T2
Apart from using themodel residuals, distributionsmay also
be generated from the score matrix Tp based on the training
data. A multivariate t-test (Hotelling’s T2) [23] is used to
assign a probability that the predicted score value of any
given observation is different from the mean of the
distribution of Tp from the training set. For the case of
PLS-DA, class-specific distributions of Tp might be used if
the within-class variations are not assumed to be equal, with
the added uncertainty of founding each distribution on fewer
degrees of freedom. It is evident that the additional
information in OPLS-DA in terms of the To matrix might
be used in a similar fashion to Tp and ultimately to aid
the classification. This is based on the assumption that the
structured class-specific Y-orthogonal variation is reprodu-
cible and should thus appear for new observations of the
given class.
3.4. Defining classification success
Classification rates are typically measured using the true
positive (TP) rate, denoting the observations from a group
that are correctly classified as members of that group.
Another complementary measure is the true negative (TN)
rate, denoting the observations that are non-members of a
specific group and are correctly classified as such. Remaining
incorrect classifications are either defined as false positives
(FP) or false negatives (FN).Wewill use the term sensitivity to
refer to the TP/(TPþ FN) fraction and specificity to refer to
the TN/(FPþTN) fraction. These terms will be used in
various contexts throughout the paper.
3.5. Classification decision based on
OPLS-DA prediction results
Predictions from the OPLS-DA model are in the form of the
categorical variables used for estimation of the OPLS-DA
model. To make objective classification decisions using the
predicted Y-matrix, henceforth denoted as Yhat, there is a
need to develop some decision rules for this purpose. For
PLS-DA models, fixed or optimised boundaries have
commonly been used to assign class membership based on
the predicted values [20,24]. An alternative decision rule is
simply to assign class membership according to the Yhat
exhibiting the largest numerical value. Here, we have
investigated how a class-conditional probabilistic approach
based on the probability density function for the categorical
Y-variables can be used for classification decisions and
compare the probability density-based prediction to
traditional decision rules.
3.6. Estimation of probability densities
for Yhat
Class-specific distributions of Yhat are estimated by resam-
pling, which are subsequently used for classification of
future observations. By using the estimated probability
density function, rather than a predefined threshold value,
each observation can be assigned a probability to belong to
each class i in the model. Here yhat,i is modelled as a N(mi,s
2
i )
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distribution where s2i can be estimated by any suitable
resampling technique such as bootstrapping or cross-
validation. In this particular case, we have utilised
class-balanced Monte Carlo Cross-Validation (MCCV) [25]
to estimate s2i from the training data. For each cross-
validation round, a class-balanced sample is drawn without
replacement to be used as a cross-validation training set for
calculation of an OPLS-DAmodel. The complementary set of
observations, the cross-validation test set, is used to estimate
the yhat,i distribution for future unknown samples. Using
cross-validation for the estimation of the yhat,i distributions
ensure that over-fitting is reduced and helps to improve the
classification results.
The predictions of the cross-validated test sets are saved
over the cross-validation rounds into Yhat,cv, which has L
columns (for L classes). Yhat,cv is subsequently used to
estimate the distribution of yhat,cv,i, based on the observations
belonging to each class i. yhat,cv,i is treated as a continuous
random variable with the distribution N(mi, s
2
i ). From the
resampling phase, we estimate s2i by the sample variance s
2
i
for each yhat,cv,i as described in Equation (4), where x denotes
the resampled observations in class i, x the mean of class i
and n the number of observations in class i.
s2i ¼
Xn
j¼1
ðxj  xÞ2
n 1 (4)
3.7. Using probability densities in
classification
Given the estimated class-conditional distributions,
P(yhatjclassi, mi, s2i ), for yhat and the prior probabilities for
each class, P(classi), the posterior probability for new
samples to belong to class i can be calculated by applying
Bayes’ theorem. Here the class-conditional distribution
used is the probability density function (pdf) in the form of
the cumulative distribution function (cdf) (Equation (5)).
FðxÞ ¼ PðX  xÞ (5)
Hence, the likelihood for an observation to belong to class i
is increasing (to a maximum value of 1) with an increasing
yhat value. The posterior probability, P(classijx), for an
observation x to belong to class i is expressed in Equation (6),
where z is the normalisation factor (Equation (7)) and
P(classi) is the prior probability for a sample to belong to the
class. The prior probability is set to the frequency, that is, the
relative class size, for the presented examples, but could
denote any subjective prior.
PðclassijyhatÞ ¼ z1 PðclassiÞPðyhat
classi;mi; s2i Þ (6)
z ¼
XL
i¼1
PðclassiÞPðyhat
classi;mi; s2i Þ (7)
Thus, P(classijx) is calculated independently for each class
i, and then normalised to unity over all classes as in Equa-
tion (7).
The classification decisions are based upon the posterior
probabilities by assigning the observation to the class with
the highest probability, which is an optimal Bayesian
decision rule. In addition, the normalised probability of
the assigned class gives a quantitative measurement of how
certain the classification is. The normalisation factor may be
viewed as a measurement of our general belief in the
classification. A high normalisation factor indicates that
the observation fits poorly into all of the classes, which
reduces the reliability of the classification.
3.8. Making use of Y-orthogonal variation
in classification
In addition to the discriminative information present in the
predictive components of the OPLS-DA model, there is also
information contained in the Y-orthogonal components. The
To matrix can, in some cases, contain information that may
be of value for discrimination. This may contradict the
intuitive view of the Y-orthogonal variation, since by
definition it is orthogonal to Y, which is used to describe
the classes in our model. Nonetheless, To can be considered
to contain information regarding the amount and the
characteristics of the within-class variance, which in some
cases may be suitable for class discrimination. The direction
of To is, however, forced by the orthogonality constraints in
relation to Y as well as within To, whichmay cause (from this
perspective) relevant variation to partly end up in the
residual matrix E. A simple and generally valid way of
addressing this issue would be to calculate score components
from (ToP
T
o þE) using PCA as described in Equation (8), and
subsequently utilise TPCA for discriminatory purposes.
ToP
T
o þ E ¼ TPCAPTPCA þ EPCA (8)
Class-specific boundaries can now be defined in the TPCA
space using Hotelling’s T2 statistic [23] analogously to the
common Hotelling’s T2 boundaries for Tp. Let us now
assume that we face a classification problem with L classes
where subsets of observations overlap to a great extent in the
predictive Tp directions. One of the classes does, however,
exhibits a much greater within-class variation relative to the
other classes. This within-class variationmanifests itself in an
increase in relative spread of one or several of the
TPCA-vectors. Based on this information, it is reasonable to
alter the belief of an observation belonging to this particular
class based on the TPCA-information, in particular when the
information in Tp is less helpful for discrimination. This
approach has similarities to SIMCA classification, which is
making use of the residual for the observations to
class-specific PCA models, and is employed to assign class
membership by excluding classes where the residual is large.
We employ Y-orthogonal variation for classification by
calculating Hotelling’s T2crit separately for each class i. If t
2
PCA;i
is larger than T2crit;i for one or more classes, this indicates that
the observations probably do not belong to these classes in
the given model based on the Y-orthogonal variation. This
can be used to add a simple decision rule to our classifier
(Equation (9)), where t2PCA is Hotelling’s T
2 value for the
observation as defined in Equation (10).
Pðclassijt2PCA;T2crit;iÞ ¼
0; t2PCA > T
2
crit;i
1; t2PCA  T2crit;i
(
(9)
t2PCA ¼
XA
a¼1
t2PCA;a
s2PCA;a
(10)
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T2crit;i is Hotelling’s T
2 value at a (1-a) significance level
given A latent variables and (NA) degrees of freedom for
class i. This enables the usage of the Y-orthogonal
information as a one-class classifier by defining an exclusion
rule for each of the possible classes for a given observation.
4. RESULTS
In the following paragraphs, we will demonstrate the
predictive and interpretational benefits of the outlined
strategy using a set of real and simulated data sets.
4.1. The HgCl2 data set
The Mercury Chloride (HgCl2) data set originates from a
metabonomics-based toxicity study (Elaine Holmes, unpub-
lished work), where the effect of HgCl2 on the metabolite
composition of mouse urine has been studied using 1HNMR
spectroscopy. The data set consists of three classes: controls,
low-dose and high-dose, where each class contains five
animals. Each NMR spectra was phased and baseline
corrected before the spectra was integrated over 0.04 ppm
regions, which is conventional for this type of data. This
resulted in 262 variables after the region equivalent to
the H2O peak was removed from the spectra. Here, we have
employed the samples collected at 72 and 96h post-dose for
classification, where the 72 h samples were utilised for model
training and the 96 h samples for model validation.
The OPLS-DA classification results represented by the
sensitivity and specificity levels for four different decision
rules are shown in Figure 3. The decision rules are (i) fixed
threshold (Yhat> 1/L, DRfixed), (ii) classification according to
the largest Yhat (DRmax), (iii) density-based predictions
(DRdensity) and (iv) density-based predictions using TPCA
to assess class-specific difference of Y-orthogonal variation
(DRdensity-o). The DRfixed and DRmax decision rules show
slightly lower overall sensitivity and specificity compared to
the results of the DRdensity and DRdensity-o decision rules but
are roughly comparable for the three classes. It is, however,
noteworthy that classifications based on the DRdensity
and DRdensity-o decision rules demonstrate more even
classification performances between the classes compared
to the DRfixed or the DRmax rules where class 3 (high-dose)
animals have a much lower sensitivity.
The density-based classification rule also provides
additionalmodel information compared to the other decision
rules. In Figure 4, the probabilities for each observation (row)
in the external test set (96 h) to belong to each class are
visualised. The correct class is highlighted by a white
rectangle, while black rectangles signify incorrectly classified
observations. The highest normalised probability is shown
next to all observations in Figure 4B, which is used to
determine class belonging. This can be interpreted as the
probability that the observation belongs to that particular
class compared to the remaining classes. In addition, the
normalisation factor (see Equation (7) for a definition) is also
displayed in Figure 4C. This parameter can be considered a
measurement of the general belief in the classification, since a
low value means either that the observations fit poorly into
all the classes, or simply that the estimation of the probability
Figure 3. OPLS-DA results for the HgCl2 data set. The HgCl2 72 h post-dose samples are used
as training set whereas the 96 h post-dose samples are used as external test set in the OPLS-DA
model. Sensitivity and specificity levels from a model with two predictive components and five
Y-orthogonal components using mean-centred data are shown, where 400MC rounds were
employed for estimation of the Yhat distributions. Classification results based on different
decision rules are shown in (A) DRfixed, (B) DRdensity, (C) DRmax and (D) DRdensity-o, respectively.
Sens¼Sensitivity, Spec¼Specificity.
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densities have resulted in a distribution displaying high
variance. This can be confirmed if class 3 is further
investigated. In Figure 4C it can be seen that the inverse
normalisation factor levels for the class 3 observations (rows
11–15) are slightly lower compared to observations in
classes 1 and 2 (rows 1–10). Investigation of the estimated
probability densities from the MCCV (Figure 5) shows
that class 3 indeed has a high variance compared to class
1 (controls) and class 2 (low-dose).
4.2. The breast cancer data set
The methodology is further illustrated by a public two-class
data set investigating differences between benign and
malignant forms of breast cancer (see, for instance
Reference [26]). The investigated samples are benign (class
1; 444 samples) and malignant (class 2; 239 samples) tumour
tissue described by nine variables characterising morpho-
logical cell properties. Sixteen samples with missing data
were removed prior to modelling. The data set, containing
683 observations in total, was randomly split into one
training data set (containing 20% of the observations) and
one external test set (containing 80% of the observations).
The same trend as for the HgCl2 data set is observed in this
data set. The sensitivity levels are more evenly spread
between the classes using the density-based class assignment
compared to the DRfixed or the DRmax decision rules,
respectively. In addition, the density-based classification rule
is also producing better overall sensitivity and specificity
levels compared to the DRfixed rule or the DRmax rule, seen in
Figure 6. The DRdensity-o rule produces slightly lower overall
sensitivity and specificity values compared to the DRdensity
rule. This is mainly due to the lack of differences in
magnitude of within-class variation across the classes and
ultimately a consequence of the implicit assumption in the
Hotelling T2 test of TPCA that a fraction a¼ 0.05 of the
observations are outliers. We show in a later example that
this assumption can be highly beneficial for classification
success when differences exist in magnitude between the
classes do exist.
4.3. The simulated data sets
As previously stated, we aim to provide a classification
methodology that combines the strengths of PLS-DA and
SIMCA classification. If differences in mean values exist
between the classes, the Tp matrix will form the predictive
basis for classification as in PLS-DA. The results will, in this
case, outperform SIMCA classification and will be largely
equivalent to PLS-DA (equivalent in the two-class case).
Should the main difference between the classes be based on
variance, the TPCA modifier (see Equations (8)–(10)) will
provide auxiliary information to enable the method to act
partly as a one-class classifier. The proposed method will, in
this case, provide comparable results as SIMCA classification
but will outperform traditional PLS-DA as no distinct
predictive direction is available.
We demonstrate the strengths of this hybrid methodology
using a set of simulated data sets containing gradients of
these properties for a two-class case. The SIMCA, OPLS-DA
and OPLS-DA with the TPCA modifier methodologies are
compared in parallel. Since OPLS-DA without the TPCA
modifier will produce identical predictions as PLS-DA in the
two-class case, the comparison is made between OPLS-DA
with and without the TPCA modifier. All conclusions
regarding OPLS-DA without the TPCA modifier are thus
directly transferable to PLS-DA in this context. There are
essentially four extreme cases of data set properties.
1. If no difference between classes is available based on
neither mean values nor variance, all methods generate
Figure 4. Visualisation of probabilities and additional quality
parameters for the probability density based decision rule.
The correct class is highlighted by a white rectangle, while
black rectangles signify incorrectly classified observations.
The highest normalised probability (values within white
rectangles) can be interpreted as the probability that
the observation belongs to that particular class. In addition,
the normalisation factor (see Equation (7) for a definition) is
also displayed. In (A), class prediction probabilities are shown.
In (B), the probability for chosen class is shown. In (C), the
inverse normalisation factor z1 is shown.
Figure 5. Estimated distributions for the HgCl2 classes.
Distributions are estimated for classes 1–3 by class-balanced
MCCV for 400CV rounds. Class 1 is displayed in the left-most
plot area, class 2 in the centre plot area and class 3 in the
right-most plot area, respectively. Dashed lines denote the
estimated distribution for the test set during MCCV whereas
solid lines show the estimated distribution for the correspond-
ing training set, also during MCCV.
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equally poor classifications (approximately 50% speci-
ficity).
2. If the difference between classes is based on mean values
only, OPLS-DA andOPLS-DAwith theTPCAmodifier will
outperform SIMCA classification.
3. If the difference between the classes is based on variance
only, OPLS-DA with the TPCA modifier and SIMCA
classification will outperform OPLS-DA.
4. If the difference between the classes is based on both
variance and means, OPLS-DA with the TPCA modifier
will outperform OPLS-DA and SIMCA classification.
The classification performance of SIMCA (DRdmodxþ),
OPLS-DA (DRdensity) and OPLS-DA with the TPCA modifier
(DRdensity-o) is demonstrated for each of these extreme cases,
as well as the intermediate ones by 25 simulated data sets.
These data sets are represented on a five by five grid as
illustrated in Figure 7A for the four main cases listed above.
Along the horizontal (x) axis the difference in within-class
variance is increasing and along the vertical (y) axis the
difference in between-classmeans is increasing. Each data set
contains N¼ 200 observations in each class and K¼ 2000
variables of spectral type. Results are shown for an external
test set of equivalent size as the training set, independently
drawn from the same distribution as the training set.
Classification results for each one of these methods are
shown in Figure 7B–D in the form of specificity for the class
with the least within-class variance. The specificity result for
this class is intended to mimic a situation where SIMCA
classification will be successful. Figure 7B illustrates how the
performance of SIMCA classification is enhanced with
increased difference in the amount of within-class variance
between the two classes, while the performance of OPLS-DA
(Figure 7C) is improved with increased difference between
the means of the two classes. OPLS-DA using the TPCA
modifier utilises both increased difference in means as well
as difference inwithin-class variance between the two classes
for classification.
5. DISCUSSION
We have demonstrated how OPLS-DA can be applied for
classification of data with one or more classes. The OPLS-DA
method is well suited for classification of data that have
multi-collinear and noisy variables, which is common for
many types of biological data. In cases where Y-orthogonal
variation is present in the data, the OPLS-DA algorithm will
model the discriminatory components and the Y-orthogonal
components separately, which results in a model that is
easier to interpret compared to the standard PLS-DA model.
The probability-based classification appears, in the pre-
sented examples, to be more adaptive to different levels of
class homogeneities resulting in different levels of with-
in-class variance. This renders the classifier less prone to
produce biased sensitivity and specificity levels between
classes in the multi-class case. If these conclusions are
generally applicable, such qualities make the probability-
basedOPLS-DA classification rule an attractive alternative to
classification decisions based on a fixed or optimised
threshold level for classification of the predicted Y-matrix.
Figure 6. Sensitivity and specificity plot for breast cancer data set. Twenty per cent
(137 samples) of the datawere used as training set while the remaining 546 samples
were used as external test set in the OPLS-DA model. Sensitivity and specificity
levels from a model with one predictive component and two Y-orthogonal com-
ponents usingmean-centred data are shown, where 100MC roundswere employed
for estimation of the Yhat distributions. Classification results based on different
decision rules are shown in (A) DRfixed, (B) DRmax, (C) DRdensity and (D) DRdensity-o,
respectively. Sens¼Sensitivity, Spec¼Specificity.
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The probabilistic framework for class decision-making
also opens up for the introduction of additional information
sources to the classifier. This enables use of prior prob-
abilities, to compensate for skewed samples sizes, but most
importantly allows for incorporation of the class-specific
Y-orthogonal variation in a statistical framework. Here, we
have demonstrated how the Y-orthogonal variation,
represented by PCA of the Y-orthogonal score components
To and the residual E (Equations (8)–(10)), can be used to aid
classification in cases where the Y-orthogonal variation is
differing in magnitude between classes. This is essentially a
representation of differences in within-class variation that
can be used for discriminatory purposes given that the
sampledwithin-class variation is representative for the entire
population of samples. More specifically, this was accom-
plished by defining class-specific Hotelling’s T2 boundaries
for each tPCA, which were subsequently used to assign
probabilities that each observation belongs to the class-
specific distribution of tPCA. The probability assignments are
utilised to accept or reject observations to or from each class.
This is an added decision rule that has similarities to a
so-called one-class classifier, which in principle is defining
a rule for including or excluding a predicted observation to a
class. The analogy to SIMCA classification is evident; where
the residual (DModX) for a set of class-specific PCA models
is used for class discrimination. However, in order to make
proper use of the within-class variance difference in the TPCA
components, with the final aim of improving classification
success, the variance in the different classes has to differ
significantly.
Based on a probabilistic framework suggested here, it is
easy to add not only discrete decision rules, as in the example
Figure 7. Simulated data and classification results. (A) Schematic overview of the
layout of the 25 simulated data sets on a five by five grid. The data set in the top left
corner lacks differences both inmeans and variance between the two classes. In the
horizontal (x) direction, the difference in variance between the classes is increasing
whereas in the vertical (y) direction the difference of themeans for the two classes is
increasing. This demonstrates the principal cases where SIMCA, OPLS-DA and
OPLS-DA with the TPCA modifier are successful. (B) Specificity results for SIMCA
(DRdmodxþ) for each one of the 25 data sets based on the low-variance class using
two principal components. (C) Specificity results for OPLS-DA without the TPCA
modifier (DRdensity) for the low-variance class, using one predictive component and
one Y-orthogonal component. (D) Specificity results for OPLS-DA with the TPCA
modifier (DRdensity-o) for the low-variance class. One predictive component, one
Y-orthogonal component and one component for the TPCA modifier were utilised for
model training. This demonstrates how this method takes into account both
differences in mean values as well as differences in variance between classes
to improve the classification. Classification results are shown for an external test set
independently drawn from the same distribution as the training set. Hundred MC
rounds were employed for estimation of the Yhat distributions from the training data.
Minor fluctuations in the classification results are due to the random properties of
the utilised data sets. Spec¼Specificity.
Copyright # 2007 John Wiley & Sons, Ltd. J. Chemometrics 2006; 20: 341–351
DOI: 10.1002/cem
OPLS discriminant analysis 349
given here, but it is also possible to incorporate additional
continuous probabilities based on other model parameters or
information. Such model parameters could for instance be
based on residual variation such as distance to model,
DModX, or any other quality parameter. Additional
conditional probabilities could be interpreted as a type of
penalty function, which is modifying the probability for an
observation to be assigned to a given class. As is the case with
the TPCA modifier, we implicitly assume independency
between Yhat and TPCA in order to adjust the posterior
probability. This assumption, in our experience, holds for
most cases, but we still recommend investigation of the
origin of the information in TPCA prior to the usage for
discriminatory purposes.
In terms of regression prediction results, OPLS-DA is
nearly identical to PLS-DAmodelling. The primary benefit of
OPLS-DA modelling lies in the ease of interpretation,
especially in the multi-class case. This is achieved by the
separate modelling of predictive and class-related variation
in the X-matrix through the identification of Y-orthogonal
variation (see Figure 1, Introduction). For discriminant
analysis of data containing Y-orthogonal variation, it can
be of great value to interpret the sources of the Y-orthogonal
variation. This can help to ensure both the stability of the
classifier as well as increasing understanding of the system
studied. However, in-depth analysis of the Y-orthogonal
variation is out of the scope of this paper and is somethingwe
intend to study in more detail in our future work.
6. CONCLUSIONS
Refined properties of the OPLS-DA methodology judged
against characteristics of conventional PLS-DA classification
have been elaborated in the presented study. We illustrate
how Y-orthogonal variation can be useful not only for
evaluation, but also for classification, thus rendering
PLS-DA/SIMCA hybrid discriminatory models. When
overlap exists between classes in the predictive Tp directions
and within-class variances differ to a great extent, the
proposed strategy will increase the specificity of the
classifications. Finally, we outline a set of decision rules
based on prediction densities as an alternative to traditional
decision rules founded on fixed or optimised threshold
values. The demonstrated density functions are based on
resampling from MCCV but alternative resampling
methods, such as bootstrapping, might alternatively be
employed for variance estimation. The usage of density
functions exhibits comparable classifications as the evalu-
ated decision rules in the illustrated examples, but tends to
generate less biased classification results in terms of
sensitivity and specificity of the class predictions.
Acknowledgements
The breast cancer data set was obtained from Dr William H.
Wolberg, University ofWisconsinHospitals,Madison via the
UCI Repository of machine learning databases (http://
www.ics.uci.edu/mlearn/MLRepository.html). This work
was supported by grants from The Swedish Foundation for
Strategic Research (M. B., J. T.), The Knut and Alice Wallen-
berg Foundation (J. T.), The METAGRAD Project funded by
AstraZeneca and Unilever plc. (M. R.) and Wellcome Trust
Functional Genomics Initiative BAIR (Biological Atlas of
Insulin Resistance) (066786) (O. C.).
REFERENCES
1. Belousov A, Verzakov S, von Frese J. A flexible classifi-
cation approach with optimal generalisation perform-
ance: support vector machines. Chemometrics Intell. Lab.
Syst. 2002; 64: 15–25.
2. Johnson RA, Wichern DW. Applied Multivariate Analysis.
Prentice-Hall: Englewood Cliffs, NJ, 1992.
3. Wold S, Ruhe A, Wold H, Dunn WI. The collinearity
problem in linear regression. The partial least squares
approach to generalized inverses. SIAM J. Sci. Stat. Com-
put. 1984; 5: 735–743.
4. Sorich MJ, Miners JO, McKinnon RA, Winkler DA,
Burden FR, Smith PA. Comparison of linear and
nonlinear classification algorithms for the prediction of
drug and chemical metabolism by human UDP-
glucuronosyltransferase isoforms. J. Chem. Inf. Comput.
Sci. 2003; 43: 2019–2024.
5. Kriegl JM, Arnhold T, Beck B, Fox T. A support vector
machine approach to classify human cytochrome P450
3A4 inhibitors. J. Comput. Aided Mol. Des. 2005; 19:
189–201.
6. Wold S. Pattern recognition by means of disjoint princi-
pal components models. Pattern Recognit. 1976; 8:
127–139.
7. Wold S, Esbensen K, Geladi P. Principal component
analysis. Chemometrics Intell. Lab. Syst. 1987; 2: 37–52.
8. Albano C, Dunn WJ III, Edlund U, Johansson E, Norde´n
B, Sjo¨stro¨mM,Wold S. Four levels of pattern recognition.
Anal. Chim. Acta 1978; 103: 429–443.
9. Holmes E, Nicholls AW, Lindon JC, Connor SC, Connelly
JC, Haselden JN, Damment SJ, Spraul M, Neidig P,
Nicholson JK. Chemometric models for toxicity classifi-
cation based on NMR spectra of biofluids. Chem. Res.
Toxicol. 2000; 13: 471–478.
10. Bicciato S, Luchini A, Di Bello C. Marker identification
and classification of cancer types using gene expression
data and SIMCA. Methods Inf. Med. 2004; 43: 4–8.
11. Martens H, Naes T.Multivariate Calibration. JohnWiley &
Sons: Chichester, 1992.
12. Jonsson P, Bruce SJ, Moritz T, Trygg J, Sjo¨stro¨mM, Plumb
R, Granger J, Maibaum E, Nicholson JK, Holmes E, Antti
H. Extraction, interpretation and validation of infor-
mation for comparing samples in metabolic LC/MS data
sets. Analyst 2005; 130: 701–707.
13. Perez-Enciso M, Tenenhaus M. Prediction of clinical
outcome with microarray data: a partial least squares
discriminant analysis (PLS-DA) approach. Hum. Genet.
2003; 112: 581–592.
14. Wold S, Antti H, Lindgren F, O¨hman J. Orthogonal signal
correction of near-infrared spectra. Chemometrics Intell.
Lab. Syst. 1998; 44: 175–185.
15. Trygg J, Wold S. Orthogonal projections to latent struc-
tures (O-PLS). J. Chemometrics 2002; 16: 119–128.
16. Westerhuis J, de Jong S, Smilde A. Direct orthogonal signal
correction. Chemometrics Intell. Lab. Syst. 2001; 56: 13–25.
17. Kvalheim OM, Karstang TV. Interpretation of latent-
variable regression-models. Chemometrics Intell. Lab. Syst.
1989; 2: 37–52.
18. Cloarec O, Dumas ME, Craig A, Barton RH, Trygg J,
Hudson J, Blancher C, Gauguier D, Lindon JC, Holmes E,
Nicholson J. Statistical total correlation spectroscopy: an
exploratory approach for latent biomarker identification
from metabolic 1H NMR data sets. Anal. Chem. 2005; 77:
1282–1289.
Copyright # 2007 John Wiley & Sons, Ltd. J. Chemometrics 2006; 20: 341–351
DOI: 10.1002/cem
350 M. Bylesjo¨ et al.
19. Trygg J. Prediction and spectral profile estimation inmulti-
variate calibration. J. Chemometrics 2004; 18: 166–172.
20. Keun HC, Ebbels TMD, Antti H, Bollard ME, Beckonert
O, Holmes E, Lindon JC, Nicholson JK. Improved
analysis of multivariate data by variable stability scaling:
application to NMR-based metabolic profiling. Anal.
Chim. Acta 2003; 490: 265–276.
21. Nguyen DV, Rocke DM. Tumor classification by partial
least squares using microarray gene expression data.
Bioinformatics 2002; 18: 39–50.
22. Trygg J. O2-PLS for qualitative and quantitative analysis in
multivariate calibration. J. Chemometrics 2002; 16: 283–293.
23. Hotelling H. The generalization of Student’s ratio. Ann.
Math. Stat. 1931; 2: 360–378.
24. Bylesjo¨ M, Eriksson D, Sjo¨din A, Sjo¨stro¨m M, Jansson S,
Antti H, Trygg J. MASQOT: a method for cDNA micro-
array spot quality control. BMC Bioinformatics 2005; 6:
250.
25. Shao J. Linear-model selection by cross-validation. J. Am.
Stat. Assoc. 1993; 88: 486–494.
26. Wolberg WH, Mangasarian OL. Multisurface method of
pattern separation for medical diagnosis applied to
breast cytology. Proc. Natl Acad. Sci. USA 1990; 87:
9193–9196.
Copyright # 2007 John Wiley & Sons, Ltd. J. Chemometrics 2006; 20: 341–351
DOI: 10.1002/cem
OPLS discriminant analysis 351
Appendix C: Paper V
225
Statistically Integrated Metabonomic-Proteomic Studies on a
Human Prostate Cancer Xenograft Model in Mice
Mattias Rantalainen,† Olivier Cloarec,† Olaf Beckonert,,†,# I. D. Wilson,‡ David Jackson,§
Robert Tonge,§ Rachel Rowlinson,§ Steve Rayner,§ Janice Nickson,§ Robert W. Wilkinson,|
Jonathan D. Mills,| Johan Trygg,*,⊥ Jeremy K. Nicholson,† and Elaine Holmes*,†
Biological Chemistry, Faculty of Natural Sciences, Imperial College, London, South Kensington, London SW7
2AZ, United Kingdom, Department of Drug Metabolism and Pharmacokinetics, AstraZeneca, Mereside, Alderley
Park, Macclesfield, Cheshire SK10 4TG, United Kingdom, Pathways, DECS, AstraZeneca, Mereside, Alderley
Park, Macclesfield SK10 4TG, United Kingdom, Cancer Bioscience, AstraZeneca, Mereside, Alderley Park,
Macclesfield SK10 4TG, United Kingdom, and Research Group for Chemometrics, Institute of Chemistry, Umeå
University, Umeå, S-901 87, Sweden
Received March 28, 2006
A novel statistically integrated proteometabonomic method has been developed and applied to a human
tumor xenograft mouse model of prostate cancer. Parallel 2D-DIGE proteomic and 1H NMR metabolic
profile data were collected on blood plasma from mice implanted with a prostate cancer (PC-3) xenograft
and from matched control animals. To interpret the xenograft-induced differences in plasma profiles,
multivariate statistical algorithms including orthogonal projection to latent structure (OPLS) were applied
to generate models characterizing the disease profile. Two approaches to integrating metabonomic
data matrices are presented based on OPLS algorithms to provide a framework for generating models
relating to the specific and common sources of variation in the metabolite concentrations and protein
abundances that can be directly related to the disease model. Multiple correlations between metabolites
and proteins were found, including associations between serotransferrin precursor and both tyrosine
and 3-D-hydroxybutyrate. Additionally, a correlation between decreased concentration of tyrosine and
increased presence of gelsolin was also observed. This approach can provide enhanced recovery of
combination candidate biomarkers across multi-omic platforms, thus, enhancing understanding of in
vivo model systems studied by multiple omic technologies
Keywords: NMR ¥ 2D DIGE ¥ OPLS ¥ prostate tumor ¥ integration ¥ multivariate
Introduction
The current perceived wisdom is that the application of the
new “omics” sciences to biological systems will result in new
biomarkers for disease diagnosis, patient stratification, and
monitoring of drug efficacy. In isolation, any one omics
platform provides a limited window into the biological activity
of a system under study. There are numerous examples of the
use of parallel omics platforms for studying cellular and
complex organism systems including yeast,1 plants,2,3 and
mammals.4,5 From these publications, it appears that correla-
tions between proteins, transcripts, and metabolites are often
weak. One contributing factor to this observation is that the
time displacement between events at the various system levels
is not accommodated in the modeling and analysis of the data.
A fully integrated statistical analysis of information from
multiple biomolecular organization levels has the potential to
improve the understanding of the system, by defining how
variables relate to each other as well as to the perturbations
studied, but is much more complex than examining the
individual platform data. Nevertheless, defining such relation-
ships between the different biological levels has the potential
to increase our ability to understand and find sets of biomarkers
that are both specific and reliable. For example, by integrating
information from proteomics and metabonomics, the biological
endpoint (metabolites) could help to validate and confirm
hypotheses built on proteomic information.
One area that might be expected to benefit substantially from
such an integration of omic data is that of cancer biology where
drug discovery programs frequently use human tumor xe-
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nografts as an in vivo model of the disease. Such preclinical
models utilize human cancer cells or tissues, which are
transplanted into immunocompromized rodents, such as the
athymic nude mouse. Many human tumor xenografts, when
grown either subcutaneously or orthotopically, have been
observed to display several key features of tumorgenesis
including histological appearance, aberrant genetic signatures
(oncogene expression/suppressor gene repression), high pro-
liferative indices, angiogenesis, invasion, and metastasis.6
Traditionally, such model systems have been used in efficacy
screens, primarily focusing on growth inhibition effects prior
to advancing drugs into the clinic.7 Of late, tumor xenograft
models have also been exploited and used in the development
of pharmacodynamic and surrogate marker end-points, which
in turn can be applied clinically to improve optimal therapeutic
dose selection and therapeutic margin predictions.8 A better
understanding of the biology of these models, and how they
compare to the human disease for which they act as a model,
may well lead to new diagnostic markers and to improvements
in drug discovery.
One widely used preclinical model system for prostate cancer
is the PC3 tumor xenograft in the athymic nude mouse. Prostate
cancer is a malignant neoplasm that arises in the male prostate
gland, which is diagnosed in 30 000 men annually across the
U.K. and is responsible for 10 100 of the deaths attributable to
all cancer,9 and represents an important area for the discovery
of new medicines and treatment regimens. Within the oncology
therapeutic area there are several established biochemical
biomarkers/clinical-assays, which have demonstrated some
clinical utility including the serine protease prostate specific
antigen (PSA),10 and carcinoembryonic antigen (CEA).11,12 While
the PSA test remains the ‘gold’ standard diagnostic for prostate
cancer, it has been shown to be unreliable in many cases with
both high false-negative and false-positive discovery rates,
which results in a high frequency of unnecessary and invasive
biopsies being carried out. Thus, for men aged under 60 with
prostate cancer, the PSA test might have a false-negative
discovery rate of up to 82%. For men aged over 60, the PSA
test gave a false-negative discovery rate of 65% when the
threshold for performing a biopsy was set to 4.1 ng/mL.13
Thus, despite recent advances and the promises of emerging
technologies, there is still a need in oncology to identify and
validate more biochemical or molecular biomarkers that are
cost-effective and easy to implement with clinical applicability
to pan-cancers and different disease settings, and to validate
the utility of animal cancer models. Here, using a prostate
tumor xenograft model, we obtained both proteomic and
metabonomic data and, in addition to examining the individual
levels of biomolecular information, have applied a global
strategy to integrating the data to identify candidate molecular
biomarkers for preclinical cancer studies.
Methods
Human Tumor Xenograft Model. The human prostate
carcinoma line PC3 was obtained from the American Type
Culture Collection (http://www.lgcpromochem.com/atcc/) main-
tained in vitro using Iscoves Modified Dulbeccos Medium
culture medium, supplemented with 10% heat-inactivated fetal
calf serum and 1% glutamine (all reagents from Sigma, U.K.).
Cell cultures were maintained at 37 °C in a humidified
incubator in an atmosphere of 5% CO2 in air.
Male Swiss athymic nude (nu/nu genotype) mice were bred
and housed in negative pressure isolators (PFI Systems Ltd.,
Oxon, U.K.) at Alderley Park, U.K. Experiments were conducted
on mice greater than 18 g in weight between the ages of 8-12
weeks, in full accordance with the U.K. Home Office Animal
(Scientific Procedures) Act 1986. The experiment was con-
ducted in line with the policy to reduce, refine, and replace
animal experimentation. Animals were randomized into two
groups of five; one group received a tumor transplant, while
the other group (control) did not. Human tumor xenografts
were established by injecting 100 íL of PC3 tumor cells (1 
106 cells) mixed 50:50 with Matrigel (Becton and Dickinson,
U.K.) subcutaneously on the dorsal flank of mice. Tumors were
measured up to three times per week with callipers, and tumor
volumes were calculated as described previously.14
Animals were terminally bled on day 30, at which stage all
the mice within the tumor-treated group had established
xenografts (0.28-0.71 ( 0.09 cm3 SEM). Blood was collected
into heparinized tubes and centrifuged at 3000 rpm for 15 min
at room temperature to obtain plasma, which was removed
and frozen/stored at -20 °C.
1H NMR Analysis of Blood Plasma. 1H NMR spectra were
acquired on each sample at 600.13 MHz on a Bruker DRX600
spectrometer at ambient probe temperature (298 K). 1H NMR
spectra were acquired using the standard solvent suppression
pulse sequence ((relaxation delay-90°-t1-90°-tm-90°-acquire
FID); Bruker Analytische GmbH, Rheinstetten, Germany) in
which a secondary irradiation field is applied at the water
resonance frequency during the relaxation delay (D) of 3 s and
during the mixing period tm (100 ms), with t1 fixed at 3 ís.
Typically, 128 transients were collected into 32 K data points,
with a spectral width of 12 000 Hz and an acquisition time per
scan of 1.36 s. The 1D Carr-Purcell-Meiboom-Gill (CPMG)
spin-echo pulse sequence [D-90-(ô-180-ô)n acquisition] (ô )
200 ís, n ) 200) with standard presaturation of the water
resonance, using a fixed total spin-spin relaxation delay of 80
ms was applied. Only the CPMG spectra are presented here,
since models for the standard 1D spectra were similar but
slightly less robust due to variation in the lipoprotein composi-
tion unrelated to the disease model.
2D-Gel (DIGE) Analysis of Blood Plasma. Plasma samples
were protein-assayed using a modified Bradford assay with the
Bio-Rad protein assay reagent.15
Isoelectric Focusing. Cy-Dye-labeled protein was applied to
24 cm 3-10 NL IPG strips, and the strips were allowed to
rehydrate overnight under a mineral oil overlay, followed by
isoelectric focusing using the Multiphor II system (GE Health-
care) for a total of 110 kV/h in a stepped rising-voltage protocol.
A total of 50 íg of each plasma sample (individual Cy 3 and
pooled internal standard Cy 5) was loaded per strip. Gels were
run in singlicate (10 gels).
2D-DIGE. Minimal lysine labeling of protein with Cy 3 and
Cy 5 dyes (GE Healthcare) was carried out for plasma as
described previously, except for the use of a differing lysis
buffer.16 The final buffer composition for isoelectric focusing
was adjusted after labeling to 7 M urea, 2 M thiourea, 4% (w/
v) CHAPS, 30 mM DTT (0.46% w/v), and 0.2% (v/v) Pharmalytes
pH 3-10. Tris-HCl solution (1 M, pH 8.5) was used to reach a
final pH of 8.5. All samples were labeled with Cy 5 and mixed
in equal protein amounts to provide a control pool. Individual
samples were Cy 3-labeled. This is the ‘pooled internal stan-
dard’ design.17 After focusing, IPG strips were equilibrated in a
two-step protocol in pH 6.8 equilibration buffer (100 mM Tris,
6 M urea, 30% (v/v) glycerol, and 1% (w/v) SDS) containing
1% (w/v) DTT for 15 min, followed by 4% (w/v) IAA for 15 min,
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and applied to vertical 10% Laemmli SDS-PAGE gels (10.27%
T, 2.6% C) for the second dimension separation using a
modified ESA investigator gel system. A bromophenol blue
dyefront was used to monitor electrophoresis, and gels were
removed from the tanks upon migration of the dyefront from
the gel.
The resulting images were scanned using a Typhoon 9400
scanner (GE Healthcare) and saved as .gel files for analysis. Scan
settings were optimized to obtain a maximum signal of
approximately 80 000 counts (of 100 004 maximum possible)
per channel. For plasma gels, the two most abundant spots of
albumin were allowed to saturate, to increase visualization of
less abundant species. This effect was subsequently monitored
so as to be identical for all gels. Removing saturated detected
species from the analysis did not have any significant effect
on DIA alteration ratios as assessed by later DIA analyses and
was therefore not necessary (data not shown). The optimal PMT
values for each scan channel were as follows: plasma Cy 3
495V, plasma Cy 5 470V. Resolution for final scans was set as
100 ím.
Image Analysis. Analysis was carried out using DeCyder V
4.0 (GE Healthcare). The DIA module was used to detect spots
in single gels with the following settings: 1500 spots were
estimated for plasma detection, a maximum spot slope cutoff
of 1.6 was employed, and a minimum volume of 6000 units.
The biological variation analysis (BVA) module was used to
match spot maps between different gels and determine sig-
nificant changes in abundance between classes. Manual seed-
ing of matches across gels was carried out before automatic
matching, which was then followed by manual inspection and
correction of matching where necessary. Tumor-associated
altered proteins in plasma were defined by at least 1.25 average
fold abundance change between groups (5 PC-3 bearing mice
against 5 controls), and a t-test P value of 0.05 or below.
Protein Identification. Protein spots of interest were identi-
fied by mass spectroscopy after being cut from preparatory gels.
Preparatory Gels. For plasma 2D-DIGE proteins of interest,
two gels were run for spot excision using a pool of all samples.
Total protein load was 1.6 mg per gel, and this was not Cy dye-
labeled. Focusing and 2D-PAGE separation were carried out
as for the study above, but gels were cast with PAG film support.
Protein visualization was by colloidal Coomassie staining
adapted from the literature for one gel, and silver staining for
the other using a protocol modified from that of Blum et al.18-20
Circular adhesive visible and fluorescent reference markers (GE
Healthcare) were attached to the gel support film prior to
scanning for triangulation purposes. Gels were then scanned
using the ImageScanner (GE Healthcare) to produce 8-bit .tif
files, which were opened in ImageMaster 2D V 4.01 software
(GE Healthcare) for analysis. Spots from the study were
identified by protein profile pattern comparison and manually
detected on the preparatory gel scans. A pick list was generated
and exported, and spots were excised using the Ettan Spot-
Picker Robotic system (GE Healthcare) using a 2 mm diameter
cutting head. Spots were dispensed into a 96-well plate with
MilliQ water. For storage at -20 °C until MS analysis, all water
was drawn off the spots.
Mass Spectrometry. Mass Spectroscopic identification of
protein spots was carried out using the 4700 TOF-TOF (Applied
Biosystems). Tryptic digestion and extraction of the resulting
peptides was according to published methodology.21 Peptides
were run on the 4700 TOF-TOF (Applied Biosystems, U.K.) in
MS positive mode for mass fingerprinting, or LC-MSMS mode
for peptide sequencing. LC was carried out using an Ultimate
nanoLC system. Fractions were collected using a Probot
fraction collector (Dionex, U.K.). Peptide masses were searched
against a mammalian subset of an in-house nonredundant
protein database using Mascot (www.matrixscience.com). Re-
sults were manually checked to assign confident hits based on
protein coverage, observed gel mass, and delta error.
If unmatched peaks not consistent with the identity pro-
posed were present, the observed peaks could match several
proteins, or no clear identity was obtained, the sample was
analyzed by MS/MS QTOF (Micromass, U.K.). Data were
collected from m/z 50-2000 Da. MS/MS spectra were searched
against Mascot Daemon and also partially manually interpreted
to derive sequence information of at least six consecutive amino
acids. These were searched against a mammalian subset of the
Swiss-Prot/TrEMBL databases, and proprietary databases. Re-
ported hits were confirmed by examination of further tryptic
peptides predicted by the identity. Further contributing factors
were whether both techniques identified the same protein, the
expected mass and pI of the protein from the gel, and user
assessment of the quality and amount of sequence data.
Data Analysis and Integration. 1. Orthogonal Projections
to Latent Structures (OPLS and O2PLS). Chemometrics meth-
ods have previously been frequently applied for analysis of a
variety of high dimensional data sets and are one of the most
common ways of analyzing high-resolution NMR data sets
within metabonomics.22-24 Orthogonal Projections to Latent
Structures, OPLS,25 is a supervised multivariate projection
method similar to Partial Least Squares (PLS)26 but with an
integrated Orthogonal Signal Correction filter (OSC)27 modified
for PLS. The OPLS method is designed to separate the variance
of the data matrix X according to the variance of the data matrix
Y, into three parts: the first part represents the variance that
is related to Y, the second part the interfering systematic
variation not related (orthogonal) to Y, and the last part
contains some residual variance not interfering with the
prediction of Y. OPLS is an extension of PLS and has similar
objectives to Orthogonal Signal Correction but is integrated
directly in the modeling, which allows an easier validation of
orthogonal components. O2PLS28,29 is a generalization of OPLS,
which allows modeling and prediction in both directions
between two data matrices. By separating the modeling of the
X - Y related (predictive) variance and the structured noise
(orthogonal) present in the data, prediction in both directions
is possible although each data matrix might have collinear
variables as well as structured noise. In addition, removal of
orthogonal variation from the predictive models makes the
models more coherent and also makes their relation back to
the original variables easier to interpret.
The X matrix is the measured data matrix, for example, NMR
data. The Y-block either represents a matrix of random
variables against which the regression is carried out, or in the
case of OPLS Discriminant Analysis (OPLS-DA), the Y matrix
is made of dummy variables, consisting of ones and zeros that
indicates the class for each observation. In the O2PLS case, both
X and Y matrices may be made up of measured data, which
may have collinear and noisy variables. The score matrices and
the predictive regression coefficient matrices allow an inter-
pretation of the modeled variance, both for the predictive
components, describing relating variance between X and Y, and
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the orthogonal components, describing systematic but or-
thogonal variation between X and Y. Thus it is possible to
analyze the NMR data (X) matrix and the proteomic data (Y)
matrix in a joint model. The influence of the original variables
on the OPLS model can be interpreted by inspection of the
predictive regression coefficients, which are related to how each
variable influences the model for prediction of the response
variables (Y) in OPLS. For interpretation and visualization of
the predictive regression coefficients, the method developed
by Cloarec et al.30 was applied. Detailed OPLS model notation
is provided in the Supporting Information.
2. Multivariate Data Analysis of 1H NMR Data. 1H NMR data
were calibrated using the glucose anomeric doublet at 5.23
ppm. The spectra were interpolated on a common chemical
shift scale using cubic spline interpolation. The water peak area
(ä 4.5-6) was excluded from each spectrum. Because of slight
difference in plasma volume, each spectrum was normalized
to the sum of 100 units. The NMR data analysis was performed
Figure 1. Schematics of two separate strategies for co-analyzing NMR and DIGE data. (A) Analysis of NMR and DIGE data independently
with subsequent investigation and interpretation of links between the information collected from the two biological levels. (B)
Simultaneous analysis and data integration of NMR and DIGE data using O2PLS.
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in four steps, as outlined in Figure 1A. First, a discriminant
model was built, with mean centered and unit variance scaled
data using OPLS-DA, to investigate differences between control
and PC3 tumor-implanted animals. The predictive regression
codefficients from this model were used to interpret the NMR
data and define the most prominent differences between
control and PC3 observations in terms of variables or metabo-
lites. The set of metabolic variables, which were changing, were
later used as regressands in an OPLS model (mean centered
and unit variance scaled data), where the relationship between
selected metabolic variable(s) and the DIGE data were inves-
tigated.
All preprocessing of data and multivariate modeling was
carried out in MATLAB (Version 7.01, The Mathworks inc,
Natick, MA) using in-house routines.
3. Multivariate Data Analysis of 2D Gel Data. For each spot
on a 2D gel, spot volumes were used to calculate log2 ratios
between the test sample (Cy3) and the internal standard control
pool (Cy5). The test sample was control or PC3 mouse plasma.
Spot intensities were calculated for each spot on a 2D gel as
the average spot volume between the test sample and the
internal standard control pool. A total of 392 spots were
detected which were present on all gels; these spots were
selected and used for further multivariate data analysis. DIGE
Figure 2. (A) Cross-validated OPLS-DA scores calculated from the NMR data showing differentiation between the control and PC3
xenograft group with the corresponding regression coefficients. Upright oriented signals represent plasma metabolites that are present
in greater concentrations in the PC3 group, and downward facing signals represent metabolites found in higher concentrations in
control plasma. Coloring of spectra is proportional to the predictive OPLS-DA regression coefficients and hence to the importance in
discriminating between the two groups. (B) DIGE OPLS-DA score plot (cross-validated scores) and the corresponding predictive OPLS-
DA regression coefficients from DIGE model. Coloring of spectra is proportional to the predictive OPLS-DA regression coefficients.
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data were mean-centered and scaled to unit variance prior to
multivariate modeling. The analysis of the DIGE data follows
the same steps as for the 1H NMR data, outlined in Figure 1A.
Where the protein abundance was found to change between
control and PC3 animals, individual DIGE spots were used as
regressands in OPLS modeling to elucidate which 1H NMR
variables they primarily related to.
4. Analysis of Correlations Patterns between Metabonomic
and Proteomic Data. Correlations between metabolites, found
by 1H NMR analysis, and proteins, identified by 2D-DIGE and
mass spectroscopy, indicate a similarity in variation between
biological entities on these two levels, but do not give any
causal information or evidence of biochemical relationships.
However, visualization of metabolite-protein relationships by
a correlation map provides a global overview of correlation
patterns between the metabonomic and the proteomic data
sets, both regarding specific metabolite-protein correlations
as well as regarding the extent of correlations between these
data sets, which may subsequently be investigated by further
data analysis or additional experimental investigation. To
Table 1. Metabolites that Differentiate Control Group from the PC3 Xenograft Groupa
chemical
shift
(ppm) pred. regr. coeff
mean
(ctrl)
mean
(pc3) assignment
change
in PC3
0.97, 1.02 -0.73 1.00E-02 6.58E-03 Valine V
1.0 -0.64 4.25E-03 3.16E-03 Isoleucine V
1.2, 2.3, 2.38 0.82 2.15E-03 2.84E-03 3-hyroxybutyrate v
1.91 0.69 7.02E-03 9.75E-03 Acetate v
2.44 0.74 3.21E-03 4.24E-03 Glutamine/Glutamate change in ratio v
0.95, 1.71 -0.73 2.98E-03 2.30E-03 Leucine V
1.69, 1.91, 3.01 -0.75 3.83E-03 3.17E-03 Lysine V
3.1, 3.19, 4.42 0.76 8.86E-03 1.12E-02 Amino acid resonances mixed with Glucose v
6.9, 7.2 -0.81 1.72E-03 1.00E-03 Tyrosine V
7.37 -0.82 4.35E-04 2.86E-04 Phenylalanine V
7.53, 7.27, 7.74 -0.71 4.45E-04 2.55E-04 Tryptophan V
a Identification of metabolites was achieved using OPLS-DA, and metabolites are displayed with their assignment and corresponding NMR chemical shifts
along with control and PC3 mean (a.u.) and predictive OPLS-DA regression coefficient.
Table 2. List of Protein Spots with the Largest Predictive Regression Coefficients As Calculated from OPLS-DA Analysis of the DIGE
Dataa
spot
pred.
regr.
coeff.
log2
(pc3/control) intensity assignment
815 0.94 0.83 2.61 Serotransferrin_precursor_TRFE_MOUSE_Swissprot-815
558 0.92 0.37 0.60 No_ID-558
1154 0.90 1.25 5.85 Serotransferrin_precursor_TRFE_MOUSE_Swissprot_/
_Fibrinogen_A_alpha_polypeptide_Q99K47_Trembl-1154
612 -0.90 -0.43 0.97 Not_Visible-612
1164 0.90 1.91 3.85 Serotransferrin_precursor_TRFE_MOUSE_Swissprot_/
_Fibrinogen_A_alpha_polypeptide_Q99K47_Trembl-1164
1229 0.90 0.87 0.63 Alpha-enolase_ENOA_MOUSE_Swissnew_/
_Beta-2-Glycoprotein_1_precursor_APOH_MOUSE_Swissprot
325 -0.88 -0.25 3.75 Complement_factor_H_precursor_CFAH_MOUSE_Swissprot-325
994 0.87 0.96 1.97 Not_Visible-994
669 0.86 0.45 4.23 Gelsolin_precursor_GELS_MOUSE_Swissprot-669
657 -0.84 -0.87 0.60 Not_Visible-657
1404 -0.84 -0.85 2.80 Major_urinary_protein_1_precursor_MUP1_MOUSE_Swissnew
599 0.84 1.16 0.33 Plasminogen_precursor_PLMN_MOUSE_Swissprot_/
_Fibrinogen_gamma_polypeptide_Q8VC87_Trembl
327 -0.83 -0.35 2.19 Complement_factor_H_precursor_CFAH_MOUSE_Swissprot-327
1269 0.83 0.41 1.79 Many_hits-1269
792 -0.83 -0.17 2.43 Not_Visible-792
664 0.82 0.41 15.27 Gelsolin_precursor_GELS_MOUSE_Swissprot-664
1132 0.82 0.16 13.54 #N/A
813 0.82 0.36 2.60 Not_Visible-813
1325 0.82 0.40 0.95 Complement_C4_precursor_CO4_MOUSE_Swissprot
318 -0.81 -0.20 0.36 #N/A
606 -0.80 -0.36 0.80 Not_Visible-606
1267 0.80 0.50 1.31 Not_Visible-1267
1369 0.80 0.48 2.83 No_ID-1369
1131 0.80 0.17 80.47 #N/A
661 0.80 0.34 14.53 Gelsolin_precursor_GELS_MOUSE_Swissprot-661
1162 0.79 0.73 2.51 Serotransferrin_precursor_TRFE_MOUSE_Swissprot-1162
659 0.78 0.43 0.44 Not_Visible-659
617 0.77 1.20 0.75 Fibrinogen_gamma_polypeptide_Q8VC87_Trembl
1271 0.77 0.29 9.47 #N/A
a Coefficients larger than ( 0.77 are shown (p ) 0.01). #NA indicates unknown protein identity.
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reduce the risk of finding spurious correlations between
metabonomic and proteomic data, correlations of interest were
confirmed by cross-validated OPLS modeling between the
variables.
5. Integration of 1H NMR and DIGE Data Using O2PLS
Modeling. 1H NMR and DIGE data were integrated by O2PLS
modeling. The O2PLS algorithm enables construction of a linear
latent variable model which allows prediction in both directions
between X and Y matrices (represented by metabonomic and
proteomic data, respectively), even though the data matrices
may contain collinear and noisy variables. The O2PLS model
in conjunction with cross-validation also provides an estimate
of how much of the variance present in each omics data matrix
is shared between the NMR and DIGE data, and how much
variance is unique to each data matrix (Figure 1B). By modeling
co-variance between X and Y matrices and orthogonal variation
separately, we are able to establish the parts of the model in
which class discriminatory variance was present. Finding
discriminatory variance in the orthogonal variation or the
residual matrix can be defined as unique variance to the given
data set, while discriminatory information found in the X-Y
co-varying variance indicates discriminatory variance patterns
which are present in both X and Y matrices; that is, there may
be common variance patterns, described by the predictive
components, between the X matrix (NMR) and Y matrix (2D-
DIGE) that are class-discriminating. In addition, there may be
variance patterns in the orthogonal components or in the
residual matrix for, e.g., the X matrix (NMR), which is class
discriminatory to some extent, but not relating to variance
patterns found in the Y matrix (2D-DIGE). These variance
patterns would then be considered to be unique for the
metabolic data.
Model Validation Methods. Cross-validation by 5-fold cross-
validation was applied for validation of all multivariate models.
Results
Metabonomic analysis of blood plasma was performed using
1H NMR spectroscopy, and a typical NMR spectrum from PC3
and control animals is shown in the Supporting Information
(Figure S1). OPLS-DA modeling of the 1H NMR data was used
to investigate the differences in metabolic concentrations
between samples obtained from PC3 xenograft-implanted mice
and the matched controls, using a model with one predictive
component and one orthogonal component. Although com-
plete discrimination between control mice and xenograft mice
was not observed in the OPLS score plot (scores were calculated
from cross-validation to ensure that over fitting was avoided)
of the 1H NMR data (Figure 2A), there was an underlying
difference between the two sample groups, which was further
exploited. The corresponding predictive regression coefficients
for the OPLS model provide an interpretation of the difference
between the classes in terms of the chemical shifts that are
most influential on this model (Figure 2A). The 1H NMR shifts
Figure 3. Visualization of correlations between NMR variables (x-axis) and DIGE variables (y-axis) in the form of a correlation map
(correlations > ( 0.77 are shown in figure). Red colored areas indicate positive correlations, and blue colored areas indicate negative
correlations between NMR and DIGE variables. The inset shows the region corresponding to the tyrosine resonance in the 1H NMR
spectrum, expanded in the x- and y-axis directions. The dashed lines show an example of how the correlation map may be used to
identify proteins associated with a specific metabolite and vice versa. In this case, the marked DIGE spot, which is negatively correlated
with the ä 7.20 tyrosine NMR signal, is identified as serotransferrin precursor/fibrinogen A alpha polypeptide.
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that had the largest influence on the OPLS-DA model, that is,
those that changed the most between the two classes, con-
tained resonances from the amino acids valine, isoleucine,
glutamine, leucine, lysine, tyrosine, and phenylalanine together
with glucose, 3-D-hydroxybutyrate and acetate (Table 1).
Proteomic Analysis by 2D-DIGE and MS. The proteomic
data contained 392 protein spots that were present on all 10
DIGE gels (a typical DIGE gel for plasma from a PC3 and a
control is presented in Supporting Information, Figure S2).
OPLS-DA (one predictive component and one orthogonal
component) was used to analyze changes in protein levels
between the control and PC3 animals. A pattern of class
discrimination was observable in an OPLS-DA model, described
by the score plot of the DIGE model, indicating a consistent
difference between the two classes (Figure 2B), although as with
the NMR data, complete discrimination between the control
and disease class was not achieved. The predictive regression
coefficients for the DIGE model show several variables of
Figure 4. (A) NMR spectral region for the 3-D-hydroxybutyrate resonance at 1.20 and 2.38 ppm (red NMR spectra represent controls)
and predictive DIGE regression coefficients for the OPLS models where DIGE data is regressed against the ä 2.38 NMR peak from
3-D-hydroxybutyrate. Upright oriented signals represent proteins that have a positive covariation with the 3-D-hydroxybutyrate NMR
signal (i.e., proteins found to be present in increased levels when 3-D-hydroxybutyrate is found in increased levels, and vice versa).
Downward oriented signals represent proteins that have a negative covariation with the 3-D-hydroxybutyrate NMR signal (i.e., proteins
found to be present in decreased levels when 3-D-hydroxybutyrate is found in increased level, and vice versa). Coloring of spectra is
proportional to the predictive OPLS-DA regression coefficients indicating those DIGE variables that are important for predicting the
3-D-hydroxybutyrate abundance. (B) NMR spectral region for the tyrosine resonances at 7 ppm (red NMR spectra represent controls)
and the corresponding predictive DIGE regression coefficients for the OPLS models where DIGE data is regressed against the 6.90
ppm NMR peak from tyrosine. (See panel A for further explanation on interpretation).
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importance for the discriminant model (Figure 2B). A list of
the most important proteins/DIGE spots for discrimination
between PC3 and control animals is found in Table 2.
Correlation patterns between 1H NMR data and 2D-DIGE
data. Patterns of correlation between 1H NMR data and 2D-
DIGE data were initially explored by visualization of the data
as a correlation map, to provide an overview of similarities
between variables in the two data sets (Figure 3). The visualiza-
tion in Figure 3 can be used to aid the identification of proteins
associated (correlated) to specific metabolite signals and vice
versa. To further investigate and confirm the relationships
observed between NMR regions and protein spots, OPLS was
used. OPLS models were constructed between 2D-DIGE data
spots and individual 1H NMR data peaks that showed the
highest discriminatory power between control and PC3 ani-
mals. This approach provides a means of adding further
confidence in correlations between NMR and DIGE variables
since we are able to apply cross-validation for the OPLS models.
The separate OPLS models were built by, for example, regress-
ing all NMR variables against a single DIGE variable, as well as
in the opposite direction, using all variables in the DIGE data
regressed against one particular NMR shift. For example, 3-D-
Table 3. List of Protein Spots Correlated with 3-D-Hydroxybutyrate As Determined by OPLS Modeling between DIGE Data and the
Signal of 3-D-Hydroxybutyrate at ä 2.38 in the NMR Spectraa
spot
pred.
regr.
coeff.
log2
(pc3/control) intensity assignment
815 0.95 0.83 2.61 Serotransferrin_precursor_TRFE_MOUSE_Swissprot-815
813 0.92 0.36 2.60 Not_Visible-813
561 -0.92 -0.54 1.50 Not_Visible-561
567 -0.89 -0.64 1.27 EGF_receptor_precursor_EGFR_MOUSE_Swissprot_/
_Alpha-1-antitrypsin_1-1_precursor_A1T1_MOUSE_Swissprot
1377 0.85 0.76 2.95 L-immunoglobulin, _many_accessions_and_homologues
325 -0.85 -0.25 3.75 Complement_factor_H_precursor_CFAH_MOUSE_Swissprot-325
557 -0.84 -0.34 2.04 Not_Visible-557
1154 0.82 1.25 5.85 Serotransferrin_precursor_TRFE_MOUSE_Swissprot_/
_Fibrinogen_A_alpha_polypeptide_Q99K47_Trembl-1154
558 0.81 0.37 0.60 No_ID-558
1162 0.81 0.73 2.51 Serotransferrin_precursor_TRFE_MOUSE_Swissprot-1162
607 -0.80 -0.29 0.85 #N/A
1369 0.80 0.48 2.83 No_ID-1369
659 0.79 0.43 0.44 Not_Visible-659
1381 0.79 0.44 8.93 #N/A
835 0.77 0.18 1.10 #N/A
a Coefficients >0.77 are shown. #NA indicates unknown protein identity.
Table 4. OPLS Derived List of Protein Spots Correlated to Tyrosine at ä 6.9 (Coefficients > 0.77 Are Shown)a
spot
pred.
regr.
coeff.
log2
(pc3/control) intensity assignment
1394 0.93977 -0.32755 1.1196 Not_Visible-1394
606 0.92448 -0.35625 0.80146 Not_Visible-606
1164 -0.87737 1.9111 3.8519 Serotransferrin_precursor_TRFE_MOUSE_Swissprot_/
_Fibrinogen_A_alpha_polypeptide_Q99K47_Trembl-1164
687 -0.87657 0.26526 1.2965 #N/A
1268 -0.87614 0.46461 1.1793 Many_hits-1268
661 -0.85964 0.33827 14.529 Gelsolin_precursor_GELS_MOUSE_Swissprot-661
669 -0.85953 0.44619 4.2317 Gelsolin_precursor_GELS_MOUSE_Swissprot-669
445 -0.85685 0.15232 25.334 #N/A
664 -0.85622 0.40892 15.266 Gelsolin_precursor_GELS_MOUSE_Swissprot-664
657 0.85239 -0.86555 0.59985 Not_Visible-657
558 -0.84613 0.37117 0.6003 #N/A
1245 -0.84159 0.59568 0.98304 Alpha-1-antitrypsin_1-1_precursor_A1T1_MOUSE_Swissprotsee_comment
998 -0.83225 0.14949 26.11 #N/A
653 0.83141 -0.26414 1.7734 #N/A
1154 -0.82511 1.2507 5.849 Serotransferrin_precursor_TRFE_MOUSE_Swissprot_/
_Fibrinogen_A_alpha_polypeptide_Q99K47_Trembl-1154
1241 -0.8113 0.34979 0.80196 #N/A
1337 0.81062 -0.20541 2.8918 #N/A
607 0.79681 -0.2904 0.85119 #N/A
77 -0.78963 0.19651 18.724 #N/A
1246 -0.78801 0.39359 1.4509 #N/A
1377 -0.78739 0.75947 2.9547 L-immunoglobulin,_many_accessions_and_homologues
994 -0.78101 0.96443 1.971 Not_Visible-994
667 0.77968 -0.90524 0.67597 #N/A
1122 0.77607 -0.31947 13.061 #N/A
1276 -0.77393 0.45069 2.3157 #N/A
1267 -0.77068 0.50226 1.3077 Not_Visible-1267
a #NA indicates unknown protein identity.
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hydroxybutyrate was found in significantly higher concentra-
tions in the plasma of PC3 mice. Interpretation of the predictive
regression coefficients for a model where DIGE data were
regressed against the 3-D-hydroxybutyrate NMR signal (up
regulated in PC3) (Figure 4A) allowed the identification of
several DIGE spots with both high positive and negative
predictive regression coefficients against this metabolite. Like-
wise, the OPLS model generated for the tyrosine resonance at
ä 6.9 (down-regulated in PC3 animals) (Figure 2A) showed
associations between this metabolite and several protein spots
(Figure 4B).
The predictive regression coefficients provide a means of
interpretation of which, and how, variables in one data matrix,
for example, NMR, relate to the variables in the other data
matrix, for example, DIGE. In addition to a transparent model,
which enables interpretation of the patterns of change, model
statistics such as R2 (goodness of fit) and Q2 (goodness of
prediction)29 yield information about how well the data are
modeled as well as quantitative information of the proportion
of variance that is modeled and possible to predict. These
criteria will be used for interpretation later on. DIGE spots with
a high influence on the regression model for prediction of the
intensity of the ä 2.38 NMR resonance, corresponding to 3-D-
hydroxybutyrate, are listed in Table 3. DIGE spots with high
influence on the regression model for prediction of the intensity
of the ä 6.9 NMR resonance, corresponding to tyrosine, are
listed in Table 4.
Integration of 1H NMR Data and DIGE Data Using O2PLS.
O2PLS was used to integrate and model information (variance)
in the 1H NMR and the DIGE data matrices. This approach
enables the modeling and prediction of how these data
matrices share variance patterns between them; it also enables
quantification of the extent to which they can be predicted from
one to the other. An O2PLS model with three predictive
components, 5 orthogonal components for the NMR data
matrix, and 3 orthogonal components for the DIGE data matrix
was constructed. The amount of the DIGE data correlating
variance in the NMR data, expressed as R2X, was found to be
59.7%, while the amount of the NMR data correlating variance
in the DIGE data (R2Y) was 51.0%. Although the summarizing
measurement of predictive ability of the model over all
variables (Q2), that is its ability to predict DIGE levels from the
NMR data and vice versa, was low (9%), we were able to define
subsets of variables where the Q2 level was high (>50%). For
example, for a subset of the variables (metabolites and proteins)
in each data matrix, it is possible to model and predict using
the other, indicated by a high Q2, while a majority of variables
do not vary in patterns that allow prediction between the two
data sets. The goodness of prediction (Q2) for each individual
variable in the NMR data is plotted in Figure 5A, and the
equivalent plot of Q2 levels for the DIGE data is found in Figure
5B.
To investigate if there was any discriminatory information
present in the DIGE-orthogonal (ToP′o) and residual (E) part
of the NMR data, as defined by the O2PLS model, we used this
part of the variance (ToP′o + E) for discriminant analysis to
answer this question (results not shown). The OPLS-DA model
revealed that most of the discriminatory variance between
classes was found in the predictive components. Thus, in this
case, the NMR variance described by the DIGE-orthogonal
components and in the residual matrix describes metabolite
variation not related to class discrimination nor to the DIGE
variables. The DIGE-orthogonal variation in the NMR data, that
is, that part of the NMR data which was not correlated with
the DIGE data, added together with the NMR residuals was
further analyzed by PCA to elucidate which variable regions
show high variance between the samples, which is neither
discriminative nor predictable by the DIGE data matrix. The
PCA loading,
Figure 5. O2PLS modeling between NMR and DIGE data (mean centered). (A) Q2 values are indicated by coloring of the NMR spectrum,
high Q2 values indicates regions that are well-predicted when using the proteomic (DIGE) data to predict the metabolite levels (NMR).
(B) The bar plot describes the DIGE data (average ratio between PC3 and control animals), while the coloring represents the Q2 value
for each DIGE variable, high Q2 values indicate variables that are well-predicted when using the metabonomic (NMR) data to predict
the protein levels (DIGE).
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describing the contributing NMR signals to this variance, is
plotted in Figure 6, showing that lactate, lipoproteins, TMAO,
and glucose have high PCA loading values.
Discussion
Methodological Advantages. Discovering and defining the
relationships between measured variables from different bio-
logical levels is a challenging task, which has a great potential
for improving the way we understand biological information
and generate biological knowledge. In addition to studying the
effects of PC3 tumor implantation on the individual plasma
metabonomic and proteomic profiles, we have also shown for
the first time that it is possible to statistically integrate
proteomic and metabonomic data using the multivariate OPLS
modeling framework. Integrated analysis of multiple data sets
as described here is a step toward this goal. We demonstrate
this by showing how variance patterns in metabolites (e.g., 3-D-
hydroxybutyrate and tyrosine), measured by 1H NMR, may be
related to proteins, measured by 2D-DIGE, which have similar
variance patterns. For instance, for the model where proteins
were regressed against tyrosine, we detect links to fibrinogen.
This approach is generally applicable to proteomic and
metabonomic data, but could also be used for integration of
other types of “omic” data. The method requires that the data
have been collected in parallel on samples from the same
animals and that the data matrices are as complete as possible.
When the OPLS modeling framework was used, it was possible
to establish coexpression patterns between these metabolites
and protein changes in combination in response to disease.
The O2PLS model allowed the separation and quantification
of shared variance and the prediction of metabolic data from
proteomic data and vice versa in addition to identifying
variance patterns unique to each data matrix. In addition, the
data can also be separated or modeled in distinct parts relating
to metabolites and proteins that co-vary in response to a
biological challenge and parts not covarying (residual and class-
orthogonal), that is, that are not affected by the tumor
implantation.
Cross-validation has been applied to validation of all mul-
tivariate models, which allow us to estimate the predictive
ability (Q2) for our models and thereby ensures that models
are not over-fitted and to visualize which variables were well-
predicted between the two data sets. The correlation maps
generated by linking the NMR and DIGE data sets show
associations between many proteins and metabolites (Figure
7) and provide leads for further analysis and modeling. These
correlations may be used to generate hypotheses on biological
relationships or pathway activity that can be further tested
experimentally in vivo or in vitro. However, because of the
current state of our knowledge of the proteome, most of the
proteins detected as significant in the current study are, as yet,
unidentified, and biological interpretation of correlations be-
tween metabolites and proteins must be undertaken with some
caution, without further validation. Extended effort into protein
identification may well prove to be a fertile source of new
insight into the biology of these implanted tumors.
Several solutions have been proposed for modeling biological
events at a systems level. Of these, networks are perhaps the
most widely used to express biological events in terms of
pathways, for example, KEGG. However, this type of modeling
can be over-constrained by the prior knowledge used to build
them. When the proposed framework for integrating metabo-
nomic and proteomic data is used, no such assumptions are
made and the models are not limited by pathway constraints
and are therefore open to alternative solutions.
Where biological sense can be made out of co-varying
proteins and metabolites, the results are more robust, since
the change in protein expression can to some extent validate
the change in metabolite levels and vice versa. Thus, there is
an opportunity to extract and utilize more information from
each animal study carried out; hence, there is the possibility
to reduce the number of early studies than would otherwise
be required, which is in alignment with the current emphasis
in the pharmaceutical industry to reduce, replace, and refine
animal experimentation. Additionally, the appearance of ab-
normal behavior in one of the data matrices, for example, an
animal with abnormal levels of a particular metabolite, can be
confirmed as being biologically idiosyncratic where the protein
expression profile is also abnormal. However, not all changes
in the levels or activities of proteins will result in a change in
metabolite levels in the same biofluid or tissue at the same
time, or even at all, and the parts of the NMR matrix that do
not co vary with the proteomic matrix capture this.
Biological Consequences of Prostate Tumor Implantation
in the Mouse: From these data it is clear that there are
differences between both metabolic and proteomic levels of
biomolecular organization for PC3 tumor-bearing mice com-
Figure 6. (A) PCA loadings of the residual matrix added together
with the DIGE orthogonal variation (ToP′o + E) from the O2PLS
model between NMR and DIGE data matrices. High loadings
represent NMR regions where variance patterns are present that
are not present in the DIGE data, indicating NMR variables that
have unique variation pattern, are very variable, or are very noisy.
(B) PCA loadings of the residual matrix added together with the
NMR orthogonal variation (UoC′o + F) from the O2PLS model
between NMR and DIGE data matrices. High loadings represent
DIGE regions where variance patterns are present that are not
present in the NMR data.
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pared to the controls. In the case of the plasma metabolite
profiles, clear differences were observed between PC3 and
control mice. These changes predominantly consisted of
decreased amounts of amino acids (valine, isoleucine, glutamine,
leucine, lysine, tyrosine, phenylalanine) and increased levels
of glucose, 3-D-hydroxybutyrate, and acetate. Reduced free
amino acid concentrations in blood plasma have previously
been observed for cancer patients with colorectal cancers and
liver cirrhosis.31 Decreased quantities of free amino acids in
plasma have also been observed in conjunction with cachexia
in humans (reviewed by Pisters et al.32).
Increased amounts of 3-D-hydroxybutyrate in the blood
plasma may be explained by increased energy metabolism in
the tumor, which results in large amounts of lactate produced
by the tumor.33 The lactate is converted back to glucose in the
liver, in the Cori cycle,34 but in cases when lactate is very
abundant, the Cori cycle might not be able to accommodate
the conversion of all lactate to glucose, effectively resulting in
an accumulation of Acetyl-CoA. Subsequently, if the TCA cycle
then is not able to accommodate all the Acetyl-CoA, ketogenesis
will occur. In this case, when ketone bodies are being produced,
acetoacetate can be converted to 3-D-hydroxybutyrate by 3-D-
hydroxybutyrate dehydrogenase, which might explain the
increased levels of 3-D-hydroxybutyrate observed here. 3-D-
hydroxybutyrate is used as an energy source in other extrahe-
patic tissues by conversion back to acetoacetyl CoA. In vitro
and in vivo studies have shown that reduced glucose metabo-
lism in the brain due to high glucose consumption in tumor-
bearing animals appears to be compensated to some extent
by an increased metabolism of 3-D-hydroxybutyrate in the brain
tissue.35 Although anorexia is also a potential source of 3-D-
hydroxybutyrate, the levels of other ketone bodies such as
acetone and acetoacetone were not found to be elevated in
the tumor-bearing animals.
Clear differences were also observed in the plasma protein
profile between PC3 and control mice, including increased
levels of gelsolin precursor, serotransferrin precursor, R-eno-
lase/â-2-glycoprotein 1 precursor, plasminogen precursor/
fibrinogen gamma polypeptide, and complement C4 precursor.
Decreased levels in PC3 animals were observed for major
urinary protein 1 precursor and complement factor H precur-
sor. Some of these changes in plasma protein levels have
previously been reported in cancer patient studies and may
add further weight toward this model recapitulating certain
aspects of cancer biology in a pre-clinical setting. For example,
gelsolin is an actin binding protein that functions in the
modulation of the actin cytoskeleton during cell motility.
Depending on the organ-type and stage, both up-regulation
and down-regulation of the gelosin have shown a positive
association with tumorgenesis.36 High gelsolin expression has
been described as a highly significant indicator of poor survival
in breast37 and non-small cell lung cancer (NSCLC) patients.38,39
Serotransferrin precursor was found in elevated levels in
relation to adenocarcinoma/hyperplasia in humans;40 se-
rotransferrin was also found in reduced levels in human plasma
during acute phase neoplastic disease.41 Alpha-enolase is a
multifunctional enzyme that has been shown to be an elevated
biomarker in a number of cancers including pancreatic and
prostate.42-44 As well as its role in glycolysis, through surface
expression, R-enolase is a mediator of plasminogen activation.45
Plasminogen precursor/fibrinogen gamma polypeptide were
also raised in the tumor-bearing animals; interestingly, these
factors are also involved in the coagulation cascade. For many
years, both clinical and epidemiological studies have linked
Figure 7. Visualization of correlations between selected DIGE spots and NMR data points with a correlation to class of >0.77. Edges
in the network are present between nodes (NMR/DIGE variables) where the correlation is >0.85. (Key: blue node ) NMR variable; red
node ) DIGE spot; red edge ) positive correlation >0.85; blue edge ) negative correlation < -0.85).
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haemostasis disorders with certain cancers.46 Recent studies
in a transgenic cancer model have suggested tumor cells may
themselves participate in the coagulation cascade using the
fibrin matrix to support tumor expansion and invasion.47
Increased levels of complement C4 precursor were observed
in the PC3 mice possibly pointing to an elevated immune
response to the tumor xenograft; interestingly, complement
factor H precursor, another member of this inflammatory
pathway, was decreased in the same cohort of animals.
Conclusions
The initial development of a framework for co-modeling
multi-omic data types has been exemplified using the PC3
xenograft model for prostate cancer, whereby a series of
associations between individual proteins and metabolites, for
example, gelsolin and tyrosine, have been suggested. However,
this method is of general applicability for integration and
interpretation of multivariate analytical data generated across
different platforms and could just as easily be applied to the
co-analysis of gene expression data with proteomic data. We
demonstrate how the O2PLS strategy for data integration can
enable relationships between variables from metabonomic and
proteomic data to be modeled, interpreted, and validated.
Although this study only had five animals in each class (control/
PC3), our modeling strategy proved to be useful for describing
and interpreting the data; an increased number of observations
would be expected to give improved models and better
predictions. In addition we expect that the variance described
by the orthogonal components will describe more information
for a larger data set, where we are likely to have systematic-,
but not treatment- and/or class-related, variation present; e.g.,
for a large data set with many observations, it would be
expected to observe metabolites which are varying between
animals but independent of class. Variables showing this type
of variation, which is not to be considered as random biological
noise but rather variation linked to some unobserved factors,
might also have correlations and systematic variation between
them, and between biological organization levels, which could
be further exploited.
Development of improved diagnostic methods for prostate
cancer is in great need since current diagnostic biomarkers,
such as PSA, do not provide safe and reliable test results for a
large proportion of patients. Appropriate multivariate data
analysis methods, which have the ability to handle high
dimensional, collinear, and noisy data, used together with data
generated from omics methodologies, such as metabonomics,
proteomics, or transcriptomics, have the potential to provide
more robust means of disease diagnosis in the future. We have
presented a framework for modeling complex data, derived
from different analytical platforms, and shown that the integra-
tion of such data, for example, metabolite and protein expres-
sion changes, can enable the derivation of statistical relation-
ships between certain metabolites and proteins from which
hypotheses regarding biological relationships may be formed
and subsequently tested.
Abbreviations: CHAPS; 3-[(3-cholamidopropyl)-dimethylam-
monio]-1-propane-sulfonate; CPMG, Carr-Purcell-Meiboom-
Gill; DIGE, difference gel electrophoresis; DTT, dithiothreitol;
IAA, iodoacetamide; IPG, immobilized pH gradients; MS, mass
spectrometry; NMR; nuclear magnetic resonance; PC3, prostatic
carcinoma 3 (cell line); PMT, photomultiplier tube; PSA,
prostate specific antigen; QTOF, quadrupole-time-of-flight;
TOF, time-of-flight; PCA, principal component analysis; OPLS,
orthogonal projections to latent structures; SDS, sodium dode-
cyl sulfate.
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The global metabolite profiles of endogenous compounds excreted in urine by male Wistar-
derived and Zucker (fa/fa) obese rats were investigated from 4 to 20 weeks of age using both 1H
NMR spectroscopy and HPLC-TOF/MS with electrospray ionisation (ESI). Multivariate data
analysis was then performed on the resulting data which showed that the composition of
the samples changed with age, enabling age-related metabolic trajectories to be constructed.
At 4 weeks it was possible to observe differences between the urinary metabolite profiles from
the two strains, with the difference becoming more pronounced over time resulting in a marked
divergence in their metabolic trajectories at 8–10 weeks. The changes in metabolite profiles
detected using 1H NMR spectroscopy included increased protein and glucose combined with
reduced taurine concentrations in the urine of the Zucker animals compared to the Wistar-derived
strain. In the case of HPLC-MS a number of ions were found to be present at increased levels in
the urine of 20 week old Zucker rats compared to Wistar-derived rats including m/z 71.0204,
111.0054, 115.0019, 133.0167 and 149.0454 (negative ion ESI) and m/z 97.0764 and 162.1147
(positive ion ESI). Conversely, ions m/z 101.026 and 173.085 (negative ion ESI) and m/z
187.144 and 215.103 (positive ion ESI) were present in decreased amounts in urine from Zucker
compared to Wistar-derived rats. Metabolite identities proposed for these ions include fumarate,
maleate, furoic acid, ribose, suberic acid, carnitine and pyrimidine nucleoside. The utility of
applying metabonomics to understanding disease processes and the biological relevance of
some of the findings are discussed.
Introduction
An obvious area for the application of ‘‘global metabolite’’
profiling methods of analysis of the type employed in
metabonomics is for the investigation of metabolic disease.
The use of such metabonomic techniques might be expected to
uncover new biomarkers of the disease and its progression,
provide new insights into biological processes and, perhaps,
reveal new therapeutic targets. Analytical techniques such as
1H NMR spectroscopy, HPLC-MS and GC-MS are now
routinely applied for determination of the changes in
metabolite profiles associated with organ-specific toxicity,1–10
gender, strain and diurnal effects in e.g. rodents11–17 and
increasingly applications are being shown for human dis-
ease.18–20 For example, serum metabolite profiling by GC
with multivariate analysis has shown that a subset of serum
fatty acids provide discrimination between patients with Type
II diabetes mellitus and healthy controls.20
In recent studies we have shown that consistent, age-
related, changes in the urinary metabolites of normal
male (Wistar-derived) animals can be detected using both
1H NMR spectroscopy and HPLC-MS over the period 4
to 20 weeks.21 We have in addition recently performed
metabolic profiling preliminary studies in Zucker (fa/fa)
obese rats22 where differences in metabolic profiles were
observed between male 12 week old Zucker (fa/fa) obese
and Wistar-derived animals. The Zucker rat provides an
important animal disease model for the study of obesity and
the onset of insulin resistance of the sort that in humans
leads to Type II diabetes23,24 and so we were interested to
observe that samples from these animals were readily
distinguished from those of the normal Wistar-derived
strain.22 The results of the studies presented here describe a
more complete investigation to determine the nature and
degree of difference between normal and Zucker rats, and to
see how this evolved with time.
Materials and methods
Chemicals
Acetonitrile, HPLC grade, was purchased from Riedel-de
Hae¨n (Sigma Aldrich, GmbH); HPLC grade water was pur-
chased from Fisher Scientific (Loughborough, UK). Leucine
enkephalin, sodium phosphate, D2O (99 atom%), formic acid
and sodium trimethylsilylpropionic acid-[2H4] (TSP) were
purchased from Sigma-Aldrich (Poole, UK). The metabo-
nomics performance test mix, used for verification of the
LC-MS system (containing theophylline, caffeine, nortripty-
line, hippuric acid, and 4-nitrobenzoic acid), was obtained
from Waters Corporation (MA, USA).
Dept of Drug Metabolism and Pharmacokinetics, AstraZeneca
Pharmaceuticals, Mereside, Alderley Park, Macclesfield, UK SK10 4TG.
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Animals and sample collection
Fortnightly urine samples were collected from male Alderley
Park (Wistar-derived) and Zucker (fa/fa) obese rats (n = 6) by
minimal bladder manipulation at the same time each morning
from 4 to 20 weeks of age. One Wistar-derived animal died
between the 10 and 12 week collections. Food (standard rat
and mouse diet) and water was available ad libitum throughout
the time course. Samples were stored at 220 uC prior to
analysis. All experiments were performed in compliance with
the relevant UK regulations (Animals (Scientific Procedures)
Act, 1986).
Sample analysis
Urine samples were analysed by 1H NMR spectroscopy within
2 weeks of each collection; HPLC-MS analysis was carried out
as a single batch at the end of the collection period.
1H NMR spectroscopy
Urine was buffered 2 : 1 with phosphate buffer (0.2 M in D2O;
pH 7.4) containing TSP (0.5 mg ml21) prior to analysis by 1H
NMR spectroscopy. Analysis was carried out using a Bruker
DRX500 NMR spectrometer (Bruker Spectrospin Ltd,
Coventry, UK) operating at 500 MHz 1H resonance frequency.
1H NMR spectra were acquired at 30 uC, with a 90u pulse
width over a spectral width of 9980.04 Hz into 64k data
points. Typically, 128 or 256 transients were collected with
an acquisition time of 3.28 s and a relaxation delay of 1 s.
Solvent suppression was achieved by applying the standard
‘Noesypresat’ pulse sequence (Bruker Spectrospin Ltd). All
spectra were manually phase and baseline corrected and the
TSP resonance was set to 0.00 ppm.
HPLC-MS
For analysis by HPLC-MS, urine samples were centrifuged
(13 000 rpm; 5 min; room temperature) to remove debris
and then analysed neat. Chromatography was performed on a
Waters Alliance1 2795 HPLC system (Waters Corporation,
Milford, USA) equipped with a column oven. The HPLC
system was coupled to a Waters Micromass QTof-microTM
(Manchester, UK) equipped with an electrospray source
operating in either positive or negative ion mode. The source
temperature was set at 120 uC with a cone gas flow of 50 l h21,
a desolvation gas temperature of 250 uC and a desolvation gas
flow of 400 l h21 were employed. The capillary voltage was set
at 3.2 kV for positive ion mode and 2.6 kV in negative ion
mode and the cone voltage to 30 V. A scan time of 0.4 s with
an inter-scan delay of 0.1 s was used throughout, with collision
energy of 4 eV using argon as the collision gas. A lock-mass of
leucine enkephalin at a concentration of 0.2 ng ml21, in 50 : 50
acetonitrile : water + 0.1% formic acid for positive ion mode
([M + H]+ = 556.2771) and 1.0 ng ml21 in 50 : 50 acetonitrile :
water for negative ion mode ([M 2 H]2 = 554.2615), was
employed via a lock spray interface. Data were collected in
centroid mode, the lock spray frequency was set at 5 s and the
lock-mass data were averaged over 10 scans for correction.
An aliquot of urine (5 or 10 ml for negative or positive ion
mode respectively) was injected onto a 2.1 mm 6 10 cm
Symmetry1 C18 3.5 mm column (Waters Corporation) held
at 40 uC. The column was eluted with a linear gradient of
0–20% B over 0.5–4 min, 20–95% B over 4–8 min, the
composition was held at 95% B for 1 min then returned to
100% A at 9.1 min at an eluent flow rate of 600 ml min21;
where A = 0.1% formic acid (aq) and B = 0.1% formic acid in
acetonitrile. A ‘‘purge–wash–purge’’ cycle was employed on
the autosampler, with 90% aqueous methanol used for the
wash solvent and 0.1% aqueous formic acid used as the purge
solvent, this ensured that the carry-over between injections
was minimized. The mass spectrometric data were collected in
full scan mode from m/z 50 to 850 from 0–10 min, in positive
and negative ion mode. The column eluent was split such that
approximately 100 ml min21 was directed to the mass spectro-
meter. Retention time consistency and mass accuracy were
confirmed throughout the run by injection of the metabo-
nomics performance test mix and repeat injection of a
‘‘standard’’ urine sample after every 10 samples.
Data analysis
1H NMR spectroscopy
Using the AMIX software package (version 2.7.5, Bruker
Analytische Meßtechnik, Germany), each spectrum was
segmented into regions of 0.04 ppm (from 0.2 ppm–10.0 ppm;
256 segments) and the integral value for each segment was
calculated.2,3 The regions of the spectrum associated with
water and urea (4.5–5.05 and 5.5–6.05 ppm) were then
removed and the segmented data were exported into
Microsoft Excel (version 7.0a), where the integral values were
scaled to the total of the summed integrals of each spectrum in
order to partially compensate for differences in urinary
dilution. To compensate for peak shift occurring for citrate
the spectral regions describing half of the AB resonance were
averaged (2.50, 2.54 & 2.58 ppm) whilst the regions from the
second half were deleted (2.62, 2.66, 2.70, 2.74 ppm). The two
regions describing allantoin were also averaged (5.38,
5.42 ppm) for the same reason. The pre-processed NMR data
were imported to R version 2.125 for analysis and visualization
by multivariate statistical methods including PCA, PLS
regression26 and PLS discriminant analysis. Data were mean
centred and Pareto scaled prior to analysis, for PLS-DA
analysis the data were mean centred and scaled to unit
variance. Metabolic trajectories were constructed with the
average score for each time point defining the path of the
trajectory. Age prediction by PLS regression was undertaken
on the NMR data where the PLS model was calculated by
regression against rat age at the time of urine collection, hence
assuming a linear time relation. Predictive performance of the
PLS models was evaluated by 5-fold cross validation.
Within the data set a small number of outliers were
identified (due to excessive urinary dilution leading to
experimental noise) and were removed from the analysis.
HPLC-MS
The HPLC-MS data were analysed using the Micromass
MarkerLynx Applications Manager version 1.0 (Waters Ltd).
MarkerLynx incorporates a peak deconvolution package that
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allows detection of the mass, retention time (RT) and intensity
of the peaks eluting in each chromatogram. The data were
combined into a single matrix by aligning peaks with the same
mass–retention time pair together from each data file in the
data set. The intensities for each peak were normalised to the
sum of the peak intensity for each data set. The pre-processed
HPLC-MS data were imported to R version 2.125 for analysis
and visualization by multivariate statistical methods including
PCA, PLS regression26 and PLS discriminant analysis. Data
were mean centred and Pareto scaled prior to analysis by PCA
and PLS, for PLS-DA analysis the data were scaled to unit
variance. Metabolic trajectories were constructed with the
average score for each time point defining the path of the
trajectory. Age prediction by PLS regression was undertaken
on the HPLC-MS data where the PLS model was calculated by
regression against rat age at the time of urine collection, hence
assuming a linear time relation. Predictive performance of the
PLS model was evaluated by 5-fold cross validation. For the
selection of discriminatory variables using weights from PLS-
DA analysis, a simple criterion was used to first exclude
spurious discriminatory markers prior to modelling. Variables
were excluded when all observations in one of the classes had a
mean and variance of zero (due to the threshold used in the
pre-processing step) and the mean intensity of the other class
was below a given threshold k (where k was set to 5 in this case
for normalized data).
Results
1H NMR spectroscopy
Age-related alterations to the 1H NMR urinary profile
obtained from normal Wistar-derived rats have been described
in detail elsewhere21 and featured increases in creatinine,
taurine, amino acids and fatty acids and decreased amounts of
citrate, glucose and myoinositol. Compared to the Wistar-
derived rats the urine from the Zucker animals at 4 weeks
showed a number of obvious differences by 1H NMR
spectroscopy by visual inspection. Thus, at 4 weeks, the ratio
of the Krebs cycle intermediates citrate to succinate and
a-ketoglutarate was much more obviously in favour of citrate
in the Zucker animals, whilst the resonances for taurine were
much more prominent in the Zucker compared to the normal
strain (see Fig. 1(a) and (c)). By 8 weeks, concentrations of
taurine in the urine of the Wistar-derived animals were
Fig. 1 1H NMR spectra (0.5–8.5 ppm) of urine obtained from male Wistar-derived rats at 4 and 20 weeks old (a,b) and from Zucker rats at 4 and
20 weeks old (c,d).
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generally similar to those of the Zucker rats, whilst by 12 weeks
of age the taurine resonances in the urine of the Zuckers were
much less prominent (Fig. 2). By 18 weeks of age taurine
represented one of the most significant signals in the 1H NMR
spectra of all of the Wistar-derived rats but was absent from
half of the urines of the Zucker animals. At the final time point
of the study (20 weeks) glucose was clearly present in the urine
of 4 of the 6 rats together with obvious signs of protein in two
(confirmed by ‘‘dip stick’’ analysis). In the case of three out of
the four animals presenting glucose in the urine at week 20
taurine had been absent at 18 weeks. In the urine of the Zucker
animals at 20 weeks concentrations of hippurate also appeared
to be reduced compared to the Wistar-derived strain (Fig. 1(b)
and (d)). In addition, in contrast to all of the time points up
until 20 weeks, the ratios of a-ketoglutarate and succinate to
citrate were no longer in favour of citrate in the Zucker
animals (Fig. 1(d)).
Acetate was also present in the urine of 4 out of 6 of the
Zucker animals at 20 weeks old (Fig. 1(d)). The presence of
acetate has been suggested as being an artefact associated
with bacterial degradation of urine samples left to stand in
the collecting vessel.27 However, in this instance the samples
were ‘‘spot’’ urines, collected directly from the animals
and immediately frozen, with NMR analysis immediately on
thawing, suggesting that these elevated concentrations of
acetate reflect alterations in the biochemistry of the Zucker
animals. Given the mode of collection and analysis, if the
observed acetate was derived from microbial fermentation
of the samples this degradation must have occurred in
the bladder.
Chemometric analysis of these data was performed using a
variety of techniques including PCA and PLS-DA with age
prediction by PLS regression as previously described for
normal Wistar-derived animals.21 The PLS regression-based
prediction of age for the Zucker animals using the NMR
spectral data is shown in Fig. 3 and shows that it is possible to
demonstrate a clear relationship between the age of the
animals and urinary composition. As we have noted else-
where,21 such results reinforce the need for appropriate control
groups in experiments aiming to investigate approaches
designed to affect disease progression, as pre-dose samples
will not enable age-related processes to be accounted for.
Metabolic trajectories by PCA (Fig. 4) show that the two
strains of animal, whilst similar at early time points follow
different paths from ca. 8–10 weeks. Whilst age prediction by
PLS regression is possible for both the Wistar-derived strain
(reported earlier) and for the Zucker animals (reported here),
the time related changes were different between the two strains.
Interpretation of the two strain-specific age predicting PLS
models also confirms the different pattern of age-related
metabolic changes for each strain. The PLS weight plots for
Zucker and Wistar-derived animal models (Fig. 5(b) and (d)),
which relate to the PLS scores plots (Figs. 5(a) and (c))
describe different time related patterns between the two
Fig. 2 Normalised spectral intensity of the spectral region arising
from taurine (3.40–3.44 ppm) obtained from 1H NMR spectra of urine
samples collected from male Zucker and Wistar-derived rats between 4
and 20 weeks old. Data expressed as mean ¡ standard deviation.
Fig. 3 1H NMR spectroscopy and PLS regression for the Zucker
rats: cross validated age predictions by a PLS model with three
components. Data expressed as mean ¡ standard deviation.
Fig. 4 PCA trajectories showing time related changes for Wistar (red)
and Zucker (blue) animals, the data point for each individual animal is
displayed as a number representing the time point of sample collection
(week) whilst the mean data point for each strain at each time point is
displayed as a dot, labelled with the week number.
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strains. Spectral regions associated with taurine, creatinine
and creatine dominate the age-progression in Wistar-derived
animals whilst in Zucker rats the PLS weights are more
complex showing that taurine and hippurate are negatively
correlated with age. Thus the Wistar-derived strain shows a
rapid change for the period from 4 to 10 weeks, but from
12 weeks onwards seem to move into a ‘‘holding pattern’’ with
all of the subsequent samples occupying a relatively similar
position in ‘‘metabolic space’’ as described by the PCA and
PLS models. In contrast the Zucker animals, whilst occupying
a similar metabolic space as the Wistar-derived rats for the
first 4 to 10 weeks of the experiment then move off at a
tangent, with no apparent ‘‘stabilisation’’ of the trajectory of
the type seen for the normal animals.
Discriminant analysis by PLS-DA was carried out to detect
the general metabolic differences between Zucker animals of
age 14–20 weeks (at an age where the profile has diverged
from the Wistar-derived animals) and Wistar-derived animals
of age 10–20 weeks (at an age where the metabolite profile has
reached the ‘‘holding pattern’’). The PLS weights from this
model describe the major changes in metabolic profiles, which
give rise to the changes seen in Fig. 4 between the older
animals of each strain. We found that the most prominent
changes were decreased signal intensity for the following
urinary components (spectral region shown in ppm) in
Zucker rat urine: hippurate (7.82, 7.78, 7.66, 7.54, 3.98),
allantoin (5.40), creatinine (4.06, 3.06, 3.02), taurine (3.42,
3.26), a-ketoglutarate (2.46) and succinate (2.42). Urinary
Fig. 5 (a) PLS trajectory of Wistar-derived animals. (b) Corresponding PLS weight plot for (a), where labels are NMR shifts (ppm). (c) PLS
trajectory of the Zucker animals (d) Corresponding PLS weight plot for (c), where labels are NMR shifts (ppm).
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components (ppm) found to be increased in the urine of
Zucker rats included N-acetyl-glycoproteins (2.10, 2.14) and
an unassigned component at 1.74 ppm. Interestingly, the
glucose resonance at 5.26 ppm had a low weighting in the PLS
discrimination between Zucker and Wistar-derived urine,
associated with an increased excretion in the Zucker urine,
compared to metabolites reported above which had a greater
discriminatory power in defining the two rat strains. This can
be explained by the fact that the glucose level is just beginning
to increase significantly in the Zucker urine at 20 weeks, and
not over all the ages modelled (14–20 weeks).
HPLC-MS
The urine samples from both Wistar-derived and Zucker
animals were also analysed using gradient reversed-phase
HPLC with detection via both positive and negative electro-
spray ionisation mass spectrometry (ESI-MS).
Positive ion ESI HPLC-MS. A typical HPLC-TOF/MS total
ion current chromatogram (TIC) for positive ion ESI analysis
of urine from a 12 week Wistar-derived rat is shown in Fig. 6
with the corresponding mass spectrum for hippurate (m/z
180.0658; RT 3.77 min; mass error 1.5 ppm). Multivariate
statistical analysis (PLS and PLS-DA) revealed differences in
the urinary profile due to both age and strain. Comparison of
the two strains at 20 weeks by PLS-DA identified a number of
ions contributing most to their divergence; these are listed
in Table 1. These ions were selected based on the PLS-DA
weights as described in the methods, followed by visual
examination of the corresponding extracted ion chromatogram
for each m/z value. The identity of these compounds is as yet
undetermined, although postulated atomic compositions
and metabolite identities have been suggested for a number
of them including 2-ethyl-imidazole (m/z 97.0764), carnitine
Fig. 6 A typical HPLC-TOF/MS total ion current chromatogram
(TIC) for positive ion analysis from 12 week old Wistar-derived rats.
The inset is the mass spectrum of hippurate corresponding to the peak
in the TIC at 3.77 min. Hippurate (m/z 180.0660) is detected with a
mass accuracy of 1.5 ppm. T
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(m/z 162.1147), pyrimidine nucleoside (m/z 215.1018) and
1-ethoxycarbonyl 1,4-(N-methylamine) piperidine (m/z
187.1444). Work to further characterise these molecules is
ongoing.
Age prediction by PLS, as undertaken for the NMR data,
was also applied to the positive ESI HPLC-MS data. The
results for the Zucker urine samples, which clearly demon-
strated an age-related progression, are shown in Fig. 7. The
corresponding PLS scores, visualized as a trajectory, and
weights for the Zucker animals are shown in Fig. 8(a) and (b).
Negative ion ESI HPLC-MS. A typical HPLC-TOF/MS
total ion current chromatogram (TIC) for negative ion ESI
analysis of urine from a 12 week Wistar-derived rat is shown
in Fig. 9 with the corresponding mass spectrum for hippurate
(m/z 178.0504; RT 3.88 min; mass error 1.6 ppm). Compared
Fig. 7 HPLC-MS, positive mode and PLS regression: cross validated
age predictions by a PLS model with three components. Data
expressed as mean ¡ standard deviation.
Fig. 8 HPLC-MS, positive mode: (a) PLS trajectory (mean centered and Pareto scaled data) of urine obtained from Zucker animals, aged 4–20 weeks
and (b) corresponding PLS weight plot for (a), where labels are RT_m/z. HPLC-MS, negative mode: (c) PLS trajectory (mean centered and Pareto
scaled data) of urine obtained from Zucker animals, aged 4–20 weeks and (d) corresponding PLS weight plot for (c), where labels are RT_m/z.
This journal is  The Royal Society of Chemistry 2006 Mol. BioSyst., 2006, 2, 193–202 | 199
to the positive ion mode fewer ions were present but
nevertheless, age and strain-related differences could still be
detected by PLS-DA analysis of these data (shown in Fig. 8(c)
and (d) for the Zucker animals). The major ions responsible
for the differences between the two strains at week 20, together
with potential atomic compositions and identities where
possible are given in Table 2. As for the positive ion analysis,
these ions were selected based on the PLS-DA weights as
described in the methods, followed by visual examination of
the corresponding extracted ion chromatogram for each m/z
value. Postulated metabolite identities include fumarate (m/z
115.0019), ribose (m/z 149.0454), suberic acid (m/z 173.0819)
and a-ketobutyric acid (m/z 101.0047). Work to further
characterise these molecules is ongoing. Age prediction by
PLS was also performed on the negative ESI HPLC-MS data
obtained for the Zucker urine samples with the results shown
in Fig. 10. As with the 1H NMR and positive ESI data a clear
age-related progression was seen.
Discussion
In a previous metabonomics study clear differences were
observed in the composition of the urine of 12 week old
male Wistar-derived and Zucker (fa/fa) animals22 illustrating
the potential for 1H NMR spectroscopy and HPLC-MS to
investigate metabolic disease. These differences in urinary
profiles at 12 weeks were reflected in the relative concentra-
tions of a diverse range of metabolites including taurine,
hippurate, formate, betaine, a-ketoglutarate, succinate and
acetate. However, whilst these preliminary studies were
promising they were based only on a single time point and
were therefore of limited value in defining disease-related
profiles for biomarker identification for monitoring disease
onset and progression. In addition, subsequent studies in male
Wistar-derived animals showed that, as might have been
expected, urinary metabolic profiles are not stable even in
physiologically normal animals but change rapidly over the
first few months as the animals develop and mature.21 In order
Fig. 9 A typical HPLC-TOF/MS total ion current chromatogram
(TIC) for negative ion analysis from 12 week old Wistar-derived rats.
The inset is the mass spectrum of hippurate corresponding to the peak
in the TIC at 3.88 min. Hippurate (m/z 178.0504) is detected with a
mass accuracy of 1.6 ppm.
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to more fully understand the development of metabolic disease
in the Zucker (fa/fa) strain an investigation of these age-related
changes was clearly indicated. As this study has shown both
high resolution 1H NMR spectroscopy and HPLC-ESI-MS (in
positive and negative ESI modes), were capable of revealing
age-related changes in the composition of the urine of the
Zucker animals. Differences in urinary composition between
the normal and Zucker strains were seen from 4 weeks and
onwards, although after ca. 10 weeks the differences were
further accentuated. The changes occurring after 10 weeks
were initially rapid, but, as we have noted previously,21 in the
case of the normal Wistar-derived strain the urinary metabolite
profile eventually became relatively stable. In the case of the
Zucker animals the urine composition continued to change
with age, and did not stabilise. Larger differences between the
two groups were seen at later time points, and at 20 weeks of
age the differences no doubt reflected an increasingly
abnormal state of health of the Zucker animals. In the case
of 1H NMR spectroscopy the most obvious changes observed
in the metabolite profiles included both the appearance of
protein and glucose and the decline of taurine from the
samples, together with changes in the relative proportions of
Krebs cycle intermediates.
Whilst the appearance of glucose in the urine might perhaps
have been anticipated as an obvious consequence of the
development of a diabetic state in these animals the reasons for
the reduction in taurine are less clear. The contrast between
increasing concentrations of taurine appearing in the urine of
the Wistar-derived animals (highlighted in the previously
reported age-related changes in the Wistar-derived animals21),
where concentrations at 4 weeks were low but at 20 weeks
formed one of the dominant signals in the spectra, and the
decline in those of the Zucker animals, which were initially
much higher than those for the Wistar-derived strain, is also
noteworthy. It is not clear whether there is a direct link
between the observed decline in taurine concentrations and
the development of insulin resistance. Taurine is the most
abundant free amino acid in many tissues having numerous
roles including conjugation of bile acids and cytoprotection
against myocardial and hepatic necrosis and pulmonary
fibrosis.28 It may be noteworthy that in studies on the plasma
metabonome of these animals taurocholate concentration was
elevated in Zucker compared with Wistar-derived animals at
20 weeks of age.29 In addition, taurine has also been reported
to influence blood glucose and insulin levels 30 and it has
been suggested that taurine plays a role in the function and
integrity of pancreatic b cells, the site of insulin secretion. It is
also worth noting that taurine has been shown to decrease
body weight in hyperglycaemic obese mice and suppress the
development of atherosclerotic lesions in mice.31,32 As taurine
may be important in attenuating the adverse effects of
increased glucose it is possible that the decline in urinary
taurine reported here, prior to an elevation in urinary glucose,
could act as a trigger for the consequent development of
diabetes, but this is clearly speculation at this point. The
relatively mild increase in glucose and thus its low weighting
in the PLS model, probably reflects the pre-diabetic state of
the Zucker rats at this age compared to ZDF rats which
consistently develop diabetes at an early age.33 The onset of
diabetes in Zucker (fa/fa) obese rats was not consistent thus
glucose was only elevated in the urine of 4 out of 6 animals by
the end of this study. Investigation of the metabolic profile
associated with further disease progression in this model would
clearly be of interest.
Other perturbations of interest include increased acetate,
which has been reported in the urine of patients with Type II
diabetes by NMR34 with the authors suggesting that the
elevation was due to impaired renal function rather than
metabolic alteration. Additionally, citric acid cycle intermedi-
ates have been reported to act as signalling molecules
suggesting a link between energy homeostasis/metabolic
status and haemodynamic regulation. Their role in signalling
which results in perturbed concentrations of citrate, succinate
and a-ketoglutarate has been associated with the molecular
pathology of diseases such as hypertension, atherosclerosis
and diabetes.35 The changing ratio of citric acid cycle inter-
mediates as the Zucker rats age may therefore be indicative
of a signalling response occurring in these animals as they
progress towards a diseased state.
As we have indicted above, our preliminary comparison of
the urinary metabolic profiles of Zucker and Wistar-derived
animals showed clear differences at 12 weeks of age22 but the
data accumulated in the present study demonstrate that this
represented only a partial and inadequate description.
We have previously highlighted the importance of age-
related control groups in studies on the toxicological evalua-
tion of compounds undertaken in normal animals where
metabonomics studies are performed as part of the investiga-
tion.21 The data obtained for the Zucker (fa/fa) obese rats
suggest that similar care must be taken in the study of disease
models. However, these data also highlight the potential of
non-invasive measurements of urinary metabolite profiles to
monitor the effectiveness of treatments designed to prevent or
modify the onset of metabolic disease in an animal model.
Conclusions
The metabolic profiles of the urine of Zucker (fa/fa) obese rats
were found to differ significantly with age from those of a
Fig. 10 HPLC-MS, negative mode and PLS regression: cross
validated age predictions by a PLS model with three components.
Data expressed as mean ¡ standard deviation.
This journal is  The Royal Society of Chemistry 2006 Mol. BioSyst., 2006, 2, 193–202 | 201
normal Wistar-derived strain by both 1H NMR and HPLC-
MS-based techniques, following quite different metabolic
trajectories from about 10 weeks of age. The ability to define
a pre-disease state in an animal model of disease could have
implications in the design of experiments aimed at intervention
therapies.
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The metabonomics of aging and development in the rat: an investigation
into the effect of age on the profile of endogenous metabolites in the urine of
male rats using 1H NMR and HPLC-TOF MS
R. E. Williams, E. M. Lenz, J. S. Lowden, M. Rantalainen{ and I. D. Wilson*
Received 19th January 2005, Accepted 6th April 2005
First published as an Advance Article on the web 22nd April 2005
DOI: 10.1039/b500852b
The effect of aging and development in male Wistar-derived rats on the profile of endogenous
metabolites excreted in the urine was investigated using both 1H NMR spectroscopy and HPLC-
TOF MS using electrospray ionisation (ESI). The endogenous metabolites were profiled in
samples collected from male rats every two weeks from just after weaning at 4 weeks up to
20 weeks of age. Multivariate data analysis enabled clusters to be visualised within the data
according to age, with urine collected at 4 and 6 weeks showing the greatest differences by both
analytical techniques. Markers detected by 1H NMR spectroscopy included creatinine, taurine,
hippurate and resonances associated with amino acids/fatty acids, which increased with age,
whilst citrate and resonances resulting from glucose/myoinositol declined. A number of ions were
detected by HPLC-MS that were only present in urine samples at 4 weeks of age in both positive
and negative ESI, with a range of ions, including e.g. carnitine, increasing with age. Age
predictions by PLS-regression modelling demonstrated an age-related trend within these data,
between 4 and 12 weeks for HPLC-MS and 4–16 weeks for NMR. The possible utility of these
techniques for metabonomic investigations of age-related changes in the rat is discussed and
the importance of employing suitable control animals in pharmacological and toxicological
studies is highlighted.
Introduction
The use of comprehensive ‘‘global metabolite’’ profiling
methods of analysis for biological fluids and tissues employed
in metabonomic studies can provide novel insights into bio-
logical processes. Typically such studies have been performed
using 1H NMR spectroscopy combined with multivariate data
analysis and this methodology is now well established for the
evaluation of metabolic perturbations associated with organ-
specific toxicity,1–10 or differences between genders, strains and
diurnal effects in rodents11–18 etc. 1H NMR Spectroscopy is
particularly useful as a profiling technique because it enables
the multicomponent analysis of proton-containing low mole-
cular weight metabolites to be carried out simultaneously,
without the need for metabolite pre-selection. More recently
HPLC–MS has emerged as an additional technique, comple-
mentary to NMR spectroscopy.19–26 HPLC-MS-based techni-
ques can offer increased sensitivity for certain molecules
compared to NMR, and can detect ‘‘NMR-invisible’’ moieties
such as sulfates. When applied together NMR and HPLC-MS
have the power to provide a more comprehensive metabolic
fingerprint than either alone, that better reflects the composi-
tion of the sample under investigation. The complementary
nature of the combination of NMR and HPLC-MS for
metabonomics has been demonstrated by several toxicological
studies.24,25
Whilst the identification of biomarkers for overt toxicity
can be relatively straightforward, the successful exploitation
of these biomarkers can be compromised by a lack of
appreciation of factors that affect the urinary profile of
control animals and inappropriate use of experimental
controls. For example, in the case of C57BL10J mice, urine
samples collected in the morning were found to contain
higher concentrations of creatine, hippurate, trimethylamine,
succinate, citrate and a-ketoglutarate and decreased amounts
of taurine, trimethylamine-N-oxide, spermine and 3-hydroxy-
iso-valerate than samples collected in the afternoon.16
Similarly, urine samples collected from C57BL10J and
Alpk:ApfCD mice were distinguished based on differences in
the TCA cycle intermediates and metabolites of the methyl-
amine pathway.13 Such studies have demonstrated the
sensitivity of NMR-based metabonomics to detect metabolic
differences as a result of subtle perturbations within the same
species. Similar work has demonstrated that HPLC-MS can
also successfully discriminate samples based on strain and
diurnal variation.21,26
The importance of using age-matched controls for NMR-
based metabonomic analysis has previously been alluded to
with respect to age.27,28 Decreases in citrate and a-ketogluta-
rate and increases in taurine and creatinine were observed in
aging rats, whilst young rats were reported to excrete
significant amounts of betaine and trimethylamine N-oxide.27
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Such changes, albeit based on sparse sampling over a 20 month
period, suggest that the global metabolite profiling techniques
used for metabonomic studies may offer new insights into
the changes that occur during growth and development,
and may offer an interesting approach to studying the
metabolic changes that characterise the process of maturation
and aging. In addition metabonomics may also offer an
interesting means of distinguishing between normal age related
changes and changes in diseases whose onset/progression is
associated with ageing (e.g. neuro-degenerative diseases,
osteoporosis etc.).
Here we describe the 1H NMR and HPLC-MS-observed
changes in the urinary endogenous metabolic profile asso-
ciated with aging in male rats, from a Wistar-derived strain,
over a 5 month period.
Experimental
Chemicals
Acetonitrile, HPLC grade, was purchased from Riedel-de
Hae¨n (Sigma Aldrich, GmbH); HPLC grade water was
purchased from Fisher Scientific (Loughborough, UK).
Leucine enkephalin, sodium phosphate, D2O (99 atom%),
formic acid and sodium trimethylsilylpropionic acid-[2H4]
(TSP) were purchased from Sigma-Aldrich (Poole, UK).
The metabonomics performance test mix, used for verification
of the LC-MS system (containing theophylline, caffeine,
nortriptyline, hippuric acid, and 4-nitrobenzoic acid), was
obtained from Waters Corporation (MA, USA).
Animals and sample collection
Fortnightly urine samples were collected from male Alderley
Park (Wistar-derived) rats (n 5 6) by bladder manipulation
at the same time each morning from 4 to 20 weeks of age.
Food (standard rat and mouse diet) and water was available
ad libitum throughout the time course. Samples were stored at
220 uC prior to analysis.
Sample analysis
Urine samples were analysed by 1H NMR spectroscopy within
2 weeks of each collection; HPLC-MS analysis was carried out
as a single batch at the end of the collection period.
1H NMR spectroscopy
Urine was buffered 2 : 1 with phosphate buffer (0.2 M in D2O;
pH 7.4) containing TSP (0.5 mg ml21) prior to analysis by 1H
NMR spectroscopy. Analysis was carried out using a Bruker
DRX500 NMR spectrometer (Bruker Spectrospin Ltd.,
Coventry, UK) operating at 500 MHz 1H resonance frequency.
1H NMR spectra were acquired at 30 uC, with a 90u pulse
width over a spectral width of 9980.04 Hz into 64 K data
points. Typically, 128 or 256 transients were collected with an
acquisition time of 3.28 s and a relaxation delay of 1 s. Solvent
suppression was achieved by applying the standard
‘Noesypresat’ pulse sequence (Bruker Spectrospin Ltd.). All
spectra were manually phase and baseline corrected and the
TSP resonance was set to 0.00 ppm.
HPLC-MS
For analysis by HPLC-MS, urine samples were centrifuged
(13 000 rpm; 5 min; room temperature) to remove debris and
then analysed neat. Chromatography was performed on a
Waters Alliance1 2795 HPLC system (Waters Corporation,
Milford, USA) equipped with a column oven. The HPLC
system was coupled to a Waters Micromass QTof-micro2
(Manchester, UK) equipped with an electrospray source
operating in either positive or negative ion mode. The source
temperature was set at 120 uC with a cone gas flow of 50 l h21,
a desolvation gas temperature of 250 uC and a desolvation gas
flow of 400 l h21 were employed. The capillary voltage was set
at 3.2 kV for positive ion mode and 2.6 kV in negative ion
mode and the cone voltage to 30 V. A scan time of 0.4 s with
an inter-scan delay of 0.1 s was used throughout, with a
collision energy of 4 eV using argon as the collision gas. A
lock-mass of leucine enkephalin at a concentration of
0.2 ng mL21, in 50 : 50 acetonitrile–water + 0.1% formic acid
for positive ion mode ([M + H]+ 5 556.2771) and 1.0 ng mL21
in 50 : 50 acetonitrile–water for negative ion mode
([M 2 H]2 5 554.2615), was employed via a lock spray inter-
face. Data were collected in centroid mode, the lock spray
frequency was set at 5 s and the lock mass data were averaged
over 10 scans for correction.
An aliquot of urine (5 or 10 ml for negative or positive ion
mode respectively) was injected onto a 2.1 mm 6 10 cm
Symmetry1 C18 3.5 mm column (Waters Corporation) held at
40 uC. The column was eluted with a linear gradient of 0–20%
B over 0.5–4 min, 20–95% B over 4–8 min, the composition
was held at 95% B for 1 min then returned to 100% A at 9.1 min
at an eluent flow rate of 600 ml min21; where A 5 0.1% formic
acid (aq) and B 5 0.1% formic acid in acetonitrile. A ‘‘purge–
wash–purge’’ cycle was employed on the autosampler, with
90% aqueous methanol used for the wash solvent and 0.1%
aqueous formic acid used as the purge solvent, this ensured
that the carry-over between injections was minimized. The
mass spectrometric data was collected in full scan mode from
m/z 50 to 850 from 0–10 min, in positive and negative ion
mode. The column eluent was split such that approximately
100 ml min21 were directed to the mass spectrometer.
Retention time consistency and mass accuracy were confirmed
throughout the run by injection of the metabonomics
performance test mix (Waters MA, USA), comprising a
mixture of theophyline, caffeine, nortryptillyne and hippuric
acid, and repeat injection of a ‘‘standard’’ urine sample after
every 10 samples.
Data analysis
1H NMR spectroscopy
Using the AMIX software package (version 2.7.5, Bruker
Analytische Meßtechnik, Germany), each spectrum was
segmented into regions of 0.04 ppm (from 0.2 ppm–10.0 ppm;
256 segments) and the integral value for each segment was
calculated.5,6 The regions of the spectrum associated with water
and urea (4.5–5.05 and 5.5–6.05 ppm) were then removed and
the segmented data were exported into Microsoft Excel
(version 7.0a), where the integral values were scaled to the
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total of the summed integrals of each spectrum in order to
partially compensate for differences in urinary dilution. To
compensate for peak shift occurring for citrate the spectral
regions describing half of the AB resonance were averaged
(2.50; 2.54 and 2.58 buckets) whilst the regions from the
second half were deleted (2.62; 2.66; 2.70; 2.74). The two
buckets describing allantoin were also averaged (5.38; 5.42) for
the same reason. The scaled data were then imported into
SIMCA-P (version 10.0.2; Umetrics, Sweden) for analysis by
pattern recognition methods including PCA and PLS-DA. For
this analysis Pareto scaling was employed. In addition, the
data was averaged at each time point within Excel and
imported into SIMCA-P (version 10.0.2; Umetrics, Sweden).
PCA was carried out, using Pareto scaling, to generate a time-
related metabolic trajectory.
Within the data set four outliers (rat 2, 6 weeks; rat 4, 18 and
20 weeks; rat 6, 10 weeks) were identified due to excessive
urinary dilution leading to experimental noise. These samples
were removed from the analysis. Rat 6 died between the 10 and
12 week collections.
Age prediction by PLS was undertaken on the NMR data
which was mean centred and pareto scaled prior to age predic-
tions by PLS regression.29 The PLS model was calculated by
regression against rat age at the time of urine collection.
Predictive performance of the PLS model was evaluated by
n-fold cross validation with n 5 5. PLS modelling and
visualisation were carried out in R30 using in-house routines.
HPLC-MS
The LC-MS data were analysed using the Micromass
MarkerLynx Applications Manager version 1.0 (Waters Ltd.).
MarkerLynx incorporates a peak deconvolution package that
allows detection of the mass, retention time and intensity of
the peaks eluting in each chromatogram. The data were
combined into a single matrix by aligning peaks with the same
mass/retention time pair together from each data file in the
Fig. 1 1H NMR spectroscopy: 1H NMR spectra (0.5–4.6 and 6.4–
8.1 ppm) obtained from urine samples collected from a male AP rat at
(A) 4 weeks (B) 12 weeks and (C) 20 weeks of age.
Fig. 2 1H NMR spectroscopy and PCA: (A) scores plot (t(1) versus
t(2) versus t(3)) obtained from 1H NMR spectra of individual urine
samples collected from male AP rats between 4 and 20 weeks of age;
(B) scores plot (t(1) versus t(2)) obtained from 1H NMR spectra of
individual urine samples collected from male AP rats between 8 and
20 weeks of age; (C) scores plot (t(1) versus t(2)) obtained from 1H
NMR spectra of mean urine samples collected from male AP rats aged
between 4 and 20 weeks demonstrating a time-related mean trajectory.
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dataset. The intensities for each peak were normalised to the
sum of the peak intensity for each data set. The processed data
list was then analysed by PCA and PLS-DA using SIMCA-P
(version 10.0.2; Umetrics, Sweden) and employing unit
variance scaling.
Age prediction by PLS analysis was performed on positive
ion HPLC-MS data which was mean centred and Pareto scaled
prior to age predictions by PLS regression.29 The PLS model
was calculated by regression against rat age at the time of urine
collection. Predictive performance of the PLS model was
Fig. 3 1H NMR spectroscopy—metabolic alterations: (A–F) normalised intensities obtained from specific spectral regions, with corresponding
metabolite identity, obtained from 1H NMR spectra of urine samples collected from male AP rats aged between 4 and 20 weeks old. Data expressed
as mean ¡ standard deviation.
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evaluated by n-fold cross validation with n 5 5. PLS modelling
and visualisation were carried out in R28 using in-house
routines as for the NMR data.
Results
1H NMR spectroscopy
Age-related alterations to the urinary profile were readily
apparent in the NMR spectra following visual examination,
with increases in creatinine and taurine being observed (Fig. 1).
Such age-related increases have been noted previously in the
rat using 1H NMR.27,28 In order to fully characterise the
metabolic changes PCA was employed revealing a clear
clustering of the data according to age, with the urine samples
collected from rats at 4 and 6 weeks old clustering most
prominently (Fig. 2A). Removal of the 4 and 6 week data sets
from the analysis demonstrates that whilst clustering of
samples still exists according to age, specifically at 8 weeks,
the progression of samples with time is less apparent (Fig. 2B).
This is further demonstrated with the mean trajectory obtained
from this data (Fig. 2C) where after 8 weeks the data points
locate largely within the same region of the scores plot. The
variables that contributed to the clustering were investigated in
order to define metabolic changes associated with age.
Increases in creatinine and taurine were observed (Fig. 3A
and B respectively, see also the NMR spectra shown in Fig. 1)
as well as a general decline in citrate (Fig. 3C) (also noted by
previous workers27). A general increase in signals arising from
low molecular mass compounds such as amino acids/fatty
acids (0.80–1.04) was also observed with increasing age,
particularly at 0.86 ppm (Fig. 3F).
Some age-related variability in the urinary hippurate
concentration was observed (Fig. 3D) with its excretion being
relatively low, and variable, in urine from animals aged 4 and
6 weeks, but becoming present in increased (and less variable)
amounts with increasing age. Furthermore, resonances result-
ing from the presence of glucose/myoinositol (between y3.52
and 3.72 ppm) declined with age (Fig. 3E), being most
prominent at 4 and 6 weeks. Similarly unassigned resonances
at 4.24–4.32 ppm, 2.38 and 2.20 ppm, present at low con-
centrations in the urine even at the 4 and 6 week time-points
also declined with age.
Given the clear observation of age-related changes in the
urine of these animals shown in Fig. 1–3 further analysis of the
data was undertaken using PLS regression30 in order to
determine if it might be possible to model and predict the age
of the animals based on the urinary NMR spectra. The results
of this approach are shown in Fig. 4, in which a clear, almost
linear, trend is seen from 4 to ca. 16 weeks after which the rate
of change appears to be more modest.
HPLC-MS
The urine samples were also analysed using gradient reversed-
phase HPLC with detection via both positive and negative
electrospray ionisation mass spectrometry (ESI-MS).
Positive ion ESI HPLC-MS. Examination of the total ion
current (TIC) and 2-dimensional mass chromatograms
obtained from positive ESI HPLC-MS analysis revealed
significant differences in the urinary profile between animals
at 4 weeks and 20 weeks old. Typical examples of the
2-dimensional mass versus time chromatograms for urines
from the 4 and 20 week time points are shown in Fig. 5. As can
be seen, the 2-D mass chromatogram at 4 weeks contains
significantly more ions and, although some ions are present at
both time points (e.g. the prominent ion at approximately
3.8 min corresponding to m/z 580) the pattern does change
(Fig. 5). Both of the chromatograms shown in this figure are
visualised to the same threshold. As was seen with the NMR
samples, multivariate data analysis revealed distinct clustering
of the samples (using PLS-DA), such that the urines collected
at 4 and 6 weeks were distinct from the remaining data, with
the samples obtained at 8 weeks also clustering as a separate
group to a lesser extent (Fig. 6A). Clustering was still observed
within the data following removal of the 4, 6 and 8 week data
although a clear time-related trajectory was not apparent
(Fig. 6B).
Ions which have the highest influence on the model, accord-
ing to the PLS weights, are shown in Table 1. A significant
number of ions appeared to be present specifically in the 4 week
urine samples only, including ions at m/z 181, 199, 229, 237,
239, 248, 285, 299 respectively (accurate mass, postulated
atomic composition and retention times for these compounds
are given in Table 1). At 6 and 8 weeks, an increase in an ion of
m/z 127 was observed, whilst the ions m/z 136 and 162
(identified as carnitine by standard addition) were seen to
increase over the whole time course. The time course for three
of these ions (m/z 162, 181 and 299) is shown in Fig. 7. The
identity of the majority of these compounds is as yet undeter-
mined and work to further characterise these molecules is on
going.
Age prediction by PLS as undertaken for the NMR data was
also applied to the positive ESI HPLC-MS results as shown in
Fig. 4 1H NMR spectroscopy and PLS regression: cross validated
age predictions by a PLS model with three components. Data
expressed as mean ¡ standard deviation.
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Fig. 8. In this case, although the PLS model shows a
pronounced age-related trend it is less striking than that
produced by the NMR data.
Negative ion ESI HPLC-MS. Typical 2-dimensional nega-
tive ion HPLC-MS results are shown in Fig. 9. Compared to
the positive ion mode fewer ions were present but nevertheless,
age-related differences could still be detected. For example, the
ion at approximately m/z 473, RT 5.7 min is present at 4 weeks
but not at 20 weeks and the ion at approximately m/z 249, RT
7.5 min is detected at 20, but not 4 weeks. Using PLS-DA,
clustering within the data set was observed such that the 4
and 6 week data separated from the remaining time points
(Fig. 10A). However, as this figure shows the separation was
not as pronounced as that observed with the positive ESI
HPLC-MS analysis. Consistent with the pattern observed for
both the 1H NMR and positive ion HPLC-MS data, removal
of the early time points leads to a further clustering, however,
the time trajectory is less apparent within the samples collected
from animals over 10 weeks old (Fig. 10B).
A number of ions were found predominantly in the urine
samples collected from 4 week old animals, including m/z (RT,
mins): 189 (3.47); 197 (5.22), 208 (3.31), 215 (4.53), 289 (5.33),
317 (5.71), 369 (5.25), 399 (4.98), 413 (5.39), 439 (5.55) and 473
(5.70). At 6 weeks of age, ions of m/z 219 (4.25), 125 (3.53),168
(2.76), 265 (5.21), 373 (5.15), 203 (4.98), 218 (3.91) and 301
(2.79). Proposed atomic compositions for a number of these
ions are shown in Table 2, however metabolite identifications
have not been possible, despite searches of available databases
using accurate masses and atomic compositions. Ions that
increased over time included 294 (0.49), 175 (1.86) and 167
(0.79). The postulated atomic compositions for two of these
metabolites are C6H7O6 (m/z 175.0272) and C5H4N4O3 (m/z
167.0248) which correspond to ascorbic acid and urate
Fig. 5 HPLC-MS, positive ion mode: 2-dimensional mass chromato-
gram (m/z 50–600; 1.0–8.0 min) obtained from HPLC-MS analysis
of urine samples collected from (A) a 4 week old rat and (B) a 20 week
old rat.
Fig. 6 HPLC-MS, positive ion mode, and PLS-DA: scores plots (t(1) versus t(2) versus t(3)) obtained from positive ion HPLC-MS
analysis of individual urine samples collected from (A) male AP rats between 4 and 20 weeks old and from (B) male AP rats between 10 and
20 weeks old.
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respectively. However, as was the case with many of the ions
detected by HPLC with positive ESI-MS the identity of many
of these compounds is as yet undetermined and work to
characterise these structures is on going.
Age prediction by PLS was also performed on the negative
ESI HPLC-MS data with the results shown in Fig. 11. Once
again an age-related progression can be observed over the 6 to
12 week period.
Discussion
Both high resolution 1H NMR spectroscopy and HPLC-ESI-
MS, in positive and negative ionisation mode were able to
detect clear, age-related, changes in urinary composition.
These changes were initially rapid, but by ca. 12–16 weeks
(depending upon the analytical technique employed) the
composition of the urine stabilised and was more constant,
providing relatively stable profiles. The largest differences
between samples, detected by both NMR spectroscopy and
HPLC-MS techniques, were seen for the early samples (4
and 6 weeks) perhaps reflecting changes corresponding to a
changeover of the animals from weaning to weaned. Indeed,
the changes in urinary metabolite profiles that were observed
in this study no doubt reflect a large number of processes that
will have been taking place during the development of these
animals. Previous studies with NMR spectroscopy have
Table 1 HPLC-MS positive ion mode: ions that change in positive ion mode and some suggested atomic compositions and proposed metabolite
identities
Trend RT/min m/z Postulated atomic composition (accurate mass) Suggested metabolite identity
Increasing at 4 weeks 3.0 181.0874 C10H13O3 (181.0865) —
Increasing at 4 weeks 5.4 229.1469 C12H21O4 (229.1440) —
Increasing at 4 weeks 4.4 199.0988 C10H15O4 (199.0970) —
Increasing at 4 weeks 5.7 237.1524 C11H25O3S (237.1524) —
C14H21O3 (237.1491) —
Increasing at 4 weeks 4.1 285.1296 C11H26O4PS (285.1289) —
C10H17N6O4 (285.0311) —
Increasing at 4 weeks 5.4 248.1721 C11H24N2O4
Increasing at 4 weeks 4.4 239.0946 CPH1PO5S (239.0953) —
C12H15O5 (239.0919) —
Increasing at 4 weeks 5.7 299.1296 C18H19O4 (299.1283) Enterolactone
Increasing at 6 and 8 weeks 2.7 127.0384 C6H7O3 (127.0395) —
Increasing with age 0.6 136.04977 C3H8N2O4 (136.0484) —
Increasing with age 0.6 162.1111 C7H16NO30 (162.1130) Carnitine
Fig. 7 HPLC-MS, positive ion—metabolic alterations: (A–C) normalised peak intensities obtained for specific m/z values obtained from positive
ion HPLC-MS analysis of urine samples collected from male AP rats between 4 and 20 weeks old. Data expressed as mean¡ standard deviation.
The ion m/z 162.1111 represents carnitine.
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demonstrated a dependence of the excretion profile in the
aromatic region of the spectrum on the gut microflora. In
particular, it has been demonstrated that the excretion of
hippurate and m-hydroxyphenylpropionic acid (m-HPPA) can
alter according to diet and environment.12,33–35 Rats that are
void of gut microflora, either due to the use of antibiotics, or
establishment of germ-free strains, take about three to four
weeks to establish a stable urinary aromatic profile.35,36 The
proposed excretion of large amounts of phenolic acid-derived
components in the urine at 4 weeks by HPLC-MS, coupled
with the instability observed in hippurate excretion (by NMR),
suggest that at this age the gut microflora are rapidly altering
in the young rat. These animals were weaned at three weeks of
age, thus it is probable that the observed changes reflect, at
least in part, the maturation of the gut microflora as it adapts
to an adult diet. So, in addition to the maturation of the gut
microflora reflected in the changes in the profile of aromatic
components such as hippurate there will also have been the
development of the urine concentrating ability by the kidney
with its associated age-related changes in renal function.31,32
Clearly changes in kidney function can be expected to be
reflected in urinary composition. Newborn rats are not capable
of producing concentrated urine which is consistent with the
expression of transporter proteins that mediate urea transport
in the kidney increasing during postnatal development.31
Furthermore, it has been demonstrated that the water channel
aquaporin-2 is expressed at low levels in the kidney during
early postnatal life, reaching maximal expression at 10 weeks
of age associated with a concurrent increase in urine
osmolality32 suggesting a role in urine concentrating abilities.
The urinary concentrations of the renal enzyme, b-N-
acetylglucosaminidase (NAG), in rat urine increase signifi-
cantly in adult rats (3–6 months) compared to young rats
(1 month old), whilst from 3 months of age, increases in urinary
protein and creatinine have been reported demonstrating
changes in renal function with age.36 Much evidence exists
for age-related changes in creatinine excretion in humans, with
increases being observed in children as they progress to
adulthood34 with concentrations declining later in life37,38
correlating with changes in muscle mass and nutritional status.
Hence the changes observed regarding the excretion of creatine
in this study, and previously by Bell et al.,27 using 1H NMR
spectroscopy probably reflect the growth of the animals. Other
developmental events that will have been taking place will have
included changes in xenobiotic metabolising capabilities,
reflected in differing susceptibilities to toxins. In the liver
there will also have been age-related metabolism differences
for metabolites such as free fatty acids; changes in taurine and
creatinine etc. Sexual maturation will also, no doubt, have
made a contribution to the changes in these profiles.
In addition to the potential for using these techniques as a
means of studying aging in rodents these data highlight the
great care that must be taken when performing metabonomic
studies in animals for e.g., toxicologlogical or pharmacologoi-
cal purposes. Thus, in toxicological studies in the rat an
increase in the urinary excretion of taurine has been associated
Fig. 8 HPLC-MS, positive ion mode, and PLS regression: cross
validated age predictions by a PLS model with three components. Data
expressed as mean ¡ standard deviation.
Fig. 9 HPLC-MS, negative ion mode: 2-dimensional mass chroma-
togram (m/z 50–600; 1.0–8.0 min) obtained from HPLC-MS analysis
of urine samples collected from (A) a 4 week old rat and (B) a 20 week
old rat.
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with liver injury, e.g., following exposure to chemicals such as
hydrazine and carbon tetrachloride.39,40 Often preliminary
toxicology studies are performed in animals of 8 to10 weeks
in age and reproductive toxicity studies may also start in
relatively young anuimals. The pronounced increase in taurine
excretion observed here must therefore be taken into account
when using this metabolite as a marker and the importance
of ensuring adequate control animal data cannot be over-
emphasised. Clearly pre-dose samples for each animal will not
provide suitable controls for a long term/chronic study, or
indeed even for a 1–2 week study if undertaken in the first 4 to
16 weeks of life.
Conclusions
Both of the analytical technologies were capable of detecting
age-related differences in the urinary metabolic profile of rats
with the changes being most pronounced in the younger
animals (ca. 4–16 weeks). As a result of the maturity of 1H
NMR spectroscopy as a technique for metabonomic research
many of the metabolites responsible for the age-related urinary
metabolite profiles could be identified. However, in the case of
HPLC-MS, whilst the detection of biomarkers was facile, the
process of identification currently remains much more
demanding, due in part to the limited databases available.
Significant effort must be directed towards defining the urinary
MS-detected metabonome if HPLC-MS-based approaches are
to fulfil their potential.
As well as demonstrating the potential of these techniques
for studying aging and development the significant changes in
profile over 2 week periods highlights the importance of
Fig. 10 HPLC-MS, negative ion mode, and PLS-DA: scores plots (t(1) versus t(2) versus t(3)) obtained from negative ion HPLC-MS analysis of
individual urine samples collected from (A) male AP rats between 4 and 20 weeks old (B) male AP rats between 10 and 20 weeks old.
Table 2 HPLC-MS negative ion mode: ions that decrease in negative
ion mode from 4 weeks of age onwards and some suggested atomic
compositions
m/z (RT/min) Proposed atomic composition (ppm error)
125.0265 (3.53) C3H9O3S (5.60)
168.0327 (2.76) C4H10NO4S (2.38)
197.0870 (5.22) C7H17O4S (11.16)
C4H13N4O5 (8.12)
289.1680 (5.33) C14H25O6 (10.02)
C15H21N4O2 (5.19)
317.2009 (5.71) C19H27NO3 (5.04)
369.1226 (5.25) C18H25O4S2 (8.67)
C18H17N4O5 (7.31)
Fig. 11 HPLC-MS, negative ion mode, and PLS regression: cross
validated age predictions by a PLS model with three components. Data
expressed as mean ¡ standard deviation.
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ensuring that suitable age matched controls are employed for
metabonomic studies in e.g., toxicology and pharmacology.
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